
<html lang="en"     class="pb-page"  data-request-id="af33b6c8-6144-48bb-b889-80771030a5e0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.5b01960;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-16;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?" /></meta><meta name="dc.Creator" content="Matthew G.  Bursavich" /></meta><meta name="dc.Creator" content="Bryce A.  Harrison" /></meta><meta name="dc.Creator" content="Jean-François  Blain" /></meta><meta name="dc.Description" content="The rapidly aging population desperately requires new therapies for Alzheimer’s disease. Despite years of pharmaceutical research, limited clinical success has been realized, with several failed di..." /></meta><meta name="Description" content="The rapidly aging population desperately requires new therapies for Alzheimer’s disease. Despite years of pharmaceutical research, limited clinical success has been realized, with several failed di..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 5, 2016" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01960" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01960" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01960" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01960" /></link>
        
    
    

<title>Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon? | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01960" /></meta><meta property="og:title" content="Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0001.jpeg" /></meta><meta property="og:description" content="The rapidly aging population desperately requires new therapies for Alzheimer’s disease. Despite years of pharmaceutical research, limited clinical success has been realized, with several failed disease modification therapies in recent years. On the basis of compelling genetic evidence, the pharmaceutical industry has put a large emphasis on brain beta amyloid (Aβ) either through its removal via antibodies or by targeting the proteases responsible for its production. In this Perspective, we focus on the development of small molecules that improve the activity of one such protease, gamma secretase, through an allosteric binding site to preferentially increase the concentration of the shorter non-amyloidogenic Aβ species. After a few early failures due to poor drug-like properties, the industry is now on the cusp of delivering gamma secretase modulators for clinical proof-of-mechanism studies that combine potency and efficacy with improved drug-like properties such as lower cLogP, high central nervous system multiparameter optimization scores, and high sp3 character." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01960"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01960">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01960&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01960&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01960&amp;href=/doi/10.1021/acs.jmedchem.5b01960" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 7389-7409</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01380" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.5b01690" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+G.++Bursavich">Matthew G. Bursavich</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryce+A.++Harrison">Bryce A. Harrison</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Fran%C3%A7ois++Blain">Jean-François Blain</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">FORUM Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#2f424e5b5b014d5a5d5c4e59464c476f42405d5f47464c5d404c44014c4042"><span class="__cf_email__" data-cfemail="0c616d7878226e797e7f6d7a656f644c61637e7c64656f7e636f67226f6361">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01960&amp;href=/doi/10.1021%2Facs.jmedchem.5b01960" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 7389–7409</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 23, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 December 2015</li><li><span class="item_label"><b>Published</b> online</span>5 April 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 August 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01960" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01960</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7389%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMatthew%2BG.%2BBursavich%252C%2BBryce%2BA.%2BHarrison%252C%2BJean-Fran%25C3%25A7ois%2BBlain%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D16%26contentID%3Dacs.jmedchem.5b01960%26title%3DGamma%2BSecretase%2BModulators%253A%2BNew%2BAlzheimer%25E2%2580%2599s%2BDrugs%2Bon%2Bthe%2BHorizon%253F%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7409%26publicationDate%3DAugust%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01960"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3597</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">82</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01960" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;G. Bursavich&quot;},{&quot;first_name&quot;:&quot;Bryce&quot;,&quot;last_name&quot;:&quot;A. Harrison&quot;},{&quot;first_name&quot;:&quot;Jean-François&quot;,&quot;last_name&quot;:&quot;Blain&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7389-7409&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01960&quot;},&quot;abstract&quot;:&quot;The rapidly aging population desperately requires new therapies for Alzheimer’s disease. Despite years of pharmaceutical research, limited clinical success has been realized, with several failed disease modification therapies in recent years. On the basis of compelling genetic evidence, the pharmaceutical industry has put a large emphasis on brain beta amyloid (Aβ) either through its removal via antibodies or by targeting the proteases responsible for its production. In this Perspective, we focus on the development of small molecules that improve the activity of one such protease, gamma secretase, through an allosteric binding site to preferentially increase the concentration of the shorter non-amyloidogenic Aβ species. After a few early failures due to poor drug-like properties, the industry is now on the cusp of delivering gamma secretase modulators for clinical proof-of-mechanism studies that combine potency and efficacy with improved drug-like properties such as lower cLogP, high central nervous system mu&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01960&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01960" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01960&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01960" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01960&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01960" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01960&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01960&amp;href=/doi/10.1021/acs.jmedchem.5b01960" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01960" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01960" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01960%26sid%3Dliteratum%253Aachs%26pmid%3D27007185%26genre%3Darticle%26aulast%3DBursavich%26date%3D2016%26atitle%3DGamma%2BSecretase%2BModulators%253A%2BNew%2BAlzheimer%25E2%2580%2599s%2BDrugs%2Bon%2Bthe%2BHorizon%253F%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D16%26spage%3D7389%26epage%3D7409%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292588" title="Partition coefficient">Partition coefficient</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/jmcmar.2016.59.issue-16/20160825/jmcmar.2016.59.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The rapidly aging population desperately requires new therapies for Alzheimer’s disease. Despite years of pharmaceutical research, limited clinical success has been realized, with several failed disease modification therapies in recent years. On the basis of compelling genetic evidence, the pharmaceutical industry has put a large emphasis on brain beta amyloid (Aβ) either through its removal via antibodies or by targeting the proteases responsible for its production. In this Perspective, we focus on the development of small molecules that improve the activity of one such protease, gamma secretase, through an allosteric binding site to preferentially increase the concentration of the shorter non-amyloidogenic Aβ species. After a few early failures due to poor drug-like properties, the industry is now on the cusp of delivering gamma secretase modulators for clinical proof-of-mechanism studies that combine potency and efficacy with improved drug-like properties such as lower cLogP, high central nervous system multiparameter optimization scores, and high sp<sup>3</sup> character.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is thought to affect about 5.3 million people in the United States and is currently ranked as the sixth leading cause of death. Costs of care for these patients are estimated at $226 billion and are expected to rise to as much as $1.1 trillion by 2050.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These figures clearly highlight the urgent need for therapies that will affect the course of the disease to prevent, or at least delay, the onset of cognitive decline.</div><div class="NLM_p">The two classes of drugs approved for AD treatment aim to alleviate the symptoms of the disease by modulating the action of neurotransmitters, either acetylcholine or glutamate. Standard-of-care therapy consists of an acetylcholinesterase inhibitor (donepezil, rivastigmine, or galantamine) and/or a partial <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid (NMDA) receptor antagonist (memantine). Unfortunately, these symptomatic treatments do not show long-term efficacy, nor do they change the course of disease progression. Despite decades of research and many failed clinical trials, the field has made very little progress in terms of therapeutic approaches.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">The two characteristic neuropathological markers of AD are amyloid plaques, composed mainly of beta amyloid (Aβ) peptides, and neurofibrillary tangles, composed of hyperphosphorylated tau. The Aβ peptides that form the core of the amyloid plaques are produced by sequential proteolytic cleavage of amyloid precursor protein (APP) by beta amyloid cleavage enzyme 1 (BACE1) and gamma secretase (GS). The discovery that mutations in APP cause familial Alzheimer’s disease (FAD)<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> led to the formulation of the amyloid hypothesis of AD.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> Originally, this hypothesis stated that amyloid deposits in the brain are the primary cause of the disease and that through a gain of toxic function they instigate a cascade of events that drive the pathology. The hypothesis has been further refined over many years, and it is now believed that a form of soluble Aβ rather than the Aβ aggregates found in plaques is responsible for the neurotoxicity.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, the precise identity of the toxic form of Aβ and its kinetic dynamics with other Aβ forms are still not clear. Importantly, additional support for the amyloid hypothesis comes from a recently reported APP mutation in an Icelandic population that provides a protective effect against AD by potentially reducing Aβ production by ∼20%.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, it is still unclear whether Aβ drives the disease pathophysiology, an Aβ threshold mediates the toxicity, or Aβ is merely a trigger for downstream events.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">The processing of APP follows this sequence: first, BACE1 cleaves APP to generate a 99 amino acid fragment (C99) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a), which then undergoes a series of cleavage events by GS to produce Aβ peptides of different lengths (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>b), of which Aβ38, -40, and -42 are the most abundant in the cerebrospinal fluid (CSF).<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> The longer peptides, particularly Aβ42, have been shown to be the most prone to aggregation, with an increased Aβ42:Aβ40 ratio observed in the familial form of the disease.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In 1999, the protein responsible for the proteolytic activity of GS, presenilin (PS), was formally identified.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Interestingly, mutations in both genes for PS-1 and PS-2 had been discovered in FAD populations and suggested to be causative of the disease,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> further supporting the amyloid hypothesis.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Processing of APP. (a) In step 1, APP is processed by BACE1, which releases the soluble APPβ, leaving C99 (Aβ plus AICD) in the membrane. (b) In step 2, GS releases AICD by cleaving C99 at the ε cleavage site (endopeptidase activity). This is followed by ζ and γ cleavages (carboxypeptidase activities), which further process the Aβ substrate into peptides of different lengths (see <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> for details).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Not surprisingly, the pharmaceutical industry became interested in developing drugs to prevent the production of toxic Aβ peptides in the hopes of reducing amyloid plaque buildup, thereby delaying the progression of AD symptoms. Therefore, considerable work has been performed to develop BACE inhibitors and gamma secretase inhibitors (GSIs). Several BACE inhibitors are presently under evaluation in the clinic and have been reviewed elsewhere.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17-20)</a> GSIs have been abandoned as a treatment for AD because of mechanism-based toxicities (weight loss, skin cancers, infections, etc.), as exemplified in a phase 3 clinical trial with semagacestat.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> These toxicities are believed to arise from inhibition of the processing of other GS substrates such as Notch.</div><div class="NLM_p last">The finding in 2001 by Weggen et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> that certain compounds could modify the activity of GS to produce less Aβ42 without affecting the total amount of Aβ produced or the processing of other GS substrates offered an additional therapeutic approach. These compounds, termed gamma secretase modulators (GSMs), were hypothesized to provide a safer alternative to GSIs for the reduction of toxic Aβ42 in the treatment of AD. In this Perspective, we focus on the evolution of GSMs and the potential path for their improvement and development.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Gamma Secretase: An Unusual Protease</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71830" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71830" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Gamma secretase, an aspartyl protease, is a member of the intramembrane cleaving protease family (I-CLiPs), which also includes signal peptide peptidases, rhomboid proteases, and site-2 peptidases. These enzymes have their active site within the lipid bilayer of cellular membranes and cleave their substrates through regulated intramembrane proteolysis (RIP). Gamma secretase itself is a complex composed of four different proteins, presenilin (PS), nicastrin (Nct), anterior pharynx-defective 1 (Aph-1) and presenilin enhancer 2 (Pen-2), which are present in a 1:1:1:1 stoichiometry.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">In humans, PS is encoded by either the PSEN1 gene on chromosome 14 or the PSEN2 gene on chromosome 1, and mutations in both genes have been found to cause FAD.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Today, more than 180 mutations in PSEN1 have been reported, making it the most common cause of early-onset FAD.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The products of these genes, namely, PS-1 and PS-2, are nine transmembrane domain (TMD) proteins that form the catalytic subunit of GS. PS undergoes endoproteolysis in an intracellular loop between TMD6 and TMD7 to produce the fragments that constitute its active form.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The two aspartic acids forming the catalytic site are located in TMD6 and TMD7, and mutation of either one of these aspartic acids renders GS inactive.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> As for the other components of the GS complex, it has been suggested that Nct is involved in maturation of the complex<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and binding of the substrate,<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> Aph-1 is involved in the assembly and activity of the complex,<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> and Pen-2 appears to be important for activity,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> complex stability, and trafficking.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Most importantly, the four components need to be expressed together for maximal GS activity.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The atomic structure of human GS has recently been solved at 3.4 Å resolution via single-particle cryogenic electron microscopy.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> While this new three-dimensional structure does not include a GSI or GSM, it provides a more thorough understanding of this enzyme on a molecular basis.</div><div class="NLM_p">GS cleaves type-I transmembrane proteins, with over 90 reported substrates,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> earning it the nickname “proteasome of the membrane”.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> APP and Notch are the best characterized of these substrates. GS cleavage of APP is unusual in that the cleavage site is loosely defined. Additionally, GS harbors both endopeptidase and carboxypeptidase activities,<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> which allow the generation of Aβ peptides of different lengths. After APP is cleaved by BACE (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a), GS catalyzes a series of cleavages within the transmembrane domain of the remaining fragment (C99), termed epsilon (ε), zeta (ζ), and gamma (γ) cleavages (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>b). The ε cleavage releases the APP intracellular domain (AICD) and produces Aβ49 or Aβ48.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Then, in a stepwise manner, the carboxypeptidase cleavages ζ and γ take place to generate both Aβ40 and Aβ42.<a onclick="showRef(event, 'ref40 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref42">(40, 42)</a> In a series of elegant studies, Ihara and colleagues elucidated two major lines of Aβ production: ε cleavage between Leu49 and Val50 of C99 preferentially produces Aβ40, and cleavage between Thr48 and Leu49 preferentially produces Aβ42.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> They also showed that the successive cleavage events occur every three to four amino acids, consistent with the α-helical structure of the transmembrane domain of APP (3.6 amino acids/turn).<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> More recently, the tri- and tetrapeptide model has been refined to include other cleavage events that happen to a lesser extent, including those forming shorter Aβ peptides.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> These results suggest that GS performs four cycles to generate Aβ40 (49 → 46 → 43 → 40) and three cycles to generate Aβ42 (48 → 45 → 42) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a). Many FAD-causing mutations in PS have been found to decrease the catalytic activity of GS,<a onclick="showRef(event, 'ref39 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref39 ref48 ref49">(39, 48, 49)</a> with the most pronounced effect on the fourth cleavage cycle (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b).<a onclick="showRef(event, 'ref39 ref50'); return false;" href="javascript:void(0);" class="ref ref39 ref50">(39, 50)</a> This loss of function contributes to the increased Aβ42:Aβ40 ratio observed in the familial form of the disease.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Stepwise cleavage model for Aβ generation and potential effect of PS FAD mutations and GSMs. (a) In a normal situation, C99 is sequentially cleaved by GS ε, ζ, and γ cleavages. The first cleavage cycle (ε) between amino acids 50 and 49 or 49 and 48 determines the Aβ peptide production line (49 → 46 → 43 → 40 or 48 → 45 → 42). (b) Many PS mutations affect the fourth cleavage cycle of the complex, leading to the increased Aβ42:Aβ40 ratio observed in FAD. (c) GSMs increase the processivity of the complex, leading to increased production of the shorter, non-amyloidogenic peptides Aβ37 and Aβ38. The thickness of the arrows depicts the cleavage efficiency.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Pharmacological Targeting of Gamma Secretase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As mentioned earlier, the pharmaceutical industry became interested in targeting GS because of the genetic evidence suggesting a role for Aβ in the pathophysiology of AD. Two key GSIs, semagacestat and avagacesat (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), have been tested in late-stage clinical trials for AD.<a onclick="showRef(event, 'ref21 ref52'); return false;" href="javascript:void(0);" class="ref ref21 ref52">(21, 52)</a> In view of the large number of substrates cleaved by GS, it is not surprising that many side effects were observed following treatment with these GSIs. One of the main culprits thought to be responsible for the majority of side effects is Notch. Indeed, Notch is processed in a similar way as APP, where the ε cleavage event releases the Notch intracellular domain (NICD), which then translocates to the nucleus to regulate gene expression and mediates important intercellular communication functions such as cellular differentiation.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> By blocking the ε cleavage step, GSIs impair Notch signaling, which likely leads to several adverse events such as skin cancer and/or decreased lymphocyte counts, both of which were observed in the semagacestat phase 3 trial.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In that trial, semagacestat was also reported to worsen memory, and in addition to inhibition of Notch processing, it is possible that the accumulation of C99 in the membrane<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> or the inhibition of EphA4 processing<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> may have contributed to this effect. Alternatively, on the basis of its pharmacokinetic (PK) profile, the concentration-dependent change in Aβ produced by semagacestat<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> might have been responsible for the apparent increase in the Aβ42:Aβ40 ratio observed in the study,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> which could have also precipitated the memory decline.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> While avagacestat claims a reported window of 137–193-fold selectivity for APP processing over Notch,<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> it demonstrated a side-effect profile similar to that of semagacestat in the clinic.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> This result could be explained by an overestimation of the apparent selectivity between Notch and APP due to the use of different assays (reporter assay for Notch and Aβ production for APP) to measure compound potency. In fact, measurement of ε and γ cleavages in a single assay revealed the selectivity window to be no more than 3-fold.<a onclick="showRef(event, 'ref39 ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref39 ref59 ref60">(39, 59, 60)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. GSIs: semagacestat and avagacestat.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another way of targeting GS was discovered in 2001, when it was reported that a subset of nonsteroidal anti-inflammatory drugs (NSAIDs) could specifically lower Aβ42 and increase Aβ38 by a mechanism independent of cyclooxygenase inhibition.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Sulindac sulfide, indomethacin, ibuprofen, and flurbiprofen (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) were all shown to mediate this effect at extremely high concentrations (25–300 μM). Modulation of GS in this manner was especially promising since Aβ42 is considered to be the most aggregation-prone and thus the most toxic Aβ peptide. Changing the ratio of longer Aβ peptides to shorter ones has since been shown to prevent the aggregation of Aβ42 in vitro<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and plaque formation in vivo.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Early NSAID GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of this idea, NSAID derivatives with increased potency toward GS compared with the original NSAIDs were quickly developed.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63, 64)</a> However, these molecules possessed poor drug-like properties, requiring very high doses to achieve the appropriate unbound drug concentration at the target in the central nervous system (CNS). Proof-of-mechanism (POM) studies in humans with these NSAID derivatives have been further complicated by the dose-limiting toxicity of the molecules. Non-NSAID GSMs were later discovered and found to have a slightly different mechanism of action than the NSAID-like molecules. In addition to lowering Aβ42 and increasing Aβ38, these second-generation compounds also increase Aβ37 and decrease Aβ40, albeit with lower potency.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><div class="NLM_p">Many groups have investigated the mechanism by which GSMs exert their effect. Beher et al.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> were the first to report that NSAID-based GSMs are noncompetitive inhibitors of Aβ42 production and noncompetitive antagonists of transition-state GSIs. This suggested the presence of an allosteric binding site that, when occupied, could change the conformation of the enzyme with specific effects on Aβ42 production. Recently, a more definitive binding site for GSMs has been uncovered via molecular photoprobes. Multiple groups have demonstrated that GSMs interact with the N-terminal fragment of presenilin (PS-NTF).<a onclick="showRef(event, 'ref67 ref68 ref69 ref70 ref71 ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref67 ref68 ref69 ref70 ref71 ref72 ref73">(67-73)</a> However, different scaffolds appear to bind in different locations, as imidazole-based GSMs have limited ability to displace NSAID GSMs and vice versa.<a onclick="showRef(event, 'ref69 ref72'); return false;" href="javascript:void(0);" class="ref ref69 ref72">(69, 72)</a> Indeed, it has been proposed that a photoprobe based on NSAID GSM-1 binds within TMD1 of PS<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> while an arylimidazole GSM photoprobe based on ST1120 GSMs binds in the extracellular pocket formed by hydrophilic loop 1 (HL1)/TMD2/TMD5.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Interestingly, occupation of the binding site appears to change the active-site conformation in such a way that the Aβ generation pattern is modified to increase the shorter peptides and decrease the longer ones.</div><div class="NLM_p">This change in the cleavage pattern could be explained by two possible mechanisms: a decrease in the probability of releasing longer Aβ from the enzyme–substrate complex, as defined by the dissociation constant (<i>k</i><sub>b</sub>) of GS, or an increase in the processive cleavage activity, as defined by the catalytic constant (<i>k</i><sub>cat</sub>) of GS. As discussed earlier, GS harbors both endo- and carboxypeptidase activities and performs multiple cleavage cycles to generate its products. Chavez-Gutierrez et al.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> showed that the <i>k</i><sub>cat</sub> of the ε cleavage event was not affected by GSMs but was reduced by certain FAD-causing PS mutations. By using C99 as a substrate, they also demonstrated that the Aβ40:Aβ43 and Aβ38:Aβ42 ratios were decreased by all of the mutations studied, suggesting an impairment of the fourth cleavage cycle of GS (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b). Moreover, GSMs mostly increased the ratio of Aβ38 to Aβ42, again suggesting an effect on the fourth cleavage step. By using Aβ42 as a substrate, Okochi et al.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> measured the kinetic constants for the γ cleavage and reported that GSMs increased <i>k</i><sub>cat</sub> and decreased <i>k</i><sub>b</sub> whereas FAD-causing PS mutations had the opposite effect (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c). Taken together, this evidence suggests that GSMs could reverse the effect of PS mutations to restore the normal balance of GS activity to treat the underlying disease pathology.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">While their development has been challenging, the literature now contains many examples of very potent GSMs targeting this unique intramembrane cleaving protease. Unfortunately, these highly potent compounds also typically possess poor drug-like properties, borne out in their high aromatic ring count or low fraction sp<sup>3</sup> character (Fsp<sup>3</sup>) values,<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> high molecular weight (MW), high lipophilicity (cLogP), and low multiparameter optimization (MPO) scores.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The CNS MPO score,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> which relies upon several commonly used physicochemical properties, has been proposed by Pfizer researchers as a method to identify compounds with increased probability of success. A CNS MPO value is given for the alignment of six key physicochemical parameters: the calculated octanol–water partition coefficient (cLogP), the calculated distribution coefficient at pH 7.4 (cLogD), the molecular weight, the topological polar surface area, the number of hydrogen-bond donors, and the p<i>K</i><sub>a</sub> of the most basic center. Each parameter provides a value between 0 and 1 to afford a possible summary score of 6, with 74% of marketed CNS drugs possessing an MPO score ≥4. An increase in the CNS MPO score also appears to be correlated with an improvement in a number of other in vitro properties (permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety).</div><div class="NLM_p last">Historical GSMs have been extensively reviewed elsewhere, and thus, we will particularly focus on compounds disclosed since 2011.<a onclick="showRef(event, 'ref63 ref77'); return false;" href="javascript:void(0);" class="ref ref63 ref77">(63, 77)</a> There are many hurdles remaining in this field to deliver safe, efficacious GSMs, and it appears that several research groups have subsequently moved on from pursuing GSMs in favor of more traditional targets. However, we believe that endeavoring to persevere in the development of potent and efficacious GSMs that possess good drug-like properties will soon enable POM studies in human clinical trials.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Carboxylic Acid GSMs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first-generation GSMs based on NSAID derivatives have been extensively reviewed.<a onclick="showRef(event, 'ref63 ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref63 ref78 ref79">(63, 78, 79)</a> A couple of novel carboxylic acids, CHF5074<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> and EVP-0015962<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), have been investigated in clinical trials. CHF5074 failed to demonstrate efficacy because of limited potency (EC<sub>50</sub> = 40 μM), poor drug-like properties, and extremely poor CNS penetration (brain to plasma ratio (B:P) = 0.03–0.05).<a onclick="showRef(event, 'ref80 ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref80 ref82 ref83">(80, 82, 83)</a> This compound required very high doses to achieve the necessary efficacious unbound drug concentration in the CNS, which was complicated by dose-limiting toxicity. Detailed results from the EVP-0015962 trial have yet to be reported. While it showed improved in vitro potency with reproducible animal efficacy, it suffers from the same poor drug-like properties as other NSAID-like GSMs.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0007.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. NSAID-based GSMs investigated in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Alkenyl GSMs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Recent non-carboxylic acid GSMs have been inspired by the work of the Eisai group and their discovery of very important GSMs in 2005 (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> These compounds possess the key arylimidazole group now found in nearly all GSMs. Here the arylimidazole is linked via an olefin to a lactam (compound <b>1</b>, E2012)<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> or a heterocycle (compound <b>2</b>, E2212; structure not disclosed) possessing a key hydrogen-bond acceptor. Compound <b>1</b> was shown to be a potent early GSM (EC<sub>50</sub> = 83 nM) and was the first non-carboxylic acid GSM to enter clinical trials in 2006. Compound <b>1</b> demonstrated lenticular opacity in a 13 week rat safety study, which caused concerns for this class of GSMs. Eisai recently established that <b>1</b> inhibits 24-dehydrocholesterol reductase, leading to increased desmosterol and decreased cholesterol in the lens.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> These sustained and prolonged sterol changes produce cataracts and can be monitored by preceding changes in the plasma. Follow-up studies up to the highest dose tolerated in monkeys for 13 weeks did not show ocular toxicity, as the elevation of desmosterol in the plasma was very mild. While the phase 1 studies with <b>1</b> demonstrated dose-dependent plasma reductions of Aβ40/42,<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Eisai decided to develop their improved compound <b>2</b> instead. In a phase 1 clinical trial, <b>2</b> was demonstrated to be safe and well-tolerated at single oral doses from 10 to 250 mg, the maximum dose studied.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> The pharmacodynamic response measured in plasma increased with the dose and was shown to be 54% Aβ42 reduction (area under the curve for 0–24 h (AUC<sub>0–24h</sub>) of 44%) at the 250 mg dose. While the structure of E2212 has never been disclosed, it has been speculated<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> to be compound <b>2</b> on the basis of several Eisai process chemistry patents.<a onclick="showRef(event, 'ref90 ref91 ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref90 ref91 ref92 ref93">(90-93)</a> This very potent compound (EC<sub>50</sub> = 17 nM) still possesses a centralized double bond, four aromatic rings, high MW (480), high cLogP (5.5), and a low MPO score (3.1). No further development of <b>2</b> has been reported to date, and there is much need to optimize the drug-like properties after this initial effort to develop non-carboxylic acid GSMs.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0008.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Eisai GSMs investigated in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Schering-Plough group described a series of oxadiazolines based on the structure of compound <b>1</b>.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> A conformational constraint was engineered between the amide carbonyl and the α-methyl carbon via a cyclized hydroxyamidine (oxadiazoline), which maintains the potential hydrogen-bond acceptor of the amide. Rewardingly, compound <b>3</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) had good potency in cells (EC<sub>50</sub> = 58 nM). Oral dosing in rats at 3 and 10 mg/kg resulted in total brain exposures of 0.8 and 5 μM at 3 h post dose and demonstrated CSF Aβ42 reductions of 30% and 51%, respectively. Compound <b>3</b> demonstrated good absorption, distribution, metabolism, and elimination (ADME) properties, including no cytochrome P450 (CYP) inhibition (3A4, 2D6, and 2C9), but a high cLogP (5.2) and moderate hERG inhibition (hERG IC<sub>50</sub> = 740 nM in a voltage clamp cellular assay) led to considerable analogue design. One of the more interesting and well-characterized analogues was compound <b>4</b>. Introduction of a hydroxyl group improves the potency (EC<sub>50</sub> = 29 nM) with a lower cLogP (4.4 vs 5.2) and also improves the potential hERG issue (hERG IC<sub>50</sub> = 3.3 μM in a voltage clamp cellular assay). Dosing rats with compound <b>4</b> at 10 mg/kg p.o. resulted in a total brain exposure of 0.54 μM at 3 h post dose and demonstrated Aβ42 reductions of 66% and 37% in the CSF and cortex, respectively. While this compound demonstrated both good potency and efficacy, it suffers from poor CNS drug-like properties, as measured by a cLogP of 4.4 and an MPO score of 3.3.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0009.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Schering-Plough oxadiazoline GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ring expansion of the oxadiazolines by the Schering group led to the discovery of the oxadiazine scaffold.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94, 95)</a> A trifluorophenyl group was substituted at either C3 or C4 of the fused oxadiazine to afford potent compounds with unfortunately high cLogPs (4.6) and low MPO scores (3.4). Substitution at C3 afforded compound <b>5</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>), which demonstrated good in vitro potency (EC<sub>50</sub> = 48 nM). Dosing rats at 10 mg/kg p.o. resulted in a CSF Aβ42 reduction of 45% at 3 h post dose. While the unbound brain concentration at 3 h was not reported, PK assessment in rats demonstrated sustained exposures, with 4 μM observed in the brain at 6 h. Compound <b>5</b> did not demonstrate a CYP liability, but a potential hERG issue was identified (83% hERG inhibition in a functional assay at 10 μM). Substitution at C4 afforded compound <b>6</b>, which also demonstrated good in vitro potency (EC<sub>50</sub> = 33 nM). Dosing rats with compound <b>6</b> at 10 mg/kg p.o. resulted in a robust CSF Aβ42 reduction of 62% at 3 h post dose. Again, the unbound brain concentration at 3 h was not reported, but PK assessment in rats demonstrated sustained exposures, with 6.2 μM observed in the brain at 6 h. Compound <b>6</b> also did not inhibit CYPs but still showed a potential hERG issue (76% hERG inhibition in a functional assay at 10 μM). Further investigation demonstrated that there was no effect with either compound <b>5</b> or <b>6</b> on QTc intervals in dogs at sufficient exposure multiples over the required exposures for pharmacological effects. Compound <b>6</b> was further profiled in cynomologous monkeys and demonstrated robust Aβ42 reductions of 70% and 44% in the CSF and cortex, respectively, with approximately 8.4 μM in the brain at 4 h following a 30 mg/kg dose. While this compound demonstrated good potency, efficacy, and initial safety relative to both CYPs and hERG, follow up studies have not yet been reported. However, this compound still suffers from poor drug-like properties as measured by a cLogP of 4.6 and an MPO score of 3.4.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0010.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Schering-Plough oxadiazine GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further ring expansion by the Schering group led to the discovery of azepane oxadiazine <b>7</b> (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>), which demonstrated 2–3-fold weaker in vitro potency than the related oxadiazine <b>6</b> (EC<sub>50</sub> = 88 vs 33 nM, respectively) as well as an increased cLogP (5.0) and decreased MPO score (3.1).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Another ring expansion led to the discovery of oxadiazepine <b>8</b>, which demonstrated better in vitro potency (EC<sub>50</sub> = 39 nM) and a slightly better cLogP (4.6) and MPO score (3.3). Dosing rats with compound <b>8</b> at 3, 10, and 30 mg/kg p.o. resulted in dose-dependent reductions of Aβ42 in the CSF by 43%, 61%, and 78% at 3 h post dose. Unfortunately, the unbound brain concentration at 3 h was not reported, but PK assessment in rats demonstrated sustained exposures, with 3.7 μM observed in the brain at 6 h. Compound <b>8</b> also did not inhibit CYPs and demonstrated a reduced potential hERG issue (33% inhibition of hERG in a functional assay at 10 μM). Once again, although this compound demonstrated good potency, efficacy, and safety relative to CYPs and hERG, follow up studies have not yet been reported. Like other analogues in this series, this compound still suffers from poor drug-like properties, as measured by the high cLogP of 4.6 and low MPO score of 3.3.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0011.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Schering-Plough oxadiazine and oxadiazepine GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Anilines</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46382" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46382" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In order to remove the potential liability of the olefin linker in compound <b>1</b>, many groups have replaced the olefin with a nitrogen linker.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> The Janssen group described a series of N-linked bicyclic heterocycles (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>) designed to mimic the structure of <b>1</b>.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Compound <b>9</b> was designed to contain an intramolecular hydrogen bond between the aniline and amide carbonyl along with a steric clash between the carbonyl and the α-methyl carbon to preorganize the molecule into the proposed bioactive conformation. Unfortunately, compound <b>9</b> was determined to have an EC<sub>50</sub> of 550 nM (∼7 times weaker than <b>1</b>) and did not demonstrate any in vivo efficacy at a dose of 30 mg/kg in mice. To further improve these designs, compound <b>10</b> was engineered with a conformational constraint between the same amide carbonyl and the α-methyl carbon. Compound <b>10</b> led to a further reduction in potency (EC<sub>50</sub> = 813 nM) and only a modest Aβ42 reduction of 12% in mouse brain when dosed p.o. at 30 mg/kg. The regioisomeric compound <b>11</b> was ∼5 times more potent (EC<sub>50</sub> = 182 nM) and demonstrated more pronounced Aβ42 reduction (35%) in mouse brain following a 30 mg/kg oral dose. Several analogues related to compound <b>11</b> showed improved potency and demonstrated 30–40% Aβ42 reduction in mouse brain. While compound <b>11</b> possesses a respectable cLogP (3.6) and MPO score (4.1), the in vitro potency and associated brain exposure (total and/or unbound) for this class of compounds are not correlated with the in vivo efficacy. For most of the compounds in this class, <i>f</i><sub>u,brain</sub> was less than 0.1%, and many compounds demonstrated in vivo efficacy at estimated unbound brain concentrations much lower than their respective in vitro Aβ42 EC<sub>50</sub> values. These confounding results, seemingly inconsistent with the free drug principle, have led many research groups to discontinue their GSM programs in favor of more traditional targets. Furthermore, many of the analogues in this class also demonstrated low solubility, CYP inhibition, and potential hERG liabilities. This class of compounds suffers from poor drug-like properties, as measured by the number of aromatic rings, high cLogP, and low MPO score.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0012.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Janssen aniline GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Janssen group investigated compounds with other bicyclic heterocycles in the central core (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). Benzimidazole <b>12</b> led to a further improvement in potency (EC<sub>50</sub> = 17 nM) and demonstrated a robust Aβ42 reduction of 43% in mouse brain when dosed p.o. at 30 mg/kg. Similarly, benzimidazole <b>13</b> demonstrated good potency and efficacy (EC<sub>50</sub> = 43 nM; 45% Aβ42 reduction in mouse brain at 30 mg/kg p.o.). Of note, an analogue of <b>12</b> with the benzimidazole free N–H (compound not shown) was 12-fold less potent (EC<sub>50</sub> = 203 nM). Indazole <b>14</b> with R = H was moderately potent (EC<sub>50</sub> = 131 nM), but compound <b>15</b> with R = Me demonstrated high potency (EC<sub>50</sub> = 18 nM) and a robust Aβ42 reduction of 41% in mouse brain following oral treatment at 30 mg/kg. Unfortunately, the benzoxazoles, which cannot incorporate the added methyl group pushing the aromatic group out of the plane via steric clash, possess only limited potency, as evidenced by compound <b>16</b> (EC<sub>50</sub> = 5.3 μM). Again, many of these analogues also demonstrated low solubility, CYP inhibition, and potential hERG liabilities. This class of compounds also possesses poor drug-like properties, as measured by the number of aromatic rings (Fsp<sup>3</sup> values as low as 0.08), higher cLogPs, and lower MPO scores.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0013.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Other Janssen aniline GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further optimization of the series by the Janssen group, with an effort to improve the drug-like properties by changing the central aromatic ring to a pyridine, afforded the optimized compound <b>17</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>), which maintained high potency (EC<sub>50</sub> = 16 nM) and demonstrated a robust Aβ42 reduction of 62% in mouse brain when dosed p.o. at 30 mg/kg. This compound also showed improved in vitro ADME properties, and only moderate CYP inhibition (low-micromolar for 3A4, 2D6, and 2C19) and minimal hERG channel binding (IC<sub>50</sub> = 8.6 μM) were observed. Compound <b>17</b> was also shown to be highly selective in a CEREP panel and negative in both Ames and GreenScreen genotoxicity assays. Unfortunately, in subsequent studies signs of liver toxicity, which are not uncommon for highly planar, lipophilic compounds,<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> were observed in dogs dosed with <b>17</b> at 20 mg/kg, halting all further development. Again, this compound suffers from poor drug-like properties as measured by the number of aromatic rings (Fsp<sup>3</sup> = 0.13), cLogP (4.3), and MPO score (3.5).</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0014.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Optimized Janssen aniline GSM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Three Boehringer Ingelheim patents describe a series of aniline-linked pyrimidine compounds with fused five- or six-membered rings (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>).<a onclick="showRef(event, 'ref99 ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref99 ref100 ref101">(99-101)</a> Compound <b>18</b> is the most potent of a series of thienopyrimidines and demonstrated a modest EC<sub>50</sub> of only 90 nM in H4 cells. A series of dihydropteridinones, such as compounds <b>19</b> and <b>20</b>, are interesting because of their good predicted physicochemical properties and improved potencies (22 and 46 nM, respectively). While there appears to be an overall improvement in reducing the cLogP and increasing the MPO score for compounds <b>19</b> and <b>20</b>, no ADME or in vivo efficacy data have been provided for these compounds.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0015.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Boehringer Ingelheim pyrimidine GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Three recent FORUM Pharmaceuticals patent applications describe a series of aniline-linked pyrimidomorpholines (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>). In the first application, compound <b>21</b> represents the basic structure and possesses good potency (EC<sub>50</sub> = 39 nM) with a low cLogP (2.7) and good MPO score (4.8).<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Introduction of fluorine atoms on the phenyl ring affords compound <b>22</b> with improved potency (EC<sub>50</sub> = 14 nM), a good cLogP value (3.0), and still a good MPO score (4.5). While other substituents on the aromatic ring maintain or improve the potency, these new analogues also possess higher cLogPs and lower MPO scores. Compound <b>23</b> moves away from the <i>N</i>-aryl group with the introduction of a trifluoroethyl group to nearly double the sp<sup>3</sup> character (Fsp<sup>3</sup> = 0.32 for <b>23</b> vs 0.17 for <b>21</b>). Compound <b>23</b> demonstrates modest potency (EC<sub>50</sub> = 101 nM) with a low cLogP (2.5) and even better MPO score (4.9). While no in vivo efficacy data are reported in this patent application, several potent compounds possessing higher sp<sup>3</sup> character, lower cLogPs, and higher MPO scores have been identified within this scaffold.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0016.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. FORUM N-substituted pyrimidomorpholine GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further expand upon these compounds and increase the sp<sup>3</sup> character, the FORUM group focused on the aniline portion of the scaffold (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Here compound <b>24</b> represents the basic structure and possesses good potency (EC<sub>50</sub> = 25 nM) with a good cLogP (3.3), good MPO score (4.4), and high sp<sup>3</sup> character (Fsp<sup>3</sup> = 0.35). Again, while other substituents on the phenyl ring maintain or improve the potency, those new analogues also possess higher cLogPs and lower MPO scores. Interestingly, compound <b>25</b> utilizes a tetrahydropyran as a nonaromatic replacement in this region of the molecule that maintains a high sp<sup>3</sup> character (Fsp<sup>3</sup> = 0.35). This design motif has not previously been described in this region of a GSM; it results in good potency (EC<sub>50</sub> = 41 nM), but also leads to an increased cLogP (3.9) and decreased MPO score (3.7). Compound <b>26</b> also moves away from the <i>N</i>-aryl group with the introduction of a trifluoroethyl group, which increases the sp<sup>3</sup> character to over half the atoms in the compound (Fsp<sup>3</sup> = 0.53). Compound <b>26</b> demonstrates modest potency (EC<sub>50</sub> = 105 nM) with a low cLogP (2.5) and an excellent MPO score (4.8). While there appears to be a significant improvement in the sp<sup>3</sup> character of these GSMs, the challenge of identifying compounds with excellent potencies, low cLogP values, and high MPO scores still remains.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0017.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. FORUM N-substituted pyrimidomorpholines with increased sp<sup>3</sup> character.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a third patent application, the FORUM group investigated the vector of the aryl group via substitution at C7 of the pyrimidomorpholine core structure (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Compound <b>27</b> represents the basic structure and possesses increased potency (EC<sub>50</sub> = 16 nM) with a respectable cLogP value (3.4) and a good MPO score (4.3). Again, while other substituents on the phenyl group maintain or improve the potency, those new analogues also possess higher cLogPs and lower MPO scores. In an effort to improve the drug-like properties by removing one of the aromatic rings (which would increase the sp<sup>3</sup> character, lower the molecular weight, lower the cLogP value, and increase the MPO score), several nonaromatic right-hand-side groups were explored. The spirocyclopropyl analogue <b>28</b> possesses good potency (EC<sub>50</sub> = 49 nM) with a low cLogP (1.6), excellent MPO score (5.4) and increased Fsp<sup>3</sup> (0.35). The fused pyrrolidine analogue <b>29</b> also possesses good potency (EC<sub>50</sub> = 71 nM) with a low cLogP (1.9), excellent MPO score (5.4), and high Fsp<sup>3</sup> (0.35). While there appears to be a significant improvement in this GSM scaffold with respect to high sp<sup>3</sup> character, lower molecular weight, lower lipophilicity, and higher MPO score, the challenge of combining these good drug-like properties with excellent potency still remains.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0018.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. FORUM C-substituted pyrimidomorpholines with increased sp<sup>3</sup> character.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Bristol-Meyers Squibb group has described a series of compounds based on the optimization of compound <b>30</b> (EC<sub>50</sub> = 29 nM) (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>). One of their lead compounds, <b>31</b> (BMS-869780),<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> has been described as their first optimized candidate. This GSM replaces the typical methylimidazole with a chloroimidazole. Compound <b>31</b> possesses excellent in vitro potency (EC<sub>50</sub> = 6 nM) but a high cLogP (4.4) and a low MPO score (3.3). Compound <b>31</b> demonstrated robust in vivo efficacy in both mouse and rat brain. In mice, 30 and 100 mg/kg oral doses produced Aβ42 AUC<sub>0–24h</sub> reductions of 31% and 55%, respectively, and a 10 mg/kg oral dose in rats produced an Aβ42 AUC<sub>0–24h</sub> reduction of 47%. Safety studies eventually revealed activity in the human pregnane X receptor (PXR) transcriptional reporter assay at all concentrations greater than 0.3 μM. Further experiments confirmed the induction of CYP3A4 and the potential risk of drug–drug interactions. Finally, liver lipidosis was observed in rats after four daily doses each of 10, 30, and 100 mg/kg, indicating hepatotoxicity at the exposures required for Aβ42 lowering. Further studies with <b>31</b> have been discontinued because of potential safety concerns at the projected human daily dose required to afford a desired Aβ42 AUC<sub>0–24h</sub> reduction of 25% (700 mg). Efforts to optimize solubility, hERG, CYP3A4, and PXR afforded compound <b>32</b> (BMS-932481).<a onclick="showRef(event, 'ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref106 ref107">(106, 107)</a> This GSM deviates from the typical methylimidazole with the inclusion of the methyltriazole. Compound <b>32</b> demonstrates excellent potency (EC<sub>50</sub> = 7 nM) and very robust in vivo activity. A phase 1 clinical trial with <b>32</b> reportedly demonstrated reductions in CSF Aβ42 with a single dose of 900 mg.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> While this compound apparently demonstrated efficacy, it still suffers from poor drug-like properties as measured by both high cLogP (4.5) and low MPO score (3.0).</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0019.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Bristol-Meyers Squibb aniline GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Bristol-Meyers Squibb group has also recently described a series of tricyclics designed to further optimize compound <b>30</b> via a conformational restriction linking the key aniline to the central heterocycle (<a class="ref internalNav" href="#fig18" aria-label="Figure 18">Figure 18</a>).<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> The first set of compounds explored a thiazole ring system to form the key tricycle. Compound <b>33</b> possessed similar potency (EC<sub>50</sub> = 29 nM) but at the expense of a higher cLogP (4.4 vs 3.7) relative to compound <b>30</b>. Unfortunately, compound <b>34</b> demonstrated lower potency (EC<sub>50</sub> = 140 nM) with even worse calculated properties. Compound <b>33</b> was further profiled to show good metabolic stability and no appreciable hERG activity, but significant CYP3A4 inhibition (IC<sub>50</sub> = 0.7 μM) was identified as a potential issue. Dosing compound <b>33</b> in 3xTg-AD mice at 30 and 100 mg/kg p.o. resulted in brain Aβ42 reductions of 40% and 50%, respectively, at 3 h post dose. The 30 mg/kg dose afforded 8 and 8.9 μM exposures in the plasma and brain, respectively, at 3 h, and the 100 mg/kg dose afforded 25 μM in the plasma at 3 h. The measured human and mouse plasma protein binding was extremely high (>99.8%), and thus, the associated unbound brain concentration in the 30 mg/kg dose that affords 40% Aβ42 reduction is less than 18 nM (assuming equal brain and plasma binding, whereas the brain binding is often higher). Here the calculated unbound brain exposure is roughly 2-fold lower than the in vitro EC<sub>50</sub> for Aβ42, producing an apparent disconnect with the in vitro–in vivo correlation, as is often observed for this target.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0020.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Bristol-Meyers Squibb tricyclic thiazole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Bristol-Meyers Squibb team then explored both pyrazole and imidazole tricyclic designs (<a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>). While pyrazole compound <b>35</b> was equipotent with the thiazole (EC<sub>50</sub> = 40 nM), both the CYP3A4 inhibition (IC<sub>50</sub> = 0.3 μM) and the CNS drug-like properties as measured by the cLogP (4.6) and MPO score (3.6) were worse. Replacing the pyrazole with an imidazole and the central aniline with a ketone afforded compound <b>36</b> with a significantly lower cLogP (2.9) and a better MPO score (5.0). Unfortunately, compound <b>36</b> also possessed much lower potency (EC<sub>50</sub> = 1.1 μM) and still demonstrated CYP3A4 inhibition (IC<sub>50</sub> = 0.3–0.5 μM).</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0021.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Bristol-Meyers Squibb tricyclic pyrazole and imidazole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To improve the potency and potentially address the CYP3A4 inhibition issue, a series of tricyclic diazepinones were also designed (<a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>). Compound <b>37</b> was demonstrated to be equipotent to thiazole <b>33</b> (EC<sub>50</sub> = 50 nM) but still exhibited CYP3A4 inhibition (IC<sub>50</sub> = 0.15 μM). Rewardingly, introduction of the chloroimidazole in compound <b>38</b> resulted in a moderately potent analogue (EC<sub>50</sub> = 190 nM) and dramatically improved the problematic CYP3A4 inhibition (IC<sub>50</sub> > 13 μM). The data suggest that the CYP3A4 inhibition closely tracks with the basicity of the imidazole, as the basic methylimidazole is a substantially more potent inhibitor than the weakly basic chloroimidazole. Unfortunately, compound <b>37</b> did not demonstrate any Aβ42 reduction when tested in 3xTg-AD mice at an oral dose of 30 mg/kg. These various tricyclic compounds provide new avenues for structure–activity relationship (SAR) exploration but have not yet delivered potent, efficacious compounds without absorption, distribution, metabolism, elimination, and toxicity (ADMET) issues and good predicted CNS drug-like properties.</div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0022.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Bristol-Meyers Squibb tricyclic pyridine GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Researchers at Amgen carried out high-throughput screening (HTS) for modulators of Aβ42 production in an HEK293 cell line stably expressing guinea pig Swedish mutant SFV-APP695sw. This screen identified oxazole <b>39</b> (<a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>) as a novel GSM chemotype.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> While the imidazole-based GSMs nearly universally require a methoxy group on the aniline for potency, this same methoxy substitution resulted in a loss in potency for this series. Optimization of <b>39</b> ultimately led to compound <b>40</b>. Replacement of the oxazole with a methylpyridine improved the potency and reduced the CYP inhibition. Conversion of the sulfonamide to a carboxamide improved the brain exposure, although this modification also required the introduction of a methylene spacer between the carbonyl and terminal aryl group to maintain potency. Compound <b>40</b> (EC<sub>50</sub> = 0.26 μM) is 6 times more potent than compound <b>39</b> but also significantly more lipophilic (cLogP = 5.9). While compound <b>40</b> demonstrated 33% Aβ42 reduction in rat brain at a dose of 100 mg/kg, other compounds in this series with increased in vitro potency failed to demonstrate improved in vivo efficacy. The authors claim various issues with this scaffold, including high cLogPs, low passive membrane permeability, and “flat,” “shallow”, “non-additive” SAR.</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0023.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Amgen aniline GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Removal of the Aniline</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Torrey Pines Therapeutics group also focused early on the arylimidazole group.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Compound <b>41</b> (<a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>) was identified via an HTS campaign of 80 000 compounds and found to possess low-micromolar activity (EC<sub>50</sub> = 1.5 μM). Further optimization afforded compound <b>42</b> with greatly improved potency (EC<sub>50</sub> = 29 nM) that demonstrated 30–40% Aβ42 reduction in the brain after 3 days of repeated oral doses of 50 and 100 mg/kg in Tg2576 female mice.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> While compound <b>42</b> represents a significant potency improvement upon the initial HTS hit, it still suffers from poor drug-like properties as measured by the three contiguous aromatic rings, high cLogP (6.0), and low MPO score (3.2).</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0024.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Torrey Pines early GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Wagner et al.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> worked to improve the properties of these early thiazole GSMs by the addition of heteroatoms to lower the cLogP and improve the solubility. The introduction of an <i>N</i>-ethylpyrazole ring afforded compound <b>43</b> (<a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>), which demonstrated moderate potency (EC<sub>50</sub> = 347 nM) and reduced lipophilicity (cLogP = 3.7). The kinetic solubility of compound <b>43</b> was measured as 2.3 μM at pH 6.6. A pyridine was then introduced to afford compound <b>44</b> (cLogP = 3.1), which demonstrated only weak in vitro potency (EC<sub>50</sub> = 1.3 μM). Combination of the pyridine with a methoxy group provided compound <b>45</b>, the most potent compound reported in this effort. This analogue demonstrated good in vitro potency (EC<sub>50</sub> = 30 nM) with a cLogP of 3.3 and a calculated MPO score of 4.3. Unfortunately, no kinetic solubility measurement results were provided to directly compare this improved compound with the others in the series. Compound <b>45</b> was shown to decrease Aβ42 levels and increase Aβ33, Aβ34, Aβ37, and Aβ38 peptides in vitro. The potential for this class of GSMs remains to be determined since no efficacy or ADMET data have been published. While compound <b>45</b> still has four aromatic rings, it does appear to possess better drug-like properties as measured by its cLogP and MPO score. A related set of compounds in a recent patent application further engineered five- and six-membered nonaromatic rings to provide a series of compounds represented by compound <b>46</b>,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> which demonstrated excellent potency (EC<sub>50</sub> = 6 nM) with good predicted drug-like properties as evidenced by a cLogP of 3.3 and an MPO score of 4.5. The ADMET properties and in vivo efficacy for this class of compounds also remain to be seen.</div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0025.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Improvements to the early thiazole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Merck group has described a series of triazole-based GSMs (<a class="ref internalNav" href="#fig24" aria-label="Figure 24">Figure 24</a>). Their recent efforts have focused on converting triazoles <b>47</b> into triazoloamides <b>48</b> to increase the potency while reducing the potential hERG liabilities.<a onclick="showRef(event, 'ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref115 ref116">(115, 116)</a> The optimized amide <b>49</b> possesses moderate drug-like properties, as measured by the cLogP (3.7) and MPO score (3.8), and modest cellular potency (EC<sub>50</sub> = 90 nM) but demonstrated a potential hERG liability (IC<sub>50</sub> = 0.8 μM). Various conformational constraints led to triazololactams <b>50</b> and <b>51</b>. Rewardingly, compound <b>50</b> possesses even better drug-like properties, better cellular potency (EC<sub>50</sub> = 20 nM), and very low hERG activity (IC<sub>50</sub> = 32 μM). Compound <b>51</b> also possesses good predicted CNS drug-like properties and excellent cellular potency (EC<sub>50</sub> = 9 nM) with low hERG activity (IC<sub>50</sub> = 5.4 μM). Several compounds in this series were dosed at 50 mg/kg p.o. but demonstrated no efficacy due to minimal brain exposures and blood to plasma ratios less than 0.1. Clearly this GSM scaffold combines good potency with acceptable predicted drug-like properties, but a real need to improve the PK properties remains.</div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0026.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Merck triazole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Toward the goal of improving the PK properties, a variety of substitutions were explored by the Merck team with the optimized 6-fluorobenzazepinone (<a class="ref internalNav" href="#fig25" aria-label="Figure 25">Figure 25</a>).<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117, 118)</a> The optimized compound <b>52</b> demonstrated good cellular potency (EC<sub>50</sub> = 58 nM), no potential hERG issue as measured in a binding assay (IC<sub>50</sub> = 8.3 μM), and an improved B:P of 1. Dosing compound <b>52</b> in YAC-APP mice at 100 mg/kg p.o. resulted in a robust brain Aβ42 reduction of 74% at 6 h post dose with 14 μM CNS exposure. The methoxy analogue <b>53</b> demonstrated even better cellular potency (EC<sub>50</sub> = 13 nM), no potential hERG issue as measured in a binding assay (IC<sub>50</sub> = 6.5 μM), and a B:P of 0.65. Dosing compound <b>53</b> in YAC-APP mice at 100 mg/kg p.o. resulted in a brain Aβ42 reduction of 68% at 6 h post dose with 8.5 μM CNS exposure. The methyltriazole analogue <b>54</b> also demonstrated good cellular potency (EC<sub>50</sub> = 42 nM), no potential hERG issue as measured in a binding assay (IC<sub>50</sub> = 19 μM), and an improved B:P of 1. Dosing compound <b>54</b> in YAC-APP mice, now at 50 mg/kg p.o., resulted in a brain Aβ42 reduction of 38% at 6 h post dose with 4.5 μM CNS exposure. Reverting back to the methylimidazole provided compound <b>55</b>, which also possessed good cellular potency (EC<sub>50</sub> = 31 nM), but a potential hERG issue was measured in a binding assay (IC<sub>50</sub> = 1.9 μM). A follow-up functional hERG assay in a CHO cell line demonstrated a significantly reduced hERG liability (EC<sub>50</sub> = 13 μM). Dosing compound <b>55</b> in YAC-APP mice, now at 30 mg/kg p.o., resulted in a brain Aβ42 reduction of 30% at 6 h post dose with 1.6 μM CNS exposure and a measured B:P of 0.31. Because of the observed Aβ42 reduction at limited exposure in mice, dosing <b>55</b> in rats at 100 mg/kg was explored and resulted in a robust brain Aβ42 reduction of 92% at 6 h post dose with 35 μM CNS exposure. On the basis of these promising results, the efficacy of compound <b>55</b> was further explored in nonhuman primates. Unfortunately, this compound displayed no oral bioavailability in rhesus monkeys, so an alternative dosing strategy had to be undertaken. Dosing via i.v. infusion (6 mg/kg bolus followed by 44 mg/kg infusion over 4 h) demonstrated significant Aβ42 lowering in rhesus CSF—up to 90% with sustained Aβ42 reductions over a 20 h period. Upon further profiling, compound <b>55</b> was determined to possess significant activity at the serotonin reuptake transporter (IC<sub>50</sub> = 32 nM), so this off-target activity will need to be monitored for future compounds from this class.</div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0027.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Merck triazole GSMs with improved drug metabolism and pharmacokinetic properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Takeda group has described a series of piperazine ureas and amides that demonstrate both in vitro potency and in vivo efficacy (<a class="ref internalNav" href="#fig26" aria-label="Figure 26">Figure 26</a>).<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Here the in vitro potency is reported as an inflection point (IP) and maximum inhibition at 3 μM because the compounds only partially modulate Aβ42 production in the primary rat cortical neuron assay. These compounds, similar to NSAID-like GSMs, do not modulate Aβ40 production. The initial compound <b>56</b> demonstrates an IP of 56 nM with a maximum inhibition of 57% at 3 μM. Dosing mice at 100 mg/kg resulted in only minimal reductions of Aβ42 levels in the plasma (16%) and brain (4%) at 3 h post dose. Compound <b>56</b> also possesses high in vitro metabolic clearance (150 μL min<sup>–1</sup> mg<sup>–1</sup>) as measured in mouse hepatic microsomes. SAR exploration of the methylimidazole led to the identification of oxazole <b>57</b>, which demonstrates an improved IP of 34 nM, a maximum inhibition of 67% at 3 μM, but similar in vitro metabolic clearance (130 μL min<sup>–1</sup> mg<sup>–1</sup>). Incorporation of a methyl group onto the piperazine linker and replacement of the α-methylnaphthalene with a trifluoromethylbenzimidazole led to the improved compound <b>58</b>, which demonstrated an improved IP of 21 nM, a maximum inhibition of 60% at 3 μM, and a significantly improved in vitro metabolic clearance (67 μL min<sup>–1</sup> mg<sup>–1</sup>). Rewardingly, dosing mice with compound <b>58</b> at 100 mg/kg p.o. resulted in Aβ42 reductions in the plasma and brain by 64% and 59%, respectively, at 3 h post dose. The potential for this class of GSMs remains to be determined, and while the MW is still high (514), compound <b>58</b> appears to possess improved drug-like properties as measured by the cLogP value and MPO score.</div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0028.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Takeda piperazine GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Researchers at Dainippon Sumitomo designed and synthesized amides based on <b>1</b> with the goal of removing the cinnamide olefin.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> A series of cyclic amines were coupled with 3-methoxy-4-imidazole phenyl carboxylic acid to afford a library of 200 compounds. From this initial library, the aminopiperidine motif <b>59</b> (<a class="ref internalNav" href="#fig27" aria-label="Figure 27">Figure 27</a>) was identified. Further optimization of the aminopiperidine led to compound <b>60</b>, which produced a 97% reduction of Aβ42 at 2.5 μM in rat primary cortical neurons, while the enantiomer showed only a 55% reduction in the same assay. Compound <b>60</b> demonstrated 55% Aβ42 reduction in wild-type mouse hippocampus with an oral dose of 100 mg/kg. Further work from the Dainippon Sumitomo group in this class of molecules remains to be seen.</div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0029.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Dainippon Sumitomo piperidine amide GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Janssen group has also described a series of bicyclic heterocycles designed from the simple amide <b>61</b>, a weakly active (EC<sub>50</sub> = 2.6 μM), low-MW, low-lipophilicity, high-MPO starting point (<a class="ref internalNav" href="#fig28" aria-label="Figure 28">Figure 28</a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> To increase the potency and brain penetration potential, the amide was cyclized to give triazole <b>62</b>. While this led to a 2-fold increase in potency (EC<sub>50</sub> = 1.3 μM), it was proposed that the remaining N–H hydrogen-bond donor might limit brain penetration. Furthermore, this compound possesses four contiguous aromatic rings with very low sp<sup>3</sup> character (Fsp<sup>3</sup> = 0.11). The methylated triazole compound <b>63</b> demonstrated a 2-fold improvement in potency (EC<sub>50</sub> = 0.62 μM).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> On the basis of the hypothesis that the fluorophenyl group should not be coplanar with the triazole, a methylene spacer was introduced to provide compound <b>64</b>. While this did not afford an improvement in potency (EC<sub>50</sub> = 0.85 μM), it provided the design concept for compound <b>65</b>, which demonstrated a significant increase in potency (EC<sub>50</sub> = 0.22 μM) and improvement in the sp<sup>3</sup> character (Fsp<sup>3</sup> = 0.26). Unfortunately, the change also led to an increase in cLogP and considerable lowering of the MPO score.</div><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0030.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Janssen triazole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Janssen group also investigated substituents on the phenyl ring and heteroatoms in the saturated carbocycle (<a class="ref internalNav" href="#fig29" aria-label="Figure 29">Figure 29</a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> For these compounds, the absolute configuration was determined using vibrational circular dichroism. Ortho substituents on the aromatic ring provided a significant boost in potency, as highlighted by compound <b>66</b> (EC<sub>50</sub> = 24 nM), which demonstrated 46% Aβ42 reduction in rat brain at 4 h following a 30 mg/kg oral dose. Unfortunately, this compound was shown to be a highly potent CYP3A4 inhibitor (IC<sub>50</sub> = 0.1 μM). Replacement of the CF<sub>3</sub> group with an OCF<sub>3</sub> group and incorporation of a pyridine provided the very potent and efficacious compound <b>67</b>. This compound was shown to have an EC<sub>50</sub> of 28 nM and result in a robust 66% reduction of Aβ42 in rat brain 4 h following a 30 mg/kg oral dose. Furthermore, this compound had no activity against CYP3A4 (IC<sub>50</sub> > 10 μM). Compound <b>67</b> was further profiled in dogs and demonstrated 50% Aβ42 reduction in the CSF following an oral dose of 20 mg/kg. It was also shown to have no effects on liver function in the canine model, a clear improvement over some of Janssen’s earlier compounds. While the in vivo efficacy and the initial safety data look promising, these compounds still possess relatively high cLogP values and low MPO scores. Further work from the Janssen group in this class of compounds remains to be seen.</div><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0031.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Janssen triazole GSMs with improved properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Janssen team continued to explore this series of compounds with the incorporation of a cyanoindole. The key compounds in the patent application appear to be the <i>o</i>-phenyl-substituted compounds <b>68</b>–<b>70</b> (<a class="ref internalNav" href="#fig30" aria-label="Figure 30">Figure 30</a>).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> While the stereochemistry is undefined, the enantiomer demonstrating a negative optical rotation in dimethylformamide is preferred. Compound <b>68</b> is both very potent and efficacious, demonstrating an EC<sub>50</sub> of 20 nM and a robust 66% reduction of Aβ42 and 40% increase of Aβ38 in mouse brain 4 h following a 30 mg/kg oral dose. This compound was also recently highlighted to have no effects on liver function in follow up safety studies.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Compound <b>69</b> demonstrated an EC<sub>50</sub> of 21 nM and a robust Aβ42 reduction of 73% but only a modest 10% increase of Aβ38 in mouse brain 4 h following a 30 mg/kg oral dose. Compound <b>70</b> is also both potent and efficacious, demonstrating an EC<sub>50</sub> of 45 nM and a robust 57% reduction of Aβ42 and 41% increase of Aβ38 in mouse brain 4 h following a 30 mg/kg oral dose. While the potency, in vivo efficacy, and initial safety data look promising, these compounds still possess relatively high cLogP values and low MPO scores, again demonstrating the difficulty of obtaining compounds with good predicted CNS drug-like properties.</div><figure id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0032.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Janssen cyanoindole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Takeda group has also published a series of related compounds incorporating an oxazole in place of the typical methylimidazole (<a class="ref internalNav" href="#fig31" aria-label="Figure 31">Figure 31</a>).<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> In comparison with the data from Janssen, oxazole <b>71</b> appears to be less active than imidazole <b>66</b> (EC<sub>50</sub> = 0.38 μM) with a slight improvement in the drug-like properties as measured by the cLogP value and MPO score. Insertion of an ether to form a triazolooxazine core (compound not shown but analogous to <b>67</b>) leads to a 2.5-fold reduction in potency. Optimization of the aryl group afforded the more potent compound <b>72</b>, which was shown to have an EC<sub>50</sub> of 60 nM at the expense of a higher cLogP and lower MPO score. Dosing mice at 10 mg/kg p.o. resulted in Aβ42 reductions in the plasma and brain by 69% and 50%, respectively, at 3 h post dose with exposures of 13.2 and 4.8 μM measured in the plasma and brain, respectively. Unfortunately, like many GSMs, compound <b>72</b> does not appear to possess good CNS drug-like properties as measured by a higher cLogP value (4.3) and a lower MPO score (3.4).</div><figure id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0033.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Takeda oxazole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pfizer has reported their efforts to generate GSMs with improved properties relative to <b>1</b> by removing the cinnamide olefin and reducing the lipophilicity. They were able to achieve these aims by attaching an amide directly to the methoxyphenyl ring to afford compound <b>73</b> (<a class="ref internalNav" href="#fig32" aria-label="Figure 32">Figure 32</a>), which showed an improved clogP (2.8) and modest in vitro potency (EC<sub>50</sub> = 0.32 μM).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Various amide groups were tolerated and further optimization led to dihydrobenzofuran compound <b>74</b> (EC<sub>50</sub> = 0.19 μM), which possesses good drug-like properties as measured by the MW (403), cLogP (1.9), and MPO score (5.2). It demonstrated 36% Aβ42 lowering in guinea pig brain with a 100 mg/kg oral dose and afforded 89 nM unbound brain exposure at 4 h post dose. However, efforts to further improve the potency of this series proved unsuccessful, as CYP inhibition issues were encountered for the more potent analogues.</div><figure id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0034.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Pfizer amide GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To improve on these compounds, the Pfizer group designed a series of pyridopyrazine-1,6-diones in which the amide nitrogen is tied back onto the pyridine ring to generate a bicyclic core (<a class="ref internalNav" href="#fig33" aria-label="Figure 33">Figure 33</a>).<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> These compounds demonstrate good physicochemical properties and improved in vitro potency. Various groups could be incorporated into the right-hand side of the molecule to generate potent analogues. For example, the ether-linked analogue <b>75</b> demonstrated an EC<sub>50</sub> of 100 nM with low rat and human liver microsome clearance as well as minimal CYP inhibition. Compound <b>75</b> also demonstrated good bioavailability (88%) and achieved 2.1 μM brain exposure at 1 h following an oral dose of 5 mg/kg in rats. Compound <b>75</b> exhibited a dose-dependent reduction of Aβ42 in guinea pig brain, with an observed reduction of 45% at 4 h post 30 mg/kg p.o. dose. Even greater potency was obtained by incorporating an indole to give compound <b>76</b> (EC<sub>50</sub> = 6 nM).<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> While this compound had acceptable apparent intrinsic clearance (28.3 mL min<sup>–1</sup> kg<sup>–1</sup>) in human liver microsomes, oral dosing in rats at 30 mg/kg resulted in only a 21% reduction of brain Aβ42 at 4 h post dose. This limited reduction can be attributed to extremely low unbound compound exposure in rat brain (5 nM). One reason for the low brain exposure was the measured <i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub> of 0.2. The relative brain to plasma exposure was restored in P-gp knockout mice, indicating that the compound was a P-gp efflux substrate. Further optimization of compound <b>75</b> produced compound <b>77</b>, and the stereochemistry of the methyl group adjacent to the trifluoromethyl group was established by X-ray crystallography.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> This compound was the first Pfizer compound with good physicochemical properties reported to have excellent potency (EC<sub>50</sub> = 6 nM) along with low clearance in human liver microsomes (12.7 mL min<sup>–1</sup> kg<sup>–1</sup>) and low potential for multidrug resistance protein efflux (ratio = 1.4). Dosing compound <b>77</b> at 60 mg/kg p.o. in guinea pigs produced a 41% reduction of brain Aβ42 with 225 nM unbound brain exposure at 3 h post dose. The success of this compound has been attributed to maintaining good sp<sup>3</sup> character (Fsp<sup>3</sup> = 0.38) and the ability of fluorine to prevent metabolism of the pendant phenyl ring while also maintaining good physicochemical properties.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Clickable photoaffinity probes related to compounds <b>75</b> and <b>76</b> were used to demonstrate that these pyridopyrazine-1,6-diones bind to the PS1-NTF.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><figure id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0035.jpeg" id="gr33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Pfizer pyridopyrazine-1,6-dione GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a related patent application, researchers at Pfizer reported engineering of conformational restrictions in the alkyl chain via four-, five-, and six-membered rings.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Several compounds in this patent application demonstrate high potencies (EC<sub>50</sub> < 20 nM) with good predicted drug-like properties. Compound <b>78</b> (<a class="ref internalNav" href="#fig34" aria-label="Figure 34">Figure 34</a>) demonstrates high in vitro potency (EC<sub>50</sub> = 14 nM) with an MW of 486, a cLogP of 2.8, and a calculated MPO score of 4.7. The slightly more lipophilic compound <b>79</b> possesses even better in vitro potency (EC<sub>50</sub> = 9 nM), albeit at the expense of a higher MW (521), a higher cLogP (3.4), and a slightly lower calculated MPO score (4.1). Adding a single fluorine atom in compound <b>79</b> provides compound <b>80</b>, which also demonstrates excellent potency (EC<sub>50</sub> = 8 nM) with an MW of 538, a cLogP of 3.5, and a calculated MPO score of 4.0. Even though the molecular weights of these compounds are higher, the compounds are predicted to possess good drug-like properties as measured by their cLogPs, MPO scores, and high sp<sup>3</sup> character (Fsp<sup>3</sup> = 0.4). While no in vivo or other ADME data for this tetrahydrofuran scaffold have been published, it appears the Pfizer group has succeeded in combining excellent potency with good predicted CNS drug-like properties, a notable milestone for GSM drug design.</div><figure id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0036.jpeg" id="gr34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Pfizer pyridopyrazine-1,6-dione GSMs with conformational restrictions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several patent applications from the Janssen group have also described a series of pyridopyrazine-1,6-diones that succeed in combining excellent potency and efficacy with good predicted CNS drug-like properties as well as high sp<sup>3</sup> character (Fsp<sup>3</sup> up to 0.4) (<a class="ref internalNav" href="#fig35" aria-label="Figure 35">Figure 35</a>).<a onclick="showRef(event, 'ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref131 ref132">(131, 132)</a> For example, compound <b>81</b> combines excellent potency (EC<sub>50</sub> = 6 nM) with a cLogP of 3.0 and an MPO score of 4.5 and demonstrates 42% Aβ42 lowering in mouse brain at 4 h post 10 mg/kg p.o. dose. A number of different substituents could also be incorporated onto the right side of the molecule. In addition to benzofuran <b>81</b>, compounds such as indole <b>82</b> (EC<sub>50</sub> = 10 nM, 61% Aβ42 lowering in mouse brain at 30 mg/kg p.o.) appear very interesting. Tricyclic structures such as compound <b>83</b> (EC<sub>50</sub> = 50 nM) were also investigated, but these compounds tended to be slightly larger and less potent.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Further work from the Janssen group in this class of compounds has yet to be reported.</div><figure id="fig35" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0037.jpeg" id="gr35" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. Janssen pyridopyrazine-1,6-dione GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Natural Product GSMs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A few groups have investigated natural-product-based GSMs. Natural products and their derivatives have historically been an invaluable source of therapeutic agents. While many natural products and their derivatives possess higher molecular weights, more rotatable bonds, and more stereogenic centers than a typical small-molecule drug, their chemical structures have been selected by evolution to have the structural prerequisites for binding proteins and crossing biological membranes. Consequently, natural products may represent privileged chemical scaffolds for drug discovery, although it remains to be seen whether they will succeed in delivering a promising GSM.</div><div class="NLM_p">Satori Pharmaceuticals reported the discovery of a novel class of triterpene glycoside GSMs obtained by screening a library of natural product extracts (<a class="ref internalNav" href="#fig36" aria-label="Figure 36">Figure 36</a>). Bioassay-guided fractionation identified compound <b>84</b> as the active component from a black cohash extract.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> In a different profile compared with other GSMs, compound <b>84</b> lowered Aβ42 (EC<sub>50</sub> = 100 nM) and Aβ38 while increasing both Aβ39 and Aβ37 and having little effect on Aβ40 and total Aβ. Like all GSMs, the natural product also did not alter Notch processing. Unfortunately, compound <b>84</b> was highly cleared in vivo and demonstrated very low brain exposure. The high clearance results from the instability of the enol ether, the glycoside, and the acetate ester. Several rounds of optimization led to compound <b>85</b>, which was obtained via reduction of the enol ether double bond, glycoside replacement with a substituted morpholine, and conversion of the acetate to an ethyl group.<a onclick="showRef(event, 'ref135 ref136 ref137'); return false;" href="javascript:void(0);" class="ref ref135 ref136 ref137">(135-137)</a> This compound maintained modest potency (EC<sub>50</sub> = 110 nM) and demonstrated improved clearance (0.50 mL min<sup>–1</sup> kg<sup>–1</sup>), good oral bioavailability (50%), and low CYP3A4 inhibition (IC<sub>50</sub> = 37 μM). When dosed at 100 mg/kg p.o., compound <b>85</b> reduced Aβ42 by 50% in rat brain. This compound was tolerated at 90 mg kg<sup>–1</sup> day<sup>–1</sup> in a 14 day rat toxicology study and selected as the development candidate. This work has since been discontinued, and Satori Pharmaceuticals subsequently shut down after this class of compounds was found to disrupt adrenal function in monkeys.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></div><figure id="fig36" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0038.jpeg" id="gr36" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. Satori natural product GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Researchers at the University of Florida have evaluated the ability of steroids to reduce Aβ42 by screening 170 natural and synthetic steroids at 10 μM in CHO cells.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Many nonacidic steroids were found to increase Aβ42, while acidic steroids were found to lower Aβ42. Of the steroids that lowered Aβ42, the most potent were 5β-cholanic acid <b>86</b> (EC<sub>50</sub> = 5.7 μM) and its endogenous analogue lithocholic acid <b>87</b> (62% Aβ42 reduction at 10 μM) (<a class="ref internalNav" href="#fig37" aria-label="Figure 37">Figure 37</a>). Compound <b>86</b> was shown to have a similar profile as the early carboxylic acid GSMs, lowering Aβ42 and increasing Aβ38 without changing Aβ40 or total Aβ. The compounds also had no effect on Notch processing. The authors hypothesized that various endogenous steroids could play a role in modulating Aβ production in vivo, but more evidence is needed to establish this hypothesis. Similar to the Satori natural products, when measured against typical small molecules, these steroids possess high cLogPs and low MPO scores. It is unclear whether these compounds will be pursued any further as therapeutics.</div><figure id="fig37" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0039.jpeg" id="gr37" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 37. University of Florida steroid GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig37"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">There is a desperate need for drugs that alter the course of AD and prevent, or at least delay, the onset of cognitive decline. The pharmaceutical industry became interested in GS many years ago because of the genetic evidence ascribing a central role for Aβ in the development of AD. The identification of potent, efficacious, and safe agents targeting this unique intramembrane protease for POM studies has been very elusive. After the failure of GSIs in the clinic, it became clear that GSMs would be a safer approach. The inhibition of GS may not be tolerable in a chronic dosing paradigm because of its many substrates, but increasing its processivity with GSMs may address the underlying molecular deficit in FAD. GSMs provide the potential to reduce the accumulation of the toxic Aβ species by changing the Aβ42:Aβ40 ratio and increasing the shorter non-amyloidogenic Aβ species, such as Aβ38 and Aβ37. This approach is not unlike that for statins, where the changing the LDL:HDL ratio impacts cardiovascular disease. Initially the challenge was to improve the potency of the compounds, which was achieved rather quickly. Unfortunately, most of these GSMs have not yet been able to combine excellent in vitro potency and in vivo efficacy with good drug-like properties. There are several reports of moderately active GSMs with respectable drug-like properties, but the challenge of further increasing the potency without a significant increase in the lipophilicity (cLogP) and aromatic ring count (i.e., lower Fsp<sup>3</sup>) still remains. This challenge may be especially daunting because of the hydrophobic nature of this intramembrane protease. Only compounds with highly desirable drug-like properties will address the solubility, permeability, metabolic stability, CYP inhibition, hERG liability, P-gp efflux, and toxicity issues observed for so many GSMs.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Delivering a safe and efficacious GSM for POM studies in human clinical trials will absolutely require the combination of potency/efficacy with good drug-like properties. It appears for the first time that GSMs may be on the cusp of achieving this goal. We believe continued focus to reduce the aromaticity (increase the Fsp<sup>3</sup>), molecular weight, and lipophilicity while increasing the CNS MPO score will be key in the generation of a drug in this class. As some GSMs have demonstrated promise in reversing the effects of PS1 mutations, the initial proof-of-concept studies may come from a prevention trial in asymptomatic FAD patients similar to the planned DIAN trials. Furthermore, it will be exciting to consider GSMs used in combination with other emerging Alzheimer’s therapies.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01960" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew G. Bursavich</span> - <span class="hlFld-Affiliation affiliation">FORUM Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e28f839696cc8097909183948b818aa28f8d90928a8b81908d8189cc818d8f"><span class="__cf_email__" data-cfemail="85e8e4f1f1abe7f0f7f6e4f3ece6edc5e8eaf7f5edece6f7eae6eeabe6eae8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryce A. Harrison</span> - <span class="hlFld-Affiliation affiliation">FORUM Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-François Blain</span> - <span class="hlFld-Affiliation affiliation">FORUM Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57441" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57441" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Matthew G. Bursavich</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=BIO-d3897e2154-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Matthew G. Bursavich</b> obtained his B.S. degree in chemistry from Louisiana State University. He completed his Ph.D. studies in organic chemistry at the University of Wisconsin-Madison under the direction of Prof. Daniel H. Rich, where he designed, synthesized, and developed strategies targeting aspartic protease inhibitors, including BACE. He began his industrial career at Wyeth developing hit-generation strategies and leading projects to develop new leads for oncology, inflammation and neuroscience targets. He then joined Myriad Pharmaceuticals in Utah, leading teams to identify new hits for oncology targets and progress them into late-stage studies. In 2011, he joined the Department of Medicinal Chemistry at FORUM Pharmaceuticals, where he is an associate director leading neuroscience teams in the pursuit of medicines for serious brain diseases.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Bryce A. Harrison</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=BIO-d3897e2159-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Bryce A. Harrison</b> obtained his B.S. degree in chemistry from Brigham Young University. He continued his education at Harvard University, where he completed his Ph.D. in organic chemistry in the lab of Prof. Gregory L. Verdine, investigating diversity-based approaches to peptide mimetics. This work was followed by postdoctoral studies on the synthesis of marine natural products with Prof. Erik J. Sorensen at Princeton University. Upon completion of his postdoctoral studies, he joined Lexicon Pharmaceuticals in Princeton, NJ, working as a medicinal chemist in the areas of diabetes and ophthalmology. In 2014, he moved to FORUM Pharmaceuticals and joined the medicinal chemistry team in pursuit of treatments for serious brain diseases.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Jean-François Blain</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=BIO-d3897e2164-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jean-François Blain</b> obtained his B.Sc. in biochemistry from Université de Sherbrooke, Canada, where he also obtained his M.Sc. in pharmacology under the supervision of Dr. Pierre Sirois. He subsequently moved to Montreal, Canada, to pursue his Ph.D in Neurological Sciences at McGill University under the supervision of Dr. Judes Poirier, where he worked on components of brain cholesterol metabolism, apolipoprotein E, and Aβ. Before joining FORUM Pharmaceuticals in 2010, he held positions at Merck Research Laboratories in Boston, MA, and a joint appointment at the Harvard School of Public Health and the Broad Institute in Cambridge, MA. He has been working on Alzheimer’s disease for over 15 years.</p></figure></div><div class="ack" id="ACK-d3897e2169-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57223" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57223" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank our many, many colleagues at FORUM Pharmaceuticals for their sustained contribution to our efforts to deliver a safe, efficacious GSM. We especially appreciate Drs. Duane A. Burnett and Gerhard Koenig for their insightful discussions in the preparation of this document.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i14" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i14"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i15" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i15"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, elimination, and toxicity</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">beta amyloid peptide</p></td></tr><tr><td class="NLM_term">AICD</td><td class="NLM_def"><p class="first last">amyloid precursor protein intracellular domain</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">Aph-1</td><td class="NLM_def"><p class="first last">anterior pharynx-defective 1</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">beta amyloid cleavage enzyme 1</p></td></tr><tr><td class="NLM_term">B:P</td><td class="NLM_def"><p class="first last">brain to plasma ratio</p></td></tr><tr><td class="NLM_term">cLogP</td><td class="NLM_def"><p class="first last">calculated logarithm of the octanol/water partition coefficient</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">FAD</td><td class="NLM_def"><p class="first last">familial Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">GS</td><td class="NLM_def"><p class="first last">gamma secretase</p></td></tr><tr><td class="NLM_term">GSI</td><td class="NLM_def"><p class="first last">gamma secretase inhibitor</p></td></tr><tr><td class="NLM_term">GSM</td><td class="NLM_def"><p class="first last">gamma secretase modulator</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">I-CLiPs</td><td class="NLM_def"><p class="first last">intramembrane cleaving protease family</p></td></tr><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">multiparameter optimization</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">Nct</td><td class="NLM_def"><p class="first last">nicastrin</p></td></tr><tr><td class="NLM_term">NICD</td><td class="NLM_def"><p class="first last">Notch intracellular domain</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid</p></td></tr><tr><td class="NLM_term">NSAID</td><td class="NLM_def"><p class="first last">nonsteroidal anti-inflammatory drug</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">POM</td><td class="NLM_def"><p class="first last">proof of mechanism</p></td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">presenilin</p></td></tr><tr><td class="NLM_term">Pen-2</td><td class="NLM_def"><p class="first last">presenilin enhancer protein 2</p></td></tr><tr><td class="NLM_term">PSEN</td><td class="NLM_def"><p class="first last">presenilin gene</p></td></tr><tr><td class="NLM_term">NTF</td><td class="NLM_def"><p class="first last">N-terminal fragment</p></td></tr><tr><td class="NLM_term">PXR</td><td class="NLM_def"><p class="first last">pregnane X receptor</p></td></tr><tr><td class="NLM_term">RIP</td><td class="NLM_def"><p class="first last">regulated intramembrane proteolysis</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TMD</td><td class="NLM_def"><p class="first last">transmembrane domain</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 140 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><a href="http://www.alz.org/facts/overview.asp" class="extLink">http://www.alz.org/facts/overview.asp</a> (accessed Dec 1, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.alz.org%2Ffacts%2Foverview.asp+%28accessed+Dec+1%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morstorf, T.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=K.+Zhongauthor=T.+Morstorf&title=Alzheimer%E2%80%99s+disease+drug-development+pipeline%3A+Few+candidates%2C+frequent+failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eZqgcPWBde3I7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DZhong%26aufirst%3DK.%26aulast%3DMorstorf%26aufirst%3DT.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug-development%2520pipeline%253A%2520Few%2520candidates%252C%2520frequent%2520failures%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chartier-Harlin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mant, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roques, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pericak-Vance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roses, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span> </span><span class="NLM_article-title">Segregation of a missense mutation in the amyloid precursor protein gene with familial alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span><span class="refDoi"> DOI: 10.1038/349704a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F349704a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1671712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFyhu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=1991&pages=704-706&author=A.+Goateauthor=M.+C.+Chartier-Harlinauthor=M.+Mullanauthor=J.+Brownauthor=F.+Crawfordauthor=L.+Fidaniauthor=L.+Giuffraauthor=A.+Haynesauthor=N.+Irvingauthor=L.+Jamesauthor=R.+Mantauthor=P.+Newtonauthor=K.+Rookeauthor=P.+Roquesauthor=C.+Talbotauthor=M.+Pericak-Vanceauthor=A.+Rosesauthor=R.+Williamsonauthor=M.+Rossorauthor=M.+Owenauthor=J.+Hardy&title=Segregation+of+a+missense+mutation+in+the+amyloid+precursor+protein+gene+with+familial+alzheimer%E2%80%99s+disease&doi=10.1038%2F349704a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease</span></div><div class="casAuthors">Goate, Alison; Chartier-Harlin, Marie Christine; Mullan, Mike; Brown, Jeremy; Crawford, Fiona; Fidani, Liana; Giuffra, Luis; Haynes, Andrew; Irving, Nick; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">6311</span>),
    <span class="NLM_cas:pages">704-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">To avoid the problems that heterogeneity poses for genetic anal., the authors examd. the cosegregation of Alzheimer's disease (AD) and markers along the long arm of chromosome 21 in a single family with AD confirmed by autopsy.  In this kindred, which shows linkage to chromosome 21 markers, there is a point mutation in the APP gene.  This mutation causes an amino-acid substitution (Val→Ile) close to the carboxy terminus of the β-amyloid peptide.  Screening other cases of familial AD revealed a second unrelated family in which this variant occurs.  This suggests that some cases of AD could be caused by mutations in the APP gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv7EvQ1MkXVbVg90H21EOLACvtfcHk0lg1amLfoJl7zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFyhu7k%253D&md5=5b27eb7cea61e5121c8d9f3d27fc2c0b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F349704a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F349704a0%26sid%3Dliteratum%253Aachs%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DChartier-Harlin%26aufirst%3DM.%2BC.%26aulast%3DMullan%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DCrawford%26aufirst%3DF.%26aulast%3DFidani%26aufirst%3DL.%26aulast%3DGiuffra%26aufirst%3DL.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DIrving%26aufirst%3DN.%26aulast%3DJames%26aufirst%3DL.%26aulast%3DMant%26aufirst%3DR.%26aulast%3DNewton%26aufirst%3DP.%26aulast%3DRooke%26aufirst%3DK.%26aulast%3DRoques%26aufirst%3DP.%26aulast%3DTalbot%26aufirst%3DC.%26aulast%3DPericak-Vance%26aufirst%3DM.%26aulast%3DRoses%26aufirst%3DA.%26aulast%3DWilliamson%26aufirst%3DR.%26aulast%3DRossor%26aufirst%3DM.%26aulast%3DOwen%26aufirst%3DM.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DSegregation%2520of%2520a%2520missense%2520mutation%2520in%2520the%2520amyloid%2520precursor%2520protein%2520gene%2520with%2520familial%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1991%26volume%3D349%26spage%3D704%26epage%3D706%26doi%3D10.1038%2F349704a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Amyloid deposition as the central event in the aetiology of alzheimer’s disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1016/0165-6147(91)90609-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2F0165-6147%2891%2990609-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1763432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383-388&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+deposition+as+the+central+event+in+the+aetiology+of+alzheimer%E2%80%99s+disease&doi=10.1016%2F0165-6147%2891%2990609-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid deposition as the central event in the etiology of Alzheimer's disease</span></div><div class="casAuthors">Hardy, John; Allsop, David</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">383-8</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A review with 50 refs. of pathol. and etiol. of Alzheimer's disease; the function of β-amyloid precursor protein and the mechanism of formation of cerebrovascular amyloid peptide β/A4; and the progression of the disease from amyloid formation to neurofibrillary tangles and cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRPqP0OKB5rVg90H21EOLACvtfcHk0lg1amLfoJl7zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D&md5=7756055cd27bec2821c9926267a93872</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2891%2990609-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252891%252990609-V%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520deposition%2520as%2520the%2520central%2520event%2520in%2520the%2520aetiology%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D383%26epage%3D388%26doi%3D10.1016%2F0165-6147%2891%2990609-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: The amyloid cascade hypothesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+The+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lg1amLfoJl7zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520The%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The molecular pathology of alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span><span class="refDoi"> DOI: 10.1016/0896-6273(91)90052-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2F0896-6273%2891%2990052-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1673054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK3MXltlartrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=487-498&author=D.+J.+Selkoe&title=The+molecular+pathology+of+alzheimer%E2%80%99s+disease&doi=10.1016%2F0896-6273%2891%2990052-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular pathology of Alzheimer's disease</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">487-98</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    </div><div class="casAbstract">A review with 123 refs.  The salient features of the altered biochem. of Alzheimer's disease brain tissue and the possible role of these changes in the pathogenesis of this complex disease are reviewed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo89M2XS8q9lLVg90H21EOLACvtfcHk0lg1amLfoJl7zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXltlartrk%253D&md5=4745e85e182053674cb6a67fe4b1cfb8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2891%2990052-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252891%252990052-2%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520molecular%2520pathology%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D1991%26volume%3D6%26spage%3D487%26epage%3D498%26doi%3D10.1016%2F0896-6273%2891%2990052-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Benilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The toxic abeta oligomer and alzheimer’s disease: An emperor in need of clothes</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span><span class="refDoi"> DOI: 10.1038/nn.3028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Fnn.3028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22286176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlOltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=349-357&author=I.+Benilovaauthor=E.+Karranauthor=B.+De+Strooper&title=The+toxic+abeta+oligomer+and+alzheimer%E2%80%99s+disease%3A+An+emperor+in+need+of+clothes&doi=10.1038%2Fnn.3028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes</span></div><div class="casAuthors">Benilova, Iryna; Karran, Eric; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-357</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'toxic Aβ oligomer' hypothesis has attracted considerable attention among Alzheimer's disease researchers as a way of resolving the lack of correlation between deposited amyloid-β (Aβ) in amyloid plaques-in terms of both amt. and location-and cognitive impairment or neurodegeneration.  However, the lack of a common, agreed-upon exptl. description of the toxic Aβ oligomer makes interpretation and direct comparison of data between different research groups impossible.  Here we critically review the evidence supporting toxic Aβ oligomers as drivers of neurodegeneration and make some suggestions that might facilitate progress in this complex field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov5Kqo0wOIJ7Vg90H21EOLACvtfcHk0ljvs76zZWuhwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlOltrc%253D&md5=071f3c9b1e0fe9b2e66363c44d87e381</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnn.3028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3028%26sid%3Dliteratum%253Aachs%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520toxic%2520abeta%2520oligomer%2520and%2520alzheimer%25E2%2580%2599s%2520disease%253A%2520An%2520emperor%2520in%2520need%2520of%2520clothes%26jtitle%3DNat.%2520Neurosci.%26date%3D2012%26volume%3D15%26spage%3D349%26epage%3D357%26doi%3D10.1038%2Fnn.3028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A mutation in app protects against alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Jonssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+app+protects+against+alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0ljvs76zZWuhwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJonsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520app%2520protects%2520against%2520alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for alzheimer’s disease: An appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span><span class="refDoi"> DOI: 10.1038/nrd3505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Fnrd3505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=21852788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+alzheimer%E2%80%99s+disease%3A+An+appraisal+for+the+development+of+therapeutics&doi=10.1038%2Fnrd3505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics</span></div><div class="casAuthors">Karran, Eric; Mercken, Marc; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">698-712</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the brain is a central event in Alzheimer's disease pathol., has dominated research for the past twenty years.  Several therapeutics that were purported to reduce amyloid-β prodn. or aggregation have failed in Phase III clin. testing, and many others are in various stages of development.  Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clin. trials will constitute a valid test of this hypothesis and explore whether amyloid-β-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-zjcfHaQ87Vg90H21EOLACvtfcHk0ljvs76zZWuhwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L&md5=cf2824a56a4c3df6e265d8788970729d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3505%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520alzheimer%25E2%2580%2599s%2520disease%253A%2520An%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712%26doi%3D10.1038%2Fnrd3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smirnov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klafki, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyrks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruther, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornhuber, J.</span><span> </span><span class="NLM_article-title">Highly conserved and disease-specific patterns of carboxyterminally truncated abeta peptides 1–37/38/39 in addition to 1–40/42 in alzheimer’s disease and in patients with chronic neuroinflammation</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.00818.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1046%2Fj.1471-4159.2002.00818.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=12065657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFGktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2002&pages=481-496&author=J.+Wiltfangauthor=H.+Esselmannauthor=M.+Biblauthor=A.+Smirnovauthor=M.+Ottoauthor=S.+Paulauthor=B.+Schmidtauthor=H.+W.+Klafkiauthor=M.+Malerauthor=T.+Dyrksauthor=M.+Bienertauthor=M.+Beyermannauthor=E.+Rutherauthor=J.+Kornhuber&title=Highly+conserved+and+disease-specific+patterns+of+carboxyterminally+truncated+abeta+peptides+1%E2%80%9337%2F38%2F39+in+addition+to+1%E2%80%9340%2F42+in+alzheimer%E2%80%99s+disease+and+in+patients+with+chronic+neuroinflammation&doi=10.1046%2Fj.1471-4159.2002.00818.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Highly conserved and disease-specific patterns of carboxyterminally truncated Aβ peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation</span></div><div class="casAuthors">Wiltfang, J.; Esselmann, H.; Bibl, M.; Smirnov, A.; Otto, M.; Paul, S.; Schmidt, B.; Klafki, H.-W.; Maler, M.; Dyrks, T.; Bienert, M.; Beyermann, M.; Ruther, E.; Kornhuber, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">481-496</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Human lumbar CSF patterns of Aβ peptides were analyzed by urea-based β-amyloid SDS-PAGE with western immunoblot (Aβ-SDS-PAGE/immunoblot).  A highly conserved pattern of C-terminally truncated Aβ1-37/38/39 was found in addn. to Aβ1-40 and Aβ1-42.  Remarkably, Aβ1-38 was present at a higher concn. than Aβ1-42, being the second prominent Aβ peptide species in CSF.  Patients with Alzheimer's disease (AD) and patients with chronic inflammatory CNS disease (CID) were differentiated by unique CSF Aβ peptide patterns from patients with other neuropsychiatric diseases (OND).  This became evident only when the authors investigated the amt. of Aβ peptides relative to their total Aβ peptide concn. (Aβ1-x%, fractional Aβ peptide pattern), which may reflect disease-specific υ-secretase activities.  Remarkably, patients with AD and CID shared elevated Aβ1-38% values, whereas otherwise the patterns were distinct, allowing sepn. of AD from CID or OND patients without overlap.  The presence of one or two ApoE ε4 alleles resulted in an overall redn. of CSF Aβ peptides, which was pronounced for Aβ1-42.  The severity of dementia was significantly correlated to the fractional Aβ peptide pattern but not to the abs. Aβ peptide concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8ATekdr8UGrVg90H21EOLACvtfcHk0liDB-zXhpsfvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFGktrc%253D&md5=896100941428364397314e7b5af9831b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.00818.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.00818.x%26sid%3Dliteratum%253Aachs%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DEsselmann%26aufirst%3DH.%26aulast%3DBibl%26aufirst%3DM.%26aulast%3DSmirnov%26aufirst%3DA.%26aulast%3DOtto%26aufirst%3DM.%26aulast%3DPaul%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DKlafki%26aufirst%3DH.%2BW.%26aulast%3DMaler%26aufirst%3DM.%26aulast%3DDyrks%26aufirst%3DT.%26aulast%3DBienert%26aufirst%3DM.%26aulast%3DBeyermann%26aufirst%3DM.%26aulast%3DRuther%26aufirst%3DE.%26aulast%3DKornhuber%26aufirst%3DJ.%26atitle%3DHighly%2520conserved%2520and%2520disease-specific%2520patterns%2520of%2520carboxyterminally%2520truncated%2520abeta%2520peptides%25201%25E2%2580%259337%252F38%252F39%2520in%2520addition%2520to%25201%25E2%2580%259340%252F42%2520in%2520alzheimer%25E2%2580%2599s%2520disease%2520and%2520in%2520patients%2520with%2520chronic%2520neuroinflammation%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D81%26spage%3D481%26epage%3D496%26doi%3D10.1046%2Fj.1471-4159.2002.00818.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Portelius, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westman-Brinkmalm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span> </span><span class="NLM_article-title">Determination of β-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry</span> <span class="citation_source-journal">J. Proteome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1010</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span><span class="refDoi"> DOI: 10.1021/pr050475v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr050475v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFOiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1010-1016&author=E.+Porteliusauthor=A.+Westman-Brinkmalmauthor=H.+Zetterbergauthor=K.+Blennow&title=Determination+of+%CE%B2-amyloid+peptide+signatures+in+cerebrospinal+fluid+using+immunoprecipitation-mass+spectrometry&doi=10.1021%2Fpr050475v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of β-Amyloid Peptide Signatures in Cerebrospinal Fluid Using Immunoprecipitation-Mass Spectrometry</span></div><div class="casAuthors">Portelius, Erik; Westman-Brinkmalm, Ann; Zetterberg, Henrik; Blennow, Kaj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1010-1016</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Early pathogenic events in Alzheimer's disease (AD) involve increased prodn. and/or reduced clearance of β-amyloid (Aβ), esp. the 42 amino acid fragment Aβ1-42.  The Aβ1-42 peptide is generated through cleavage of the amyloid precursor protein by β- and γ-secretase and is catabolized by a variety of proteolytic enzymes such as insulin-degrading enzyme and neprilysin.  Here, the authors describe a method that employs immunopptn. combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to det. the pattern of C-terminally truncated Aβ peptides in cerebrospinal fluid (CSF).  Using antibodies coupled to magnetic beads, the authors have detected 18 C-terminally and 2 N-terminally truncated Aβ peptides in CSF.  By detg. the identity and profile of the truncated Aβ peptides, more insight may be gained about differences in the metab. and structural properties of Aβ in AD.  Finally, the Aβ fragment signatures may prove useful as a diagnostic test for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxSKih56iERrVg90H21EOLACvtfcHk0liDB-zXhpsfvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFOiur8%253D&md5=1927c8e4b3d609915546a68956144e01</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fpr050475v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr050475v%26sid%3Dliteratum%253Aachs%26aulast%3DPortelius%26aufirst%3DE.%26aulast%3DWestman-Brinkmalm%26aufirst%3DA.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DBlennow%26aufirst%3DK.%26atitle%3DDetermination%2520of%2520%25CE%25B2-amyloid%2520peptide%2520signatures%2520in%2520cerebrospinal%2520fluid%2520using%2520immunoprecipitation-mass%2520spectrometry%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2006%26volume%3D5%26spage%3D1010%26epage%3D1016%26doi%3D10.1021%2Fpr050475v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bentahir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyabi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhamme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horre, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Presenilin clinical mutations can affect γ-secretase activity by different mechanisms</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">732</span><span class="NLM_x">–</span> <span class="NLM_lpage">742</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2005.03578.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1111%2Fj.1471-4159.2005.03578.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=16405513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFCnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2006&pages=732-742&author=M.+Bentahirauthor=O.+Nyabiauthor=J.+Verhammeauthor=A.+Toliaauthor=K.+Horreauthor=J.+Wiltfangauthor=H.+Esselmannauthor=B.+De+Strooper&title=Presenilin+clinical+mutations+can+affect+%CE%B3-secretase+activity+by+different+mechanisms&doi=10.1111%2Fj.1471-4159.2005.03578.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Presenilin clinical mutations can affect γ-secretase activity by different mechanisms</span></div><div class="casAuthors">Bentahir, Mostafa; Nyabi, Omar; Verhamme, Jan; Tolia, Alexandra; Horre, Katrien; Wiltfang, Jens; Esselmann, Hermann; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">732-742</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Mutations in human presenilin (PS) genes cause aggressive forms of familial Alzheimer's disease.  Presenilins are polytopic proteins that harbor the catalytic site of the γ-secretase complex and cleave many type I transmembrane proteins including β-amyloid precursor protein (APP), Notch and syndecan 3.  Contradictory results have been published concerning whether PS mutations cause 'abnormal' gain or (partial) loss of function of γ-secretase.  To avoid the possibility that wild-type PS confounds the interpretation of the results, we used presenilin-deficient cells to analyze the effects of different clin. mutations on APP, Notch, syndecan 3 and N-cadherin substrate processing, and on γ-secretase complex formation.  A loss in APP and Notch substrate processing at ε and S3 cleavage sites was obsd. with all presenilin mutants, whereas APP processing at the γ site was affected in variable ways.  PS1-Δ9 and PS1-L166P mutations caused a redn. in β-amyloid peptide (Aβ)40 prodn. whereas PS1-G384A mutant significantly increased Aβ42.  Interestingly PS2, a close homolog of PS1, appeared to be a less efficient producer of Aβ than PS1.  Finally, subtle differences in γ-secretase complex assembly were obsd.  Overall, our results indicate that the different mutations in PS affect γ-secretase structure or function in multiple ways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptpHnflldicLVg90H21EOLACvtfcHk0liDB-zXhpsfvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFCnurY%253D&md5=d6023fb0564be7d6d2a29848a7fdc68e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03578.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03578.x%26sid%3Dliteratum%253Aachs%26aulast%3DBentahir%26aufirst%3DM.%26aulast%3DNyabi%26aufirst%3DO.%26aulast%3DVerhamme%26aufirst%3DJ.%26aulast%3DTolia%26aufirst%3DA.%26aulast%3DHorre%26aufirst%3DK.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DEsselmann%26aufirst%3DH.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DPresenilin%2520clinical%2520mutations%2520can%2520affect%2520%25CE%25B3-secretase%2520activity%2520by%2520different%2520mechanisms%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D96%26spage%3D732%26epage%3D742%26doi%3D10.1111%2Fj.1471-4159.2005.03578.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wolfe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostaszewski, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimberly, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">398</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span><span class="refDoi"> DOI: 10.1038/19077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F19077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10206644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK1MXisFGqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=1999&pages=513-517&author=M.+S.+Wolfeauthor=W.+Xiaauthor=B.+L.+Ostaszewskiauthor=T.+S.+Diehlauthor=W.+T.+Kimberlyauthor=D.+J.+Selkoe&title=Two+transmembrane+aspartates+in+presenilin-1+required+for+presenilin+endoproteolysis+and+gamma-secretase+activity&doi=10.1038%2F19077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity</span></div><div class="casAuthors">Wolfe, Michael S.; Xia, Weiming; Ostaszewski, Beth L.; Diehl, Thekla S.; Kimberly, W. Taylor; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">398</span>
        (<span class="NLM_cas:issue">6727</span>),
    <span class="NLM_cas:pages">513-517</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Accumulation of the amyloid-β protein (Aβ) in the cerebral cortex is an early and invariant event in the pathogenesis of Alzheimer's disease.  The final step in the generation of Aβ from the β-amyloid precursor protein is an apparently intra-membranous proteolysis by the elusive γ-secretase(s).  The most common cause of familial Alzheimer's disease is mutation of the genes encoding presenilins 1 and 2, which alters γ-secretase activity to increase the prodn. of the highly amyloidogenic Aβ42 isoform.  Moreover, deletion of presenilin-1 in mice greatly reduces γ-secretase activity, indicating that presenilin-1 mediates most of this proteolytic event.  Here we report that mutation of either of two conserved transmembrane (TM) aspartate residues in presenilin-1, Asp 257 (in TM6) and Asp 385 (in TM7), substantially reduces Aβ prodn. and increases the amts. of the carboxy-terminal fragments of 1-amyloid precursor protein that are the substrates of γ-secretase.  We obsd. these effects in three different cell lines as well as in cell-free microsomes.  Either of the Asp → Ala mutations also prevented the normal endoproteolysis of presenilin-1 in the TM6 → TM7 cytoplasmic loop.  In a functional presenilin-1 variant (carrying a deletion in exon 9) that is assocd. with familial Alzheimer's disease and which does not require this cleavage, the Asp 385 → Ala mutation still inhibited γ-secretase activity.  Our results indicate that the two transmembrane aspartate residues are crit. for both presenilin-1 endoproteolysis and γ-secretase activity, and suggest that presenilin 1 is either a unique di-aspartyl cofactor for γ-secretase or is itself γ-secretase, an auto-activated intra-membranous aspartyl protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIBUrgEzFHtbVg90H21EOLACvtfcHk0ljYiAykB-Dcww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisFGqt7g%253D&md5=c7b52439e0e35003e8c20242b21da860</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2F19077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F19077%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DOstaszewski%26aufirst%3DB.%2BL.%26aulast%3DDiehl%26aufirst%3DT.%2BS.%26aulast%3DKimberly%26aufirst%3DW.%2BT.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DTwo%2520transmembrane%2520aspartates%2520in%2520presenilin-1%2520required%2520for%2520presenilin%2520endoproteolysis%2520and%2520gamma-secretase%2520activity%26jtitle%3DNature%26date%3D1999%26volume%3D398%26spage%3D513%26epage%3D517%26doi%3D10.1038%2F19077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craessaerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumm, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeter, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrijvers, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopan, R.</span><span> </span><span class="NLM_article-title">A presenilin-1-dependent gamma-secretase-like protease mediates release of notch intracellular domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">398</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span><span class="refDoi"> DOI: 10.1038/19083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F19083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10206645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK1MXisFGqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=1999&pages=518-522&author=B.+De+Strooperauthor=W.+Annaertauthor=P.+Cupersauthor=P.+Saftigauthor=K.+Craessaertsauthor=J.+S.+Mummauthor=E.+H.+Schroeterauthor=V.+Schrijversauthor=M.+S.+Wolfeauthor=W.+J.+Rayauthor=A.+Goateauthor=R.+Kopan&title=A+presenilin-1-dependent+gamma-secretase-like+protease+mediates+release+of+notch+intracellular+domain&doi=10.1038%2F19083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain</span></div><div class="casAuthors">De Strooper, Bart; Annaert, Wim; Cupers, Philippe; Saftig, Paul; Craessaerts, Katleen; Mumm, Jeffrey S.; Schroeter, Eric H.; Schrijvers, Vincent; Wolfe, Michael S.; Ray, William J.; Goate, Alison; Kopan, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">398</span>
        (<span class="NLM_cas:issue">6727</span>),
    <span class="NLM_cas:pages">518-522</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Signaling through the receptor protein Notch, which is involved in crucial cell-fate decisions during development, requires ligand-induced cleavage of Notch.  This cleavage occurs within the predicted transmembrane domain, releasing the Notch intra-cellular domain (NICD), and is reminiscent of γ-secretase-mediated cleavage of β-amyloid precursor protein (APP), a crit. event in the pathogenesis of Alzheimer's disease.  A deficiency in presenilin-1 (PS1) inhibits processing of APP by γ-secretase in mammalian cells, and genetic interactions between Notch and PS1 homologs in Caenorhabditis elegans indicate that the presenilins may modulate the Notch signaling pathway.  Here we report that, in mammalian cells, PS1 deficiency also reduces the proteolytic release of NICD from a truncated Notch construct, thus identifying the specific biochem. step of the Notch signaling pathway that is affected by PS1.  Moreover, several γ-secretase inhibitors block this same step in Notch processing, indicating that related protease activities are responsible for cleavage within the predicted transmembrane domains of Notch and APP.  Thus the targeting of γ-secretase for the treatment of Alzheimer's disease may risk toxicity caused by reduced Notch signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQagjvTdUe8rVg90H21EOLACvtfcHk0ljYiAykB-Dcww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisFGqt7k%253D&md5=b42222d870cb32d3093addb8ccb2a5a2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F19083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F19083%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DAnnaert%26aufirst%3DW.%26aulast%3DCupers%26aufirst%3DP.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DCraessaerts%26aufirst%3DK.%26aulast%3DMumm%26aufirst%3DJ.%2BS.%26aulast%3DSchroeter%26aufirst%3DE.%2BH.%26aulast%3DSchrijvers%26aufirst%3DV.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DKopan%26aufirst%3DR.%26atitle%3DA%2520presenilin-1-dependent%2520gamma-secretase-like%2520protease%2520mediates%2520release%2520of%2520notch%2520intracellular%2520domain%26jtitle%3DNature%26date%3D1999%26volume%3D398%26spage%3D518%26epage%3D522%26doi%3D10.1038%2F19083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Sherrington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaev, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaeva, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foncin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruni, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montesi, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainero, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinessi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumakov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanseau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polinsky, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasco, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Silva, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haines, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pericak-Vance, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roses, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St George-Hyslop, P. H.</span><span> </span><span class="NLM_article-title">Cloning of a gene bearing missense mutations in early-onset familial alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">754</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span><span class="refDoi"> DOI: 10.1038/375754a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F375754a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=7596406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVymtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=1995&pages=754-760&author=R.+Sherringtonauthor=E.+I.+Rogaevauthor=Y.+Liangauthor=E.+A.+Rogaevaauthor=G.+Levesqueauthor=M.+Ikedaauthor=H.+Chiauthor=C.+Linauthor=G.+Liauthor=K.+Holmanauthor=T.+Tsudaauthor=L.+Marauthor=J.+F.+Foncinauthor=A.+C.+Bruniauthor=M.+P.+Montesiauthor=S.+Sorbiauthor=I.+Raineroauthor=L.+Pinessiauthor=L.+Neeauthor=I.+Chumakovauthor=D.+Pollenauthor=A.+Brookesauthor=P.+Sanseauauthor=R.+J.+Polinskyauthor=W.+Wascoauthor=H.+A.+Da+Silvaauthor=J.+L.+Hainesauthor=M.+A.+Pericak-Vanceauthor=R.+E.+Tanziauthor=A.+D.+Rosesauthor=P.+E.+Fraserauthor=J.+M.+Rommensauthor=P.+H.+St+George-Hyslop&title=Cloning+of+a+gene+bearing+missense+mutations+in+early-onset+familial+alzheimer%E2%80%99s+disease&doi=10.1038%2F375754a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease</span></div><div class="casAuthors">Sherrington, R.; Rogaev, E. I.; Liang, Y.; Rogaeva, E. A.; Levesque, G.; Ikeda, M.; Chi, H.; Lin, C.; Li, G.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">375</span>
        (<span class="NLM_cas:issue">6534</span>),
    <span class="NLM_cas:pages">754-60</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Some cases of Alzheimer's disease are inherited as an autosomal dominant trait.  Genetic linkage studies have mapped a locus (AD3) assocd. with susceptibility to a very aggressive form of Alzheimer's disease to chromosome 14q24.3.  The authors have defined a minimal cosegregating region contg. the AD3 gene, and isolated at least 19 different transcripts encoded within this region.  One of these transcripts (S182) corresponds to a novel gene whose product is predicted to contain multiple transmembrane domains and resembles an integral membrane protein.  Five different missense mutations have been found that cosegregate with early-onset familial Alzheimer's disease.  Because these changes occurred in conserved domains of the gene, and are not present in normal controls, they are likely to be causative of AD3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp49ubD8AKFQ7Vg90H21EOLACvtfcHk0ljYiAykB-Dcww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVymtbo%253D&md5=c68c5ca80245a13604d3710cb5e3ab28</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2F375754a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F375754a0%26sid%3Dliteratum%253Aachs%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DRogaev%26aufirst%3DE.%2BI.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DRogaeva%26aufirst%3DE.%2BA.%26aulast%3DLevesque%26aufirst%3DG.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DChi%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DHolman%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DT.%26aulast%3DMar%26aufirst%3DL.%26aulast%3DFoncin%26aufirst%3DJ.%2BF.%26aulast%3DBruni%26aufirst%3DA.%2BC.%26aulast%3DMontesi%26aufirst%3DM.%2BP.%26aulast%3DSorbi%26aufirst%3DS.%26aulast%3DRainero%26aufirst%3DI.%26aulast%3DPinessi%26aufirst%3DL.%26aulast%3DNee%26aufirst%3DL.%26aulast%3DChumakov%26aufirst%3DI.%26aulast%3DPollen%26aufirst%3DD.%26aulast%3DBrookes%26aufirst%3DA.%26aulast%3DSanseau%26aufirst%3DP.%26aulast%3DPolinsky%26aufirst%3DR.%2BJ.%26aulast%3DWasco%26aufirst%3DW.%26aulast%3DDa%2BSilva%26aufirst%3DH.%2BA.%26aulast%3DHaines%26aufirst%3DJ.%2BL.%26aulast%3DPericak-Vance%26aufirst%3DM.%2BA.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DRoses%26aufirst%3DA.%2BD.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26aulast%3DRommens%26aufirst%3DJ.%2BM.%26aulast%3DSt%2BGeorge-Hyslop%26aufirst%3DP.%2BH.%26atitle%3DCloning%2520of%2520a%2520gene%2520bearing%2520missense%2520mutations%2520in%2520early-onset%2520familial%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1995%26volume%3D375%26spage%3D754%26epage%3D760%26doi%3D10.1038%2F375754a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Rogaev, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaeva, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacmias, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piacentini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaducci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumakov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannfelt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George-Hyslop, P. H.</span><span> </span><span class="NLM_article-title">Familial alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the alzheimer’s disease type 3 gene</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span><span class="refDoi"> DOI: 10.1038/376775a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F376775a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=7651536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=775-778&author=E.+I.+Rogaevauthor=R.+Sherringtonauthor=E.+A.+Rogaevaauthor=G.+Levesqueauthor=M.+Ikedaauthor=Y.+Liangauthor=H.+Chiauthor=C.+Linauthor=K.+Holmanauthor=T.+Tsudaauthor=L.+Marauthor=S.+Sorbiauthor=B.+Nacmiasauthor=S.+Piacentiniauthor=L.+Amaducciauthor=I.+Chumakovauthor=D.+Cohenauthor=P.+Lannfeltauthor=P.+E.+Fraserauthor=J.+M.+Rommensauthor=P.+H.+St.+George-Hyslop&title=Familial+alzheimer%E2%80%99s+disease+in+kindreds+with+missense+mutations+in+a+gene+on+chromosome+1+related+to+the+alzheimer%E2%80%99s+disease+type+3+gene&doi=10.1038%2F376775a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene</span></div><div class="casAuthors">Rogaev, E. I.; Sherrington, R.; Rogaeva, E. A.; Levesque, G.; Ikeda, M.; Liang, Y.; Chi, H.; Lin, C.; Holman, K.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">6543</span>),
    <span class="NLM_cas:pages">775-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">We report the cloning of a novel gene (E5-1) encoded on chromosome 1 which has substantial nucleotide and amino-acid sequence similarity to the S182 gene on chromosome 14q24.3.  Mutations, including three new missense mutations in the S182 gene, are assocd. with the AD3 subtype of early-onset familial Alzheimer's disease (AD).  Both the E5-1 and the S182 proteins are predicted to be integral membrane proteins with seven-membrane-spanning domains, and a large exposed loop between the sixth and seventh transmembrane domains.  Anal. of the nucleotide sequence of the open reading frame (ORF) of the E5-1 gene led to the discovery of two missense substitutions at conserved amino-acid residues in affected members of pedigrees with a form of familial AD that has a later age of onset than the AD3 subtype (50-70 yr vs. 30-60 yr for AD3).  These observations imply that the E5-1 gene on chromosome 1 and the S182 gene on chromosome 14q24.3 are members of a family of genes (presenilins) with related functions, and indicates that mutations in conserved residues of E5-1 could also play a role in the genesis of AD.  The authors results also indicate that still other AD susceptibility genes exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopES5CZyuo6LVg90H21EOLACvtfcHk0livizI1itwN0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFChsL4%253D&md5=8566f773f8d12ab5339a9fb16cb8dfd5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2F376775a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F376775a0%26sid%3Dliteratum%253Aachs%26aulast%3DRogaev%26aufirst%3DE.%2BI.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DRogaeva%26aufirst%3DE.%2BA.%26aulast%3DLevesque%26aufirst%3DG.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DChi%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DHolman%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DT.%26aulast%3DMar%26aufirst%3DL.%26aulast%3DSorbi%26aufirst%3DS.%26aulast%3DNacmias%26aufirst%3DB.%26aulast%3DPiacentini%26aufirst%3DS.%26aulast%3DAmaducci%26aufirst%3DL.%26aulast%3DChumakov%26aufirst%3DI.%26aulast%3DCohen%26aufirst%3DD.%26aulast%3DLannfelt%26aufirst%3DP.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26aulast%3DRommens%26aufirst%3DJ.%2BM.%26aulast%3DSt.%2BGeorge-Hyslop%26aufirst%3DP.%2BH.%26atitle%3DFamilial%2520alzheimer%25E2%2580%2599s%2520disease%2520in%2520kindreds%2520with%2520missense%2520mutations%2520in%2520a%2520gene%2520on%2520chromosome%25201%2520related%2520to%2520the%2520alzheimer%25E2%2580%2599s%2520disease%2520type%25203%2520gene%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D775%26epage%3D778%26doi%3D10.1038%2F376775a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span> </span><span class="NLM_article-title">Nonpeptide bace1 inhibitors: Design and synthesis</span> <span class="citation_source-journal">Methods Princ. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span><span class="refDoi"> DOI: 10.1002/9783527630943.ch17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1002%2F9783527630943.ch17" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2011&pages=481-509&author=D.+C.+Coleauthor=M.+G.+Bursavich&title=Nonpeptide+bace1+inhibitors%3A+Design+and+synthesis&doi=10.1002%2F9783527630943.ch17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F9783527630943.ch17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9783527630943.ch17%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26atitle%3DNonpeptide%2520bace1%2520inhibitors%253A%2520Design%2520and%2520synthesis%26jtitle%3DMethods%2520Princ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D45%26spage%3D481%26epage%3D509%26doi%3D10.1002%2F9783527630943.ch17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopcova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J.</span><span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant bace1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2045</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+bace1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0livizI1itwN0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520bace1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemma, S.</span><span> </span><span class="NLM_article-title">The structural evolution of beta-secretase inhibitors: A focus on the development of small-molecule inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1787</span><span class="NLM_x">–</span> <span class="NLM_lpage">1807</span><span class="refDoi"> DOI: 10.2174/15680266113139990137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.2174%2F15680266113139990137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23931442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1787-1807&author=S.+Butiniauthor=S.+Brogiauthor=E.+Novellinoauthor=G.+Campianiauthor=A.+K.+Ghoshauthor=M.+Brindisiauthor=S.+Gemma&title=The+structural+evolution+of+beta-secretase+inhibitors%3A+A+focus+on+the+development+of+small-molecule+inhibitors&doi=10.2174%2F15680266113139990137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Structural Evolution of β-Secretase Inhibitors: A Focus on the Development of Small-Molecule Inhibitors</span></div><div class="casAuthors">Butini, Stefania; Brogi, Simone; Novellino, Ettore; Campiani, Giuseppe; Ghosh, Arun K.; Brindisi, Margherita; Gemma, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1787-1807</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Effective treatment of Alzheimer's disease (AD) remains a crit. unmet need in medicine.  The lack of useful treatment for AD led to an intense search for novel therapies based on the amyloid hypothesis, which states that amyloid β-42 (Aβ 42) plays an early and crucial role in all cases of AD. β-Secretase (also known as BACE-1 β-site APP-cleaving enzyme, Asp-2 or memapsin-2) is an aspartyl protease representing the rate limiting step in the generation of Aβ peptide fragments, therefore it could represent an important target in the steady hunt for a disease-modifying treatment.  Generally, β-secretase inhibitors are grouped into two families: peptidomimetic and nonpeptidomimetic inhibitors.  However, irresp. of the class, serious challenges with respect to blood-brain barrier (BBB) penetration and selectivity still remain.  Discovering a small mol. inhibitor of β-secretase represents an unnerving challenge but, due to its significant potential as a therapeutic target, growing efforts in this task are evident from both academic and industrial labs.  In this frame, the rising availability of crystal structures of β-secretase-inhibitor complexes represents an invaluable opportunity for optimization.  Nevertheless, beyond the inhibitory activity, the major issue of the current research approaches is about problems assocd. with BBB penetration and pharmacokinetic properties.  This review follows the structural evolution of the early β-secretase inhibitors and gives a snap-shot of the hottest chem. templates in the literature of the last five years, showing research progress in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9SkCa5mjCv7Vg90H21EOLACvtfcHk0lhZOJBxto729A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsLrI&md5=05e8126a28f1d7560530a0a67304864f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990137%26sid%3Dliteratum%253Aachs%26aulast%3DButini%26aufirst%3DS.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DGemma%26aufirst%3DS.%26atitle%3DThe%2520structural%2520evolution%2520of%2520beta-secretase%2520inhibitors%253A%2520A%2520focus%2520on%2520the%2520development%2520of%2520small-molecule%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1787%26epage%3D1807%26doi%3D10.2174%2F15680266113139990137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendran, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span> </span><span class="NLM_article-title">Function, therapeutic potential and cell biology of bace proteases: Current status and future prospects</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1111/jnc.12715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1111%2Fjnc.12715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24646365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2014&pages=4-28&author=R.+Vassarauthor=P.+H.+Kuhnauthor=C.+Haassauthor=M.+E.+Kennedyauthor=L.+Rajendranauthor=P.+C.+Wongauthor=S.+F.+Lichtenthaler&title=Function%2C+therapeutic+potential+and+cell+biology+of+bace+proteases%3A+Current+status+and+future+prospects&doi=10.1111%2Fjnc.12715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects</span></div><div class="casAuthors">Vassar, Robert; Kuhn, Peer-Hendrik; Haass, Christian; Kennedy, Matthew E.; Rajendran, Lawrence; Wong, Philip C.; Lichtenthaler, Stefan F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-28</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The β-site APP cleaving enzymes 1 and 2 (BACE1 and BACE2) were initially identified as transmembrane aspartyl proteases cleaving the amyloid precursor protein (APP).  BACE1 is a major drug target for Alzheimer's disease because BACE1-mediated cleavage of APP is the first step in the generation of the pathogenic amyloid-β peptides.  BACE1, which is highly expressed in the nervous system, is also required for myelination by cleaving neuregulin 1.  Several recent proteomic and in vivo studies using BACE1- and BACE2-deficient mice demonstrate a much wider range of physiol. substrates and functions for both proteases within and outside of the nervous system.  For BACE1 this includes axon guidance, neurogenesis, muscle spindle formation, and neuronal network functions, whereas BACE2 was shown to be involved in pigmentation and pancreatic β-cell function.  This review highlights the recent progress in understanding cell biol., substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer's disease.  The protease BACE1 is a major drug target in Alzheimer disease.  Together with its homolog BACE2, both proteases have an increasing no. of functions within and outside of the nervous system.  This review highlights recent progress in understanding cell biol., substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxkCRjc9dYMLVg90H21EOLACvtfcHk0lhZOJBxto729A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtL7M&md5=79e394bb720ad6639f8efc86138fcd60</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12715%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKuhn%26aufirst%3DP.%2BH.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DRajendran%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26atitle%3DFunction%252C%2520therapeutic%2520potential%2520and%2520cell%2520biology%2520of%2520bace%2520proteases%253A%2520Current%2520status%2520and%2520future%2520prospects%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D130%26spage%3D4%26epage%3D28%26doi%3D10.1111%2Fjnc.12715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Doody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieburtz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethuraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R.</span><span> </span><span class="NLM_article-title">A phase 3 trial of semagacestat for treatment of alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span><span class="refDoi"> DOI: 10.1056/NEJMoa1210951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1056%2FNEJMoa1210951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23883379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2nur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=341-350&author=R.+S.+Doodyauthor=R.+Ramanauthor=M.+Farlowauthor=T.+Iwatsuboauthor=B.+Vellasauthor=S.+Joffeauthor=K.+Kieburtzauthor=F.+Heauthor=X.+Sunauthor=R.+G.+Thomasauthor=P.+S.+Aisenauthor=E.+Siemersauthor=G.+Sethuramanauthor=R.+Mohs&title=A+phase+3+trial+of+semagacestat+for+treatment+of+alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1210951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 3 trial of semagacestat for treatment of Alzheimer's disease</span></div><div class="casAuthors">Doody, Rachelle S.; Raman, Rema; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; He, Feng; Sun, Xiaoying; Thomas, Ronald G.; Aisen, Paul S.; Siemers, Eric; Sethuraman, Gopalan; Mohs, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-350</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease is characterized by the presence of cortical amyloid-beta (Aβ) protein plaques, which result from the sequential action of β-secretase and γ-secretase on amyloid precursor protein.  Semagacestat is a small-mol. γ-secretase inhibitor that was developed as a potential treatment for Alzheimer's disease.  Methods: We conducted a double-blind, placebo-controlled trial in which 1537 patients with probable Alzheimer's disease underwent randomization to receive 100 mg of semagacestat, 140 mg of semagacestat, or placebo daily.  Changes in cognition from baseline to week 76 were assessed with the use of the cognitive subscale of the Alzheimer's Disease Assessment Scale for cognition (ADAS-cog), on which scores range from 0 to 70 and higher scores indicate greater cognitive impairment, and changes in functioning were assessed with the Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) scale, on which scores range from 0 to 78 and higher scores indicate better functioning.  A mixed-model repeated-measures anal. was used.  Results: The trial was terminated before completion on the basis of a recommendation by the data and safety monitoring board.  At termination, there were 189 patients in the group receiving placebo, 153 patients in the group receiving 100 mg of semagacestat, and 121 patients in the group receiving 140 mg of semagacestat.  The ADAS-cog scores worsened in all three groups (mean change, 6.4 points in the placebo group, 7.5 points in the group receiving 100 mg of the study drug, and 7.8 points in the group receiving 140 mg; P = 0.15 and P = 0.07, resp., for the comparison with placebo).  The ADCS-ADL scores also worsened in all groups (mean change at week 76, -9.0 points in the placebo group, -10.5 points in the 100-mg group, and -12.6 points in the 140-mg group; P = 0.14 and P<0.001, resp., for the comparison with placebo).  Patients treated with semagacestat lost more wt. and had more skin cancers and infections, treatment discontinuations due to adverse events, and serious adverse events (P<0.001 for all comparisons with placebo).  Lab. abnormalities included reduced levels of lymphocytes, T cells, Igs, albumin, total protein, and uric acid and elevated levels of eosinophils, monocytes, and cholesterol; the urine pH was also elevated.  Conclusions: As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability.  Semagacestat was assocd. with more adverse events, including skin cancers and infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMQCX6dUTyl7Vg90H21EOLACvtfcHk0lh4zKDJHvKdSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2nur7L&md5=366f2545b2156100af31993c809feac1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1210951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1210951%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DJoffe%26aufirst%3DS.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DSethuraman%26aufirst%3DG.%26aulast%3DMohs%26aufirst%3DR.%26atitle%3DA%2520phase%25203%2520trial%2520of%2520semagacestat%2520for%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D341%26epage%3D350%26doi%3D10.1056%2FNEJMoa1210951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Henley, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundell, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethuraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span> </span><span class="NLM_article-title">Safety profile of semagacestat, a gamma-secretase inhibitor: Identity trial findings</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2032</span><span class="refDoi"> DOI: 10.1185/03007995.2014.939167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1185%2F03007995.2014.939167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24983746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Oktb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=2021-2032&author=D.+B.+Henleyauthor=K.+L.+Sundellauthor=G.+Sethuramanauthor=S.+A.+Dowsettauthor=P.+C.+May&title=Safety+profile+of+semagacestat%2C+a+gamma-secretase+inhibitor%3A+Identity+trial+findings&doi=10.1185%2F03007995.2014.939167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings</span></div><div class="casAuthors">Henley, David B.; Sundell, Karen L.; Sethuraman, Gopalan; Dowsett, Sherie A.; May, Patrick C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2021-2032</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Objective: Semagacestat, a γ-secretase inhibitor, demonstrated an unfavorable risk-benefit profile in a Phase 3 study of patients with Alzheimer's disease (IDENTITY trials), and clin. development was halted.  To assist in future development of γ-secretase inhibitors, we report detailed safety findings from the IDENTITY study, with emphasis on those that might be mechanistically linked to γ-secretase inhibition.  Research design and methods: The IDENTITY trial was a double-blind, placebo-controlled trial of semagacestat (100 mg and 140 mg), in which 1537 patients age 55 years and older with probable Alzheimer's disease were randomized.  Treatment-emergent adverse events (TEAEs) are reported by body system along with pertinent lab., vital sign, and ECG findings.  Results: Semagacestat treatment was assocd. with increased reporting of suspected Notch-related adverse events (gastrointestinal, infection, and skin cancer related).  Other relevant safety findings assocd. with semagacestat treatment included cognitive and functional worsening, skin-related TEAEs, renal and hepatic changes, increased QT interval, and wt. loss.  With few exceptions, differences between semagacestat and placebo treatment groups were no longer significant after cessation of treatment with active drug.  Conclusions: Many of these safety findings can be attributed to γ-secretase inhibition, and may be valuable to researchers developing γ-secretase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC2ZGLarufNrVg90H21EOLACvtfcHk0lh4zKDJHvKdSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Oktb3N&md5=7c2d61aafe7bbf26ce9d853d8b5f590a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1185%2F03007995.2014.939167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F03007995.2014.939167%26sid%3Dliteratum%253Aachs%26aulast%3DHenley%26aufirst%3DD.%2BB.%26aulast%3DSundell%26aufirst%3DK.%2BL.%26aulast%3DSethuraman%26aufirst%3DG.%26aulast%3DDowsett%26aufirst%3DS.%2BA.%26aulast%3DMay%26aufirst%3DP.%2BC.%26atitle%3DSafety%2520profile%2520of%2520semagacestat%252C%2520a%2520gamma-secretase%2520inhibitor%253A%2520Identity%2520trial%2520findings%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2014%26volume%3D30%26spage%3D2021%26epage%3D2032%26doi%3D10.1185%2F03007995.2014.939167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Lessons from a failed gamma-secretase alzheimer trial</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.cell.2014.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.cell.2014.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=25417150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2msrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2014&pages=721-726&author=B.+De+Strooper&title=Lessons+from+a+failed+gamma-secretase+alzheimer+trial&doi=10.1016%2Fj.cell.2014.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from a Failed γ-Secretase Alzheimer Trial</span></div><div class="casAuthors">De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">721-726</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  γ-Secretase proteases have been assocd. with pathol. in Alzheimer disease (AD), but we are just beginning to understand their basic mechanisms and physiol. roles.  A neg. drug trial with a broad spectrum γ-secretase inhibitor in AD patients has severely dampened enthusiasm for the potential of pursuing γ-secretase research therapeutically.  This pessimism is unwarranted: anal. of available information presented here demonstrates significant confounds for interpreting the outcome of the trial and argues that the major lessons pertain to broad knowledge gaps that are imperative to fill.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoltWoN44tWybVg90H21EOLACvtfcHk0lh4zKDJHvKdSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2msrnI&md5=9d19644a7135552c6c4ef2b812b4b665</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DLessons%2520from%2520a%2520failed%2520gamma-secretase%2520alzheimer%2520trial%26jtitle%3DCell%26date%3D2014%26volume%3D159%26spage%3D721%26epage%3D726%26doi%3D10.1016%2Fj.cell.2014.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Sterling, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">A subset of nsaids lower amyloidogenic abeta42 independently of cyclooxygenase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1038/35102591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F35102591" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=212-216&author=S.+Weggenauthor=J.+L.+Eriksenauthor=P.+Dasauthor=S.+A.+Sagiauthor=R.+Wangauthor=C.+U.+Pietrzikauthor=K.+A.+Findlayauthor=T.+E.+Smithauthor=M.+P.+Murphyauthor=T.+Bulterauthor=D.+E.+Kangauthor=N.+Marquez-Sterlingauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A+subset+of+nsaids+lower+amyloidogenic+abeta42+independently+of+cyclooxygenase+activity&doi=10.1038%2F35102591"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2F35102591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35102591%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DFindlay%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DBulter%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%2BE.%26aulast%3DMarquez-Sterling%26aufirst%3DN.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%2520subset%2520of%2520nsaids%2520lower%2520amyloidogenic%2520abeta42%2520independently%2520of%2520cyclooxygenase%2520activity%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D212%26epage%3D216%26doi%3D10.1038%2F35102591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Sato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title">Active gamma-secretase complexes contain only one of each component</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">33985</span><span class="NLM_x">–</span> <span class="NLM_lpage">33993</span><span class="refDoi"> DOI: 10.1074/jbc.M705248200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M705248200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=33985-33993&author=T.+Satoauthor=T.+S.+Diehlauthor=S.+Narayananauthor=S.+Funamotoauthor=Y.+Iharaauthor=B.+De+Strooperauthor=H.+Steinerauthor=C.+Haassauthor=M.+S.+Wolfe&title=Active+gamma-secretase+complexes+contain+only+one+of+each+component&doi=10.1074%2Fjbc.M705248200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M705248200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M705248200%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DT.%26aulast%3DDiehl%26aufirst%3DT.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DFunamoto%26aufirst%3DS.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3DActive%2520gamma-secretase%2520complexes%2520contain%2520only%2520one%2520of%2520each%2520component%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D33985%26epage%3D33993%26doi%3D10.1074%2Fjbc.M705248200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><a href="http://www.alzforum.org/mutations" class="extLink">http://www.alzforum.org/mutations</a> (accessed Dec 1, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.alzforum.org%2Fmutations+%28accessed+Dec+1%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Brunkan, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goate, A. M.</span><span> </span><span class="NLM_article-title">Presenilin endoproteolysis is an intramolecular cleavage</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1016/j.mcn.2004.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.mcn.2004.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=15866047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslKitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2005&pages=65-73&author=A.+L.+Brunkanauthor=M.+Martinezauthor=E.+S.+Walkerauthor=A.+M.+Goate&title=Presenilin+endoproteolysis+is+an+intramolecular+cleavage&doi=10.1016%2Fj.mcn.2004.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Presenilin endoproteolysis is an intramolecular cleavage</span></div><div class="casAuthors">Brunkan, Anne L.; Martinez, Maribel; Walker, Emily S.; Goate, Alison M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-73</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mutations in the presenilin genes (PS) account for most cases of familial Alzheimer's disease.  PS contain the active site of the γ-secretase complex that cleaves within the transmembrane domain of β-amyloid precursor protein (APP).  Full-length PS undergoes regulated endoproteolysis to produce fragments that comprise the active form of PS.  The "presenilinase" responsible for endoproteolysis is unknown but may be the same presenilin-dependent γ-secretase activity that cleaves APP.  To investigate the mechanism of endoproteolysis, the authors examd. sequence specificity at the cleavage site and tested whether PS dimers are important for endoproteolysis as well as γ-secretase activity.  No single point mutation, or a double mutation M292D/V293K, was able to completely abolish endoproteolysis and all mutants supported γ-secretase activity.  When wtPS1 was co-expressed with either M292D/V293K or D257A, it was unable to restore normal endoproteolysis to either mutant.  Lack of transcleavage by wtPS1 suggests that PS1 endoproteolysis occurs via intramol. cleavage and does not require dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxjlxGVNZNabVg90H21EOLACvtfcHk0liFKHiRROPjww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslKitr0%253D&md5=3c9873361ff2690a9b076dfc0e4f0c62</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2004.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2004.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DBrunkan%26aufirst%3DA.%2BL.%26aulast%3DMartinez%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DE.%2BS.%26aulast%3DGoate%26aufirst%3DA.%2BM.%26atitle%3DPresenilin%2520endoproteolysis%2520is%2520an%2520intramolecular%2520cleavage%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2005%26volume%3D29%26spage%3D65%26epage%3D73%26doi%3D10.1016%2Fj.mcn.2004.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Chavez-Gutierrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Strooper, B.</span><span> </span><span class="NLM_article-title">Glu(332) in the nicastrin ectodomain is essential for gamma-secretase complex maturation but not for its activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">20096</span><span class="NLM_x">–</span> <span class="NLM_lpage">20105</span><span class="refDoi"> DOI: 10.1074/jbc.M803040200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M803040200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=20096-20105&author=L.+Chavez-Gutierrezauthor=A.+Toliaauthor=E.+Maesauthor=T.+Liauthor=P.+C.+Wongauthor=B.+de+Strooper&title=Glu%28332%29+in+the+nicastrin+ectodomain+is+essential+for+gamma-secretase+complex+maturation+but+not+for+its+activity&doi=10.1074%2Fjbc.M803040200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803040200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803040200%26sid%3Dliteratum%253Aachs%26aulast%3DChavez-Gutierrez%26aufirst%3DL.%26aulast%3DTolia%26aufirst%3DA.%26aulast%3DMaes%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3Dde%2BStrooper%26aufirst%3DB.%26atitle%3DGlu%2528332%2529%2520in%2520the%2520nicastrin%2520ectodomain%2520is%2520essential%2520for%2520gamma-secretase%2520complex%2520maturation%2520but%2520not%2520for%2520its%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D20096%26epage%3D20105%26doi%3D10.1074%2Fjbc.M803040200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlant, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dann, C. E.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudhof, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G.</span><span> </span><span class="NLM_article-title">Nicastrin functions as a gamma-secretase-substrate receptor</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span><span class="refDoi"> DOI: 10.1016/j.cell.2005.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.cell.2005.05.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2005&pages=435-447&author=S.+Shahauthor=S.+F.+Leeauthor=K.+Tabuchiauthor=Y.+H.+Haoauthor=C.+Yuauthor=Q.+LaPlantauthor=H.+Ballauthor=C.+E.+Dannauthor=T.+Sudhofauthor=G.+Yu&title=Nicastrin+functions+as+a+gamma-secretase-substrate+receptor&doi=10.1016%2Fj.cell.2005.05.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BF.%26aulast%3DTabuchi%26aufirst%3DK.%26aulast%3DHao%26aufirst%3DY.%2BH.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DLaPlant%26aufirst%3DQ.%26aulast%3DBall%26aufirst%3DH.%26aulast%3DDann%26aufirst%3DC.%2BE.%26aulast%3DSudhof%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DG.%26atitle%3DNicastrin%2520functions%2520as%2520a%2520gamma-secretase-substrate%2520receptor%26jtitle%3DCell%26date%3D2005%26volume%3D122%26spage%3D435%26epage%3D447%26doi%3D10.1016%2Fj.cell.2005.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Xie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Crystal structure of the gamma-secretase component nicastrin</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">13349</span><span class="NLM_x">–</span> <span class="NLM_lpage">13354</span><span class="refDoi"> DOI: 10.1073/pnas.1414837111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1073%2Fpnas.1414837111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=13349-13354&author=T.+Xieauthor=C.+Yanauthor=R.+Zhouauthor=Y.+Zhaoauthor=L.+Sunauthor=G.+Yangauthor=P.+Luauthor=D.+Maauthor=Y.+Shi&title=Crystal+structure+of+the+gamma-secretase+component+nicastrin&doi=10.1073%2Fpnas.1414837111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1414837111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1414837111%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DCrystal%2520structure%2520of%2520the%2520gamma-secretase%2520component%2520nicastrin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D13349%26epage%3D13354%26doi%3D10.1073%2Fpnas.1414837111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Pardossi-Piquard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanemoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevalle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Checler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt-Ulms, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George-Hyslop, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span> </span><span class="NLM_article-title">Aph1 polar transmembrane residues regulate the assembly and activity of presenilin complexes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">16298</span><span class="NLM_x">–</span> <span class="NLM_lpage">16307</span><span class="refDoi"> DOI: 10.1074/jbc.M109.000067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M109.000067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=16298-16307&author=R.+Pardossi-Piquardauthor=S.+P.+Yangauthor=S.+Kanemotoauthor=Y.+Guauthor=F.+Chenauthor=C.+Bohmauthor=J.+Sevalleauthor=T.+Liauthor=P.+C.+Wongauthor=F.+Checlerauthor=G.+Schmitt-Ulmsauthor=P.+St.+George-Hyslopauthor=P.+E.+Fraser&title=Aph1+polar+transmembrane+residues+regulate+the+assembly+and+activity+of+presenilin+complexes&doi=10.1074%2Fjbc.M109.000067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.000067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.000067%26sid%3Dliteratum%253Aachs%26aulast%3DPardossi-Piquard%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DS.%2BP.%26aulast%3DKanemoto%26aufirst%3DS.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DBohm%26aufirst%3DC.%26aulast%3DSevalle%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DSchmitt-Ulms%26aufirst%3DG.%26aulast%3DSt.%2BGeorge-Hyslop%26aufirst%3DP.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26atitle%3DAph1%2520polar%2520transmembrane%2520residues%2520regulate%2520the%2520assembly%2520and%2520activity%2520of%2520presenilin%2520complexes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D16298%26epage%3D16307%26doi%3D10.1074%2Fjbc.M109.000067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Biervliet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craessaerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dejaegere, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horre, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Houtvin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezovska, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprangers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciot, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moons, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jucker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Hooge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Gamma-secretase heterogeneity in the aph1 subunit: Relevance for alzheimer’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span><span class="refDoi"> DOI: 10.1126/science.1171176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1126%2Fscience.1171176" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=639-642&author=L.+Serneelsauthor=J.+Van+Biervlietauthor=K.+Craessaertsauthor=T.+Dejaegereauthor=K.+Horreauthor=T.+Van+Houtvinauthor=H.+Esselmannauthor=S.+Paulauthor=M.+K.+Schaferauthor=O.+Berezovskaauthor=B.+T.+Hymanauthor=B.+Sprangersauthor=R.+Sciotauthor=L.+Moonsauthor=M.+Juckerauthor=Z.+Yangauthor=P.+C.+Mayauthor=E.+Karranauthor=J.+Wiltfangauthor=R.+D%E2%80%99Hoogeauthor=B.+De+Strooper&title=Gamma-secretase+heterogeneity+in+the+aph1+subunit%3A+Relevance+for+alzheimer%E2%80%99s+disease&doi=10.1126%2Fscience.1171176"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscience.1171176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1171176%26sid%3Dliteratum%253Aachs%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DVan%2BBiervliet%26aufirst%3DJ.%26aulast%3DCraessaerts%26aufirst%3DK.%26aulast%3DDejaegere%26aufirst%3DT.%26aulast%3DHorre%26aufirst%3DK.%26aulast%3DVan%2BHoutvin%26aufirst%3DT.%26aulast%3DEsselmann%26aufirst%3DH.%26aulast%3DPaul%26aufirst%3DS.%26aulast%3DSchafer%26aufirst%3DM.%2BK.%26aulast%3DBerezovska%26aufirst%3DO.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DSprangers%26aufirst%3DB.%26aulast%3DSciot%26aufirst%3DR.%26aulast%3DMoons%26aufirst%3DL.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DD%25E2%2580%2599Hooge%26aufirst%3DR.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DGamma-secretase%2520heterogeneity%2520in%2520the%2520aph1%2520subunit%253A%2520Relevance%2520for%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D639%26epage%3D642%26doi%3D10.1126%2Fscience.1171176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Bammens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez-Gutierrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwijsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Functional and topological analysis of pen-2, the fourth subunit of the gamma-secretase complex</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">12271</span><span class="NLM_x">–</span> <span class="NLM_lpage">12282</span><span class="refDoi"> DOI: 10.1074/jbc.M110.216978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M110.216978" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=12271-12282&author=L.+Bammensauthor=L.+Chavez-Gutierrezauthor=A.+Toliaauthor=A.+Zwijsenauthor=B.+De+Strooper&title=Functional+and+topological+analysis+of+pen-2%2C+the+fourth+subunit+of+the+gamma-secretase+complex&doi=10.1074%2Fjbc.M110.216978"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.216978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.216978%26sid%3Dliteratum%253Aachs%26aulast%3DBammens%26aufirst%3DL.%26aulast%3DChavez-Gutierrez%26aufirst%3DL.%26aulast%3DTolia%26aufirst%3DA.%26aulast%3DZwijsen%26aufirst%3DA.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DFunctional%2520and%2520topological%2520analysis%2520of%2520pen-2%252C%2520the%2520fourth%2520subunit%2520of%2520the%2520gamma-secretase%2520complex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D12271%26epage%3D12282%26doi%3D10.1074%2Fjbc.M110.216978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Holmes, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paturi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title">Pen-2 is essential for gamma-secretase complex stability and trafficking but partially dispensable for endoproteolysis</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4393</span><span class="NLM_x">–</span> <span class="NLM_lpage">4406</span><span class="refDoi"> DOI: 10.1021/bi500489j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi500489j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=4393-4406&author=O.+Holmesauthor=S.+Paturiauthor=D.+J.+Selkoeauthor=M.+S.+Wolfe&title=Pen-2+is+essential+for+gamma-secretase+complex+stability+and+trafficking+but+partially+dispensable+for+endoproteolysis&doi=10.1021%2Fbi500489j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fbi500489j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi500489j%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DO.%26aulast%3DPaturi%26aufirst%3DS.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3DPen-2%2520is%2520essential%2520for%2520gamma-secretase%2520complex%2520stability%2520and%2520trafficking%2520but%2520partially%2520dispensable%2520for%2520endoproteolysis%26jtitle%3DBiochemistry%26date%3D2014%26volume%3D53%26spage%3D4393%26epage%3D4406%26doi%3D10.1021%2Fbi500489j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Edbauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regula, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesold, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Reconstitution of gamma-secretase activity</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><span class="refDoi"> DOI: 10.1038/ncb960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Fncb960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=12679784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlamu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=486-488&author=D.+Edbauerauthor=E.+Winklerauthor=J.+T.+Regulaauthor=B.+Pesoldauthor=H.+Steinerauthor=C.+Haass&title=Reconstitution+of+gamma-secretase+activity&doi=10.1038%2Fncb960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Reconstitution of γ-secretase activity</span></div><div class="casAuthors">Edbauer, Dieter; Winkler, Edith; Regula, Joerg T.; Pesold, Brigitte; Steiner, Harald; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">486-488</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">γ-Secretase is a membrane protein complex with an unusual aspartyl protease activity that catalyzes the regulated intramembranous cleavage of the β-amyloid precursor protein (APP) to release the Alzheimer's disease (AD)-assocd. amyloid β-peptide (Aβ) and the APP intracellular domain (AICD).  Here we show the reconstitution of γ-secretase activity in the yeast Saccharomyces cerevisiae, which lacks endogenous γ-secretase activity.  Reconstituted γ-secretase activity depends on the presence of four complex components including presenilin (PS), nicastrin (Nct), APH-1, and PEN-2, is assocd. with endoproteolysis of PS, and produces Aβ and AICD in vitro.  Thus, the biol. activity of γ-secretase is reconstituted by the co-expression of human PS, Nct, APH-1 and PEN-2 in yeast.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTsRxQt_Ugb7Vg90H21EOLACvtfcHk0lgq6v9pQNe6KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlamu70%253D&md5=60b187dcd89c3400b62724eaecbf8fe0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fncb960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb960%26sid%3Dliteratum%253Aachs%26aulast%3DEdbauer%26aufirst%3DD.%26aulast%3DWinkler%26aufirst%3DE.%26aulast%3DRegula%26aufirst%3DJ.%2BT.%26aulast%3DPesold%26aufirst%3DB.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DReconstitution%2520of%2520gamma-secretase%2520activity%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D486%26epage%3D488%26doi%3D10.1038%2Fncb960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Bai, X.-c.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheres, S. H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">An atomic structure of human γ-secretase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">525</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span><span class="refDoi"> DOI: 10.1038/nature14892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Fnature14892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=26280335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGgurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=212-217&author=X.-c.+Baiauthor=C.+Yanauthor=G.+Yangauthor=P.+Luauthor=D.+Maauthor=L.+Sunauthor=R.+Zhouauthor=S.+H.+W.+Scheresauthor=Y.+Shi&title=An+atomic+structure+of+human+%CE%B3-secretase&doi=10.1038%2Fnature14892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">An atomic structure of human γ-secretase</span></div><div class="casAuthors">Bai, Xiao-chen; Yan, Chuangye; Yang, Guanghui; Lu, Peilong; Ma, Dan; Sun, Linfeng; Zhou, Rui; Scheres, Sjors H. W.; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">525</span>
        (<span class="NLM_cas:issue">7568</span>),
    <span class="NLM_cas:pages">212-217</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Dysfunction of the intramembrane protease γ-secretase is thought to cause Alzheimer's disease, with most mutations derived from Alzheimer's disease mapping to the catalytic subunit presenilin 1 (PS1).  Here we report an at. structure of human γ-secretase at 3.4 Å resoln., detd. by single-particle cryo-electron microscopy.  Mutations derived from Alzheimer's disease affect residues at two hotspots in PS1, each located at the center of a distinct four transmembrane segment (TM) bundle.  TM2 and, to a lesser extent, TM6 exhibit considerable flexibility, yielding a plastic active site and adaptable surrounding elements.  The active site of PS1 is accessible from the convex side of the TM horseshoe, suggesting considerable conformational changes in nicastrin extracellular domain after substrate recruitment.  Component protein APH-1 serves as a scaffold, anchoring the lone transmembrane helix from nicastrin and supporting the flexible conformation of PS1.  Ordered phospholipids stabilize the complex inside the membrane.  Our structure serves as a mol. basis for mechanistic understanding of γ-secretase function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGo99dE6LPbbVg90H21EOLACvtfcHk0lhrw3pSUIlMUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGgurfM&md5=68dd390cae90f02f8c6a3d6d9c503326</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature14892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14892%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DX.-c.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DScheres%26aufirst%3DS.%2BH.%2BW.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DAn%2520atomic%2520structure%2520of%2520human%2520%25CE%25B3-secretase%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D212%26epage%3D217%26doi%3D10.1038%2Fnature14892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Jurisch-Yaksi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannerud, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, W.</span><span> </span><span class="NLM_article-title">A fast growing spectrum of biological functions of gamma-secretase in development and disease</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1828</span><span class="NLM_x">, </span> <span class="NLM_fpage">2815</span><span class="NLM_x">–</span> <span class="NLM_lpage">2827</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2013.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bbamem.2013.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24099003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOgtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1828&publication_year=2013&pages=2815-2827&author=N.+Jurisch-Yaksiauthor=R.+Sannerudauthor=W.+Annaert&title=A+fast+growing+spectrum+of+biological+functions+of+gamma-secretase+in+development+and+disease&doi=10.1016%2Fj.bbamem.2013.04.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A fast growing spectrum of biological functions of γ-secretase in development and disease</span></div><div class="casAuthors">Jurisch-Yaksi, Nathalie; Sannerud, Ragna; Annaert, Wim</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1828</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2815-2827</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase, which assembles as a tetrameric complex, is an aspartic protease that proteolytically cleaves substrate proteins within their membrane-spanning domain; a process also known as regulated intramembrane proteolysis (RIP).  RIP regulates signaling pathways by abrogating or releasing signaling mols.  Since the discovery, already >15 years ago, of its catalytic component, presenilin, and even much earlier with the identification of amyloid precursor protein as its first substrate, γ-secretase has been commonly assocd. with Alzheimer's disease.  However, starting with Notch protein and thereafter a continuously increasing no. of novel substrates, γ-secretase is becoming linked to an equally broader range of biol. processes.  Here, the authors present an updated overview of current knowledge on the diverse mol. mechanisms and signaling pathways controlled by γ-secretase, with a focus on organ development, homeostasis, and dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp38duZNEtDLLVg90H21EOLACvtfcHk0lhrw3pSUIlMUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOgtLfE&md5=a5c48288df0911551e1f3c17f378d846</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DJurisch-Yaksi%26aufirst%3DN.%26aulast%3DSannerud%26aufirst%3DR.%26aulast%3DAnnaert%26aufirst%3DW.%26atitle%3DA%2520fast%2520growing%2520spectrum%2520of%2520biological%2520functions%2520of%2520gamma-secretase%2520in%2520development%2520and%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2013%26volume%3D1828%26spage%3D2815%26epage%3D2827%26doi%3D10.1016%2Fj.bbamem.2013.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Kopan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilagan, M. X.</span><span> </span><span class="NLM_article-title">Gamma-secretase: Proteasome of the membrane?</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1038/nrm1406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Fnrm1406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=15173829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVarsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=499-504&author=R.+Kopanauthor=M.+X.+Ilagan&title=Gamma-secretase%3A+Proteasome+of+the+membrane%3F&doi=10.1038%2Fnrm1406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Opinion: γ-Secretase: proteasome of the membrane?</span></div><div class="casAuthors">Kopan, Raphael; Ilagan, Ma. Xenia G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">499-504</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review and discussion.  γ-Secretase (I), a protease that cleaves within the membrane, was 1st recognized for its role in the prodn. of amyloidogenic Aβ peptides, but was subsequently found to mediate Notch signaling by releasing the Notch-receptor intracellular domain.  Many other I substrates have recently been identified, which indicates a broader biol. function for this unusual protease.  Emerging evidence implies that whereas some intracellular cleavage products of I function as signaling mols., others might simply be intermediates that are destined for degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAA7vqYqos2bVg90H21EOLACvtfcHk0liz6NshEpqrcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVarsbw%253D&md5=06767583dd746f5a41664a615534ebd8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrm1406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1406%26sid%3Dliteratum%253Aachs%26aulast%3DKopan%26aufirst%3DR.%26aulast%3DIlagan%26aufirst%3DM.%2BX.%26atitle%3DGamma-secretase%253A%2520Proteasome%2520of%2520the%2520membrane%253F%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D499%26epage%3D504%26doi%3D10.1038%2Fnrm1406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Chavez-Gutierrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bammens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandersteen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benurwar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lismont, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Cleynenbreugel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schymkowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The mechanism of gamma-secretase dysfunction in familial alzheimer disease</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2261</span><span class="NLM_x">–</span> <span class="NLM_lpage">2274</span><span class="refDoi"> DOI: 10.1038/emboj.2012.79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Femboj.2012.79" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22505025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFWjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=2261-2274&author=L.+Chavez-Gutierrezauthor=L.+Bammensauthor=I.+Benilovaauthor=A.+Vandersteenauthor=M.+Benurwarauthor=M.+Borgersauthor=S.+Lismontauthor=L.+Zhouauthor=S.+Van+Cleynenbreugelauthor=H.+Esselmannauthor=J.+Wiltfangauthor=L.+Serneelsauthor=E.+Karranauthor=H.+Gijsenauthor=J.+Schymkowitzauthor=F.+Rousseauauthor=K.+Broersenauthor=B.+De+Strooper&title=The+mechanism+of+gamma-secretase+dysfunction+in+familial+alzheimer+disease&doi=10.1038%2Femboj.2012.79"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of γ-secretase dysfunction in familial Alzheimer disease</span></div><div class="casAuthors">Chavez-Gutierrez, Lucia; Bammens, Leen; Benilova, Iryna; Vandersteen, Annelies; Benurwar, Manasi; Borgers, Marianne; Lismont, Sam; Zhou, Lujia; Van Cleynenbreugel, Simon; Esselmann, Hermann; Wiltfang, Jens; Serneels, Lutgarde; Karran, Eric; Gijsen, Harrie; Schymkowitz, Joost; Rousseau, Frederic; Broersen, Kerensa; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2261-2274</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanisms by which mutations in the presenilins (PSEN) or the amyloid precursor protein (APP) genes cause familial Alzheimer disease (FAD) are controversial.  FAD mutations increase the release of amyloid β (Aβ)42 relative to Aβ40 by an unknown, possibly gain-of-toxic-function, mechanism.  However, many PSEN mutations paradoxically impair γ-secretase and loss-of-function' mechanisms have also been postulated.  Here, we use kinetic studies to demonstrate that FAD mutations affect Aβ generation via three different mechanisms, resulting in qual. changes in the Aβ profiles, which are not limited to Aβ42.  Loss of ε-cleavage function is not generally obsd. among FAD mutants.  On the other hand, γ-secretase inhibitors used in the clinic appear to block the initial ε-cleavage step, but unexpectedly affect more selectively Notch than APP processing, while modulators act as activators of the carboxypeptidase-like (γ) activity.  Overall, we provide a coherent explanation for the effect of different FAD mutations, demonstrating the importance of qual. rather than quant. changes in the Aβ products, and suggest fundamental improvements for current drug development efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkaq2xb4Rkd7Vg90H21EOLACvtfcHk0liz6NshEpqrcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFWjsbg%253D&md5=75a7fd9dbecf3d24739426545aa3f6b8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Femboj.2012.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2012.79%26sid%3Dliteratum%253Aachs%26aulast%3DChavez-Gutierrez%26aufirst%3DL.%26aulast%3DBammens%26aufirst%3DL.%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DVandersteen%26aufirst%3DA.%26aulast%3DBenurwar%26aufirst%3DM.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3DLismont%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DVan%2BCleynenbreugel%26aufirst%3DS.%26aulast%3DEsselmann%26aufirst%3DH.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DSchymkowitz%26aufirst%3DJ.%26aulast%3DRousseau%26aufirst%3DF.%26aulast%3DBroersen%26aufirst%3DK.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520mechanism%2520of%2520gamma-secretase%2520dysfunction%2520in%2520familial%2520alzheimer%2520disease%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D2261%26epage%3D2274%26doi%3D10.1038%2Femboj.2012.79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title">Processive proteolysis by gamma-secretase and the mechanism of alzheimer’s disease</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">905</span><span class="refDoi"> DOI: 10.1515/hsz-2012-0140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1515%2Fhsz-2012-0140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22944690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGiurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2012&pages=899-905&author=M.+S.+Wolfe&title=Processive+proteolysis+by+gamma-secretase+and+the+mechanism+of+alzheimer%E2%80%99s+disease&doi=10.1515%2Fhsz-2012-0140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Processive proteolysis by γ-secretase and the mechanism of Alzheimer's disease</span></div><div class="casAuthors">Wolfe, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">899-905</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  γ-Secretase is a membrane-embedded protease complex with presenilin as the catalytic component.  Cleavage within the transmembrane domain of the amyloid β-protein precursor (APP) by γ-secretase produces the C-terminus of the amyloid β-peptide (Aβ), a proteolytic product prone to aggregation and strongly linked to Alzheimer's disease (AD).  Presenilin mutations are assocd. with early-onset AD, but their pathogenic mechanisms are unclear.  One hypothesis is that these mutations cause AD through a toxic gain of function, changing γ-secretase activity to increase the proportion of 42-residue Aβ over the more sol. 40-residue form.  A competing hypothesis is that the mutations cause AD through a loss of function, by reducing γ-secretase activity.  However, γ-secretase apparently has two types of activities, an endoproteolytic function that first cuts APP to generate a 48/49-residue form of Aβ, and a carboxypeptidase activity that processively trims these longer Aβ intermediates approx. every three residues to form shorter, secreted forms.  Recent studies suggest a resoln. of the gain-of-function vs. loss-of-function debate: presenilin mutations may increase the proportion of longer, more aggregation-prone Aβ by specifically decreasing the trimming activity of γ-secretase.  That is, the redn. of this particular proteolytic function of presenilin, not its endoproteolytic activity, may lead to the neurotoxic gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyz5nTenrC7bVg90H21EOLACvtfcHk0liz6NshEpqrcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGiurrM&md5=fcc7ed67a1127168594af1200f5943e3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2012-0140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2012-0140%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3DProcessive%2520proteolysis%2520by%2520gamma-secretase%2520and%2520the%2520mechanism%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiol.%2520Chem.%26date%3D2012%26volume%3D393%26spage%3D899%26epage%3D905%26doi%3D10.1515%2Fhsz-2012-0140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Weidemann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhard, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paliga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baier, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyreuther, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evin, G.</span><span> </span><span class="NLM_article-title">A novel epsilon-cleavage within the transmembrane domain of the alzheimer amyloid precursor protein demonstrates homology with notch processing</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2825</span><span class="NLM_x">–</span> <span class="NLM_lpage">2835</span><span class="refDoi"> DOI: 10.1021/bi015794o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi015794o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2825-2835&author=A.+Weidemannauthor=S.+Eggertauthor=F.+B.+Reinhardauthor=M.+Vogelauthor=K.+Paligaauthor=G.+Baierauthor=C.+L.+Mastersauthor=K.+Beyreutherauthor=G.+Evin&title=A+novel+epsilon-cleavage+within+the+transmembrane+domain+of+the+alzheimer+amyloid+precursor+protein+demonstrates+homology+with+notch+processing&doi=10.1021%2Fbi015794o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fbi015794o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi015794o%26sid%3Dliteratum%253Aachs%26aulast%3DWeidemann%26aufirst%3DA.%26aulast%3DEggert%26aufirst%3DS.%26aulast%3DReinhard%26aufirst%3DF.%2BB.%26aulast%3DVogel%26aufirst%3DM.%26aulast%3DPaliga%26aufirst%3DK.%26aulast%3DBaier%26aufirst%3DG.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBeyreuther%26aufirst%3DK.%26aulast%3DEvin%26aufirst%3DG.%26atitle%3DA%2520novel%2520epsilon-cleavage%2520within%2520the%2520transmembrane%2520domain%2520of%2520the%2520alzheimer%2520amyloid%2520precursor%2520protein%2520demonstrates%2520homology%2520with%2520notch%2520processing%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D2825%26epage%3D2835%26doi%3D10.1021%2Fbi015794o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span> </span><span class="NLM_article-title">Gamma-cleavage is dependent on zeta-cleavage during the proteolytic processing of amyloid precursor protein within its transmembrane domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">37689</span><span class="NLM_x">–</span> <span class="NLM_lpage">37697</span><span class="refDoi"> DOI: 10.1074/jbc.M507993200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M507993200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=37689-37697&author=G.+Zhaoauthor=M.+Z.+Cuiauthor=G.+Maoauthor=Y.+Dongauthor=J.+Tanauthor=L.+Sunauthor=X.+Xu&title=Gamma-cleavage+is+dependent+on+zeta-cleavage+during+the+proteolytic+processing+of+amyloid+precursor+protein+within+its+transmembrane+domain&doi=10.1074%2Fjbc.M507993200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M507993200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M507993200%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DM.%2BZ.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DGamma-cleavage%2520is%2520dependent%2520on%2520zeta-cleavage%2520during%2520the%2520proteolytic%2520processing%2520of%2520amyloid%2520precursor%2520protein%2520within%2520its%2520transmembrane%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D37689%26epage%3D37697%26doi%3D10.1074%2Fjbc.M507993200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Funamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirotani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span> </span><span class="NLM_article-title">Truncated carboxyl-terminal fragments of beta-amyloid precursor protein are processed to amyloid beta-proteins 40 and 42</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">13532</span><span class="NLM_x">–</span> <span class="NLM_lpage">13540</span><span class="refDoi"> DOI: 10.1021/bi049399k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi049399k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=13532-13540&author=S.+Funamotoauthor=M.+Morishima-Kawashimaauthor=Y.+Tanimuraauthor=N.+Hirotaniauthor=T.+C.+Saidoauthor=Y.+Ihara&title=Truncated+carboxyl-terminal+fragments+of+beta-amyloid+precursor+protein+are+processed+to+amyloid+beta-proteins+40+and+42&doi=10.1021%2Fbi049399k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi049399k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049399k%26sid%3Dliteratum%253Aachs%26aulast%3DFunamoto%26aufirst%3DS.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DTanimura%26aufirst%3DY.%26aulast%3DHirotani%26aufirst%3DN.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DIhara%26aufirst%3DY.%26atitle%3DTruncated%2520carboxyl-terminal%2520fragments%2520of%2520beta-amyloid%2520precursor%2520protein%2520are%2520processed%2520to%2520amyloid%2520beta-proteins%252040%2520and%252042%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D13532%26epage%3D13540%26doi%3D10.1021%2Fbi049399k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Yagishita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span> </span><span class="NLM_article-title">Abeta46 is processed to abeta40 and abeta43, but not to abeta42, in the low density membrane domains</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span><span class="refDoi"> DOI: 10.1074/jbc.M707103200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M707103200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=733-738&author=S.+Yagishitaauthor=M.+Morishima-Kawashimaauthor=S.+Ishiuraauthor=Y.+Ihara&title=Abeta46+is+processed+to+abeta40+and+abeta43%2C+but+not+to+abeta42%2C+in+the+low+density+membrane+domains&doi=10.1074%2Fjbc.M707103200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M707103200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M707103200%26sid%3Dliteratum%253Aachs%26aulast%3DYagishita%26aufirst%3DS.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DIshiura%26aufirst%3DS.%26aulast%3DIhara%26aufirst%3DY.%26atitle%3DAbeta46%2520is%2520processed%2520to%2520abeta40%2520and%2520abeta43%252C%2520but%2520not%2520to%2520abeta42%252C%2520in%2520the%2520low%2520density%2520membrane%2520domains%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D733%26epage%3D738%26doi%3D10.1074%2Fjbc.M707103200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Takami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagashima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span> </span><span class="NLM_article-title">Gamma-secretase: Successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">13042</span><span class="NLM_x">–</span> <span class="NLM_lpage">13052</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2362-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1523%2FJNEUROSCI.2362-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=19828817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSitL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=13042-13052&author=M.+Takamiauthor=Y.+Nagashimaauthor=Y.+Sanoauthor=S.+Ishiharaauthor=M.+Morishima-Kawashimaauthor=S.+Funamotoauthor=Y.+Ihara&title=Gamma-secretase%3A+Successive+tripeptide+and+tetrapeptide+release+from+the+transmembrane+domain+of+beta-carboxyl+terminal+fragment&doi=10.1523%2FJNEUROSCI.2362-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of β-carboxyl terminal fragment</span></div><div class="casAuthors">Takami, Mako; Nagashima, Yu; Sano, Yoshihisa; Ishihara, Seiko; Morishima-Kawashima, Maho; Funamoto, Satoru; Ihara, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">13042-13052</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid β protein (Aβ), a pathogenic mol. assocd. with Alzheimer's disease, is produced by γ-secretase, which cleaves the β-carboxyl terminal fragment (βCTF) of β-amyloid precursor protein (APP) in the middle of its transmembrane domain.  How the cleavage proceeds within the membrane has long been enigmatic.  We hypothesized previously that βCTF is cleaved first at the membrane-cytoplasm boundary, producing two long Aβs, Aβ48 and Aβ49, which are processed further by releasing three residues at each step to produce Aβ42 and Aβ40, resp.  To test this hypothesis, we used liq. chromatog. tandem mass spectrometry (LC-MS/MS) to quantify the specific tripeptides that are postulated to be released.  Using CHAPSO (3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxyl-1-propanesulfonate)-reconstituted γ-secretase system, we confirmed that Aβ49 is converted to Aβ43/40 by successively releasing two or three tripeptides and that Aβ48 is converted to Aβ42/38 by successively releasing two tripeptides or these plus an addnl. tetrapeptide.  Most unexpectedly, LC-MS/MS quantification revealed an induction period, 3-4 min, in the generation of peptides.  When extrapolated, each time line for each tripeptide appears to intercept the same point on the x-axis.  According to numerical simulation based on the successive reaction kinetics, the induction period exists.  These results strongly suggest that Aβ is generated through the stepwise processing of βCTF by γ-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYC-g_Nhz9QrVg90H21EOLACvtfcHk0ljwMetbv4ABRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSitL%252FM&md5=7123eb2419feeace3500a2ba4f42de43</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2362-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2362-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DTakami%26aufirst%3DM.%26aulast%3DNagashima%26aufirst%3DY.%26aulast%3DSano%26aufirst%3DY.%26aulast%3DIshihara%26aufirst%3DS.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DFunamoto%26aufirst%3DS.%26aulast%3DIhara%26aufirst%3DY.%26atitle%3DGamma-secretase%253A%2520Successive%2520tripeptide%2520and%2520tetrapeptide%2520release%2520from%2520the%2520transmembrane%2520domain%2520of%2520beta-carboxyl%2520terminal%2520fragment%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D13042%26epage%3D13052%26doi%3D10.1523%2FJNEUROSCI.2362-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Qi-Takahara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolios, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirotani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikoshi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kametani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span> </span><span class="NLM_article-title">Longer forms of amyloid beta protein: Implications for the mechanism of intramembrane cleavage by gamma-secretase</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1575-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1523%2FJNEUROSCI.1575-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=15647487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptV2isw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=436-445&author=Y.+Qi-Takaharaauthor=M.+Morishima-Kawashimaauthor=Y.+Tanimuraauthor=G.+Doliosauthor=N.+Hirotaniauthor=Y.+Horikoshiauthor=F.+Kametaniauthor=M.+Maedaauthor=T.+C.+Saidoauthor=R.+Wangauthor=Y.+Ihara&title=Longer+forms+of+amyloid+beta+protein%3A+Implications+for+the+mechanism+of+intramembrane+cleavage+by+gamma-secretase&doi=10.1523%2FJNEUROSCI.1575-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Longer forms of amyloid β protein: Implications for the mechanism of intramembrane cleavage by γ-secretase</span></div><div class="casAuthors">Qi-Takahara, Yue; Morishima-Kawashima, Maho; Tanimura, Yu; Dolios, Georgia; Hirotani, Naoko; Horikoshi, Yuko; Kametani, Fuyuki; Maeda, Masahiro; Saido, Takaomi C.; Wang, Rong; Ihara, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">436-445</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">γ-Cleavage of β-amyloid precursor protein (APP) in the middle of the cell membrane generates amyloid β protein (Aβ), and ε-cleavage, ∼10 residues downstream of the γ-cleavage site, releases the APP intracellular domain (AICD).  A significant link between generation of Aβ and AICD and failure to detect AICD41-99 led us to hypothesize that ε-cleavage generates longer Aβs, which are then processed to Aβ40/42.  Using newly developed gel systems and an N-end-specific monoclonal antibody, the authors have identified the longer Aβs (Aβ1-43, Aβ1-45, Aβ1-46, and Aβ1-48) within the cells and in brain tissues.  The prodn. of these longer Aβs as well as Aβ40/42 is presenilin dependent and is suppressed by {1S-benzyl-4R-[1S-carbamoyl-2-phenylethylcarbamoyl-1S-3-methylbutylcarbamoyl]-2R-hydroxy-5-phenylpentyl}carbamic acid tert-Bu ester, a transition state analog inhibitor for aspartyl protease.  In contrast, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-Bu ester, a potent dipeptide γ-secretase inhibitor, builds up Aβ1-43 and Aβ1-46 intracellularly, which was also confirmed by mass spectrometry.  Notably, suppression of Aβ40 appeared to lead to an increase in Aβ43, which in turn brings an increase in Aβ46, in a dose-dependent manner.  We therefore propose an α-helical model in which longer Aβ species generated by ε-cleavage is cleaved at every 3 residues in its carboxyl portion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZa3fdqQdlBbVg90H21EOLACvtfcHk0lgJFsmxL7qfuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptV2isw%253D%253D&md5=0fc17e80b8e775421ed5d521c80e1a30</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1575-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1575-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DQi-Takahara%26aufirst%3DY.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DTanimura%26aufirst%3DY.%26aulast%3DDolios%26aufirst%3DG.%26aulast%3DHirotani%26aufirst%3DN.%26aulast%3DHorikoshi%26aufirst%3DY.%26aulast%3DKametani%26aufirst%3DF.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DIhara%26aufirst%3DY.%26atitle%3DLonger%2520forms%2520of%2520amyloid%2520beta%2520protein%253A%2520Implications%2520for%2520the%2520mechanism%2520of%2520intramembrane%2520cleavage%2520by%2520gamma-secretase%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D436%26epage%3D445%26doi%3D10.1523%2FJNEUROSCI.1575-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Matsumura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada-Kakuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span> </span><span class="NLM_article-title">Gamma-secretase associated with lipid rafts: Multiple interactive pathways in the stepwise processing of beta-carboxyl-terminal fragment</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">5109</span><span class="NLM_x">–</span> <span class="NLM_lpage">5121</span><span class="refDoi"> DOI: 10.1074/jbc.M113.510131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M113.510131" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=5109-5121&author=N.+Matsumuraauthor=M.+Takamiauthor=M.+Okochiauthor=S.+Wada-Kakudaauthor=H.+Fujiwaraauthor=S.+Tagamiauthor=S.+Funamotoauthor=Y.+Iharaauthor=M.+Morishima-Kawashima&title=Gamma-secretase+associated+with+lipid+rafts%3A+Multiple+interactive+pathways+in+the+stepwise+processing+of+beta-carboxyl-terminal+fragment&doi=10.1074%2Fjbc.M113.510131"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.510131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.510131%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DN.%26aulast%3DTakami%26aufirst%3DM.%26aulast%3DOkochi%26aufirst%3DM.%26aulast%3DWada-Kakuda%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DTagami%26aufirst%3DS.%26aulast%3DFunamoto%26aufirst%3DS.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26atitle%3DGamma-secretase%2520associated%2520with%2520lipid%2520rafts%253A%2520Multiple%2520interactive%2520pathways%2520in%2520the%2520stepwise%2520processing%2520of%2520beta-carboxyl-terminal%2520fragment%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D5109%26epage%3D5121%26doi%3D10.1074%2Fjbc.M113.510131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Shimojo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizoroki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichinose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span> </span><span class="NLM_article-title">Enzymatic characteristics of i213t mutant presenilin-1/gamma-secretase in cell models and knock-in mouse brains: Familial alzheimer disease-linked mutation impairs gamma-site cleavage of amyloid precursor protein c-terminal fragment beta</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">16488</span><span class="NLM_x">–</span> <span class="NLM_lpage">16496</span><span class="refDoi"> DOI: 10.1074/jbc.M801279200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M801279200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=16488-16496&author=M.+Shimojoauthor=N.+Saharaauthor=T.+Mizorokiauthor=S.+Funamotoauthor=M.+Morishima-Kawashimaauthor=T.+Kudoauthor=M.+Takedaauthor=Y.+Iharaauthor=H.+Ichinoseauthor=A.+Takashima&title=Enzymatic+characteristics+of+i213t+mutant+presenilin-1%2Fgamma-secretase+in+cell+models+and+knock-in+mouse+brains%3A+Familial+alzheimer+disease-linked+mutation+impairs+gamma-site+cleavage+of+amyloid+precursor+protein+c-terminal+fragment+beta&doi=10.1074%2Fjbc.M801279200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M801279200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M801279200%26sid%3Dliteratum%253Aachs%26aulast%3DShimojo%26aufirst%3DM.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DMizoroki%26aufirst%3DT.%26aulast%3DFunamoto%26aufirst%3DS.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DKudo%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DIchinose%26aufirst%3DH.%26aulast%3DTakashima%26aufirst%3DA.%26atitle%3DEnzymatic%2520characteristics%2520of%2520i213t%2520mutant%2520presenilin-1%252Fgamma-secretase%2520in%2520cell%2520models%2520and%2520knock-in%2520mouse%2520brains%253A%2520Familial%2520alzheimer%2520disease-linked%2520mutation%2520impairs%2520gamma-site%2520cleavage%2520of%2520amyloid%2520precursor%2520protein%2520c-terminal%2520fragment%2520beta%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D16488%26epage%3D16496%26doi%3D10.1074%2Fjbc.M801279200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Okochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span> </span><span class="NLM_article-title">Gamma-secretase modulators and presenilin 1 mutants act differently on presenilin/gamma-secretase function to cleave abeta42 and abeta43</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1016/j.celrep.2012.11.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.celrep.2012.11.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23291095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=42-51&author=M.+Okochiauthor=S.+Tagamiauthor=K.+Yanagidaauthor=M.+Takamiauthor=T.+S.+Kodamaauthor=K.+Moriauthor=T.+Nakayamaauthor=Y.+Iharaauthor=M.+Takeda&title=Gamma-secretase+modulators+and+presenilin+1+mutants+act+differently+on+presenilin%2Fgamma-secretase+function+to+cleave+abeta42+and+abeta43&doi=10.1016%2Fj.celrep.2012.11.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators and Presenilin 1 Mutants Act Differently on Presenilin/γ-Secretase Function to Cleave Aβ42 and Aβ43</span></div><div class="casAuthors">Okochi, Masayasu; Tagami, Shinji; Yanagida, Kanta; Takami, Mako; Kodama, Takashi S.; Mori, Kohji; Nakayama, Taisuke; Ihara, Yasuo; Takeda, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-51</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Deciphering the mechanism by which the relative Aβ42(43) to total Aβ ratio is regulated is central to understanding Alzheimer disease (AD) etiol.; however, the mechanisms underlying changes in the Aβ42(43) ratio caused by familial mutations and γ-secretase modulators (GSMs) are unclear.  Here, we show in vitro and in living cells that presenilin (PS)/γ-secretase cleaves Aβ42 into Aβ38, and Aβ43 into Aβ40 or Aβ38.  Approx. 40% of Aβ38 is derived from Aβ43.  Aβ42(43) cleavage is involved in the regulation of the Aβ42(43) ratio in living cells.  GSMs increase the cleavage of PS/γ-secretase-bound Aβ42 (increase kcat) and slow its dissocn. from the enzyme (decrease kb), whereas PS1 mutants and inverse GSMs show the opposite effects.  Therefore, we suggest a concept to describe the Aβ42(43) prodn. process and propose how GSMs act, and we suggest that a loss of PS/γ-secretase function to cleave Aβ42(43) may initiate AD and might represent a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJEYS_49n8hbVg90H21EOLACvtfcHk0lgJFsmxL7qfuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSrsLo%253D&md5=ca7695ce5fd0d6506b27ec00cd3a4918</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.11.028%26sid%3Dliteratum%253Aachs%26aulast%3DOkochi%26aufirst%3DM.%26aulast%3DTagami%26aufirst%3DS.%26aulast%3DYanagida%26aufirst%3DK.%26aulast%3DTakami%26aufirst%3DM.%26aulast%3DKodama%26aufirst%3DT.%2BS.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DM.%26atitle%3DGamma-secretase%2520modulators%2520and%2520presenilin%25201%2520mutants%2520act%2520differently%2520on%2520presenilin%252Fgamma-secretase%2520function%2520to%2520cleave%2520abeta42%2520and%2520abeta43%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D42%26epage%3D51%26doi%3D10.1016%2Fj.celrep.2012.11.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Szaruga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veugelen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benurwar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lismont, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez-Gutierrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepulveda-Falla, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lleo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lashley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Qualitative changes in human γ-secretase underlie familial alzheimer’s disease</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">2003</span><span class="NLM_x">–</span> <span class="NLM_lpage">2013</span><span class="refDoi"> DOI: 10.1084/jem.20150892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1084%2Fjem.20150892" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2015&pages=2003-2013&author=M.+Szarugaauthor=S.+Veugelenauthor=M.+Benurwarauthor=S.+Lismontauthor=L.+Chavez-Gutierrezauthor=D.+Sepulveda-Fallaauthor=A.+Lleoauthor=N.+S.+Ryanauthor=N.+C.+Foxauthor=T.+Lashleyauthor=S.+Murayamaauthor=H.+Gijsenauthor=B.+De+Strooper&title=Qualitative+changes+in+human+%CE%B3-secretase+underlie+familial+alzheimer%E2%80%99s+disease&doi=10.1084%2Fjem.20150892"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1084%2Fjem.20150892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20150892%26sid%3Dliteratum%253Aachs%26aulast%3DSzaruga%26aufirst%3DM.%26aulast%3DVeugelen%26aufirst%3DS.%26aulast%3DBenurwar%26aufirst%3DM.%26aulast%3DLismont%26aufirst%3DS.%26aulast%3DChavez-Gutierrez%26aufirst%3DL.%26aulast%3DSepulveda-Falla%26aufirst%3DD.%26aulast%3DLleo%26aufirst%3DA.%26aulast%3DRyan%26aufirst%3DN.%2BS.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DLashley%26aufirst%3DT.%26aulast%3DMurayama%26aufirst%3DS.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DQualitative%2520changes%2520in%2520human%2520%25CE%25B3-secretase%2520underlie%2520familial%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2015%26volume%3D212%26spage%3D2003%26epage%3D2013%26doi%3D10.1084%2Fjem.20150892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Kretner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutsmiedl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span> </span><span class="NLM_article-title">Attenuated aβ42 responses to low potency γ-secretase modulators can be overcome for many pathogenic presenilin mutants by second-generation compounds</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">15240</span><span class="NLM_x">–</span> <span class="NLM_lpage">15251</span><span class="refDoi"> DOI: 10.1074/jbc.M110.213587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M110.213587" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=15240-15251&author=B.+Kretnerauthor=A.+Fukumoriauthor=A.+Gutsmiedlauthor=R.+M.+Pageauthor=T.+Luebbersauthor=G.+Galleyauthor=K.+Baumannauthor=C.+Haassauthor=H.+Steiner&title=Attenuated+a%CE%B242+responses+to+low+potency+%CE%B3-secretase+modulators+can+be+overcome+for+many+pathogenic+presenilin+mutants+by+second-generation+compounds&doi=10.1074%2Fjbc.M110.213587"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.213587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.213587%26sid%3Dliteratum%253Aachs%26aulast%3DKretner%26aufirst%3DB.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DGutsmiedl%26aufirst%3DA.%26aulast%3DPage%26aufirst%3DR.%2BM.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DGalley%26aufirst%3DG.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DAttenuated%2520a%25CE%25B242%2520responses%2520to%2520low%2520potency%2520%25CE%25B3-secretase%2520modulators%2520can%2520be%2520overcome%2520for%2520many%2520pathogenic%2520presenilin%2520mutants%2520by%2520second-generation%2520compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D15240%26epage%3D15251%26doi%3D10.1074%2Fjbc.M110.213587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Coric, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dyck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brody, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soininen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiovitz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portelius, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, R. M.</span><span> </span><span class="NLM_article-title">Safety and tolerability of the gamma-secretase inhibitor avagacestat in a phase 2 study of mild to moderate alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1430</span><span class="NLM_x">–</span> <span class="NLM_lpage">1440</span><span class="refDoi"> DOI: 10.1001/archneurol.2012.2194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1001%2Farchneurol.2012.2194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22892585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A280%3ADC%252BC38fotVSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2012&pages=1430-1440&author=V.+Coricauthor=C.+H.+van+Dyckauthor=S.+Sallowayauthor=N.+Andreasenauthor=M.+Brodyauthor=R.+W.+Richterauthor=H.+Soininenauthor=S.+Theinauthor=T.+Shiovitzauthor=G.+Pilcherauthor=S.+Colbyauthor=L.+Rollinauthor=R.+Dockensauthor=C.+Pachaiauthor=E.+Porteliusauthor=U.+Andreassonauthor=K.+Blennowauthor=H.+Soaresauthor=C.+Albrightauthor=H.+H.+Feldmanauthor=R.+M.+Berman&title=Safety+and+tolerability+of+the+gamma-secretase+inhibitor+avagacestat+in+a+phase+2+study+of+mild+to+moderate+alzheimer+disease&doi=10.1001%2Farchneurol.2012.2194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease</span></div><div class="casAuthors">Coric Vladimir; van Dyck Christopher H; Salloway Stephen; Andreasen Niels; Brody Mark; Richter Ralph W; Soininen Hilkka; Thein Stephen; Shiovitz Thomas; Pilcher Gary; Colby Susan; Rollin Linda; Dockens Randy; Pachai Chahin; Portelius Erik; Andreasson Ulf; Blennow Kaj; Soares Holly; Albright Charles; Feldman Howard H; Berman Robert M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1430-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To assess the safety, tolerability, and pharmacokinetic and pharmacodynamic effects of the -secretase inhibitor avagacestat in patients with mild to moderate Alzheimer disease (AD).  DESIGN:  Randomized, double-blind, placebo-controlled,24-week phase 2 study.  SETTING:  Global, multicenter trial.  PATIENTS:  A total of 209 outpatients with mild to moderate AD were randomized into the double-blind treatment phase.  The median age of the patients was 75 years,58.9% were APOE ε4 carriers, and baseline measures of disease severity were similar among groups.  INTERVENTION:  Avagacestat, 25, 50, 100, or 125 mg daily,or placebo administered orally daily.  MAIN OUTCOME MEASURES:  Safety and tolerability of avagacestat.  RESULTS:  Discontinuation rates for the 25-mg and 50-mg doses of avagacestat were comparable with placebo but were higher in the 100-mg and 125-mg dose groups.Trends for worsening cognition, as measured by change from baseline Alzheimer Disease Assessment Scale cognitive subscale score, were observed in the 100-mg and125-mg dose groups.  Treatment-emergent serious adverse events were similar across placebo and treatment groups.  The most common reason for discontinuation was adverse events, predominantly gastrointestinal anddermatologic.  Other adverse events occurring more frequentlyin patients undergoing treatment included reversibleglycosuria (without associated serum glucose changes), nonmelanoma skin cancer, and asymptomaticmagnetic resonance imaging findings.  Exploratory cerebrospinal fluid amyloid isoforms and tau biomarker analysis demonstrated dose-dependent but not statistically significant reductions in a small subset of patients.  CONCLUSIONS:  Avagacestat dosed at 25 and 50 mg daily was relatively well tolerated and had low discontinuation rates.  The 100-mg and 125-mg dose arms were poorly tolerated with trends for cognitive worsening.  Exploratory cerebrospinal fluid biomarker substudies provide preliminary support for -secretase target engagement,but additional studies are warranted to better characterize pharmacodynamic effects at the 25- and 50-mg doses.This study establishes an acceptable safety and tolerability dose range for future avagacestat studies in AD.  TRIAL REGISTRATION:  clinicaltrials.gov Identifier: NCT00810147</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuwXa-F7HH9okFb3mqPUYDfW6udTcc2eawDCg-tyWvWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fotVSgtw%253D%253D&md5=b0935144b0569050bd45f25029694282</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2012.2194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2012.2194%26sid%3Dliteratum%253Aachs%26aulast%3DCoric%26aufirst%3DV.%26aulast%3Dvan%2BDyck%26aufirst%3DC.%2BH.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DBrody%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DR.%2BW.%26aulast%3DSoininen%26aufirst%3DH.%26aulast%3DThein%26aufirst%3DS.%26aulast%3DShiovitz%26aufirst%3DT.%26aulast%3DPilcher%26aufirst%3DG.%26aulast%3DColby%26aufirst%3DS.%26aulast%3DRollin%26aufirst%3DL.%26aulast%3DDockens%26aufirst%3DR.%26aulast%3DPachai%26aufirst%3DC.%26aulast%3DPortelius%26aufirst%3DE.%26aulast%3DAndreasson%26aufirst%3DU.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DSoares%26aufirst%3DH.%26aulast%3DAlbright%26aufirst%3DC.%26aulast%3DFeldman%26aufirst%3DH.%2BH.%26aulast%3DBerman%26aufirst%3DR.%2BM.%26atitle%3DSafety%2520and%2520tolerability%2520of%2520the%2520gamma-secretase%2520inhibitor%2520avagacestat%2520in%2520a%2520phase%25202%2520study%2520of%2520mild%2520to%2520moderate%2520alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2012%26volume%3D69%26spage%3D1430%26epage%3D1440%26doi%3D10.1001%2Farchneurol.2012.2194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Schroeter, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisslinger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopan, R.</span><span> </span><span class="NLM_article-title">Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span><span class="refDoi"> DOI: 10.1038/30756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F30756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=9620803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFKgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=1998&pages=382-386&author=E.+H.+Schroeterauthor=J.+A.+Kisslingerauthor=R.+Kopan&title=Notch-1+signalling+requires+ligand-induced+proteolytic+release+of+intracellular+domain&doi=10.1038%2F30756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Notch-1 signaling requires ligand-induced proteolytic release of intracellular domain</span></div><div class="casAuthors">Schroeter, Eric H.; Kisslinger, Jeffrey A.; Kopan, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">6683</span>),
    <span class="NLM_cas:pages">382-386</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Notch proteins are ligand-activated transmembranes receptors involved in cell-fate selection throughout development.  No known enzymic activity is contained within Notch and the mol. mechanism by which it transduces signals across the cell membrane is poorly understood.  In many instances, Notch activation results in transcriptional changes in the nucleus through an assocn. with membranes of the CSL family of DNA-binding proteins (where CSL stands for CBF1, Su(H), Lag-1).  As Notch is located in the plasma membrane and CSL is a nuclear protein, two models have been proposed to explain how they interact.  The first suggests that the two interact transiently at the membrane.  The second postulates the Notch is cleaved by a protease, enabling the cleaved fragment to enter the nucleus.  Here we show that signaling by a constitutively active membrane-bound Notch-1 protein requires the proteolytic release of the Notch intracellular domain (NICD), which interacts preferentially with CSL.  Very small amts. of NICD are active, explaining why it is hard to detect in the nucleus in vivo.  We also show that it is ligand binding that induces release of NICD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn9GiDcGKFZLVg90H21EOLACvtfcHk0lj1V8OpEg2heg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFKgt78%253D&md5=57c820844266305f1624a6e71e06d44f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2F30756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F30756%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeter%26aufirst%3DE.%2BH.%26aulast%3DKisslinger%26aufirst%3DJ.%2BA.%26aulast%3DKopan%26aufirst%3DR.%26atitle%3DNotch-1%2520signalling%2520requires%2520ligand-induced%2520proteolytic%2520release%2520of%2520intracellular%2520domain%26jtitle%3DNature%26date%3D1998%26volume%3D393%26spage%3D382%26epage%3D386%26doi%3D10.1038%2F30756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Mitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarimizu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akashiba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shitaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, N.</span><span> </span><span class="NLM_article-title">Differential effects between gamma-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2037</span><span class="NLM_x">–</span> <span class="NLM_lpage">2050</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4264-11.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1523%2FJNEUROSCI.4264-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22323718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFantbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=2037-2050&author=Y.+Mitaniauthor=J.+Yarimizuauthor=K.+Saitaauthor=H.+Uchinoauthor=H.+Akashibaauthor=Y.+Shitakaauthor=K.+Niauthor=N.+Matsuoka&title=Differential+effects+between+gamma-secretase+inhibitors+and+modulators+on+cognitive+function+in+amyloid+precursor+protein-transgenic+and+nontransgenic+mice&doi=10.1523%2FJNEUROSCI.4264-11.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice</span></div><div class="casAuthors">Mitani, Yasuyuki; Yarimizu, Junko; Saita, Kyoko; Uchino, Hiroshi; Akashiba, Hiroki; Shitaka, Yoshitsugu; Ni, Keni; Matsuoka, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2037-2050</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">γ-Secretase inhibitors (GSIs) reduce amyloid-β (Aβ) peptides but inevitably increase the β-C-terminal fragment (β-CTF) of amyloid precursor protein (APP), potentially having undesirable effects on synapses.  In contrast, γ-secretase modulators (GSMs) reduce Aβ42 without increasing β-CTF.  Although the Aβ-lowering effects of these compds. have been extensively studied, little effort has been made to investigate their effects on cognition.  Here, we compared the effects of two GSIs-(2S)-2-hydroxy-3-methyl-N-[(2S)-1-{[(1S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl]amino}-1-oxopropan-2-yl]butanamide (LY450139, semagacestat) and (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxazol-3-yl)phenyl]methyl]amino-5,5,5-trifluoropentanamide (BMS-708163)-and a second-generation GSM [{(2S,4R)-1-[(4R)-1,1,1-trifluoro-7-methyloctan-4-yl]-2-[4-(trifluoromethyl)phenyl]piperidin-4-yl}acetic acid (GSM-2)] on spatial working memory in APP-transgenic (Tg2576) and nontransgenic mice using the Y-maze task.  While acute dosing with either GSI ameliorated memory deficits in 5.5-mo-old Tg2576 mice, these effects disappeared after 8 d subchronic dosing.  Subchronic dosing with either GSI rather impaired normal cognition in 3-mo-old Tg2576 mice, with no inhibition on the processing of other γ-secretase substrates, such as Notch, N-cadherin, or EphA4, in the brain.  LY450139 also impaired normal cognition in wild-type mice; however, the potency was 10-fold lower than that in Tg2576 mice, indicating an APP-dependent mechanism likely with β-CTF accumulation.  Immunofluorescence studies revealed that the β-CTF accumulation was localized in the presynaptic terminals of the hippocampal stratum lucidum and dentate hilus, implying an effect on presynaptic function in the mossy fibers.  In contrast, both acute and subchronic dosing with GSM-2 significantly ameliorated memory deficits in Tg2576 mice and did not affect normal cognition in wild-type mice.  We demonstrated a clear difference between GSI and GSM in effects on functional consequences, providing new insights into strategies for developing these drugs against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCQSvDeM5057Vg90H21EOLACvtfcHk0lj1V8OpEg2heg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFantbw%253D&md5=8b822c8ce2e99faaf881dde88c50224b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4264-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4264-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DMitani%26aufirst%3DY.%26aulast%3DYarimizu%26aufirst%3DJ.%26aulast%3DSaita%26aufirst%3DK.%26aulast%3DUchino%26aufirst%3DH.%26aulast%3DAkashiba%26aufirst%3DH.%26aulast%3DShitaka%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DN.%26atitle%3DDifferential%2520effects%2520between%2520gamma-secretase%2520inhibitors%2520and%2520modulators%2520on%2520cognitive%2520function%2520in%2520amyloid%2520precursor%2520protein-transgenic%2520and%2520nontransgenic%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D2037%26epage%3D2050%26doi%3D10.1523%2FJNEUROSCI.4264-11.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Inoue, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguchi-Tawarada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katahira-Tayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takai, Y.</span><span> </span><span class="NLM_article-title">Synaptic activity prompts gamma-secretase-mediated cleavage of epha4 and dendritic spine formation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1083/jcb.200809151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1083%2Fjcb.200809151" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2009&pages=551-564&author=E.+Inoueauthor=M.+Deguchi-Tawaradaauthor=A.+Togawaauthor=C.+Matsuiauthor=K.+Aritaauthor=S.+Katahira-Tayamaauthor=T.+Satoauthor=E.+Yamauchiauthor=Y.+Odaauthor=Y.+Takai&title=Synaptic+activity+prompts+gamma-secretase-mediated+cleavage+of+epha4+and+dendritic+spine+formation&doi=10.1083%2Fjcb.200809151"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200809151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200809151%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DE.%26aulast%3DDeguchi-Tawarada%26aufirst%3DM.%26aulast%3DTogawa%26aufirst%3DA.%26aulast%3DMatsui%26aufirst%3DC.%26aulast%3DArita%26aufirst%3DK.%26aulast%3DKatahira-Tayama%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DYamauchi%26aufirst%3DE.%26aulast%3DOda%26aufirst%3DY.%26aulast%3DTakai%26aufirst%3DY.%26atitle%3DSynaptic%2520activity%2520prompts%2520gamma-secretase-mediated%2520cleavage%2520of%2520epha4%2520and%2520dendritic%2520spine%2520formation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2009%26volume%3D185%26spage%3D551%26epage%3D564%26doi%3D10.1083%2Fjcb.200809151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Lanz, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karmilowicz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, K. E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebbinghaus, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spracklin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, L.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auperin, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachter, J. B.</span><span> </span><span class="NLM_article-title">Concentration-dependent modulation of amyloid-β in vivo and in vitro using the γ-secretase inhibitor, ly-450139</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">924</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span><span class="refDoi"> DOI: 10.1124/jpet.106.110700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1124%2Fjpet.106.110700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=16920992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOkurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=924-933&author=T.+A.+Lanzauthor=M.+J.+Karmilowiczauthor=K.+M.+Woodauthor=N.+Pozdnyakovauthor=P.+Duauthor=M.+A.+Piotrowskiauthor=T.+M.+Brownauthor=C.+E.+Nolanauthor=K.+E.+G.+Richterauthor=J.+E.+Finleyauthor=Q.+Feiauthor=C.+F.+Ebbinghausauthor=Y.+L.+Chenauthor=D.+K.+Spracklinauthor=B.+Tateauthor=K.+F.+Geogheganauthor=L.-F.+Lauauthor=D.+D.+Auperinauthor=J.+B.+Schachter&title=Concentration-dependent+modulation+of+amyloid-%CE%B2+in+vivo+and+in+vitro+using+the+%CE%B3-secretase+inhibitor%2C+ly-450139&doi=10.1124%2Fjpet.106.110700"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Concentration-dependent modulation of amyloid-β in vivo and in vitro using the γ-secretase inhibitor, LY-450139</span></div><div class="casAuthors">Lanz, Thomas A.; Karmilowicz, Michael J.; Wood, Kathleen M.; Pozdnyakov, Nikolay; Du, Ping; Piotrowski, Mary A.; Brown, Tracy M.; Nolan, Charles E.; Richter, Karl E. G.; Finley, James E.; Fei, Qing; Ebbinghaus, Charles F.; Chen, Yuhpyng L.; Spracklin, Douglas K.; Tate, Barbara; Geoghegan, Kieran F.; Lau, Lit-Fui; Auperin, David D.; Schachter, Joel B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">924-933</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">LY-450139 is a γ-secretase inhibitor shown to have efficacy in multiple cellular and animal models.  Paradoxically, robust elevations of plasma amyloid-β (Aβ) have been reported in dogs and humans after administration of subefficacious doses.  The present study sought to further evaluate Aβ responses to LY-450139 in the guinea pig, a nontransgenic model that has an Aβ sequence identical to that of human.  Male guinea pigs were treated with LY-450139 (0.2-60 mg/kg), and brain, cerebrospinal fluid, and plasma Aβ levels were characterized at 1, 3, 6, 9, and 14 h postdose.  Low doses significantly elevated plasma Aβ levels at early time points, with return to baseline within hours.  Higher doses inhibited Aβ levels in all compartments at early time points, but elevated plasma Aβ levels at later time points.  To det. whether this phenomenon occurs under steady-state drug exposure, guinea pigs were implanted with s.c. minipumps delivering LY-450139 (0.3-30 mg/kg/day) for 5 days.  Plasma Aβ was significantly inhibited at 10-30 mg/kg/day, but significantly elevated at 1 mg/kg/day.  To further understand the mechanism of Aβ elevation by LY-450139, H4 cells overexpressing the Swedish mutant of amyloid-precursor protein and a mouse embryonic stem cell-derived neuronal cell line were studied.  In both cellular models, elevated levels of secreted Aβ were obsd. at subefficacious concns., whereas dose-responsive inhibition was obsd. at higher concns.  These results suggest that LY-450139 modulates the γ-secretase complex, eliciting Aβ lowering at high concns. but Aβ elevation at low concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2z_DmwmXT1LVg90H21EOLACvtfcHk0ljag_wBwRMO7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOkurnN&md5=682602abb67f2b36d7d802a14b3b24de</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.110700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.110700%26sid%3Dliteratum%253Aachs%26aulast%3DLanz%26aufirst%3DT.%2BA.%26aulast%3DKarmilowicz%26aufirst%3DM.%2BJ.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DDu%26aufirst%3DP.%26aulast%3DPiotrowski%26aufirst%3DM.%2BA.%26aulast%3DBrown%26aufirst%3DT.%2BM.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DRichter%26aufirst%3DK.%2BE.%2BG.%26aulast%3DFinley%26aufirst%3DJ.%2BE.%26aulast%3DFei%26aufirst%3DQ.%26aulast%3DEbbinghaus%26aufirst%3DC.%2BF.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DLau%26aufirst%3DL.-F.%26aulast%3DAuperin%26aufirst%3DD.%2BD.%26aulast%3DSchachter%26aufirst%3DJ.%2BB.%26atitle%3DConcentration-dependent%2520modulation%2520of%2520amyloid-%25CE%25B2%2520in%2520vivo%2520and%2520in%2520vitro%2520using%2520the%2520%25CE%25B3-secretase%2520inhibitor%252C%2520ly-450139%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D924%26epage%3D933%26doi%3D10.1124%2Fjpet.106.110700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Gillman, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starrett, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcin, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElhone, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mate, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span> </span><span class="NLM_article-title">Discovery and evaluation of BMS-708163, a potent, selective and orally bioavailable gamma-secretase inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1021/ml1000239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1000239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=120-124&author=K.+W.+Gillmanauthor=J.+E.+Starrettauthor=M.+F.+Parkerauthor=K.+Xieauthor=J.+J.+Bronsonauthor=L.+R.+Marcinauthor=K.+E.+McElhoneauthor=C.+P.+Bergstromauthor=R.+A.+Mateauthor=R.+Williamsauthor=J.+E.+Meredithauthor=C.+R.+Burtonauthor=D.+M.+Bartenauthor=J.+H.+Toynauthor=S.+B.+Robertsauthor=K.+A.+Lentzauthor=J.+G.+Houstonauthor=R.+Zaczekauthor=C.+F.+Albrightauthor=C.+P.+Deciccoauthor=J.+E.+Macorauthor=R.+E.+Olson&title=Discovery+and+evaluation+of+BMS-708163%2C+a+potent%2C+selective+and+orally+bioavailable+gamma-secretase+inhibitor&doi=10.1021%2Fml1000239"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fml1000239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000239%26sid%3Dliteratum%253Aachs%26aulast%3DGillman%26aufirst%3DK.%2BW.%26aulast%3DStarrett%26aufirst%3DJ.%2BE.%26aulast%3DParker%26aufirst%3DM.%2BF.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMarcin%26aufirst%3DL.%2BR.%26aulast%3DMcElhone%26aufirst%3DK.%2BE.%26aulast%3DBergstrom%26aufirst%3DC.%2BP.%26aulast%3DMate%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DHouston%26aufirst%3DJ.%2BG.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520BMS-708163%252C%2520a%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520gamma-secretase%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D120%26epage%3D124%26doi%3D10.1021%2Fml1000239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slemmon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denton, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhyne, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raybon, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guss, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simutis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillman, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starrett, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sverdlov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaneda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coric, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, G.</span><span> </span><span class="NLM_article-title">Pharmacodynamics of selective inhibition of gamma-secretase by avagacestat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span><span class="refDoi"> DOI: 10.1124/jpet.112.199356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1124%2Fjpet.112.199356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23275065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVaisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2013&pages=686-695&author=C.+F.+Albrightauthor=R.+C.+Dockensauthor=J.+E.+Meredithauthor=R.+E.+Olsonauthor=R.+Slemmonauthor=K.+A.+Lentzauthor=J.+S.+Wangauthor=R.+R.+Dentonauthor=G.+Pilcherauthor=P.+W.+Rhyneauthor=J.+J.+Raybonauthor=D.+M.+Bartenauthor=C.+Burtonauthor=J.+H.+Toynauthor=S.+Sankaranarayananauthor=C.+Polsonauthor=V.+Gussauthor=R.+Whiteauthor=F.+Simutisauthor=T.+Sandersonauthor=K.+W.+Gillmanauthor=J.+E.+Starrettauthor=J.+Bronsonauthor=O.+Sverdlovauthor=S.+P.+Huangauthor=L.+Castanedaauthor=H.+Feldmanauthor=V.+Coricauthor=R.+Zaczekauthor=J.+E.+Macorauthor=J.+Houstonauthor=R.+M.+Bermanauthor=G.+Tong&title=Pharmacodynamics+of+selective+inhibition+of+gamma-secretase+by+avagacestat&doi=10.1124%2Fjpet.112.199356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamics of selective inhibition of γ-secretase by avagacestat</span></div><div class="casAuthors">Albright, Charles F.; Dockens, Randy C.; Meredith, Jere E., Jr.; Olson, Richard E.; Slemmon, Randy; Lentz, Kimberley A.; Wang, Jun-Sheng; Denton, R. Rex; Pilcher, Gary; Rhyne, Paul W.; Raybon, Joseph J.; Barten, Donna M.; Burton, Catherine; Toyn, Jeremy H.; Sankaranarayanan, Sethu; Polson, Craig; Guss, Valerie; White, Randy; Simutis, Frank; Sanderson, Thomas; Gillman, Kevin W.; Starrett, John E., Jr.; Bronson, Joanne; Sverdlov, Oleksandr; Huang, Shu-Pang; Castaneda, Loma; Feldman, Howard; Coric, Vlad; Zaczek, Robert; Macor, John E.; Houston, John; Berman, Robert M.; Tong, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">686-695</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A hallmark of Alzheimer's disease (AD) pathol. is the accumulation of brain amyloid β-peptide (Aβ), generated by γ-secretase-mediated cleavage of the amyloid precursor protein (APP).  Therefore, γ-secretase inhibitors (GSIs) may lower brain Aβ and offer a potential new approach to treat AD.  As γ-secretase also cleaves Notch proteins, GSIs can have undesirable effects due to interference with Notch signaling.  Avagacestat (BMS-708163) is a GSI developed for selective inhibition of APP over Notch cleavage.  Avagacestat inhibition of APP and Notch cleavage was evaluated in cell culture by measuring levels of Aβ and human Notch proteins.  In rats, dogs, and humans, selectivity was evaluated by measuring plasma blood concns. in relation to effects on cerebrospinal fluid (CSF) Aβ levels and Notch-related toxicities.  Measurements of Notch-related toxicity included goblet cell metaplasia in the gut, marginal-zone depletion in the spleen, redns. in B cells, and changes in expression of the Notch-regulated hairy and enhancer of split homolog-1 from blood cells.  In rats and dogs, acute administration of avagacestat robustly reduced CSF Aβ40 and Aβ42 levels similarly.  Chronic administration in rats and dogs, and 28-day, single- and multiple-ascending-dose administration in healthy human subjects caused similar exposure-dependent redns. in CSF Aβ40.  Consistent with the 137-fold selectivity measured in cell culture, we identified doses of avagacestat that reduce CSF Aβ levels without causing Notch-related toxicities.  Our results demonstrate the selectivity of avagacestat for APP over Notch cleavage, supporting further evaluation of avagacestat for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5fAxZamNybbVg90H21EOLACvtfcHk0lheCq0TuUNjNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVaisr8%253D&md5=91241c812b36909ea783288520bc6af5</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.199356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.199356%26sid%3Dliteratum%253Aachs%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DDockens%26aufirst%3DR.%2BC.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DSlemmon%26aufirst%3DR.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DJ.%2BS.%26aulast%3DDenton%26aufirst%3DR.%2BR.%26aulast%3DPilcher%26aufirst%3DG.%26aulast%3DRhyne%26aufirst%3DP.%2BW.%26aulast%3DRaybon%26aufirst%3DJ.%2BJ.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DBurton%26aufirst%3DC.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DPolson%26aufirst%3DC.%26aulast%3DGuss%26aufirst%3DV.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DSimutis%26aufirst%3DF.%26aulast%3DSanderson%26aufirst%3DT.%26aulast%3DGillman%26aufirst%3DK.%2BW.%26aulast%3DStarrett%26aufirst%3DJ.%2BE.%26aulast%3DBronson%26aufirst%3DJ.%26aulast%3DSverdlov%26aufirst%3DO.%26aulast%3DHuang%26aufirst%3DS.%2BP.%26aulast%3DCastaneda%26aufirst%3DL.%26aulast%3DFeldman%26aufirst%3DH.%26aulast%3DCoric%26aufirst%3DV.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DHouston%26aufirst%3DJ.%26aulast%3DBerman%26aufirst%3DR.%2BM.%26aulast%3DTong%26aufirst%3DG.%26atitle%3DPharmacodynamics%2520of%2520selective%2520inhibition%2520of%2520gamma-secretase%2520by%2520avagacestat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D344%26spage%3D686%26epage%3D695%26doi%3D10.1124%2Fjpet.112.199356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">McKee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, R. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarayskiy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span> </span><span class="NLM_article-title">An improved cell-based method for determining the γ-secretase enzyme activity against both notch and app substrates</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">213</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.1016/j.jneumeth.2012.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.jneumeth.2012.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23219895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Krurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2013&pages=14-21&author=T.+D.+McKeeauthor=R.+M.+B.+Loureiroauthor=J.+A.+Duminauthor=V.+Zarayskiyauthor=B.+Tate&title=An+improved+cell-based+method+for+determining+the+%CE%B3-secretase+enzyme+activity+against+both+notch+and+app+substrates&doi=10.1016%2Fj.jneumeth.2012.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates</span></div><div class="casAuthors">McKee, Timothy D.; Loureiro, Robyn M. B.; Dumin, Jo Ann; Zarayskiy, Vladislav; Tate, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-21</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">γ-Secretase modulators (GSM), which reduce amyloidogenic Aβ42 prodn. while maintaining total Aβ levels, and Notch-sparing γ-secretase inhibitors (GSIs) are promising therapies for the treatment of Alzheimer's Disease (AD).  To have a safety margin for therapeutic use, GSMs and GSIs need to allow Notch intracellular domain (NICD) prodn., while preventing neurotoxic Aβ peptide prodn.  Typically, GSI and GSM effects on these substrates are detd. using two different cell lines, one for the measurement of enzyme activity against each substrate.  However, predicting selectivity for different substrates across cell systems may reduce the reliability of such ratios such that the in vitro data are not useful for predicting in vivo safety margins.  This is esp. concerning since the IC50's of some GSIs vary depending upon the level of APP expression in a cell line.  To circumvent this problem, we utilized the SUP-T1 cell line which expresses a truncated Notch receptor fragment that does not need sheddase cleavage to be a γ-secretase substrate.  When combined with a sensitive method of measuring Aβ prodn., this assay system allows both substrates to be measured simultaneously, reducing the potential to calc. imprecise selectivity margins.  To demonstrate the value of this system, known GSIs and GSMs were examd. in the SUP-T1 dual substrate assay.  IC50's were detd. for both substrates and the in vitro selectivity margin was calcd.  These data suggest using a single cell line is a more accurate prediction of the fold difference between NICD inhibition and Aβ42 lowering for therapeutically promising GSIs and GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6-E8Ymt3CbVg90H21EOLACvtfcHk0lhkUUO0OsQtSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Krurs%253D&md5=3bd99971c4f9015d4ccd7c5a2e5980d6</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2012.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2012.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DLoureiro%26aufirst%3DR.%2BM.%2BB.%26aulast%3DDumin%26aufirst%3DJ.%2BA.%26aulast%3DZarayskiy%26aufirst%3DV.%26aulast%3DTate%26aufirst%3DB.%26atitle%3DAn%2520improved%2520cell-based%2520method%2520for%2520determining%2520the%2520%25CE%25B3-secretase%2520enzyme%2520activity%2520against%2520both%2520notch%2520and%2520app%2520substrates%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2013%26volume%3D213%26spage%3D14%26epage%3D21%26doi%3D10.1016%2Fj.jneumeth.2012.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span> </span><span class="NLM_article-title">BMS-708,163 targets presenilin and lacks notch-sparing activity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7209</span><span class="NLM_x">–</span> <span class="NLM_lpage">7211</span><span class="refDoi"> DOI: 10.1021/bi301137h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi301137h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ymsrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=7209-7211&author=C.+J.+Crumpauthor=S.+V.+Castroauthor=F.+Wangauthor=N.+Pozdnyakovauthor=T.+E.+Ballardauthor=S.+S.+Sisodiaauthor=K.+R.+Balesauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=BMS-708%2C163+targets+presenilin+and+lacks+notch-sparing+activity&doi=10.1021%2Fbi301137h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">BMS-708,163 Targets Presenilin and Lacks Notch-Sparing Activity</span></div><div class="casAuthors">Crump, Christina J.; Castro, Suita V.; Wang, Feng; Pozdnyakov, Nikolay; Ballard, T. Eric; Sisodia, Sangram S.; Bales, Kelly R.; Johnson, Douglas S.; Li, Yue-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">7209-7211</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Notch-sparing γ-secretase inhibitor (GSI) BMS-708,163 (Avagacestat) is currently in phase II clin. trials for Alzheimer's disease.  Unlike previously failed GSIs, BMS-708,163 is considered to be a promising drug candidate because of its reported Notch-sparing activity for the inhibition of Aβ prodn. over Notch cleavage.  We now report that BMS-708,163 binds directly to the presenilin-1 N-terminal fragment and that binding can be challenged by other pan-GSIs, but not by γ-secretase modulators.  Furthermore, BMS-708,163 blocks the binding of four different active site-directed GSI photoaffinity probes.  We therefore report that this compd. acts as a nonselective γ-secretase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbN7OtNj8yxLVg90H21EOLACvtfcHk0lhkUUO0OsQtSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ymsrzL&md5=c473842172969f3260e33ca758f08778</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fbi301137h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi301137h%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DCastro%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DBMS-708%252C163%2520targets%2520presenilin%2520and%2520lacks%2520notch-sparing%2520activity%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D7209%26epage%3D7211%26doi%3D10.1021%2Fbi301137h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Kuperstein, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozenski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonckheere, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debulpaep, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandersteen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segers-Nolten, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Werf, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramaniam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braeken, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callewaert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Hooge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schymkowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Neurotoxicity of alzheimer’s disease abeta peptides is induced by small changes in the abeta42 to abeta40 ratio</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">3408</span><span class="NLM_x">–</span> <span class="NLM_lpage">3420</span><span class="refDoi"> DOI: 10.1038/emboj.2010.211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Femboj.2010.211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=20818335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSmsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=3408-3420&author=I.+Kupersteinauthor=K.+Broersenauthor=I.+Benilovaauthor=J.+Rozenskiauthor=W.+Jonckheereauthor=M.+Debulpaepauthor=A.+Vandersteenauthor=I.+Segers-Noltenauthor=K.+Van+Der+Werfauthor=V.+Subramaniamauthor=D.+Braekenauthor=G.+Callewaertauthor=C.+Barticauthor=R.+D%E2%80%99Hoogeauthor=I.+C.+Martinsauthor=F.+Rousseauauthor=J.+Schymkowitzauthor=B.+De+Strooper&title=Neurotoxicity+of+alzheimer%E2%80%99s+disease+abeta+peptides+is+induced+by+small+changes+in+the+abeta42+to+abeta40+ratio&doi=10.1038%2Femboj.2010.211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotoxicity of Alzheimer's disease A peptides is induced by small changes in the A42 to A40 ratio</span></div><div class="casAuthors">Kuperstein, Inna; Broersen, Kerensa; Benilova, Iryna; Rozenski, Jef; Jonckheere, Wim; Debulpaep, Maja; Vandersteen, Annelies; Segers-Nolten, Ine; Van Der Werf, Kees; Subramaniam, Vinod; Braeken, Dries; Callewaert, Geert; Bartic, Carmen; D'Hooge, Rudi; Martins, Ivo Cristiano; Rousseau, Frederic; Schymkowitz, Joost; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3408-3420</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The amyloid peptides A40 and A42 of Alzheimer's disease are thought to contribute differentially to the disease process.  Although A42 seems more pathogenic than A40, the reason for this is not well understood.  We show here that small alterations in the A42:A40 ratio dramatically affect the biophys. and biol. properties of the A mixts. reflected in their aggregation kinetics, the morphol. of the resulting amyloid fibrils and synaptic function tested in vitro and in vivo.  A minor increase in the A42:A40 ratio stabilizes toxic oligomeric species with intermediate conformations.  The initial toxic impact of these A species is synaptic in nature, but this can spread into the cells leading to neuronal cell death.  The fact that the relative ratio of A peptides is more crucial than the abs. amts. of peptides for the induction of neurotoxic conformations has important implications for anti-amyloid therapy.  Our work also suggests the dynamic nature of the equil. between toxic and non-toxic intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR-22pazffF7Vg90H21EOLACvtfcHk0lhkUUO0OsQtSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSmsbzP&md5=1048db62830cd821652c6337364d067d</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Femboj.2010.211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2010.211%26sid%3Dliteratum%253Aachs%26aulast%3DKuperstein%26aufirst%3DI.%26aulast%3DBroersen%26aufirst%3DK.%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DRozenski%26aufirst%3DJ.%26aulast%3DJonckheere%26aufirst%3DW.%26aulast%3DDebulpaep%26aufirst%3DM.%26aulast%3DVandersteen%26aufirst%3DA.%26aulast%3DSegers-Nolten%26aufirst%3DI.%26aulast%3DVan%2BDer%2BWerf%26aufirst%3DK.%26aulast%3DSubramaniam%26aufirst%3DV.%26aulast%3DBraeken%26aufirst%3DD.%26aulast%3DCallewaert%26aufirst%3DG.%26aulast%3DBartic%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Hooge%26aufirst%3DR.%26aulast%3DMartins%26aufirst%3DI.%2BC.%26aulast%3DRousseau%26aufirst%3DF.%26aulast%3DSchymkowitz%26aufirst%3DJ.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DNeurotoxicity%2520of%2520alzheimer%25E2%2580%2599s%2520disease%2520abeta%2520peptides%2520is%2520induced%2520by%2520small%2520changes%2520in%2520the%2520abeta42%2520to%2520abeta40%2520ratio%26jtitle%3DEMBO%2520J.%26date%3D2010%26volume%3D29%26spage%3D3408%26epage%3D3420%26doi%3D10.1038%2Femboj.2010.211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onstead, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwizinski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span> </span><span class="NLM_article-title">Abeta40 inhibits amyloid deposition in vivo</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4849-06.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1523%2FJNEUROSCI.4849-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=17234594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSkurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=627-633&author=J.+Kimauthor=L.+Onsteadauthor=S.+Randleauthor=R.+Priceauthor=L.+Smithsonauthor=C.+Zwizinskiauthor=D.+W.+Dicksonauthor=T.+Goldeauthor=E.+McGowan&title=Abeta40+inhibits+amyloid+deposition+in+vivo&doi=10.1523%2FJNEUROSCI.4849-06.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ40 inhibits amyloid deposition in vivo</span></div><div class="casAuthors">Kim, Jungsu; Onstead, Luisa; Randle, Suzanne; Price, Robert; Smithson, Lisa; Zwizinski, Craig; Dickson, Dennis W.; Golde, Todd; McGowan, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">627-633</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Numerous studies have established a pivotal role for Aβ42 in Alzheimer's disease (AD) pathogenesis.  In contrast, although Aβ40 is the predominant form of amyloid β (Aβ) produced and accumulates to a variable degree in the human AD brain, its role in AD pathogenesis has not been established.  It has generally been assumed that an increase in Aβ40 would accelerate amyloid plaque formation in vivo.  We have crossed BRI-Aβ40 mice that selectively express high levels of Aβ40 with both Tg2576 (APPswe, K670N + M671L) mice and BRI-Aβ42A mice expressing Aβ42 selectively and analyzed parenchymal and cerebrovascular Aβ deposition in the bitransgenic mice compared with their singly transgenic littermates.  In the bitransgenic mice, the increased steady-state levels of Aβ40 decreased Aβ deposition by 60-90%.  These results demonstrate that Aβ42 and Aβ40 have opposing effects on amyloid deposition: Aβ42 promotes amyloid deposition but Aβ40 inhibits it.  In addn., increasing Aβ40 levels protected BRI-Aβ40/Tg2576 mice from the premature-death phenotype obsd. in Tg2576 mice.  The protective properties of Aβ40 with respect to amyloid deposition suggest that strategies that preferentially target Aβ40 may actually worsen the disease course and that selective increases in Aβ40 levels may actually reduce the risk for development of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBkk_HKSaW0bVg90H21EOLACvtfcHk0lhD0Nx2ESNtKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSkurg%253D&md5=503d71263bf85911413a264fe360490a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4849-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4849-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DOnstead%26aufirst%3DL.%26aulast%3DRandle%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DR.%26aulast%3DSmithson%26aufirst%3DL.%26aulast%3DZwizinski%26aufirst%3DC.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DGolde%26aufirst%3DT.%26aulast%3DMcGowan%26aufirst%3DE.%26atitle%3DAbeta40%2520inhibits%2520amyloid%2520deposition%2520in%2520vivo%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D627%26epage%3D633%26doi%3D10.1523%2FJNEUROSCI.4849-06.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-secretase modulators: A review of patents from 2008 to 2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span><span class="refDoi"> DOI: 10.1517/13543776.2011.547479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1517%2F13543776.2011.547479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=21231889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=205-226&author=M.+Petterssonauthor=G.+W.+Kauffmanauthor=C.+W.+am+Endeauthor=N.+C.+Patelauthor=C.+Stiffauthor=T.+P.+Tranauthor=D.+S.+Johnson&title=Novel+%CE%B3-secretase+modulators%3A+A+review+of+patents+from+2008+to+2010&doi=10.1517%2F13543776.2011.547479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span></div><div class="casAuthors">Pettersson, Martin; Kauffman, Gregory W.; am Ende, Christopher W.; Patel, Nandini C.; Stiff, Cory; Tran, Tuan P.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-226</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The amyloid precursor protein is first cleaved by β-secretase to generate a 99-residue membrane-bound CTF (C99 or β-CTF), which is subsequently cleaved by γ-secretase to generate amyloid β (Aβ) peptides and the APP intracellular domain.  The amyloidogenic Aβ42 has attracted considerable attention because it is thought to be the most pathogenic species assocd. with Alzheimer's disease progression.  New classes of compds., called γ-secretase modulators (GSMs), have been shown to selectively lower Aβ42 prodn. without shutting down key γ-secretase-dependent signaling pathways.  This has become an important therapeutic strategy aimed at modulating Aβ prodn.  The progress on the clin. development of γ-secretase inhibitors is briefly covered in this review, followed by a discussion of the potential differentiating attributes of GSMs.  Then, the patent literature covering novel GSMs is reviewed, focusing on patents from 2008 to 2010.  Much progress has been made in the past 2 years on developing GSMs with improved potency for lowering the prodn. of Aβ42.  However, many of these chemotypes are in a challenging chem. space and generally possess higher lipophilicity than most CNS drugs.  It will be important to gain a better understanding of the specific target(s) that these GSMs interact with in order to facilitate future drug design efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocCQHiTfGSILVg90H21EOLACvtfcHk0lhD0Nx2ESNtKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D&md5=9e52482a492eea96f9f88b59742e38ce</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.547479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.547479%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520modulators%253A%2520A%2520review%2520of%2520patents%2520from%25202008%2520to%25202010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D205%26epage%3D226%26doi%3D10.1517%2F13543776.2011.547479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Garofalo, A. W.</span><span> </span><span class="NLM_article-title">Patents targeting γ-secretase inhibition and modulation for the treatment of alzheimer’s disease: 2004 - 2008</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span><span class="refDoi"> DOI: 10.1517/13543776.18.7.693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1517%2F13543776.18.7.693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntlGgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=693-703&author=A.+W.+Garofalo&title=Patents+targeting+%CE%B3-secretase+inhibition+and+modulation+for+the+treatment+of+alzheimer%E2%80%99s+disease%3A+2004+-+2008&doi=10.1517%2F13543776.18.7.693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Patents targeting γ-secretase inhibition and modulation for the treatment of Alzheimer's disease: 2004 - 2008</span></div><div class="casAuthors">Garofalo, Albert W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">693-703</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Although Alzheimer's disease has been defined for over a century, at present there is no effective treatment.  Amyloid deposition and plaque formation are widely believed to contribute to the pathol. of the disease.  As the etiol. of plaque formation has become better understood, the search for therapies has bred small mols. capable of inhibiting or regulating the activity of γ-secretase.  This paper reviews patents from the past 4 years claiming modulators or inhibitors of γ-secretase as a treatment for Alzheimer's disease.  One or two compds. from each patent were selected to represent the claimed chem. space.  Compd. selection was influenced by literature accounts, which are also discussed.  Although an attempt has been made to include major contributions in the field, the list of patents reviewed should not be considered exhaustive.  This review seeks to expand upon a previous review covering patents from 2000-2004.  Since then there has been an increase in the no. of structural and mechanistic approaches being pursued and several compds. have entered the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptzyUbNbn4uLVg90H21EOLACvtfcHk0lhD0Nx2ESNtKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntlGgu78%253D&md5=a26891676fdd05b0b3c2501824ced28f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.7.693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.7.693%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26atitle%3DPatents%2520targeting%2520%25CE%25B3-secretase%2520inhibition%2520and%2520modulation%2520for%2520the%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%253A%25202004%2520-%25202008%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D693%26epage%3D703%26doi%3D10.1517%2F13543776.18.7.693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span> </span><span class="NLM_article-title">Development and mechanism of γ-secretase modulators for alzheimer’s disease</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3197</span><span class="NLM_x">–</span> <span class="NLM_lpage">3216</span><span class="refDoi"> DOI: 10.1021/bi400377p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi400377p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVCnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=3197-3216&author=C.+J.+Crumpauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=Development+and+mechanism+of+%CE%B3-secretase+modulators+for+alzheimer%E2%80%99s+disease&doi=10.1021%2Fbi400377p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Mechanism of γ-Secretase Modulators for Alzheimer's Disease</span></div><div class="casAuthors">Crump, Christina J.; Johnson, Douglas S.; Li, Yue-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3197-3216</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  γ-Secretase is an aspartyl intramembranal protease composed of presenilin, Nicastrin, Aph1, and Pen2 with 19 transmembrane domains.  γ-Secretase cleaves the amyloid precursor proteins (APP) to release Aβ peptides that likely play a causative role in the pathogenesis of Alzheimer's disease (AD).  In addn., γ-secretase cleaves Notch and other type I membrane proteins.  γ-Secretase inhibitors (GSIs) have been developed and used for clin. studies.  However, clin. trials have shown adverse effects of GSIs that are potentially linked with nondiscriminatory inhibition of Notch signaling, overall APP processing, and other substrate cleavages.  Therefore, these findings call for the development of disease-modifying agents that target γ-secretase activity to lower levels of Aβ42 prodn. without blocking the overall processing of γ-secretase substrates.  γ-Secretase modulators (GSMs) originally derived from nonsteroidal anti-inflammatory drugs (NSAIDs) display such characteristics and are the focus of this review.  However, first-generation GSMs have limited potential because of the low potency and undesired neuropharmacokinetic properties.  This generation of GSMs has been suggested to interact with the APP substrate, γ-secretase, or both.  To improve the potency and brain availability, second-generation GSMs, including NSAID-derived carboxylic acid and non-NSAID-derived heterocyclic chemotypes, as well as natural product-derived GSMs have been developed.  Animal studies of this generation of GSMs have shown encouraging preclin. profiles.  Moreover, using potent GSM photoaffinity probes, multiple studies unambiguously have showed that both carboxylic acid and heterocyclic GSMs specifically target presenilin, the catalytic subunit of γ-secretase.  In addn., two types of GSMs have distinct binding sites within the γ-secretase complex and exhibit different Aβ profiles.  GSMs induce a conformational change of γ-secretase to achieve modulation.  Various models are proposed and discussed.  Despite the progress of GSM research, many outstanding issues remain to be investigated to achieve the ultimate goal of developing GSMs as effective AD therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplaHViKcHC17Vg90H21EOLACvtfcHk0lhLYnFy2pHf_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVCnt7w%253D&md5=7210c05b5624c85078accf40a7cf76ac</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fbi400377p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400377p%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DDevelopment%2520and%2520mechanism%2520of%2520%25CE%25B3-secretase%2520modulators%2520for%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D3197%26epage%3D3216%26doi%3D10.1021%2Fbi400377p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrigley, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churcher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">43419</span><span class="NLM_x">–</span> <span class="NLM_lpage">43426</span><span class="refDoi"> DOI: 10.1074/jbc.M404937200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M404937200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=43419-43426&author=D.+Beherauthor=E.+E.+Clarkeauthor=J.+D.+Wrigleyauthor=A.+C.+Martinauthor=A.+Nadinauthor=I.+Churcherauthor=M.+S.+Shearman&title=Selected+non-steroidal+anti-inflammatory+drugs+and+their+derivatives+target+gamma-secretase+at+a+novel+site.+Evidence+for+an+allosteric+mechanism&doi=10.1074%2Fjbc.M404937200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M404937200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M404937200%26sid%3Dliteratum%253Aachs%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DE.%2BE.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%26aulast%3DMartin%26aufirst%3DA.%2BC.%26aulast%3DNadin%26aufirst%3DA.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DSelected%2520non-steroidal%2520anti-inflammatory%2520drugs%2520and%2520their%2520derivatives%2520target%2520gamma-secretase%2520at%2520a%2520novel%2520site.%2520Evidence%2520for%2520an%2520allosteric%2520mechanism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D43419%26epage%3D43426%26doi%3D10.1074%2Fjbc.M404937200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, D.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gertsik, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span> </span><span class="NLM_article-title">Piperidine acetic acid based γ-secretase modulators directly bind to presenilin-1</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span><span class="refDoi"> DOI: 10.1021/cn200098p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200098p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaqtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=705-710&author=C.+J.+Crumpauthor=B.+A.+Fishauthor=S.+V.+Castroauthor=D.-M.+Chauauthor=N.+Gertsikauthor=K.+Ahnauthor=C.+Stiffauthor=N.+Pozdnyakovauthor=K.+R.+Balesauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=Piperidine+acetic+acid+based+%CE%B3-secretase+modulators+directly+bind+to+presenilin-1&doi=10.1021%2Fcn200098p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Piperidine Acetic Acid Based γ-Secretase Modulators Directly Bind to Presenilin-1</span></div><div class="casAuthors">Crump, Christina J.; Fish, Benjamin A.; Castro, Suita V.; Chau, De-Ming; Gertsik, Natalya; Ahn, Kwangwook; Stiff, Cory; Pozdnyakov, Nikolay; Bales, Kelly R.; Johnson, Douglas S.; Li, Yue-Ming</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">705-710</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aβ42 is believed to play a causative role in Alzheimer's disease (AD) pathogenesis.  γ-Secretase modulators (GSMs) are actively being pursued as potential AD therapeutics because they selectively alter the cleavage site of the amyloid precursor protein (APP) to reduce the formation of Aβ42.  However, the binding partner of acid based GSMs was unresolved until now.  We have developed clickable photoaffinity probes based on piperidine acetic acid GSM-1 and identified PS1 as the target within the γ-secretase complex.  Furthermore, we provide evidence that allosteric interaction of GSMs with PS1 results in a conformational change in the active site of the γ-secretase complex leading to the obsd. modulation of γ-secretase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYLOY1hkibKrVg90H21EOLACvtfcHk0lhLYnFy2pHf_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaqtrbM&md5=6129b8b4d150647165a04d2dd40e9ba9</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fcn200098p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200098p%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DCastro%26aufirst%3DS.%2BV.%26aulast%3DChau%26aufirst%3DD.-M.%26aulast%3DGertsik%26aufirst%3DN.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DPiperidine%2520acetic%2520acid%2520based%2520%25CE%25B3-secretase%2520modulators%2520directly%2520bind%2520to%2520presenilin-1%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D705%26epage%3D710%26doi%3D10.1021%2Fcn200098p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Ohki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uemura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezovska, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoshima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span> </span><span class="NLM_article-title">Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4815</span><span class="NLM_x">–</span> <span class="NLM_lpage">4824</span><span class="refDoi"> DOI: 10.1038/emboj.2011.372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Femboj.2011.372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22002539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWltb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=4815-4824&author=Y.+Ohkiauthor=T.+Higoauthor=K.+Uemuraauthor=N.+Shimadaauthor=S.+Osawaauthor=O.+Berezovskaauthor=S.+Yokoshimaauthor=T.+Fukuyamaauthor=T.+Tomitaauthor=T.+Iwatsubo&title=Phenylpiperidine-type+%CE%B3-secretase+modulators+target+the+transmembrane+domain+1+of+presenilin+1&doi=10.1038%2Femboj.2011.372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1</span></div><div class="casAuthors">Ohki, Yu; Higo, Takuya; Uemura, Kengo; Shimada, Naoaki; Osawa, Satoko; Berezovska, Oksana; Yokoshima, Satoshi; Fukuyama, Tohru; Tomita, Taisuke; Iwatsubo, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4815-4824</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Amyloid-β peptide ending at the 42nd residue (Aβ42) is implicated in the pathogenesis of Alzheimer's disease (AD).  Small compds. that exhibit selective lowering effects on Aβ42 prodn. are termed γ-secretase modulators (GSMs) and are deemed promising therapeutic agents against AD, although the mol. target as well as the mechanism of action remains controversial.  Here, we show that a phenylpiperidine-type compd. GSM-1 directly targets the transmembrane domain (TMD) 1 of presenilin 1 (PS1) by photoaffinity labeling expts. combined with limited digestion.  Binding of GSM-1 affected the structure of the initial substrate binding and the catalytic sites of the γ-secretase, thereby decreasing prodn. of Aβ42, possibly by enhancing its conversion to Aβ38.  These data indicate an allosteric action of GSM-1 by directly binding to the TMD1 of PS1, pinpointing the target structure of the phenylpiperidine-type GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt9j8QNf1pW7Vg90H21EOLACvtfcHk0lhLYnFy2pHf_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWltb3N&md5=e7635158068cd931a820529f43790b09</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Femboj.2011.372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2011.372%26sid%3Dliteratum%253Aachs%26aulast%3DOhki%26aufirst%3DY.%26aulast%3DHigo%26aufirst%3DT.%26aulast%3DUemura%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DN.%26aulast%3DOsawa%26aufirst%3DS.%26aulast%3DBerezovska%26aufirst%3DO.%26aulast%3DYokoshima%26aufirst%3DS.%26aulast%3DFukuyama%26aufirst%3DT.%26aulast%3DTomita%26aufirst%3DT.%26aulast%3DIwatsubo%26aufirst%3DT.%26atitle%3DPhenylpiperidine-type%2520%25CE%25B3-secretase%2520modulators%2520target%2520the%2520transmembrane%2520domain%25201%2520of%2520presenilin%25201%26jtitle%3DEMBO%2520J.%26date%3D2011%26volume%3D30%26spage%3D4815%26epage%3D4824%26doi%3D10.1038%2Femboj.2011.372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Ebke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirotani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span> </span><span class="NLM_article-title">Novel gamma-secretase enzyme modulators directly target presenilin protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">37181</span><span class="NLM_x">–</span> <span class="NLM_lpage">37186</span><span class="refDoi"> DOI: 10.1074/jbc.C111.276972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.C111.276972" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=37181-37186&author=A.+Ebkeauthor=T.+Luebbersauthor=A.+Fukumoriauthor=K.+Shirotaniauthor=C.+Haassauthor=K.+Baumannauthor=H.+Steiner&title=Novel+gamma-secretase+enzyme+modulators+directly+target+presenilin+protein&doi=10.1074%2Fjbc.C111.276972"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C111.276972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C111.276972%26sid%3Dliteratum%253Aachs%26aulast%3DEbke%26aufirst%3DA.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DShirotani%26aufirst%3DK.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DNovel%2520gamma-secretase%2520enzyme%2520modulators%2520directly%2520target%2520presenilin%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D37181%26epage%3D37186%26doi%3D10.1074%2Fjbc.C111.276972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Rennhack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jumpertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ness, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baches, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulic, B.</span><span> </span><span class="NLM_article-title">Synthesis of a potent photoreactive acidic gamma-secretase modulator for target identification in cells</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6532</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmc.2012.08.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6523-6532&author=A.+Rennhackauthor=T.+Jumpertzauthor=J.+Nessauthor=S.+Bachesauthor=C.+U.+Pietrzikauthor=S.+Weggenauthor=B.+Bulic&title=Synthesis+of+a+potent+photoreactive+acidic+gamma-secretase+modulator+for+target+identification+in+cells&doi=10.1016%2Fj.bmc.2012.08.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DRennhack%26aufirst%3DA.%26aulast%3DJumpertz%26aufirst%3DT.%26aulast%3DNess%26aufirst%3DJ.%26aulast%3DBaches%26aufirst%3DS.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DBulic%26aufirst%3DB.%26atitle%3DSynthesis%2520of%2520a%2520potent%2520photoreactive%2520acidic%2520gamma-secretase%2520modulator%2520for%2520target%2520identification%2520in%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6523%26epage%3D6532%26doi%3D10.1016%2Fj.bmc.2012.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Jumpertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennhack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ness, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baches, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span> </span><span class="NLM_article-title">Presenilin is the molecular target of acidic γ-secretase modulators in living cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e30484</span><span class="refDoi"> DOI: 10.1371/journal.pone.0030484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1371%2Fjournal.pone.0030484" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30484&author=T.+Jumpertzauthor=A.+Rennhackauthor=J.+Nessauthor=S.+Bachesauthor=C.+U.+Pietrzikauthor=B.+Bulicauthor=S.+Weggen&title=Presenilin+is+the+molecular+target+of+acidic+%CE%B3-secretase+modulators+in+living+cells&doi=10.1371%2Fjournal.pone.0030484"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030484%26sid%3Dliteratum%253Aachs%26aulast%3DJumpertz%26aufirst%3DT.%26aulast%3DRennhack%26aufirst%3DA.%26aulast%3DNess%26aufirst%3DJ.%26aulast%3DBaches%26aufirst%3DS.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DWeggen%26aufirst%3DS.%26atitle%3DPresenilin%2520is%2520the%2520molecular%2520target%2520of%2520acidic%2520%25CE%25B3-secretase%2520modulators%2520in%2520living%2520cells%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30484%26doi%3D10.1371%2Fjournal.pone.0030484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Gamma-secretase modulator (gsm) photoaffinity probes reveal distinct allosteric binding sites on presenilin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">9710</span><span class="NLM_x">–</span> <span class="NLM_lpage">9720</span><span class="refDoi"> DOI: 10.1074/jbc.M112.398602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M112.398602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23396974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsVGgsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=9710-9720&author=N.+Pozdnyakovauthor=H.+E.+Murreyauthor=C.+J.+Crumpauthor=M.+Petterssonauthor=T.+E.+Ballardauthor=C.+W.+Am+Endeauthor=K.+Ahnauthor=Y.+M.+Liauthor=K.+R.+Balesauthor=D.+S.+Johnson&title=Gamma-secretase+modulator+%28gsm%29+photoaffinity+probes+reveal+distinct+allosteric+binding+sites+on+presenilin&doi=10.1074%2Fjbc.M112.398602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulator (GSM) Photoaffinity Probes Reveal Distinct Allosteric Binding Sites on Presenilin</span></div><div class="casAuthors">Pozdnyakov, Nikolay; Murrey, Heather E.; Crump, Christina J.; Pettersson, Martin; Ballard, T. Eric; am Ende, Christopher W.; Ahn, Kwangwook; Li, Yue-Ming; Bales, Kelly R.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9710-9720</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">γ-Secretase is an intramembrane aspartyl protease that cleaves the amyloid precursor protein to produce neurotoxic β-amyloid peptides (i.e. Aβ42) that have been implicated in the pathogenesis of Alzheimer disease.  Small mol. γ-secretase modulators (GSMs) have emerged as potential disease-modifying treatments for Alzheimer disease because they reduce the formation of Aβ42 while not blocking the processing of γ-secretase substrates.  We developed clickable GSM photoaffinity probes with the goal of identifying the target of various classes of GSMs and to better understand their mechanism of action.  Here, we demonstrate that the photoaffinity probe E2012-BPyne specifically labels the N-terminal fragment of presenilin-1 (PS1-NTF) in cell membranes as well as in live cells and primary neuronal cultures.  The labeling is competed in the presence of the parent imidazole GSM E2012, but not with acid GSM-1, allosteric GSI (γ-secretase inhibitor) BMS-708163, or substrate docking site peptide inhibitor pep11, providing evidence that these compds. have distinct binding sites.  Surprisingly, we found that the crosslinking of E2012-BPyne to PS1-NTF is significantly enhanced in the presence of the active site-directed GSI L-685,458 (L458).  In contrast, L458 does not affect the labeling of the acid GSM photoprobe GSM-5.  We also obsd. that E2012-BPyne specifically labels PS1-NTF (active γ-secretase) but not full-length PS1 (inactive γ-secretase) in ANP.24 cells.  Taken together, our results support the hypothesis that multiple binding sites within the γ-secretase complex exist, each of which may contribute to different modes of modulatory action.  Furthermore, the enhancement of PS1-NTF labeling by E2012-BPyne in the presence of L458 suggests a degree of cooperativity between the active site of γ-secretase and the modulatory binding site of certain GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotm37CD1tAKbVg90H21EOLACvtfcHk0lgX5Gcqf7gFbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsVGgsrc%253D&md5=ee09863af8a589d8a8bbe6e4920474fb</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.398602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.398602%26sid%3Dliteratum%253Aachs%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DMurrey%26aufirst%3DH.%2BE.%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DAm%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DGamma-secretase%2520modulator%2520%2528gsm%2529%2520photoaffinity%2520probes%2520reveal%2520distinct%2520allosteric%2520binding%2520sites%2520on%2520presenilin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D9710%26epage%3D9720%26doi%3D10.1074%2Fjbc.M112.398602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Takeo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahariev, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takegami, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishizuka-Katsura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi-Niidome, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura-Someya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirouzu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoshima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span> </span><span class="NLM_article-title">Allosteric regulation of gamma-secretase activity by a phenylimidazole-type gamma-secretase modulator</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">10544</span><span class="NLM_x">–</span> <span class="NLM_lpage">10549</span><span class="refDoi"> DOI: 10.1073/pnas.1402171111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1073%2Fpnas.1402171111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=10544-10549&author=K.+Takeoauthor=S.+Tanimuraauthor=T.+Shinodaauthor=S.+Osawaauthor=I.+K.+Zaharievauthor=N.+Takegamiauthor=Y.+Ishizuka-Katsuraauthor=N.+Shinyaauthor=S.+Takagi-Niidomeauthor=A.+Tominagaauthor=N.+Ohsawaauthor=T.+Kimura-Someyaauthor=M.+Shirouzuauthor=S.+Yokoshimaauthor=S.+Yokoyamaauthor=T.+Fukuyamaauthor=T.+Tomitaauthor=T.+Iwatsubo&title=Allosteric+regulation+of+gamma-secretase+activity+by+a+phenylimidazole-type+gamma-secretase+modulator&doi=10.1073%2Fpnas.1402171111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1402171111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1402171111%26sid%3Dliteratum%253Aachs%26aulast%3DTakeo%26aufirst%3DK.%26aulast%3DTanimura%26aufirst%3DS.%26aulast%3DShinoda%26aufirst%3DT.%26aulast%3DOsawa%26aufirst%3DS.%26aulast%3DZahariev%26aufirst%3DI.%2BK.%26aulast%3DTakegami%26aufirst%3DN.%26aulast%3DIshizuka-Katsura%26aufirst%3DY.%26aulast%3DShinya%26aufirst%3DN.%26aulast%3DTakagi-Niidome%26aufirst%3DS.%26aulast%3DTominaga%26aufirst%3DA.%26aulast%3DOhsawa%26aufirst%3DN.%26aulast%3DKimura-Someya%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DYokoshima%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DFukuyama%26aufirst%3DT.%26aulast%3DTomita%26aufirst%3DT.%26aulast%3DIwatsubo%26aufirst%3DT.%26atitle%3DAllosteric%2520regulation%2520of%2520gamma-secretase%2520activity%2520by%2520a%2520phenylimidazole-type%2520gamma-secretase%2520modulator%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D10544%26epage%3D10549%26doi%3D10.1073%2Fpnas.1402171111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from flatland: Increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span><span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+Increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhGTkxohWdD4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520Increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span>The JChem Cartridge was used for structure-based property calculation and reporting from Oracle: JChem, version 5.9.0; <span class="NLM_publisher-name">ChemAxon</span>: <span class="NLM_publisher-loc">Budapest, Hungary</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+JChem+Cartridge+was+used+for+structure-based+property+calculation+and+reporting+from+Oracle%3A+JChem%2C+version+5.9.0%3B+ChemAxon%3A+Budapest%2C+Hungary%2C+2012%3B+http%3A%2F%2Fwww.chemaxon.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DJChem%26pub%3DChemAxon%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: The development of a central nervous system multiparameter optimization (cns mpo) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+The+development+of+a+central+nervous+system+multiparameter+optimization+%28cns+mpo%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lhGTkxohWdD4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520The%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528cns%2520mpo%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">Γ-secretase modulators as potential disease modifying anti-alzheimer’s drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span><span class="refDoi"> DOI: 10.1021/jm101168r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101168r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=669-698&author=D.+Oehlrichauthor=D.+J.+C.+Berthelotauthor=H.+J.+M.+Gijsen&title=%CE%93-secretase+modulators+as+potential+disease+modifying+anti-alzheimer%E2%80%99s+drugs&doi=10.1021%2Fjm101168r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer's Drugs</span></div><div class="casAuthors">Oehlrich, Daniel; Berthelot, Didier J.-C.; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">669-698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvn89jnxR8U7Vg90H21EOLACvtfcHk0livklVvaFRGuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbfO&md5=91dfeb6984c718e941635e7b3f60f59f</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101168r%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.%2BC.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3D%25CE%2593-secretase%2520modulators%2520as%2520potential%2520disease%2520modifying%2520anti-alzheimer%25E2%2580%2599s%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D669%26epage%3D698%26doi%3D10.1021%2Fjm101168r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-secretase modulators for the treatment of alzheimer’s disease: A review focusing on patents from 2010 to 2012</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1349</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span><span class="refDoi"> DOI: 10.1517/13543776.2013.821465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1517%2F13543776.2013.821465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23875696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1349-1366&author=M.+Petterssonauthor=A.+F.+Stepanauthor=G.+W.+Kauffmanauthor=D.+S.+Johnson&title=Novel+%CE%B3-secretase+modulators+for+the+treatment+of+alzheimer%E2%80%99s+disease%3A+A+review+focusing+on+patents+from+2010+to+2012&doi=10.1517%2F13543776.2013.821465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012</span></div><div class="casAuthors">Pettersson, Martin; Stepan, Antonia F.; Kauffman, Gregory W.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1349-1366</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: γ-Secretase is the enzyme responsible for the final step of amyloid precursor protein proteolysis to generate Aβ peptides including Aβ42 which is believed to be a toxic species involved in Alzheimer's disease (AD) progression. γ-Secretase modulators (GSMs) have been shown to selectively lower Aβ42 prodn. without affecting total Aβ levels or the formation of γ-secretase substrate intracellular domains such as APP intracellular domain and Notch intracellular domain.  Therefore, GSMs have emerged as an important therapeutic strategy for the treatment of AD.  Areas covered: The literature covering novel GSMs will be reviewed focusing on patents from 2010 to 2012.  Expert opinion: During the last review period (2008 - 2010) considerable progress was made developing GSMs with improved potency for lowering Aβ42 levels, but most of the compds. resided in unfavorable central nervous system (CNS) drug space.  In this review period (2010 - 2012), there is a higher percentage of potent GSM chem. matter that resides in favorable CNS drug space.  It is anticipated that clin. candidates will emerge out of this cohort that will be able to test the GSM mechanism of action in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFLi5hAAdKc7Vg90H21EOLACvtfcHk0livklVvaFRGuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fP&md5=6b43a8feb210fa87ded92a26397b754f</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.821465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.821465%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520modulators%2520for%2520the%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%253A%2520A%2520review%2520focusing%2520on%2520patents%2520from%25202010%2520to%25202012%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D1349%26epage%3D1366%26doi%3D10.1517%2F13543776.2013.821465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F. P.</span><span> </span><span class="NLM_article-title">Secretase inhibitors and modulators as a disease-modifying approach against alzheimer’s disease</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span><span class="refDoi"> DOI: 10.1016/B978-0-12-396492-2.00005-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2FB978-0-12-396492-2.00005-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=55-69&author=H.+J.+M.+Gijsenauthor=F.+P.+Bischoff&title=Secretase+inhibitors+and+modulators+as+a+disease-modifying+approach+against+alzheimer%E2%80%99s+disease&doi=10.1016%2FB978-0-12-396492-2.00005-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-396492-2.00005-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-396492-2.00005-9%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26atitle%3DSecretase%2520inhibitors%2520and%2520modulators%2520as%2520a%2520disease-modifying%2520approach%2520against%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D55%26epage%3D69%26doi%3D10.1016%2FB978-0-12-396492-2.00005-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenacchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottonello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, A.</span><span> </span><span class="NLM_article-title">In vitro and in vivo profiling of chf5022 and chf5074 two beta-amyloid1–42 lowering agents</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span><span class="refDoi"> DOI: 10.1016/j.phrs.2006.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.phrs.2006.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=17292621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=318-328&author=B.+P.+Imbimboauthor=E.+Del+Giudiceauthor=V.+Cenacchiauthor=R.+Voltaauthor=G.+Villettiauthor=F.+Facchinettiauthor=B.+Riccardiauthor=P.+Pucciniauthor=N.+Morettoauthor=F.+Grassiauthor=S.+Ottonelloauthor=A.+Leon&title=In+vitro+and+in+vivo+profiling+of+chf5022+and+chf5074+two+beta-amyloid1%E2%80%9342+lowering+agents&doi=10.1016%2Fj.phrs.2006.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo profiling of CHF5022 and CHF5074: Two β-amyloid1-42 lowering agents</span></div><div class="casAuthors">Imbimbo, Bruno P.; Del Giudice, Elda; Cenacchi, Valentina; Volta, Roberta; Villetti, Gino; Facchinetti, Fabrizio; Riccardi, Benedetta; Puccini, Paola; Moretto, Nadia; Grassi, Francesca; Ottonello, Simone; Leon, Alberta</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">318-328</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) may delay or prevent the onset of Alzheimer's disease (AD).  A subset of NSAIDs, including flurbiprofen, has been shown to selectively inhibit the prodn. of β-amyloid1-42 (Aβ42), independently from their cyclooxygenase (COX) inhibiting activity.  We evaluated the in vitro and in vivo profiles of CHF5022 and CHF5074, two flurbiprofen analogs.  The in vitro Aβ inhibiting activity was evaluated in a human neuroglioma cell line (H4) carrying the double Swedish mutation (K595N/M596L) of the human amyloid precursor protein (APPsw).  The in vitro anti-COX activity was evaluated using human recombinant enzymes isolated from transfected Sf-9 cells.  The in vivo pharmacokinetic and pharmacodynamic profiles of the two compds. were evaluated in young APPsw transgenic mice (Tg2576) after oral gavage (100 or 300 mg kg-1 day-1 for 4-5 days) and after medicated diet (375 ppm for 4 wk).  R-Flurbiprofen was used as comparator.  In vitro, CHF5022 and CHF5074 were found to be 3- and 7-fold more potent than R-flurbiprofen in inhibiting Aβ42 secretion (IC50s of 92, 40 and 268 μM, resp.).  Differently from R-flurbiprofen, CHF5022 and CHF5074 did not affect COX-1 (at 100 μM) and COX-2 (at 300 μM) activity.  Similarly to R-flurbiprofen, no significant alteration in the expression profile of a subset of Notch intracellular domain-responsive genes was obsd. with either CHF5022 or CHF5074.  In Tg2576 mice, CHF5022 was well tolerated when administered by oral gavage (100 mg kg-1 day-1 for 5 days) or by medicated diet (56 mg kg-1 day-1 for 4 wk).  R-Flurbiprofen was poorly tolerated in the diet (32 mg kg-1 day-1) with 55% of the animals dying during the first week of treatment.  After 4-5 days of oral gavage, CHF5022 and CHF5074 plasma and brain levels at 3 h were found to increase with the dose, leading to brain concns. of about 10% and 5% of the corresponding plasma concns., resp.  In animals fed for 4 wk with compd.-supplemented diet, mean plasma (580 μM) and brain (20 μ[n.1052]) concns. of CHF5022 were 8 and 15 times higher than those of R-flurbiprofen.  Plasma Aβ42 concn. was dose-dependently decreased by CHF5022 and CHF5074.  Brain Aβ levels (formic acid-extractable) were not significantly affected by either compd., although Aβ42 levels tended to inversely correlate (P = 0.105) with CHF5022 concn. in the brain.  CHF5022 and CHF5074 thus appear to have a promising in vitro and in vivo profile.  This warrants further evaluation of their long-term effects on Aβ brain pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqOFdo5MZ1r7Vg90H21EOLACvtfcHk0ljAs8NfmhR6kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGnsbY%253D&md5=dbcb906a0f3ed14249a65783b3718a70</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2006.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2006.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DDel%2BGiudice%26aufirst%3DE.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DVolta%26aufirst%3DR.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DRiccardi%26aufirst%3DB.%26aulast%3DPuccini%26aufirst%3DP.%26aulast%3DMoretto%26aufirst%3DN.%26aulast%3DGrassi%26aufirst%3DF.%26aulast%3DOttonello%26aufirst%3DS.%26aulast%3DLeon%26aufirst%3DA.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520profiling%2520of%2520chf5022%2520and%2520chf5074%2520two%2520beta-amyloid1%25E2%2580%259342%2520lowering%2520agents%26jtitle%3DPharmacol.%2520Res.%26date%3D2007%26volume%3D55%26spage%3D318%26epage%3D328%26doi%3D10.1016%2Fj.phrs.2006.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Rogers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsenstein, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrdlicka, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albayya, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaulding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgdon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blain, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulsteke, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scrocchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portelius, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlijanian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flood, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patzke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, G.</span><span> </span><span class="NLM_article-title">Modulation of gamma-secretase by evp-0015962 reduces amyloid deposition and behavioral deficits in tg2576 mice</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="refDoi"> DOI: 10.1186/1750-1326-7-61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1186%2F1750-1326-7-61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23249765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFyqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=61&author=K.+Rogersauthor=K.+M.+Felsensteinauthor=L.+Hrdlickaauthor=Z.+Tuauthor=F.+Albayyaauthor=W.+Leeauthor=S.+Hoppauthor=M.+J.+Millerauthor=D.+Spauldingauthor=Z.+Yangauthor=H.+Hodgdonauthor=S.+Nolanauthor=M.+Wenauthor=D.+Costaauthor=J.+F.+Blainauthor=E.+Freemanauthor=B.+De+Strooperauthor=V.+Vulstekeauthor=L.+Scrocchiauthor=H.+Zetterbergauthor=E.+Porteliusauthor=B.+Hutter-Paierauthor=D.+Havasauthor=M.+Ahlijanianauthor=D.+Floodauthor=L.+Leventhalauthor=G.+Shapiroauthor=H.+Patzkeauthor=R.+Chesworthauthor=G.+Koenig&title=Modulation+of+gamma-secretase+by+evp-0015962+reduces+amyloid+deposition+and+behavioral+deficits+in+tg2576+mice&doi=10.1186%2F1750-1326-7-61"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of γ-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 mice</span></div><div class="casAuthors">Rogers, Kathryn; Felsenstein, Kevin M.; Hrdlicka, Lori; Tu, Zhiming; Albayya, Faris; Lee, Winnie; Hopp, Sarah; Miller, Mary-Jo; Spaulding, Darcie; Yang, Zhiyong; Hodgdon, Hilliary; Nolan, Scott; Wen, Melody; Costa, Don; Blain, Jean-Francois; Freeman, Emily; De Strooper, Bart; Vulsteke, Veerle; Scrocchi, Louise; Zetterberg, Henrik; Portelius, Erik; Hutter-Paier, Birgit; Havas, Daniel; Ahlijanian, Michael; Flood, Dorothy; Leventhal, Liza; Shapiro, Gideon; Patzke, Holger; Chesworth, Richard; Koenig, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: A hallmark of Alzheimer's disease is the presence of senile plaques in human brain primarily contg. the amyloid peptides Aβ42 and Aβ40.  Many drug discovery efforts have focused on decreasing the prodn. of Aβ42 through γ-secretase inhibition.  However, identification of γ-secretase inhibitors has also uncovered mechanism-based side effects.  One approach to circumvent these side effects has been modulation of γ-secretase to shift Aβ prodn. to favor shorter, less amyloidogenic peptides than Aβ42, without affecting the overall cleavage efficiency of the enzyme.  This approach, frequently called γ-secretase modulation, appears more promising and has lead to the development of new therapeutic candidates for disease modification in Alzheimer's disease.  Results: Here we describe EVP-0015962, a novel small mol. γ-secretase modulator.  EVP-0015962 decreased Aβ42 in H4 cells (IC50 = 67 nM) and increased the shorter Aβ38 by 1.7 fold at the IC50 for lowering of Aβ42.  AβTotal, as well as other carboxyl-terminal fragments of amyloid precursor protein, were not changed.  EVP-0015962 did not cause the accumulation of other γ-secretase substrates, such as the Notch and ephrin A4 receptors, whereas a γ-secretase inhibitor reduced processing of both.  A single oral dose of EVP-0015962 (30 mg/kg) decreased Aβ42 and did not alter AβTotal peptide levels in a dose-dependent manner in Tg2576 mouse brain at an age when overt Aβ deposition was not present.  In Tg2576 mice, chronic treatment with EVP-0015962 (20 or 60 mg/kg/day in a food formulation) reduced Aβ aggregates, amyloid plaques, inflammatory markers and cognitive deficits.  Conclusions: EVP-0015962 is orally bioavailable, detected in brain and a potent, selective γ-secretase modulator in vitro and in vivo.  Chronic treatment with EVP-0015962 was well tolerated in mice and lowered the prodn. of Aβ42, attenuated memory deficits and reduced Aβ plaque formation and inflammation in Tg2576 transgenic animals.  In summary, these data suggest that γ-secretase modulation with EVP-0015962 represents a viable therapeutic alternative for disease modification in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrawar6w5ZKrrVg90H21EOLACvtfcHk0ljAs8NfmhR6kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFyqt78%253D&md5=cc1497b9c84ac2a5de368c81d99789c6</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-7-61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-7-61%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DK.%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26aulast%3DHrdlicka%26aufirst%3DL.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DAlbayya%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DHopp%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26aulast%3DSpaulding%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DHodgdon%26aufirst%3DH.%26aulast%3DNolan%26aufirst%3DS.%26aulast%3DWen%26aufirst%3DM.%26aulast%3DCosta%26aufirst%3DD.%26aulast%3DBlain%26aufirst%3DJ.%2BF.%26aulast%3DFreeman%26aufirst%3DE.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVulsteke%26aufirst%3DV.%26aulast%3DScrocchi%26aufirst%3DL.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DPortelius%26aufirst%3DE.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DHavas%26aufirst%3DD.%26aulast%3DAhlijanian%26aufirst%3DM.%26aulast%3DFlood%26aufirst%3DD.%26aulast%3DLeventhal%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DG.%26aulast%3DPatzke%26aufirst%3DH.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DModulation%2520of%2520gamma-secretase%2520by%2520evp-0015962%2520reduces%2520amyloid%2520deposition%2520and%2520behavioral%2520deficits%2520in%2520tg2576%2520mice%26jtitle%3DMol.%2520Neurodegener.%26date%3D2012%26volume%3D7%26spage%3D61%26doi%3D10.1186%2F1750-1326-7-61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Ross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franceschi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigerio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivilia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicirello, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casula, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Chf5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: A 12-week, double-blind, placebo- controlled study</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span><span class="refDoi"> DOI: 10.2174/13892037113149990144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.2174%2F13892037113149990144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23968157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVylt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=742-753&author=J.+Rossauthor=S.+Sharmaauthor=J.+Winstonauthor=M.+Nunezauthor=G.+Bottiniauthor=M.+Franceschiauthor=E.+Scarpiniauthor=E.+Frigerioauthor=F.+Fiorentiniauthor=M.+Fernandezauthor=S.+Siviliaauthor=L.+Giardinoauthor=L.+Calzaauthor=D.+Norrisauthor=H.+Cicirelloauthor=D.+Casulaauthor=B.+P.+Imbimbo&title=Chf5074+reduces+biomarkers+of+neuroinflammation+in+patients+with+mild+cognitive+impairment%3A+A+12-week%2C+double-blind%2C+placebo-+controlled+study&doi=10.2174%2F13892037113149990144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study</span></div><div class="casAuthors">Ross, Joel; Sharma, Sanjiv; Winston, Jaron; Nunez, Margarita; Bottini, Gabriella; Franceschi, Massimo; Scarpini, Elio; Frigerio, Enrico; Fiorentini, Francesco; Fernandez, Mercedes; Sivilia, Sandra; Giardino, Luciana; Calza, Laura; Norris, Dottie; Cicirello, Helen; Casula, Daniela; Imbimbo, Bruno P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">742-753</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">As neuroinflammation is an early event in the pathogenesis of Alzheimer' s disease, new selective antiinflammatory drugs could lead to promising preventive strategies.  We evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of CHF5074, a new microglial modulator, in a 12-wk, double-blind, placebo-controlled, parallel groups, ascending dose study involving 96 MCI patients.  Subjects were allocated into three successive study cohorts to receive ascending, titrated doses of CHF5074 (200, 400 or 600 mg/day) or placebo.  Vital signs, cardiac safety, neuropsychol. performance and safety clin. lab. parameters were assessed on all subjects.  Plasma samples were collected throughout the study for measuring drug concns., sol. CD40 ligand (sCD40L) and TNF-α.  At the end of treatment, cerebrospinal fluid (CSF) samples were optionally collected after the last dose to measure drug levels, β- amyloid1-42 (Aβ42), tau, phospho-tau181, sCD40L and TNF-α.  Ten patients did not complete the study: one in the placebo group (consent withdrawn), two in the 200-mg/day treatment group (consent withdrawn and unable to comply) and seven in the 400-mg/day treatment group (five AEs, one consent withdrawn and one unable to comply).  The most frequent treatment-emergent adverse events were diarrhea, dizziness and back pain.  There were no clin. significant treatment related clin. lab., vital sign or ECG abnormalities.  CHF5074 total body clearance depended by gender, age and glomerular filtration rate.  CHF5074 CSF concns. increased in a dose-dependent manner.  At the end of treatment, mean sCD40L and TNF-α levels in CSF were found to be inversely related to the CHF5074 dose (p=0.037 and p=0.001, resp.).  Plasma levels of sCD40L in the 600-mg/day group were significantly lower than those measured in the placebo group (p=0.010).  No significant differences between treatment groups were found in neuropsychol. tests but a pos. dose-response trend was found on executive function in APOE4 carriers.  This study shows that CHF5074 is well tolerated in MCI patients after a 12-wk titrated treatment up to 600 mg/day and dose-dependently affects central nervous system biomarkers of neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqolNg5CMCXW7Vg90H21EOLACvtfcHk0ljxwwoEQSFCng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVylt7vJ&md5=2120581a5f9fe47f85cf140d7ccdb942</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.2174%2F13892037113149990144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13892037113149990144%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DJ.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DWinston%26aufirst%3DJ.%26aulast%3DNunez%26aufirst%3DM.%26aulast%3DBottini%26aufirst%3DG.%26aulast%3DFranceschi%26aufirst%3DM.%26aulast%3DScarpini%26aufirst%3DE.%26aulast%3DFrigerio%26aufirst%3DE.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DFernandez%26aufirst%3DM.%26aulast%3DSivilia%26aufirst%3DS.%26aulast%3DGiardino%26aufirst%3DL.%26aulast%3DCalza%26aufirst%3DL.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DCicirello%26aufirst%3DH.%26aulast%3DCasula%26aufirst%3DD.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DChf5074%2520reduces%2520biomarkers%2520of%2520neuroinflammation%2520in%2520patients%2520with%2520mild%2520cognitive%2520impairment%253A%2520A%252012-week%252C%2520double-blind%252C%2520placebo-%2520controlled%2520study%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2013%26volume%3D10%26spage%3D742%26epage%3D753%26doi%3D10.2174%2F13892037113149990144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigerio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivilia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casula, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenouda, M.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of chf5074 after short-term administration in healthy subjects</span> <span class="citation_source-journal">Alzheimer Dis. Assoc. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1097/WAD.0b013e3182622ace</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1097%2FWAD.0b013e3182622ace" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22922591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSgt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=278-286&author=B.+P.+Imbimboauthor=E.+Frigerioauthor=M.+Bredaauthor=F.+Fiorentiniauthor=M.+Fernandezauthor=S.+Siviliaauthor=L.+Giardinoauthor=L.+Calzaauthor=D.+Norrisauthor=D.+Casulaauthor=M.+Shenouda&title=Pharmacokinetics+and+pharmacodynamics+of+chf5074+after+short-term+administration+in+healthy+subjects&doi=10.1097%2FWAD.0b013e3182622ace"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects</span></div><div class="casAuthors">Imbimbo, Bruno P.; Frigerio, Enrico; Breda, Massimo; Fiorentini, Francesco; Fernandez, Mercedes; Sivilia, Sandra; Giardino, Luciana; Calza, Laura; Norris, Dottie; Casula, Daniela; Shenouda, Magdy</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease & Associated Disorders</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">278-286</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">CHF5074 has been shown to inhibit brain β-amyloid deposition and attenuate memory deficits in different transgenic mice models of Alzheimer disease.  We evaluated the safety, pharmacokinetics, and pharmacodynamics of 3 ascending dose regimens of CHF5074 (200, 400, and 600 mg/d for 14 d) in a double-blind, placebo-controlled, parallel group study involving 48 healthy subjects.  Plasma, urine, and cerebrospinal fluid (CSF) samples were collected for measuring drug and main metabolite concns. and potential biomarkers of pharmacodynamic activity (β-amyloid1-40, β-amyloid1-42, sol. CD40 ligand, and tumor necrosis factor-α).  All subjects completed the study, and no serious or severe adverse events were reported.  The max. tolerated dose was close to 600 mg/d with mild diarrhea being the most frequent adverse event at this dose.  CHF5074 reached peak plasma levels 2 to 3 h after drug administration and then was slowly eliminated (t1/2z=30 h) in the urine as glucoronide.  Systemic exposure to the drug appeared to be dose-proportional with a 2-fold accumulation ratio at steady state.  Metabolite plasma levels peaked at 4 to 5 h and accounted for about 25% of the parent compd.  Drug levels in the CSF were dose-proportional.  The drug dose-dependently lowered the levels of the sol. CD40 ligand, a marker of microglia activation, in both plasma and CSF samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJYz4mSBAT_LVg90H21EOLACvtfcHk0ljxwwoEQSFCng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSgt7rF&md5=3ba56b2989731174e5dc1d4d571bc333</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1097%2FWAD.0b013e3182622ace&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWAD.0b013e3182622ace%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DFrigerio%26aufirst%3DE.%26aulast%3DBreda%26aufirst%3DM.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DFernandez%26aufirst%3DM.%26aulast%3DSivilia%26aufirst%3DS.%26aulast%3DGiardino%26aufirst%3DL.%26aulast%3DCalza%26aufirst%3DL.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DCasula%26aufirst%3DD.%26aulast%3DShenouda%26aufirst%3DM.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520chf5074%2520after%2520short-term%2520administration%2520in%2520healthy%2520subjects%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2013%26volume%3D27%26spage%3D278%26epage%3D286%26doi%3D10.1097%2FWAD.0b013e3182622ace" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Kimura, T.; Kawano, K.; Doi, E.; Kitazawa, N.; Shin, K.; Miyagawa, T.; Kaneko, T.; Ito, K.; Takaishi, M.; Sasaki, T.; Hagiwara, H.</span><span> </span><span class="NLM_article-title">Preparation of cinnamide, 3-benzylidenepiperidin-2-one, phenylpropynamide compounds as amyloid β production inhibitors</span>. WO2005115990A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=K.+Shin&author=T.+Miyagawa&author=T.+Kaneko&author=K.+Ito&author=M.+Takaishi&author=T.+Sasaki&author=H.+Hagiwara&title=Preparation+of+cinnamide%2C+3-benzylidenepiperidin-2-one%2C+phenylpropynamide+compounds+as+amyloid+%CE%B2+production+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520cinnamide%252C%25203-benzylidenepiperidin-2-one%252C%2520phenylpropynamide%2520compounds%2520as%2520amyloid%2520%25CE%25B2%2520production%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagawa, T.</span><span> </span><span class="NLM_article-title">E2012: A novel gamma-secretase modulator-pharmacology part</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">S242</span><span class="refDoi"> DOI: 10.1016/j.jalz.2010.05.787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.jalz.2010.05.787" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S242&author=T.+Hashimotoauthor=A.+Ishibashiauthor=H.+Hagiwaraauthor=Y.+Murataauthor=O.+Takenakaauthor=T.+Miyagawa&title=E2012%3A+A+novel+gamma-secretase+modulator-pharmacology+part&doi=10.1016%2Fj.jalz.2010.05.787"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.05.787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.05.787%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DIshibashi%26aufirst%3DA.%26aulast%3DHagiwara%26aufirst%3DH.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DTakenaka%26aufirst%3DO.%26aulast%3DMiyagawa%26aufirst%3DT.%26atitle%3DE2012%253A%2520A%2520novel%2520gamma-secretase%2520modulator-pharmacology%2520part%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS242%26doi%3D10.1016%2Fj.jalz.2010.05.787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Nakano-Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinjo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suganuma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukidate, K.</span><span> </span><span class="NLM_article-title">E2012-induced cataract and its predictive biomarkers</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1093/toxsci/kft224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1093%2Ftoxsci%2Fkft224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24085193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslKj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2014&pages=249-258&author=K.+Nakano-Itoauthor=Y.+Fujikawaauthor=T.+Hiharaauthor=H.+Shinjoauthor=S.+Kotaniauthor=A.+Suganumaauthor=T.+Aokiauthor=K.+Tsukidate&title=E2012-induced+cataract+and+its+predictive+biomarkers&doi=10.1093%2Ftoxsci%2Fkft224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">E2012-Induced Cataract and Its Predictive Biomarkers</span></div><div class="casAuthors">Nakano-Ito, Kyoko; Fujikawa, Yasuhiro; Hihara, Taro; Shinjo, Hiroko; Kotani, Sadaharu; Suganuma, Akiyoshi; Aoki, Toyohiko; Tsukidate, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">249-258</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">E2012, a gamma secretase modulator without affecting Notch processing, aimed at Alzheimer's disease by redn. of amyloid β-42, induced cataract following repeated doses in the rat.  Cataract appeared first at week 10-11 of treatment as a posterior subcapsular area with granular/punctate opaque or shiny dots along the suture line, characterized histol. as lenticular fiber degeneration, which eventually coalesced to form a triangular or circular opacity.  It was assocd. with prolonged and sustained elevation of lenticular desmosterol (24-dehydrocholesterol), the final precursor of cholesterol, and decrease in lenticular cholesterol.  In vitro studies to investigate the effect of E2012 on cholesterol metab. demonstrated that E2012 inhibits 3β-hydroxysterol Δ24-reductase (DHCR24) at the final step in the cholesterol biosynthesis.  In vivo lenticular concn. of E2012 after 13-wk repeated dose with cataract was well above those where inhibition was obsd. in vitro.  There was no cataract formation at doses where desmosterol did not accumulate in the lens.  The elevation of desmosterol and decreased cholesterol levels were also seen in the liver and plasma and preceded those in the lens.  These results demonstrate that E2012 induces cataract in the rat by inhibiting DHCR24 at the final step of cholesterol synthesis with assocd. elevation in desmosterol within the lens, preceded by desmosterol changes that would serve as a predictive safety biomarker for lenticular opacity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvv1PlcqriILVg90H21EOLACvtfcHk0ljxwwoEQSFCng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslKj&md5=db86f359b417db36786a7538f2c43a7d</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkft224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkft224%26sid%3Dliteratum%253Aachs%26aulast%3DNakano-Ito%26aufirst%3DK.%26aulast%3DFujikawa%26aufirst%3DY.%26aulast%3DHihara%26aufirst%3DT.%26aulast%3DShinjo%26aufirst%3DH.%26aulast%3DKotani%26aufirst%3DS.%26aulast%3DSuganuma%26aufirst%3DA.%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DTsukidate%26aufirst%3DK.%26atitle%3DE2012-induced%2520cataract%2520and%2520its%2520predictive%2520biomarkers%26jtitle%3DToxicol.%2520Sci.%26date%3D2014%26volume%3D137%26spage%3D249%26epage%3D258%26doi%3D10.1093%2Ftoxsci%2Fkft224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Nagy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rege, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logovinsky, V.</span><span> </span><span class="NLM_article-title">E2012, a novel gamma-secretase modulator, decreases plasma amyloid-beta (aβ) levels in humans</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">S574</span><span class="refDoi"> DOI: 10.1016/j.jalz.2010.05.1958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.jalz.2010.05.1958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S574&author=C.+Nagyauthor=E.+Schuckauthor=A.+Ishibashiauthor=Y.+Nakataniauthor=B.+Regeauthor=V.+Logovinsky&title=E2012%2C+a+novel+gamma-secretase+modulator%2C+decreases+plasma+amyloid-beta+%28a%CE%B2%29+levels+in+humans&doi=10.1016%2Fj.jalz.2010.05.1958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.05.1958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.05.1958%26sid%3Dliteratum%253Aachs%26aulast%3DNagy%26aufirst%3DC.%26aulast%3DSchuck%26aufirst%3DE.%26aulast%3DIshibashi%26aufirst%3DA.%26aulast%3DNakatani%26aufirst%3DY.%26aulast%3DRege%26aufirst%3DB.%26aulast%3DLogovinsky%26aufirst%3DV.%26atitle%3DE2012%252C%2520a%2520novel%2520gamma-secretase%2520modulator%252C%2520decreases%2520plasma%2520amyloid-beta%2520%2528a%25CE%25B2%2529%2520levels%2520in%2520humans%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS574%26doi%3D10.1016%2Fj.jalz.2010.05.1958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logovinsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, J.</span><span> </span><span class="NLM_article-title">Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel gamma-secretase modulator, e2212, in healthy human subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span><span class="refDoi"> DOI: 10.1002/jcph.249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1002%2Fjcph.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24343761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFOltr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=528-536&author=Y.+Yuauthor=V.+Logovinskyauthor=E.+Schuckauthor=J.+Kaplowauthor=M.+K.+Changauthor=T.+Miyagawaauthor=N.+Wongauthor=J.+Ferry&title=Safety%2C+tolerability%2C+pharmacokinetics%2C+and+pharmacodynamics+of+the+novel+gamma-secretase+modulator%2C+e2212%2C+in+healthy+human+subjects&doi=10.1002%2Fjcph.249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel γ-secretase modulator, E2212, in healthy human subjects</span></div><div class="casAuthors">Yu, Yanke; Logovinsky, Veronika; Schuck, Edgar; Kaplow, June; Chang, Min-kun; Miyagawa, Takehiko; Wong, Nancy; Ferry, Jim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">528-536</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">E2212, a novel γ-secretase modulator, is under development for the treatment of Alzheimer's disease.  The safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending oral doses (10-250 mg, double-blind, placebo-controlled, randomized) of E2212 were evaluated.  In this phase I clin. trial, E2212 was found to be well tolerated in single doses.  Maximum tolerated dose was not achieved up to 250 mg.  Most AEs were mild to moderate in severity with no identifiable dose related pattern.  There were no clin. significant findings on phys. and ophthalmol. examns. as well as vital signs, lab., ECG and C-SSRS assessments.  E2212 was rapidly absorbed, with median tmax values ranging from 0.5 to 1.0 h.  E2212 exhibited biphasic disposition with the terminal t1/2 of 12.5-19.0 h.  Renal excretion was the minor pathway for E2212 elimination.  Increased PD response (redn. in plasma concns. of Aβ(x-42)) was obsd. with increasing doses.  The max. PD response was obsd. in the highest dose 250 mg cohort, with ΔAUAC(0-24 h) of 44.1% and Amax of 53.6%.  These results support further clin. development of E2212.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPOIqz7T9957Vg90H21EOLACvtfcHk0lgRr871R4HoSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFOltr3J&md5=2a7f24b32e99f4ea41082cc438319e8c</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1002%2Fjcph.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcph.249%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DLogovinsky%26aufirst%3DV.%26aulast%3DSchuck%26aufirst%3DE.%26aulast%3DKaplow%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DM.%2BK.%26aulast%3DMiyagawa%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DN.%26aulast%3DFerry%26aufirst%3DJ.%26atitle%3DSafety%252C%2520tolerability%252C%2520pharmacokinetics%252C%2520and%2520pharmacodynamics%2520of%2520the%2520novel%2520gamma-secretase%2520modulator%252C%2520e2212%252C%2520in%2520healthy%2520human%2520subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2014%26volume%3D54%26spage%3D528%26epage%3D536%26doi%3D10.1002%2Fjcph.249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, T. R.</span><span> </span><span class="NLM_article-title">Γ-secretase modulators: Current status and future directions</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1016/B978-0-444-63380-4.00003-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2FB978-0-444-63380-4.00003-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24418609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=101-145&author=A.+Hallauthor=T.+R.+Patel&title=%CE%93-secretase+modulators%3A+Current+status+and+future+directions&doi=10.1016%2FB978-0-444-63380-4.00003-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase modulators: current status and future directions</span></div><div class="casAuthors">Hall, Adrian; Patel, Toshal R.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-145</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  This article provides an overview of recent progress in the development of γ-secretase modulator (GSMs), focusing mainly on the peer reviewed literature, but drawing on the patent literature where necessary.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq01MNt_SYGrVg90H21EOLACvtfcHk0lgRr871R4HoSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWnt7Y%253D&md5=4f59015d982e3d5cf1ff090c105eb471</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-63380-4.00003-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-63380-4.00003-2%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DT.%2BR.%26atitle%3D%25CE%2593-secretase%2520modulators%253A%2520Current%2520status%2520and%2520future%2520directions%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D53%26spage%3D101%26epage%3D145%26doi%3D10.1016%2FB978-0-444-63380-4.00003-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Kamada, A.; Sasaki, T.; Uemura, T.</span><span> </span><span class="NLM_article-title">Method for producing 2-[(<i>E</i>)-2-(pyridin-2-yl)vinyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-<i>a</i>]pyridine compound and its intermediates</span>. JP2012121809A,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Kamada&author=T.+Sasaki&author=T.+Uemura&title=Method+for+producing+2-%5B%28E%29-2-%28pyridin-2-yl%29vinyl%5D-5%2C6%2C7%2C8-tetrahydro-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyridine+compound+and+its+intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKamada%26aufirst%3DA.%26atitle%3DMethod%2520for%2520producing%25202-%255B%2528E%2529-2-%2528pyridin-2-yl%2529vinyl%255D-5%252C6%252C7%252C8-tetrahydro-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyridine%2520compound%2520and%2520its%2520intermediates%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Nakamura, T.; Matsuda, M.; Hu, Y.; Hasegawa, D.; Hoshino, Y.; Inanaga, K.; Isomura, M.; Sato, N.; Yoshizawa, K.; Moniz, G. A.; Wilkie, G. D.; Fang, F. G.; Nishikawa, Y.</span><span> </span><span class="NLM_article-title">Process for preparing stereoisomeric cinnamide derivatives</span>. WO2010025197A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Nakamura&author=M.+Matsuda&author=Y.+Hu&author=D.+Hasegawa&author=Y.+Hoshino&author=K.+Inanaga&author=M.+Isomura&author=N.+Sato&author=K.+Yoshizawa&author=G.+A.+Moniz&author=G.+D.+Wilkie&author=F.+G.+Fang&author=Y.+Nishikawa&title=Process+for+preparing+stereoisomeric+cinnamide+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DT.%26atitle%3DProcess%2520for%2520preparing%2520stereoisomeric%2520cinnamide%2520derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Minamisono, T.; Kitazawa, N.; Kushida, I.</span><span> </span><span class="NLM_article-title">Preparation of salts of (8<i>S</i>)-2-[(<i>E</i>)-2-[6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyridin-2-yl]vinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-1,2,4-triazolo[1,5-<i>a</i>]pyridine</span>. WO2010098490A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Minamisono&author=N.+Kitazawa&author=I.+Kushida&title=Preparation+of+salts+of+%288S%29-2-%5B%28E%29-2-%5B6-methoxy-5-%284-methyl-1H-imidazol-1-yl%29pyridin-2-yl%5Dvinyl%5D-8-%5B2-%28trifluoromethyl%29phenyl%5D-5%2C6%2C7%2C8-tetrahydro-1%2C2%2C4-triazolo%5B1%2C5-a%5Dpyridine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMinamisono%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520salts%2520of%2520%25288S%2529-2-%255B%2528E%2529-2-%255B6-methoxy-5-%25284-methyl-1H-imidazol-1-yl%2529pyridin-2-yl%255Dvinyl%255D-8-%255B2-%2528trifluoromethyl%2529phenyl%255D-5%252C6%252C7%252C8-tetrahydro-1%252C2%252C4-triazolo%255B1%252C5-a%255Dpyridine%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Kamada, A.; Sasaki, T.; Uemura, T.</span><span> </span><span class="NLM_article-title">Method for producing 2-[(<i>E</i>)-2-(pyridin-2-yl)vinyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-<i>a</i>]pyridine compound and its intermediates</span>. WO2010098332A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=A.+Kamada&author=T.+Sasaki&author=T.+Uemura&title=Method+for+producing+2-%5B%28E%29-2-%28pyridin-2-yl%29vinyl%5D-5%2C6%2C7%2C8-tetrahydro-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyridine+compound+and+its+intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKamada%26aufirst%3DA.%26atitle%3DMethod%2520for%2520producing%25202-%255B%2528E%2529-2-%2528pyridin-2-yl%2529vinyl%255D-5%252C6%252C7%252C8-tetrahydro-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyridine%2520compound%2520and%2520its%2520intermediates%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Sun, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCracken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicarel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span> </span><span class="NLM_article-title">Cyclic hydroxyamidines as amide isosteres: Discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span><span class="refDoi"> DOI: 10.1021/jm201407j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201407j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=489-502&author=Z.-Y.+Sunauthor=T.+Asberomauthor=T.+Baraauthor=C.+Bennettauthor=D.+Burnettauthor=I.+Chuauthor=J.+Claderauthor=M.+Cohen-Williamsauthor=D.+Coleauthor=M.+Czarnieckiauthor=J.+Durkinauthor=G.+Galloauthor=W.+Greenleeauthor=H.+Josienauthor=X.+Huangauthor=L.+Hydeauthor=N.+Jonesauthor=I.+Kazakevichauthor=H.+Liauthor=X.+Liuauthor=J.+Leeauthor=M.+MacCossauthor=M.+B.+Mandalauthor=T.+McCrackenauthor=A.+Nomeirauthor=R.+Mazzolaauthor=A.+Palaniauthor=E.+M.+Parkerauthor=D.+A.+Pissarnitskiauthor=J.+Qinauthor=L.+Songauthor=G.+Terracinaauthor=M.+Vicarelauthor=J.+Voigtauthor=R.+Xuauthor=L.+Zhangauthor=Q.+Zhangauthor=Z.+Zhaoauthor=X.+Zhuauthor=Z.+Zhu&title=Cyclic+hydroxyamidines+as+amide+isosteres%3A+Discovery+of+oxadiazolines+and+oxadiazines+as+potent+and+highly+efficacious+%CE%B3-secretase+modulators+in+vivo&doi=10.1021%2Fjm201407j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in Vivo</span></div><div class="casAuthors">Sun, Zhong-Yue; Asberom, Theodros; Bara, Thomas; Bennett, Chad; Burnett, Duane; Chu, Inhou; Clader, John; Cohen-Williams, Mary; Cole, David; Czarniecki, Michael; Durkin, James; Gallo, Gioconda; Greenlee, William; Josien, Hubert; Huang, Xianhai; Hyde, Lynn; Jones, Nicholas; Kazakevich, Irina; Li, Hongmei; Liu, Xiaoxiang; Lee, Julie; MacCoss, Malcolm; Mandal, Mihir B.; McCracken, Troy; Nomeir, Amin; Mazzola, Robert; Palani, Anandan; Parker, Eric M.; Pissarnitski, Dmitri A.; Qin, Jun; Song, Lixin; Terracina, Giuseppe; Vicarel, Monica; Voigt, Johannes; Xu, Ruo; Zhang, Lili; Zhang, Qi; Zhao, Zhiqiang; Zhu, Xiaohong; Zhu, Zhaoning</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">489-502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic hydroxyamidines were designed and validated as isosteric replacements of the amide functionality.  Compds. with these structural motifs were found to be metabolically stable and to possess highly desirable pharmacokinetic profiles.  These designs were applied in the identification of γ-secretase modulators leading to highly efficacious agents for redn. of central nervous system Aβ42 in various animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowGuNLMGYzw7Vg90H21EOLACvtfcHk0lgaX6tPJAR4eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbbL&md5=5f64483cba26060a60de990fa423014e</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm201407j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201407j%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.-Y.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMandal%26aufirst%3DM.%2BB.%26aulast%3DMcCracken%26aufirst%3DT.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DPissarnitski%26aufirst%3DD.%2BA.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DCyclic%2520hydroxyamidines%2520as%2520amide%2520isosteres%253A%2520Discovery%2520of%2520oxadiazolines%2520and%2520oxadiazines%2520as%2520potent%2520and%2520highly%2520efficacious%2520%25CE%25B3-secretase%2520modulators%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D489%26epage%3D502%26doi%3D10.1021%2Fjm201407j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicarel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCraken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span> </span><span class="NLM_article-title">Synthesis and sar studies of fused oxadiazines as γ-secretase modulators for treatment of alzheimer’s disease</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span><span class="refDoi"> DOI: 10.1021/ml300209g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300209g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12itr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=931-935&author=X.+Huangauthor=W.+Zhouauthor=X.+Liuauthor=H.+Liauthor=G.+Sunauthor=M.+Mandalauthor=M.+Vicarelauthor=X.+Zhuauthor=C.+Bennettauthor=T.+McCrakenauthor=D.+Pissarnitskiauthor=Z.+Zhaoauthor=D.+Coleauthor=G.+Galloauthor=Z.+Zhuauthor=A.+Palaniauthor=R.+Aslanianauthor=J.+Claderauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=D.+Burnettauthor=M.+Cohen-Williamsauthor=L.+Hydeauthor=L.+Songauthor=L.+Zhangauthor=I.+Chuauthor=A.+Buevich&title=Synthesis+and+sar+studies+of+fused+oxadiazines+as+%CE%B3-secretase+modulators+for+treatment+of+alzheimer%E2%80%99s+disease&doi=10.1021%2Fml300209g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Huang, Xianhai; Zhou, Wei; Liu, Xiaoxiang; Li, Hongmei; Sun, George; Mandal, Mihirbaran; Vicarel, Monica; Zhu, Xiaohong; Bennett, Chad; McCraken, Troy; Pissarnitski, Dmitri; Zhao, Zhiqiang; Cole, David; Gallo, Gioconda; Zhu, Zhaoning; Palani, Anandan; Aslanian, Robert; Clader, John; Czarniecki, Michael; Greenlee, William; Burnett, Duane; Cohen-Williams, Mary; Hyde, Lynn; Song, Lixin; Zhang, Lili; Chu, Inhou; Buevich, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">931-935</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fused oxadiazines such as imidazolylbenzylidene pyridooxadiazines I (R = Cl, F; R1 = H, F; R2 = H; X = CH2) and imidazolylbenzylidene oxazinooxadiazines I (R = F; R1 = H, F; R2 = Me; X = O) were prepd. as selective and orally bioavailable γ-secretase modulators (GSMs) derived by analogy from pyridooxadiazoline GSMs.  The effect of structural modifications on pyridooxadiazoline GSMs differed significantly from the effects of modifications to pyridooxadiazine GSMs.  I (R = Cl, F; R1 = H, F; R2 = H; X = CH2) were found to be highly efficacious in vitro and in vivo in a no. of animal models with highly desirable phys. and pharmacol. properties.  Fused morpholine oxadiazines such as I (R = F; R1 = H, F; R2 = Me; X = O) showed improved in vitro activities and selectivities as GSMs.  The shift in specificity of APP cleavage rather than a redn. in overall γ-secretase activity and the lack of changes in substrate accumulation and Notch processing as obsd. in the animal studies of compd. I (R = R1 = F; R2 = H; X = CH2) confirm that imidazolylbenzylidene pyridooxadiazines are potent GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrLJKqS8YPSLVg90H21EOLACvtfcHk0lgaX6tPJAR4eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12itr3L&md5=42883463705abaa95287df4ea07f8936</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fml300209g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300209g%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DG.%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DMcCraken%26aufirst%3DT.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DBuevich%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520sar%2520studies%2520of%2520fused%2520oxadiazines%2520as%2520%25CE%25B3-secretase%2520modulators%2520for%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D931%26epage%3D935%26doi%3D10.1021%2Fml300209g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhondi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicarel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">The discovery of fused oxadiazepines as gamma secretase modulators for treatment of alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2012.11.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23253441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVOrurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=466-471&author=H.+Liauthor=J.+Qinauthor=P.+Dhondiauthor=W.+Zhouauthor=M.+Vicarelauthor=T.+Baraauthor=D.+Coleauthor=H.+Josienauthor=D.+Pissarnitskiauthor=Z.+Zhuauthor=A.+Palaniauthor=R.+Aslanianauthor=J.+Claderauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=M.+Cohen-Williamsauthor=L.+Hydeauthor=L.+Songauthor=L.+Zhangauthor=I.+Chuauthor=X.+Huang&title=The+discovery+of+fused+oxadiazepines+as+gamma+secretase+modulators+for+treatment+of+alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2012.11.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's disease</span></div><div class="casAuthors">Li, Hongmei; Qin, Jun; Dhondi, Pawan; Zhou, Wei; Vicarel, Monica; Bara, Thomas; Cole, David; Josien, Hubert; Pissarnitski, Dmitri; Zhu, Zhaoning; Palani, Anandan; Aslanian, Robert; Clader, John; Czarniecki, Michael; Greenlee, William; Cohen-Williams, Mary; Hyde, Lynn; Song, Lixin; Zhang, Lili; Chu, Inhou; Huang, Xianhai</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">466-471</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In an attempt to further improve overall profiles of the oxadiazine series of GSMs, in particular the hERG activity, conformational modifications of the core structure resulted in the identification of fused oxadiazepines such as 7i (I) which had an improved hERG inhibition profile and was a highly efficacious GSM in vitro and in vivo in rats.  These SAR explorations offer opportunities to identify potential drugs to treat Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJUUyjEiaFDbVg90H21EOLACvtfcHk0licSDgqEf7nnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVOrurrI&md5=d2c0ec5773714fe62e9056a98823343e</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.055%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DThe%2520discovery%2520of%2520fused%2520oxadiazepines%2520as%2520gamma%2520secretase%2520modulators%2520for%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D466%26epage%3D471%26doi%3D10.1016%2Fj.bmcl.2012.11.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Henderson, R. F.</span><span> </span><span class="NLM_article-title">Species differences in the metabolism of olefins. Implications for risk assessment</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">135–136</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/S0009-2797(01)00170-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2FS0009-2797%2801%2900170-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=11397381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktV2ltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135%E2%80%93136&publication_year=2001&pages=53-64&author=R.+F.+Henderson&title=Species+differences+in+the+metabolism+of+olefins.+Implications+for+risk+assessment&doi=10.1016%2FS0009-2797%2801%2900170-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in the metabolism of olefins. Implications for risk assessment</span></div><div class="casAuthors">Henderson, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">135-136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-64</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 22 refs.  Olefinic compds. are com. valuable because they form useful polymeric substances.  The same chem. property (presence of double bonds) that makes the olefins useful may also cause them to be toxic in the body.  The double bonds of olefins can be oxidized by cytochrome P 450 enzymes to epoxides, which are electrophiles that can react with DNA and may cause alterations in the genetic information carried by that macromol.  Epoxides can be rendered inactive toward DNA by binding to proteins, by hydrolysis to diols through epoxide hydrolase enzymes (EHs), or by forming conjugates with glutathione via glutathione S-transferase (GST) activities.  The balance between the oxidizing enzymic activities and the hydrolyzing or conjugating enzymic activities in the livers of different species can influence the potential toxicity of the olefins.  The location of the enzymes and the potential for concerted reactions in which epoxides are inactivated immediately after formation will also influence the potential toxicity of the olefins.  Cytochrome P 450 enzymes and EHs are in microsomes located in the rough endoplasmic reticulum surrounding the nucleus where the DNA is located.  GST is in the cytoplasm of the cell.  In the case of 1,3-butadiene (BD), such enzymic differences may strongly influence the toxicity in different species.  The mouse, in which BD is a potent multi-site carcinogen, has the lowest microsomal EH activity of any species.  This allows the monoepoxides formed in the microsomes by cytochrome P 450 enzymes to be further oxidized to the highly genotoxic diepoxide (DEB), and both epoxides can either be released into the blood for distribution throughout the body or can react with DNA in the nucleus.  The rat, in which BD is a weak carcinogen, has much higher levels of microsomal EH, and only trace amts. of DEB enter the bloodstream.  Major BD metabolites in primates suggest that the hydrolysis pathway is even more prominent in primates than in rats.  Data suggest that BD will be much less toxic in primates than in mice.  Considering these quant. differences in metab. may help to reduce the uncertainties in extrapolating animal data on olefin toxicity to health risk assessments for humans exposed to the compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQf50n60n2iLVg90H21EOLACvtfcHk0licSDgqEf7nnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktV2ltb0%253D&md5=050db0848b3020f59c9d58f5774db520</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2801%2900170-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252801%252900170-3%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DR.%2BF.%26atitle%3DSpecies%2520differences%2520in%2520the%2520metabolism%2520of%2520olefins.%2520Implications%2520for%2520risk%2520assessment%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2001%26volume%3D135%25E2%2580%2593136%26spage%3D53%26epage%3D64%26doi%3D10.1016%2FS0009-2797%2801%2900170-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Bischoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masungi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9089</span><span class="NLM_x">–</span> <span class="NLM_lpage">9106</span><span class="refDoi"> DOI: 10.1021/jm201710f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201710f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9089-9106&author=F.+Bischoffauthor=D.+Berthelotauthor=M.+De+Cleynauthor=G.+MacDonaldauthor=G.+Minneauthor=D.+Oehlrichauthor=S.+Pietersauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=S.+Van+Brandtauthor=I.+Velterauthor=M.+Zajaauthor=H.+Borghysauthor=C.+Masungiauthor=M.+Merckenauthor=H.+J.+M.+Gijsen&title=Design+and+synthesis+of+a+novel+series+of+bicyclic+heterocycles+as+potent+%CE%B3-secretase+modulators&doi=10.1021%2Fjm201710f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators</span></div><div class="casAuthors">Bischoff, Francois; Berthelot, Didier; De Cleyn, Michel; MacDonald, Gregor; Minne, Garrett; Oehlrich, Daniel; Pieters, Serge; Surkyn, Michel; Trabanco, Andres A.; Tresadern, Gary; Van Brandt, Sven; Velter, Ingrid; Zaja, Mirko; Borghys, Herman; Masungi, Chantal; Mercken, Marc; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9089-9106</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and the synthesis of several chem. subclasses of imidazole contg. γ-secretase modulators (GSMs) is described.  Conformational restriction of an aminopyridone into bicyclic pyridone isosteres has led to compds. with high in vitro and in vivo potency.  This has resulted in the identification of benzimidazole I as a GSM with low nanomolar potency in vitro.  In mouse, rat, and dog, this compd. displayed the typical γ-secretase modulatory profile by lowering Aβ42 and Aβ40 levels combined with an esp. pronounced increase in Aβ38 and Aβ37 levels while leaving the total levels of amyloid peptides unchanged.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtfwoI1AvXwLVg90H21EOLACvtfcHk0liXLK5E_cBDoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGrurw%253D&md5=8edaf14f066220910e0d510a563ce02f</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm201710f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201710f%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DMacDonald%26aufirst%3DG.%26aulast%3DMinne%26aufirst%3DG.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVelter%26aufirst%3DI.%26aulast%3DZaja%26aufirst%3DM.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DMasungi%26aufirst%3DC.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520novel%2520series%2520of%2520bicyclic%2520heterocycles%2520as%2520potent%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9089%26epage%3D9106%26doi%3D10.1021%2Fjm201710f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Gerlach, K.; Heine, N.; Hobson, S.; Hoenke, C.; Weber, A.</span><span> </span><span class="NLM_article-title">Preparation of dihydrothienopyrimidines γ-secretase modulators</span>. WO2013020992A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+Gerlach&author=N.+Heine&author=S.+Hobson&author=C.+Hoenke&author=A.+Weber&title=Preparation+of+dihydrothienopyrimidines+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520dihydrothienopyrimidines%2520%25CE%25B3-secretase%2520modulators%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Gerlach, K.; Eickmeier, C.; Heine, C.; Heine, N.; Weber, A.</span><span> </span><span class="NLM_article-title">Preparation of dihydropteridinones as modulators of γ-secretase for treating Alzheimer’s disease</span>. US20130225549A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+Gerlach&author=C.+Eickmeier&author=C.+Heine&author=N.+Heine&author=A.+Weber&title=Preparation+of+dihydropteridinones+as+modulators+of+%CE%B3-secretase+for+treating+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520dihydropteridinones%2520as%2520modulators%2520of%2520%25CE%25B3-secretase%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Eickmeier, C.; Gerlach, K.; Heine, N.; Weber, A.; Gross, U.</span><span> </span><span class="NLM_article-title">Preparation of spiroheterocyclodihydropteridinones as modulators of γ-secretase for treating Alzheimer’s disease</span>. US20130225593A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Eickmeier&author=K.+Gerlach&author=N.+Heine&author=A.+Weber&author=U.+Gross&title=Preparation+of+spiroheterocyclodihydropteridinones+as+modulators+of+%CE%B3-secretase+for+treating+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEickmeier%26aufirst%3DC.%26atitle%3DPreparation%2520of%2520spiroheterocyclodihydropteridinones%2520as%2520modulators%2520of%2520%25CE%25B3-secretase%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Burnett, D. A.; Bursavich, M. G.; McRiner, A. J.</span><span> </span><span class="NLM_article-title">Preparation of fused morpholinopyrimidines for treating neurodegenerative diseases</span>. WO2015066697A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+A.+Burnett&author=M.+G.+Bursavich&author=A.+J.+McRiner&title=Preparation+of+fused+morpholinopyrimidines+for+treating+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26atitle%3DPreparation%2520of%2520fused%2520morpholinopyrimidines%2520for%2520treating%2520neurodegenerative%2520diseases%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Burnett, D. A.; Bursavich, M. G.; McRiner, A. J.</span><span> </span><span class="NLM_article-title">Preparation of fused morpholinopyrimidines for treating neurodegenerative diseases</span>. WO2015066696A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+A.+Burnett&author=M.+G.+Bursavich&author=A.+J.+McRiner&title=Preparation+of+fused+morpholinopyrimidines+for+treating+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26atitle%3DPreparation%2520of%2520fused%2520morpholinopyrimidines%2520for%2520treating%2520neurodegenerative%2520diseases%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Burnett, D. A.; Bursavich, M. G.; McRiner, A. J.</span><span> </span><span class="NLM_article-title">Fused morpholinopyrimidines as beta-amyloid inhibitors and their preparation</span>. WO2015109109A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+A.+Burnett&author=M.+G.+Bursavich&author=A.+J.+McRiner&title=Fused+morpholinopyrimidines+as+beta-amyloid+inhibitors+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26atitle%3DFused%2520morpholinopyrimidines%2520as%2520beta-amyloid%2520inhibitors%2520and%2520their%2520preparation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranararyanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guss, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iben, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierdomenico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlijanian, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerritz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcin, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denton, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raybon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanabha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harden, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prack, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvyaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantone, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drexler, D. M.</span><span> </span><span class="NLM_article-title">Identification and preclinical pharmacology of the γ-secretase modulator BMS-869780</span> <span class="citation_source-journal">Int. J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2014</span><span class="NLM_x">, </span> <span class="NLM_fpage">431858</span><span class="refDoi"> DOI: 10.1155/2014/431858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1155%2F2014%2F431858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=25097793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A280%3ADC%252BC2cbptlKmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=431858&author=J.+H.+Toynauthor=J.+E.+Meredithauthor=C.+R.+Burtonauthor=S.+Sankaranararyananauthor=V.+Gussauthor=L.+G.+Ibenauthor=C.+M.+Krauseauthor=R.+Krauseauthor=X.-A.+Linauthor=M.+Pierdomenicoauthor=C.+Polsonauthor=A.+S.+Robertsonauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=L.+A.+Thompsonauthor=S.+Gerritzauthor=L.+R.+Marcinauthor=M.+A.+Higginsauthor=J.+Shiauthor=J.+E.+Macorauthor=R.+E.+Olsonauthor=K.+A.+Lentzauthor=R.+R.+Dentonauthor=J.+E.+Graceauthor=J.+Morrisonauthor=J.+Raybonauthor=X.+Zhuoauthor=K.+Snowauthor=T.+Hallauthor=R.+Padmanabhaauthor=K.+Espositoauthor=D.+Hardenauthor=M.+Prackauthor=T.+Zvyagaauthor=M.+Aglerauthor=S.+Varmaauthor=V.+Wongauthor=Y.+Zhuauthor=C.+Weiauthor=J.+L.+Cantoneauthor=D.+M.+Drexler&title=Identification+and+preclinical+pharmacology+of+the+%CE%B3-secretase+modulator+BMS-869780&doi=10.1155%2F2014%2F431858"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780</span></div><div class="casAuthors">Toyn Jeremy H; Meredith Jere E Jr; Burton Catherine R; Sankaranararyanan Sethu; Guss Valerie; Iben Lawrence G; Krause Carol M; Krause Rudy; Lin Xu-Alan; Pierdomenico Maria; Polson Craig; Robertson Alan S; Ahlijanian Michael K; Albright Charles F; Thompson Lorin A; Gerritz Samuel; Marcin Lawrence R; Higgins Mendi A; Shi Jianliang; Macor John E; Olson Richard E; Lentz Kimberley A; Denton R Rex; Grace James E; Morrison John; Raybon Joseph; Zhuo Xiaoliang; Snow Kimberly; Hall Tracey; Padmanabha Ramesh; Esposito Kim; Harden David; Prack Margaret; Zvyaga Tatyana; Agler Michele; Varma Sam; Wong Victoria; Zhu Yingjie; Wei Cong; Cantone Joseph L; Drexler Dieter M</div><div class="citationInfo"><span class="NLM_cas:title">International journal of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">431858</span>
        ISSN:<span class="NLM_cas:issn">2090-8024</span>.
    </div><div class="casAbstract">Alzheimer's disease is the most prevalent cause of dementia and is associated with accumulation of amyloid-β peptide (Aβ), particularly the 42-amino acid Aβ1-42, in the brain.  Aβ1-42 levels can be decreased by γ-secretase modulators (GSM), which are small molecules that modulate γ-secretase, an enzyme essential for Aβ production.  BMS-869780 is a potent GSM that decreased Aβ1-42 and Aβ1-40 and increased Aβ1-37 and Aβ1-38, without inhibiting overall levels of Aβ peptides or other APP processing intermediates.  BMS-869780 also did not inhibit Notch processing by γ-secretase and lowered brain Aβ1-42 without evidence of Notch-related side effects in rats.  Human pharmacokinetic (PK) parameters were predicted through allometric scaling of PK in rat, dog, and monkey and were combined with the rat pharmacodynamic (PD) parameters to predict the relationship between BMS-869780 dose, exposure and Aβ1-42 levels in human.  Off-target and safety margins were then based on comparisons to the predicted exposure required for robust Aβ1-42 lowering.  Because of insufficient safety predictions and the relatively high predicted human daily dose of 700 mg, further evaluation of BMS-869780 as a potential clinical candidate was discontinued.  Nevertheless, BMS-869780 demonstrates the potential of the GSM approach for robust lowering of brain Aβ1-42 without Notch-related side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRiQzrKw3yQB--MdeMhXAHkfW6udTcc2eZiNEqK97_Hz7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbptlKmsg%253D%253D&md5=c5da43b0bd60d8bc739651d39e6216f7</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1155%2F2014%2F431858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F431858%26sid%3Dliteratum%253Aachs%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DSankaranararyanan%26aufirst%3DS.%26aulast%3DGuss%26aufirst%3DV.%26aulast%3DIben%26aufirst%3DL.%2BG.%26aulast%3DKrause%26aufirst%3DC.%2BM.%26aulast%3DKrause%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DX.-A.%26aulast%3DPierdomenico%26aufirst%3DM.%26aulast%3DPolson%26aufirst%3DC.%26aulast%3DRobertson%26aufirst%3DA.%2BS.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DGerritz%26aufirst%3DS.%26aulast%3DMarcin%26aufirst%3DL.%2BR.%26aulast%3DHiggins%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DDenton%26aufirst%3DR.%2BR.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DMorrison%26aufirst%3DJ.%26aulast%3DRaybon%26aufirst%3DJ.%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DSnow%26aufirst%3DK.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DPadmanabha%26aufirst%3DR.%26aulast%3DEsposito%26aufirst%3DK.%26aulast%3DHarden%26aufirst%3DD.%26aulast%3DPrack%26aufirst%3DM.%26aulast%3DZvyaga%26aufirst%3DT.%26aulast%3DAgler%26aufirst%3DM.%26aulast%3DVarma%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DCantone%26aufirst%3DJ.%2BL.%26aulast%3DDrexler%26aufirst%3DD.%2BM.%26atitle%3DIdentification%2520and%2520preclinical%2520pharmacology%2520of%2520the%2520%25CE%25B3-secretase%2520modulator%2520BMS-869780%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2014%26volume%3D2014%26spage%3D431858%26doi%3D10.1155%2F2014%2F431858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Boy, K. M.; Guernon, J. M.; Zhang, Y.; Zuev, D.; Mandal, S. K.; Chandrashekharappa, S.; K, S. D.; Baligar, V.; Wu, Y.-J.; Marcin, L.; Higgins, M.; Shi, J.; Xu, L.; Toyn, J. H.; Meredith, J. E.,  Jr.; Burton, C. R.; Albright, C. F.; Lentz, K. A.; Grace, J. E.; Denton, R.; Morrison, J. S.; Kimura, R.; Ahlijanian, M. K.; Olson, R. E.; Macor, J. E.; Thompson, L. A.,  III.</span><span> </span><span class="NLM_article-title">Bicyclic pyrimidine modulators of Abeta production for the treatment of Alzheimer’s disease</span>. Presented at the 248th National Meeting of the American Chemical Society, San Francisco, CA, Aug 10–14,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Paper  <span class="NLM_fpage">MEDI-265</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Boy%2C+K.+M.%3B+Guernon%2C+J.+M.%3B+Zhang%2C+Y.%3B+Zuev%2C+D.%3B+Mandal%2C+S.+K.%3B+Chandrashekharappa%2C+S.%3B+K%2C+S.+D.%3B+Baligar%2C+V.%3B+Wu%2C+Y.-J.%3B+Marcin%2C+L.%3B+Higgins%2C+M.%3B+Shi%2C+J.%3B+Xu%2C+L.%3B+Toyn%2C+J.+H.%3B+Meredith%2C+J.+E.%2C+Jr.%3B+Burton%2C+C.+R.%3B+Albright%2C+C.+F.%3B+Lentz%2C+K.+A.%3B+Grace%2C+J.+E.%3B+Denton%2C+R.%3B+Morrison%2C+J.+S.%3B+Kimura%2C+R.%3B+Ahlijanian%2C+M.+K.%3B+Olson%2C+R.+E.%3B+Macor%2C+J.+E.%3B+Thompson%2C+L.+A.%2C+III.+Bicyclic+pyrimidine+modulators+of+Abeta+production+for+the+treatment+of+Alzheimer%E2%80%99s+disease.+Presented+at+the+248th+National+Meeting+of+the+American+Chemical+Society%2C+San+Francisco%2C+CA%2C+Aug+10%E2%80%9314%2C+2014%3B+Paper+MEDI-265."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBoy%26aufirst%3DK.%2BM.%26atitle%3DBicyclic%2520pyrimidine%2520modulators%2520of%2520Abeta%2520production%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2014%26spage%3DMEDI-265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Thompson, L. A.; Boy, K. M.; Zuev, D.; Guernon, J. M.; Zhang, Y.; Wu, Y.-J.; Marcin, L. R.; Higgins, M. A.; Shi, J.; Xu, L.; Toyn, J. H.; Meredith, J. E.; Burton, C. R.; Kimura, R.; Lentz, K. A.; Grace, J. E.; Denton, R.; Morrison, J.; Albright, C. F.; Ahlijanian, M. K.; Olson, R. E.; Macor, J. E.</span><span> </span><span class="NLM_article-title">Discovery and preclinical profile of BMS-932481, a gamma secretase modulator for the treatment of Alzheimer’s disease</span>. Presented at the 248th National Meeting of the American Chemical Society, San Francisco, CA, Aug 10–14,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Paper  <span class="NLM_fpage">MEDI-266</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thompson%2C+L.+A.%3B+Boy%2C+K.+M.%3B+Zuev%2C+D.%3B+Guernon%2C+J.+M.%3B+Zhang%2C+Y.%3B+Wu%2C+Y.-J.%3B+Marcin%2C+L.+R.%3B+Higgins%2C+M.+A.%3B+Shi%2C+J.%3B+Xu%2C+L.%3B+Toyn%2C+J.+H.%3B+Meredith%2C+J.+E.%3B+Burton%2C+C.+R.%3B+Kimura%2C+R.%3B+Lentz%2C+K.+A.%3B+Grace%2C+J.+E.%3B+Denton%2C+R.%3B+Morrison%2C+J.%3B+Albright%2C+C.+F.%3B+Ahlijanian%2C+M.+K.%3B+Olson%2C+R.+E.%3B+Macor%2C+J.+E.+Discovery+and+preclinical+profile+of+BMS-932481%2C+a+gamma+secretase+modulator+for+the+treatment+of+Alzheimer%E2%80%99s+disease.+Presented+at+the+248th+National+Meeting+of+the+American+Chemical+Society%2C+San+Francisco%2C+CA%2C+Aug+10%E2%80%9314%2C+2014%3B+Paper+MEDI-266."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DDiscovery%2520and%2520preclinical%2520profile%2520of%2520BMS-932481%252C%2520a%2520gamma%2520secretase%2520modulator%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2014%26spage%3DMEDI-266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Gasior, M.; Keswani, S. C.; AbuTarif, M.; Ahlijanian, M.; Berisha, F.; Zheng, N.</span><span> </span><span class="NLM_article-title">A Randomized, placebo-controlled, double-blind, single-dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of the gamma-secretase modulator BMS-932481 in healthy young and elderly individuals</span>. Presented at the Alzheimer’s Association International Conference 2013, Boston, MA, July 13–18,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>Abstract  <span class="NLM_fpage">P1-341</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+Gasior&author=S.+C.+Keswani&author=M.+AbuTarif&author=M.+Ahlijanian&author=F.+Berisha&author=N.+Zheng&title=A+Randomized%2C+placebo-controlled%2C+double-blind%2C+single-dose+study+to+evaluate+the+safety%2C+pharmacokinetics+and+pharmacodynamics+of+the+gamma-secretase+modulator+BMS-932481+in+healthy+young+and+elderly+individuals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGasior%26aufirst%3DM.%26atitle%3DA%2520Randomized%252C%2520placebo-controlled%252C%2520double-blind%252C%2520single-dose%2520study%2520to%2520evaluate%2520the%2520safety%252C%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520the%2520gamma-secretase%2520modulator%2520BMS-932481%2520in%2520healthy%2520young%2520and%2520elderly%2520individuals%26date%3D2013%26spage%3DP1-341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.</span><span> </span><span class="NLM_article-title">Design and optimization of tricyclic gamma-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1498</span><span class="NLM_x">–</span> <span class="NLM_lpage">1502</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2015.06.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1498-1502&author=J.+Shiauthor=D.+Zuevauthor=L.+Xuauthor=K.+A.+Lentzauthor=J.+E.+Graceauthor=J.+H.+Toynauthor=R.+E.+Olsonauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Design+and+optimization+of+tricyclic+gamma-secretase+modulators&doi=10.1016%2Fj.bmcl.2015.06.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DZuev%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DDesign%2520and%2520optimization%2520of%2520tricyclic%2520gamma-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1498%26epage%3D1502%26doi%3D10.1016%2Fj.bmcl.2015.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amegadzie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ncube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzasa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Morin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumfelt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tegley, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koegler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6447</span><span class="NLM_x">–</span> <span class="NLM_lpage">6454</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2013.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24139583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Grsb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6447-6454&author=J.+J.+Chenauthor=W.+Qianauthor=K.+Biswasauthor=C.+Yuanauthor=A.+Amegadzieauthor=Q.+Liuauthor=T.+Nixeyauthor=J.+Zhuauthor=M.+Ncubeauthor=R.+M.+Rzasaauthor=F.+Chavezauthor=N.+Chenauthor=F.+De+Morinauthor=S.+Rumfeltauthor=C.+M.+Tegleyauthor=J.+R.+Allenauthor=S.+Hitchcockauthor=R.+Hungateauthor=M.+D.+Bartbergerauthor=L.+Zalamedaauthor=Y.+Liuauthor=J.+D.+McCarterauthor=J.+Zhangauthor=L.+Zhuauthor=S.+Babu-Khanauthor=Y.+Luoauthor=J.+Bradleyauthor=P.+H.+Wenauthor=D.+L.+Reidauthor=F.+Koeglerauthor=C.+Deanauthor=D.+Hickmanauthor=T.+L.+Correllauthor=T.+Williamsonauthor=S.+Wood&title=Discovery+of+2-methylpyridine-based+biaryl+amides+as+%CE%B3-secretase+modulators+for+the+treatment+of+alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2013.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Chen, Jian Jeffrey; Qian, Wenyuan; Biswas, Kaustav; Yuan, Chester; Amegadzie, Albert; Liu, Qingyian; Nixey, Thomas; Zhu, Joe; Ncube, Mqhele; Rzasa, Robert M.; Chavez, Frank, Jr.; Chen, Ning; De Morin, Frenel; Rumfelt, Shannon; Tegley, Christopher M.; Allen, Jennifer R.; Hitchcock, Stephen; Hungate, Randy; Bartberger, Michael D.; Zalameda, Leeanne; Liu, Yichin; McCarter, John D.; Zhang, Jianhua; Zhu, Li; Babu-Khan, Safura; Luo, Yi; Bradley, Jodi; Wen, Paul H.; Reid, Darren L.; Koegler, Frank; Dean, Charles, Jr.; Hickman, Dean; Correll, Tiffany L.; Williamson, Toni; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6447-6454</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">γ-Secretase modulators (GSMs) are potentially disease-modifying treatments for Alzheimer's disease.  They selectively lower pathogenic Aβ42 levels by shifting the enzyme cleavage sites without inhibiting γ-secretase activity, possibly avoiding known adverse effects obsd. with complete inhibition of the enzyme complex.  A cell-based HTS effort identified the sulfonamide 1 as a GSM lead.  Lead optimization studies identified compd. 25 with improved cell potency, PKDM properties, and it lowered Aβ42 levels in the cerebrospinal fluid (CSF) of Sprague-Dawley rats following oral administration.  Further optimization of 25 to improve cellular potency is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPfacRASb057Vg90H21EOLACvtfcHk0ljYIiyMEVt8cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Grsb3F&md5=6282bfb2fc57efab5a32c15872e474b7</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DBiswas%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DAmegadzie%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DNcube%26aufirst%3DM.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DChavez%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DDe%2BMorin%26aufirst%3DF.%26aulast%3DRumfelt%26aufirst%3DS.%26aulast%3DTegley%26aufirst%3DC.%2BM.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DHitchcock%26aufirst%3DS.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DReid%26aufirst%3DD.%2BL.%26aulast%3DKoegler%26aufirst%3DF.%26aulast%3DDean%26aufirst%3DC.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DCorrell%26aufirst%3DT.%2BL.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25202-methylpyridine-based%2520biaryl%2520amides%2520as%2520%25CE%25B3-secretase%2520modulators%2520for%2520the%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6447%26epage%3D6454%26doi%3D10.1016%2Fj.bmcl.2013.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Cheng, S.; Comer, D. D.; Mao, L.; Balow, G. P.; Pleynet, D.</span><span> </span><span class="NLM_article-title">Aryl compounds and uses in modulating amyloid β</span>. WO2004110350A2,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+Cheng&author=D.+D.+Comer&author=L.+Mao&author=G.+P.+Balow&author=D.+Pleynet&title=Aryl+compounds+and+uses+in+modulating+amyloid+%CE%B2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DS.%26atitle%3DAryl%2520compounds%2520and%2520uses%2520in%2520modulating%2520amyloid%2520%25CE%25B2%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Kounnas, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyree, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleynet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digregorio, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velicelebi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauderman, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S. L.</span><span> </span><span class="NLM_article-title">Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span><span class="refDoi"> DOI: 10.1016/j.neuron.2010.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.neuron.2010.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=20826309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFamtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=769-780&author=M.+Z.+Kounnasauthor=A.+M.+Danksauthor=S.+Chengauthor=C.+Tyreeauthor=E.+Ackermanauthor=X.+Zhangauthor=K.+Ahnauthor=P.+Nguyenauthor=D.+Comerauthor=L.+Maoauthor=C.+Yuauthor=D.+Pleynetauthor=P.+J.+Digregorioauthor=G.+Velicelebiauthor=K.+A.+Staudermanauthor=W.+T.+Comerauthor=W.+C.+Mobleyauthor=Y.+M.+Liauthor=S.+S.+Sisodiaauthor=R.+E.+Tanziauthor=S.+L.+Wagner&title=Modulation+of+gamma-secretase+reduces+beta-amyloid+deposition+in+a+transgenic+mouse+model+of+alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuron.2010.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease</span></div><div class="casAuthors">Kounnas, Maria Z.; Danks, Anne M.; Cheng, Soan; Tyree, Curtis; Ackerman, Elizabeth; Zhang, Xulun; Ahn, Kwangwook; Nguyen, Phuong; Comer, Dan; Mao, Long; Yu, Chengzhi; Pleynet, David; Digregorio, Paul J.; Velicelebi, Gonul; Stauderman, Kenneth A.; Comer, William T.; Mobley, William C.; Li, Yue-Ming; Sisodia, Sangram S.; Tanzi, Rudolph E.; Wagner, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">769-780</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized pathol. by the abundance of senile plaques and neurofibrillary tangles in the brain.  We synthesized over 1200 novel γ-secretase modulator (GSM) compds. that reduced Aβ42 levels without inhibiting ε-site cleavage of APP and Notch, the generation of the APP and Notch intracellular domains, resp.  These compds. also reduced Aβ40 levels while concomitantly elevating levels of Aβ38 and Aβ37.  Immobilization of a potent GSM onto an agarose matrix quant. recovered Pen-2 and to a lesser degree PS-1 NTFs from cellular exts.  Moreover, oral administration (once daily) of another potent GSM to Tg 2576 transgenic AD mice displayed dose-responsive lowering of plasma and brain Aβ42; chronic daily administration led to significant redns. in both diffuse and neuritic plaques.  These effects were obsd. in the absence of Notch-related changes (e.g., intestinal proliferation of goblet cells), which are commonly assocd. with repeated exposure to functional γ-secretase inhibitors (GSIs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWuvRc6SXyvbVg90H21EOLACvtfcHk0ljYIiyMEVt8cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFamtb%252FI&md5=0963d1dd659c7a9b0e7e876244eeab97</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2010.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2010.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DKounnas%26aufirst%3DM.%2BZ.%26aulast%3DDanks%26aufirst%3DA.%2BM.%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DTyree%26aufirst%3DC.%26aulast%3DAckerman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DComer%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DPleynet%26aufirst%3DD.%26aulast%3DDigregorio%26aufirst%3DP.%2BJ.%26aulast%3DVelicelebi%26aufirst%3DG.%26aulast%3DStauderman%26aufirst%3DK.%2BA.%26aulast%3DComer%26aufirst%3DW.%2BT.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DModulation%2520of%2520gamma-secretase%2520reduces%2520beta-amyloid%2520deposition%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D67%26spage%3D769%26epage%3D780%26doi%3D10.1016%2Fj.neuron.2010.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Wagner, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynearson, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span> </span><span class="NLM_article-title">Soluble γ-secretase modulators selectively inhibit the production of the 42-amino acid amyloid β peptide variant and augment the production of multiple carboxy-truncated amyloid β species</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span><span class="refDoi"> DOI: 10.1021/bi401537v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi401537v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=702-713&author=S.+L.+Wagnerauthor=C.+Zhangauthor=S.+Chengauthor=P.+Nguyenauthor=X.+Zhangauthor=K.+D.+Rynearsonauthor=R.+Wangauthor=Y.+Liauthor=S.+S.+Sisodiaauthor=W.+C.+Mobleyauthor=R.+E.+Tanzi&title=Soluble+%CE%B3-secretase+modulators+selectively+inhibit+the+production+of+the+42-amino+acid+amyloid+%CE%B2+peptide+variant+and+augment+the+production+of+multiple+carboxy-truncated+amyloid+%CE%B2+species&doi=10.1021%2Fbi401537v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fbi401537v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi401537v%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%2BL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRynearson%26aufirst%3DK.%2BD.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26atitle%3DSoluble%2520%25CE%25B3-secretase%2520modulators%2520selectively%2520inhibit%2520the%2520production%2520of%2520the%252042-amino%2520acid%2520amyloid%2520%25CE%25B2%2520peptide%2520variant%2520and%2520augment%2520the%2520production%2520of%2520multiple%2520carboxy-truncated%2520amyloid%2520%25CE%25B2%2520species%26jtitle%3DBiochemistry%26date%3D2014%26volume%3D53%26spage%3D702%26epage%3D713%26doi%3D10.1021%2Fbi401537v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Tanzi, R. E.; Wagner, S. L.; Cheng, S.; Mobley, W. C.</span><span> </span><span class="NLM_article-title">Gamma-secretase modulators and uses thereof for treating neurological diseases</span>. WO2014165263A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+E.+Tanzi&author=S.+L.+Wagner&author=S.+Cheng&author=W.+C.+Mobley&title=Gamma-secretase+modulators+and+uses+thereof+for+treating+neurological+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26atitle%3DGamma-secretase%2520modulators%2520and%2520uses%2520thereof%2520for%2520treating%2520neurological%2520diseases%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zultanski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuthall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smotrov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moxham, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bays, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Triazoloamides as potent γ-secretase modulators with reduced herg liability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3140</span><span class="NLM_x">–</span> <span class="NLM_lpage">3146</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.03.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2012.03.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22497762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVaisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3140-3146&author=C.+Fischerauthor=S.+L.+Zultanskiauthor=H.+Zhouauthor=J.+L.+Methotauthor=S.+Shahauthor=H.+Nuthallauthor=B.+L.+Hughesauthor=N.+Smotrovauthor=A.+Hillauthor=A.+A.+Szewczakauthor=C.+M.+Moxhamauthor=N.+Baysauthor=R.+E.+Middletonauthor=B.+Munozauthor=M.+S.+Shearman&title=Triazoloamides+as+potent+%CE%B3-secretase+modulators+with+reduced+herg+liability&doi=10.1016%2Fj.bmcl.2012.03.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Triazoloamides as potent γ-secretase modulators with reduced hERG liability</span></div><div class="casAuthors">Fischer, Christian; Zultanski, Susan L.; Zhou, Hua; Methot, Joey L.; Shah, Sanjiv; Nuthall, Hugh; Hughes, Bethany L.; Smotrov, Nadja; Hill, Armetta; Szewczak, Alexander A.; Moxham, Christopher M.; Bays, Nathan; Middleton, Richard E.; Munoz, Benito; Shearman, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3140-3146</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthesis and SAR studies of novel aryl triazoles as gamma secretase modulators (GSMs) are presented in this communication.  Starting from aryl triazole leads, optimization studies were continued and the series progressed towards novel amides and lactams.  Triazole I was identified as the most potent analog in this series, displaying single-digit nanomolar Aβ42 IC50 in cell-based assays and reduced affinity for the hERG channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiDFzfhAnInrVg90H21EOLACvtfcHk0lhacx1LScw-tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVaisrg%253D&md5=6585835e1ec8b679e19bf8d687f392bb</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.03.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.03.054%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DZultanski%26aufirst%3DS.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DNuthall%26aufirst%3DH.%26aulast%3DHughes%26aufirst%3DB.%2BL.%26aulast%3DSmotrov%26aufirst%3DN.%26aulast%3DHill%26aufirst%3DA.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DMoxham%26aufirst%3DC.%2BM.%26aulast%3DBays%26aufirst%3DN.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DTriazoloamides%2520as%2520potent%2520%25CE%25B3-secretase%2520modulators%2520with%2520reduced%2520herg%2520liability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3140%26epage%3D3146%26doi%3D10.1016%2Fj.bmcl.2012.03.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zultanski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mampreian, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuthall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smotrov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenific, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouthillette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeliazkova-Mecheva, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bays, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Triazoles as γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4083</span><span class="NLM_x">–</span> <span class="NLM_lpage">4087</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2011.04.089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4083-4087&author=C.+Fischerauthor=S.+L.+Zultanskiauthor=H.+Zhouauthor=J.+L.+Methotauthor=W.+C.+Brownauthor=D.+M.+Mampreianauthor=A.+J.+Schellauthor=S.+Shahauthor=H.+Nuthallauthor=B.+L.+Hughesauthor=N.+Smotrovauthor=C.+M.+Kenificauthor=J.+C.+Cruzauthor=D.+Walkerauthor=M.+Bouthilletteauthor=G.+N.+Nikovauthor=D.+F.+Savageauthor=V.+V.+Jeliazkova-Mechevaauthor=D.+Diazauthor=A.+A.+Szewczakauthor=N.+Baysauthor=R.+E.+Middletonauthor=B.+Munozauthor=M.+S.+Shearman&title=Triazoles+as+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2011.04.089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.089%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DZultanski%26aufirst%3DS.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DBrown%26aufirst%3DW.%2BC.%26aulast%3DMampreian%26aufirst%3DD.%2BM.%26aulast%3DSchell%26aufirst%3DA.%2BJ.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DNuthall%26aufirst%3DH.%26aulast%3DHughes%26aufirst%3DB.%2BL.%26aulast%3DSmotrov%26aufirst%3DN.%26aulast%3DKenific%26aufirst%3DC.%2BM.%26aulast%3DCruz%26aufirst%3DJ.%2BC.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DBouthillette%26aufirst%3DM.%26aulast%3DNikov%26aufirst%3DG.%2BN.%26aulast%3DSavage%26aufirst%3DD.%2BF.%26aulast%3DJeliazkova-Mecheva%26aufirst%3DV.%2BV.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DBays%26aufirst%3DN.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DTriazoles%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4083%26epage%3D4087%26doi%3D10.1016%2Fj.bmcl.2011.04.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zultanski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moxham, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bays, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smotrov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanga, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenific, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouthillette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeliazkova-Mecheva, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michener, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Preparation of triazolobenzazepinone derivatives as γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3488</span><span class="NLM_x">–</span> <span class="NLM_lpage">3494</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2015.07.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3488-3494&author=C.+Fischerauthor=S.+L.+Zultanskiauthor=H.+Zhouauthor=J.+L.+Methotauthor=S.+Shahauthor=I.+Hayashiauthor=B.+L.+Hughesauthor=C.+M.+Moxhamauthor=N.+W.+Baysauthor=N.+Smotrovauthor=A.+D.+Hillauthor=B.-S.+Panauthor=Z.+Wuauthor=L.+Y.+Moyauthor=F.+Tangaauthor=C.+Kenificauthor=J.+C.+Cruzauthor=D.+Walkerauthor=M.+Bouthilletteauthor=G.+N.+Nikovauthor=S.+V.+Deshmukhauthor=V.+V.+Jeliazkova-Mechevaauthor=D.+Diazauthor=M.+S.+Michenerauthor=J.+J.+Cookauthor=B.+Munozauthor=M.+S.+Shearman&title=Preparation+of+triazolobenzazepinone+derivatives+as+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2015.07.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DZultanski%26aufirst%3DS.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DHayashi%26aufirst%3DI.%26aulast%3DHughes%26aufirst%3DB.%2BL.%26aulast%3DMoxham%26aufirst%3DC.%2BM.%26aulast%3DBays%26aufirst%3DN.%2BW.%26aulast%3DSmotrov%26aufirst%3DN.%26aulast%3DHill%26aufirst%3DA.%2BD.%26aulast%3DPan%26aufirst%3DB.-S.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DMoy%26aufirst%3DL.%2BY.%26aulast%3DTanga%26aufirst%3DF.%26aulast%3DKenific%26aufirst%3DC.%26aulast%3DCruz%26aufirst%3DJ.%2BC.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DBouthillette%26aufirst%3DM.%26aulast%3DNikov%26aufirst%3DG.%2BN.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DJeliazkova-Mecheva%26aufirst%3DV.%2BV.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DMichener%26aufirst%3DM.%2BS.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DPreparation%2520of%2520triazolobenzazepinone%2520derivatives%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3488%26epage%3D3494%26doi%3D10.1016%2Fj.bmcl.2015.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivkin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahearn, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kattar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mampreian, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeliazkova-Mecheva, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenific, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moxham, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuthall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smotrov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Potent benzoazepinone γ-secretase modulators with improved bioavailability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3495</span><span class="NLM_x">–</span> <span class="NLM_lpage">3500</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2015.06.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=26142947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVeitLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3495-3500&author=J.+L.+Methotauthor=C.+Fischerauthor=C.+Liauthor=A.+Rivkinauthor=S.+P.+Ahearnauthor=W.+C.+Brownauthor=S.+Kattarauthor=E.+Kelleyauthor=D.+M.+Mampreianauthor=A.+Schellauthor=A.+Rosenauauthor=H.+Zhouauthor=R.+Ballauthor=S.+V.+Deshmukhauthor=V.+V.+Jeliazkova-Mechevaauthor=D.+Diazauthor=L.+Y.+Moyauthor=C.+M.+Kenificauthor=C.+Moxhamauthor=S.+Shahauthor=H.+Nuthallauthor=A.+A.+Szewczakauthor=A.+Hillauthor=B.+Hughesauthor=N.+Smotrovauthor=B.+Munozauthor=T.+A.+Millerauthor=M.+S.+Shearman&title=Potent+benzoazepinone+%CE%B3-secretase+modulators+with+improved+bioavailability&doi=10.1016%2Fj.bmcl.2015.06.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Potent benzoazepinone γ-secretase modulators with improved bioavailability</span></div><div class="casAuthors">Methot, Joey L.; Fischer, Christian; Li, Chaomin; Rivkin, Alexey; Ahearn, Sean P.; Brown, William Colby; Kattar, Sam; Kelley, Elizabeth; Mampreian, Dawn M.; Schell, Adam; Rosenau, Andrew; Zhou, Hua; Ball, Richard; Deshmukh, Sujal V.; Jeliazkova-Mecheva, Valentina V.; Diaz, Damaris; Moy, Lily Y.; Kenific, Candia M.; Moxham, Chris; Shah, Sanjiv; Nuthall, Hugh; Szewczak, Alexander A.; Hill, Armetta; Hughes, Bethany; Smotrov, Nadya; Munoz, Benito; Miller, Thomas A.; Shearman, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3495-3500</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The triazolyl amide γ-secretase modulators are potent alternatives to the cinnamyl amides that have entered the clinic for the treatment of Alzheimer's disease.  Herein we build on the lead benzoazepinones described in our prior communication with imidazomethoxyarene moiety alternatives that offer opportunities to fine tune phys. properties as well as address hERG binding and PK.  Both half-life and bioavailability were significantly improved, esp. in dog, with robust brain Aβ42 lowering maintained in both transgenic mouse and rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSKJojr8UBzrVg90H21EOLACvtfcHk0liF4unDdiwCsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVeitLzI&md5=8ca036e2583ca474516a7762e3da3c5d</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.032%26sid%3Dliteratum%253Aachs%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DRivkin%26aufirst%3DA.%26aulast%3DAhearn%26aufirst%3DS.%2BP.%26aulast%3DBrown%26aufirst%3DW.%2BC.%26aulast%3DKattar%26aufirst%3DS.%26aulast%3DKelley%26aufirst%3DE.%26aulast%3DMampreian%26aufirst%3DD.%2BM.%26aulast%3DSchell%26aufirst%3DA.%26aulast%3DRosenau%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DBall%26aufirst%3DR.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DJeliazkova-Mecheva%26aufirst%3DV.%2BV.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DMoy%26aufirst%3DL.%2BY.%26aulast%3DKenific%26aufirst%3DC.%2BM.%26aulast%3DMoxham%26aufirst%3DC.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DNuthall%26aufirst%3DH.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DHill%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DB.%26aulast%3DSmotrov%26aufirst%3DN.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DMiller%26aufirst%3DT.%2BA.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DPotent%2520benzoazepinone%2520%25CE%25B3-secretase%2520modulators%2520with%2520improved%2520bioavailability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3495%26epage%3D3500%26doi%3D10.1016%2Fj.bmcl.2015.06.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Takai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terauchi, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of piperazine derivatives as a novel class of γ-secretase modulators that selectively lower aβ42 production</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1923</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmc.2015.03.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1923-1934&author=T.+Takaiauthor=T.+Koikeauthor=E.+Hondaauthor=Y.+Kajitaauthor=M.+Nakamuraauthor=S.+Morimotoauthor=Y.+Hoashiauthor=M.+Kamataauthor=T.+Watanabeauthor=T.+Igariauthor=J.+Terauchi&title=Design+and+synthesis+of+piperazine+derivatives+as+a+novel+class+of+%CE%B3-secretase+modulators+that+selectively+lower+a%CE%B242+production&doi=10.1016%2Fj.bmc.2015.03.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.055%26sid%3Dliteratum%253Aachs%26aulast%3DTakai%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DHonda%26aufirst%3DE.%26aulast%3DKajita%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DMorimoto%26aufirst%3DS.%26aulast%3DHoashi%26aufirst%3DY.%26aulast%3DKamata%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DIgari%26aufirst%3DT.%26aulast%3DTerauchi%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520piperazine%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520%25CE%25B3-secretase%2520modulators%2520that%2520selectively%2520lower%2520a%25CE%25B242%2520production%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D1923%26epage%3D1934%26doi%3D10.1016%2Fj.bmc.2015.03.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teranishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobe, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of an aminopiperidine series of γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2013.10.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=378-381&author=T.+Kobayashiauthor=S.+Iwamaauthor=A.+Fusanoauthor=Y.+Katoauthor=A.+Ikedaauthor=Y.+Teranishiauthor=A.+Nishiharaauthor=M.+Tobe&title=Design+and+synthesis+of+an+aminopiperidine+series+of+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2013.10.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.063%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DIwama%26aufirst%3DS.%26aulast%3DFusano%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DA.%26aulast%3DTeranishi%26aufirst%3DY.%26aulast%3DNishihara%26aufirst%3DA.%26aulast%3DTobe%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520an%2520aminopiperidine%2520series%2520of%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D378%26epage%3D381%26doi%3D10.1016%2Fj.bmcl.2013.10.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F. J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaroskova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velter, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">Design and synthesis of bicyclic heterocycles as potent γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4794</span><span class="NLM_x">–</span> <span class="NLM_lpage">4800</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2013.06.100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4794-4800&author=D.+Oehlrichauthor=F.+J.+R.+Romboutsauthor=D.+Berthelotauthor=F.+P.+Bischoffauthor=M.+A.+J.+De+Cleynauthor=L.+Jaroskovaauthor=G.+Macdonaldauthor=M.+Merckenauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=S.+Van+Brandtauthor=A.+I.+Velterauthor=T.+Wuauthor=H.+J.+M.+Gijsen&title=Design+and+synthesis+of+bicyclic+heterocycles+as+potent+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2013.06.100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.100%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DJaroskova%26aufirst%3DL.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVelter%26aufirst%3DA.%2BI.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520bicyclic%2520heterocycles%2520as%2520potent%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4794%26epage%3D4800%26doi%3D10.1016%2Fj.bmcl.2013.06.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Velter, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaroskova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Roosbroeck, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masungi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span> </span><span class="NLM_article-title">Anilinotriazoles as potent gamma secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5805</span><span class="NLM_x">–</span> <span class="NLM_lpage">5813</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.10.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2014.10.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5805-5813&author=A.+I.+Velterauthor=F.+P.+Bischoffauthor=D.+Berthelotauthor=M.+De+Cleynauthor=D.+Oehlrichauthor=L.+Jaroskovaauthor=G.+Macdonaldauthor=G.+Minneauthor=S.+Pietersauthor=F.+Romboutsauthor=S.+Van+Brandtauthor=Y.+Van+Roosbroeckauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=T.+Wuauthor=H.+Borghysauthor=M.+Merckenauthor=C.+Masungiauthor=H.+Gijsen&title=Anilinotriazoles+as+potent+gamma+secretase+modulators&doi=10.1016%2Fj.bmcl.2014.10.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DVelter%26aufirst%3DA.%2BI.%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DJaroskova%26aufirst%3DL.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMinne%26aufirst%3DG.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVan%2BRoosbroeck%26aufirst%3DY.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DMasungi%26aufirst%3DC.%26aulast%3DGijsen%26aufirst%3DH.%26atitle%3DAnilinotriazoles%2520as%2520potent%2520gamma%2520secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5805%26epage%3D5813%26doi%3D10.1016%2Fj.bmcl.2014.10.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Minne, G. B.; Bischoff, F. P.; Gijsen, H. J. M.; Velter, A. I.; Pieters, S. M. A.; Berthelot, D. J.-C.</span><span> </span><span class="NLM_article-title">Preparation of substituted indole derivatives and related compounds as gamma secretase modulators</span>. WO2013010904A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=G.+B.+Minne&author=F.+P.+Bischoff&author=H.+J.+M.+Gijsen&author=A.+I.+Velter&author=S.+M.+A.+Pieters&author=D.+J.-C.+Berthelot&title=Preparation+of+substituted+indole+derivatives+and+related+compounds+as+gamma+secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMinne%26aufirst%3DG.%2BB.%26atitle%3DPreparation%2520of%2520substituted%2520indole%2520derivatives%2520and%2520related%2520compounds%2520as%2520gamma%2520secretase%2520modulators%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Velter, A. I.; Bischoff, F.; De Cleyn, M.; Gijsen, H.; MacDonald, G.; Oehlrich, D.; Rombouts, F.; Surkyn, M.; Van Brandt, S.; Zavattaro, C.; Austin, N.; Mercken, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a novel series of γ-secretase modulators: Cyanoindoles, moving toward a better drug-like space?</span> Presented at the 250th National Meeting of the American Chemical Society, Boston, MA, Aug 16–20,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>Paper  <span class="NLM_fpage">MEDI-354</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Velter%2C+A.+I.%3B+Bischoff%2C+F.%3B+De+Cleyn%2C+M.%3B+Gijsen%2C+H.%3B+MacDonald%2C+G.%3B+Oehlrich%2C+D.%3B+Rombouts%2C+F.%3B+Surkyn%2C+M.%3B+Van+Brandt%2C+S.%3B+Zavattaro%2C+C.%3B+Austin%2C+N.%3B+Mercken%2C+M.+Design+and+synthesis+of+a+novel+series+of+%CE%B3-secretase+modulators%3A+Cyanoindoles%2C+moving+toward+a+better+drug-like+space%3F+Presented+at+the+250th+National+Meeting+of+the+American+Chemical+Society%2C+Boston%2C+MA%2C+Aug+16%E2%80%9320%2C+2015%3B+Paper+MEDI-354."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVelter%26aufirst%3DA.%2BI.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520novel%2520series%2520of%2520%25CE%25B3-secretase%2520modulators%253A%2520Cyanoindoles%252C%2520moving%2520toward%2520a%2520better%2520drug-like%2520space%253F%26date%3D2015%26spage%3DMEDI-354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Takai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, T.</span><span> </span><span class="NLM_article-title">Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4245</span><span class="NLM_x">–</span> <span class="NLM_lpage">4249</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2015.07.101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=26298496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSlsb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4245-4249&author=T.+Takaiauthor=Y.+Hoashiauthor=Y.+Tomataauthor=S.+Morimotoauthor=M.+Nakamuraauthor=T.+Watanabeauthor=T.+Igariauthor=T.+Koike&title=Discovery+of+novel+5%2C6%2C7%2C8-tetrahydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyridine+derivatives+as+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2015.07.101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators</span></div><div class="casAuthors">Takai, Takafumi; Hoashi, Yasutaka; Tomata, Yoshihide; Morimoto, Sachie; Nakamura, Minoru; Watanabe, Tomomichi; Igari, Tomoko; Koike, Tatsuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4245-4249</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivs. were designed, synthesized, and evaluated as γ-secretase modulators (GSMs).  An optimization study of this series resulted in the identification of I, which showed a potent Aβ42-lowering effect, high bioavailability and good blood-brain barrier permeability in mice.  Oral administration of I significantly reduced brain Aβ42 in mice at a dose of 10 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonI7aEgBKCkrVg90H21EOLACvtfcHk0lgAKbA_vhD2Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSlsb3M&md5=0515eae1461d3d3e33277d9ef6cfb09b</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.101%26sid%3Dliteratum%253Aachs%26aulast%3DTakai%26aufirst%3DT.%26aulast%3DHoashi%26aufirst%3DY.%26aulast%3DTomata%26aufirst%3DY.%26aulast%3DMorimoto%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DIgari%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%25205%252C6%252C7%252C8-tetrahydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyridine%2520derivatives%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4245%26epage%3D4249%26doi%3D10.1016%2Fj.bmcl.2015.07.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaratnam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2906</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2012.02.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22429469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2906-2911&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=R.+Liraauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+P.+Tranauthor=B.+C.+Vetelinoauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=K.+M.+Woodauthor=C.+J.+O%E2%80%99Donnell&title=Design+and+synthesis+of+dihydrobenzofuran+amides+as+orally+bioavailable%2C+centrally+active+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2012.02.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Lira, Ricardo; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Vetelino, Beth C.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Wood, Kathleen M.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2906-2911</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of a novel series of dihydrobenzofuran amides as γ-secretase modulators (GSMs) is reported.  Strategies for aligning in vitro potency with drug-like physicochem. properties and good microsomal stability while avoiding P-gp mediated efflux are discussed.  Lead compds. such as I and II have moderate to good in vitro potency and excellent selectivity against Notch.  Good oral bioavailability was achieved as well as robust brain Aβ42 lowering activity at 100 mg/kg po dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIcSb2qlgrNLVg90H21EOLACvtfcHk0lgAKbA_vhD2Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D&md5=63746bd0db38a20bb33b5e990e66610c</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.059%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dihydrobenzofuran%2520amides%2520as%2520orally%2520bioavailable%252C%2520centrally%2520active%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2906%26epage%3D2911%26doi%3D10.1016%2Fj.bmcl.2012.02.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaratnam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-secretase modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1062</span><span class="refDoi"> DOI: 10.1021/jm401782h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401782h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1046-1062&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+P.+Tranauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=B.+C.+Vetelinoauthor=K.+M.+Woodauthor=N.+Pozdnyakovauthor=P.+R.+Verhoestauthor=C.+J.+O%E2%80%99Donnell&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+a+novel+series+of+pyridopyrazine-1%2C6-dione+%CE%B3-secretase+modulators&doi=10.1021%2Fjm401782h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Pharmacological Evaluation of a Novel Series of Pyridopyrazine-1,6-dione γ-Secretase Modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Vetelino, Beth C.; Wood, Kathleen M.; Pozdnyakov, Nikolay; Verhoest, Patrick R.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1046-1062</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we describe the design and synthesis of a novel series of γ-secretase modulators (GSMs) that incorporates a pyridopiperazine-1,6-dione ring system.  To align improved potency with favorable ADME and in vitro safety, we applied prospective physicochem. property-driven design coupled with parallel medicinal chem. techniques to arrive at a novel series contg. a conformationally restricted core.  Lead compd. I exhibited good in vitro potency and ADME, which translated into a favorable in vivo pharmacokinetic profile.  Furthermore, robust redn. of brain Aβ42 was obsd. in guinea pig at 30 mg/kg dosed orally.  Through chem. biol. efforts involving the design and synthesis of a clickable photoreactive probe, we demonstrated specific labeling of the presenilin N-terminal fragment (PS1-NTF) within the γ-secretase complex, thus gaining insight into the binding site of this series of GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZjw9nXaFFiLVg90H21EOLACvtfcHk0lgAzjT6vupcwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVGkug%253D%253D&md5=a3d743eea05981a29143a0ec6b43549f</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm401782h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401782h%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520pyridopyrazine-1%252C6-dione%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1046%26epage%3D1062%26doi%3D10.1021%2Fjm401782h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos-Korcsok, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.12.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2014.12.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=25582600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=908-913&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=J.+M.+Humphreyauthor=C.+W.+am+Endeauthor=E.+Evrardauthor=I.+Efremovauthor=G.+W.+Kauffmanauthor=A.+F.+Stepanauthor=C.+M.+Stiffauthor=L.+Xieauthor=K.+R.+Balesauthor=E.+Hajos-Korcsokauthor=H.+E.+Murreyauthor=L.+R.+Pustilnikauthor=S.+J.+Steynauthor=K.+M.+Woodauthor=P.+R.+Verhoest&title=Discovery+of+indole-derived+pyridopyrazine-1%2C6-dione+%CE%B3-secretase+modulators+that+target+presenilin&doi=10.1016%2Fj.bmcl.2014.12.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Humphrey, John M.; am Ende, Christopher W.; Evrard, Edelweiss; Efremov, Ivan; Kauffman, Gregory W.; Stepan, Antonia F.; Stiff, Cory M.; Xie, Longfei; Bales, Kelly R.; Hajos-Korcsok, Eva; Murrey, Heather E.; Pustilnik, Leslie R.; Steyn, Stefanus J.; Wood, Kathleen M.; Verhoest, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">908-913</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein we describe design strategies that led to the discovery of novel pyridopyrazine-1,6-dione γ-secretase modulators (GSMs) incorporating an indole motif as a heterocyclic replacement for a naphthyl moiety that was present in the original lead 9.  Tactics involving parallel medicinal chem. and in situ monomer synthesis to prep. focused libraries are discussed.  Optimized indole GSM 29 exhibited good alignment of in vitro potency and physicochem. properties, and moderate redn. of brain Aβ42 was achieved in a rat efficacy model when dosed orally at 30 mg/kg.  Labeling expts. using a clickable, indole-derived GSM photoaffinity probe demonstrated that this series binds to the presenilin N-terminal fragment (PS1-NTF) of the γ-secretase complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD9PU4TTU4b7Vg90H21EOLACvtfcHk0lgAzjT6vupcwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVOrsQ%253D%253D&md5=fc815b92689ab399b4186c71bd1c69b3</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.059%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DHajos-Korcsok%26aufirst%3DE.%26aulast%3DMurrey%26aufirst%3DH.%2BE.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DDiscovery%2520of%2520indole-derived%2520pyridopyrazine-1%252C6-dione%2520%25CE%25B3-secretase%2520modulators%2520that%2520target%2520presenilin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D908%26epage%3D913%26doi%3D10.1016%2Fj.bmcl.2014.12.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Design of pyridopyrazine-1,6-dione γ-secretase modulators that align potency, mdr efflux ratio, and metabolic stability</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVaksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=596-601&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=J.+M.+Humphreyauthor=T.+W.+Butlerauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=P.+B.+Mullinsauthor=C.+J.+O%E2%80%99Donnellauthor=A.+F.+Stepanauthor=C.+M.+Stiffauthor=C.+Subramanyamauthor=T.+P.+Tranauthor=B.+C.+Vetelinoauthor=E.+Yangauthor=L.+Xieauthor=K.+R.+Balesauthor=L.+R.+Pustilnikauthor=S.+J.+Steynauthor=K.+M.+Woodauthor=P.+R.+Verhoest&title=Design+of+pyridopyrazine-1%2C6-dione+%CE%B3-secretase+modulators+that+align+potency%2C+mdr+efflux+ratio%2C+and+metabolic+stability&doi=10.1021%2Facsmedchemlett.5b00070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Humphrey, John M.; Butler, Todd W.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Mullins, Patrick B.; O'Donnell, Christopher J.; Stepan, Antonia F.; Stiff, Cory M.; Subramanyam, Chakrapani; Tran, Tuan P.; Vetelino, Beth Cooper; Yang, Eddie; Xie, Longfei; Bales, Kelly R.; Pustilnik, Leslie R.; Steyn, Stefanus J.; Wood, Kathleen M.; Verhoest, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we describe the design and synthesis of a series of pyridopyrazine-1,6-dione γ-secretase modulators (GSMs) for Alzheimer's disease (AD) that achieve good alignment of potency, metabolic stability, and low MDR efflux ratios, while also maintaining favorable physicochem. properties.  Specifically, incorporation of fluorine enabled design of metabolically less liable lipophilic alkyl substituents to increase potency without compromising the sp3-character.  The lead compd. I (PF-06442609) displayed a favorable rodent pharmacokinetic profile, and robust redns. of brain Aβ42 and Aβ40 were obsd. in a guinea pig time-course expt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhW3RYEYEcOrVg90H21EOLACvtfcHk0lipvIrlW2wDLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVaksrg%253D&md5=ba402f2e67fd9500123cbc7b215d3361</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00070%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DButler%26aufirst%3DT.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DDesign%2520of%2520pyridopyrazine-1%252C6-dione%2520%25CE%25B3-secretase%2520modulators%2520that%2520align%2520potency%252C%2520mdr%2520efflux%2520ratio%252C%2520and%2520metabolic%2520stability%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D596%26epage%3D601%26doi%3D10.1021%2Facsmedchemlett.5b00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Am Ende, C. W.; Green, M. E.; Johnson, D. S.; Kauffman, G. W.; O’Donnell, C. J.; Patel, N. C.; Pettersson, M. Y.; Stepan, A. F.; Stiff, C. M.; Subramanyam, C.; Tran, T. P.; Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Preparation of novel bicyclic pyridinones as γ-secretase modulators</span>. WO2014045156A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+W.+Am+Ende&author=M.+E.+Green&author=D.+S.+Johnson&author=G.+W.+Kauffman&author=C.+J.+O%E2%80%99Donnell&author=N.+C.+Patel&author=M.+Y.+Pettersson&author=A.+F.+Stepan&author=C.+M.+Stiff&author=C.+Subramanyam&author=T.+P.+Tran&author=P.+R.+Verhoest&title=Preparation+of+novel+bicyclic+pyridinones+as+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAm%2BEnde%26aufirst%3DC.%2BW.%26atitle%3DPreparation%2520of%2520novel%2520bicyclic%2520pyridinones%2520as%2520%25CE%25B3-secretase%2520modulators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Bischoff, F. P.; Velter, A. I.; Rombouts, F. J. R.; De Cleyn, M. A. J.; Van Brandt, S. F. A.; Gijsen, H. J. M.; Zavattaro, C.; Van den Keybus, F. A. M.</span><span> </span><span class="NLM_article-title">Preparation of novel substituted pyrido-piperazinone derivatives as gamma secretase modulators</span>. WO2014111457A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=F.+P.+Bischoff&author=A.+I.+Velter&author=F.+J.+R.+Rombouts&author=M.+A.+J.+De+Cleyn&author=S.+F.+A.+Van+Brandt&author=H.+J.+M.+Gijsen&author=C.+Zavattaro&author=F.+A.+M.+Van+den+Keybus&title=Preparation+of+novel+substituted+pyrido-piperazinone+derivatives+as+gamma+secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26atitle%3DPreparation%2520of%2520novel%2520substituted%2520pyrido-piperazinone%2520derivatives%2520as%2520gamma%2520secretase%2520modulators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Rombouts, F. J. R.; Trabanco-Suarez, A. A.; Gijsen, H. J. M.; Macdonald, G. J.; Bischoff, F. P.; Alonso-De Diego, S.-A.; Velter, A. I.; Van Roosbroeck, Y. E. M.</span><span> </span><span class="NLM_article-title">Preparation of substituted 3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6-dione derivatives useful for the treatment of Alzheimer’s disease</span>. WO2013171712A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=F.+J.+R.+Rombouts&author=A.+A.+Trabanco-Suarez&author=H.+J.+M.+Gijsen&author=G.+J.+Macdonald&author=F.+P.+Bischoff&author=S.-A.+Alonso-De+Diego&author=A.+I.+Velter&author=Y.+E.+M.+Van+Roosbroeck&title=Preparation+of+substituted+3%2C4-dihydro-2H-pyrido%5B1%2C2-a%5Dpyrazine-1%2C6-dione+derivatives+useful+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26atitle%3DPreparation%2520of%2520substituted%25203%252C4-dihydro-2H-pyrido%255B1%252C2-a%255Dpyrazine-1%252C6-dione%2520derivatives%2520useful%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Bischoff, F. P.; Gijsen, H. J. M.; Van den Keybus, F. A. M.; Rombouts, F. J. R.</span><span> </span><span class="NLM_article-title">Novel tricyclic 3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6-dione derivatives as gamma secretase modulators and their preparation</span>. WO2014096212A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=F.+P.+Bischoff&author=H.+J.+M.+Gijsen&author=F.+A.+M.+Van+den+Keybus&author=F.+J.+R.+Rombouts&title=Novel+tricyclic+3%2C4-dihydro-2H-pyrido%5B1%2C2-a%5Dpyrazine-1%2C6-dione+derivatives+as+gamma+secretase+modulators+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26atitle%3DNovel%2520tricyclic%25203%252C4-dihydro-2H-pyrido%255B1%252C2-a%255Dpyrazine-1%252C6-dione%2520derivatives%2520as%2520gamma%2520secretase%2520modulators%2520and%2520their%2520preparation%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Findeis, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yager, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraering, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creaser, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C. B.</span><span> </span><span class="NLM_article-title">Discovery of a novel pharmacological and structural class of gamma secretase modulators derived from the extract of actaea racemosa</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">951</span><span class="refDoi"> DOI: 10.1021/cn3000857</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn3000857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Kms77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=941-951&author=M.+A.+Findeisauthor=F.+Schroederauthor=T.+D.+McKeeauthor=D.+Yagerauthor=P.+C.+Fraeringauthor=S.+P.+Creaserauthor=W.+F.+Austinauthor=J.+Clardyauthor=R.+Wangauthor=D.+Selkoeauthor=C.+B.+Eckman&title=Discovery+of+a+novel+pharmacological+and+structural+class+of+gamma+secretase+modulators+derived+from+the+extract+of+actaea+racemosa&doi=10.1021%2Fcn3000857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Pharmacological and Structural Class of Gamma Secretase Modulators Derived from the Extract of Actaea racemosa</span></div><div class="casAuthors">Findeis, Mark A.; Schroeder, Frank; McKee, Timothy D.; Yager, Debra; Fraering, Patrick C.; Creaser, Steffen P.; Austin, Wesley F.; Clardy, Jon; Wang, Rong; Selkoe, Dennis; Eckman, Christopher B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">941-951</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A screen of a library of synthetic drugs and natural product exts. identified a botanical ext. that modulates the processing of amyloid precursor protein (APP) in cultured cells to produce a lowered ratio of amyloid-beta peptide (1-42) (Aβ42) relative to Aβ40.  This profile is of interest as a potential treatment for Alzheimer's disease.  The ext., from the black cohosh plant (Actaea racemosa), was subjected to bioassay guided fractionation to isolate active components.  Using a combination of normal-phase and reverse-phase chromatog., a novel triterpene monoglycoside, 1, was isolated.  This compd. was found to have an IC50 of 100 nM for selectively reducing the prodn. of amyloidogenic Aβ42 while having a much smaller effect on the prodn. of Aβ40 (IC50 6.3 μM) in cultured cells overexpressing APP.  Using IP-MS methods, this compd. was found to modulate the pool of total Aβ produced by reducing the proportion of Aβ42 while increasing the relative amts. of shorter and less amyloidogenic Aβ37 and Aβ39.  Concns. of 1 sufficient to lower levels of Aβ42 substantially (up to 10 μM) did not significantly affect the processing of Notch or other aspects of APP processing.  When 1 (10 μg) was administered to CD-1 normal mice intracerebroventricularly, the level of Aβ42 in brain was reduced.  Assays for off-target pharmacol. and the absence of overt signs of toxicity in mice dosed with compd. 1 suggest a comparatively selective pharmacol. for this triterpenoid.  Compd. 1 represents a new lead for the development of potential treatments for Alzheimer's disease via modulation of gamma-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroImTrUZtKrrVg90H21EOLACvtfcHk0liXtOH3dkpnfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Kms77I&md5=cb43bd10a89c2b456e0a98ad5421d1f7</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fcn3000857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn3000857%26sid%3Dliteratum%253Aachs%26aulast%3DFindeis%26aufirst%3DM.%2BA.%26aulast%3DSchroeder%26aufirst%3DF.%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DYager%26aufirst%3DD.%26aulast%3DFraering%26aufirst%3DP.%2BC.%26aulast%3DCreaser%26aufirst%3DS.%2BP.%26aulast%3DAustin%26aufirst%3DW.%2BF.%26aulast%3DClardy%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSelkoe%26aufirst%3DD.%26aulast%3DEckman%26aufirst%3DC.%2BB.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520pharmacological%2520and%2520structural%2520class%2520of%2520gamma%2520secretase%2520modulators%2520derived%2520from%2520the%2520extract%2520of%2520actaea%2520racemosa%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D941%26epage%3D951%26doi%3D10.1021%2Fcn3000857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Fuller, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creaser, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, R. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ives, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findeis, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronk, B. S.</span><span> </span><span class="NLM_article-title">Initial optimization of a new series of γ-secretase modulators derived from a triterpene glycoside</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span><span class="refDoi"> DOI: 10.1021/ml300256p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300256p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=908-913&author=N.+O.+Fullerauthor=J.+L.+Hubbsauthor=W.+F.+Austinauthor=S.+P.+Creaserauthor=T.+D.+McKeeauthor=R.+M.+B.+Loureiroauthor=B.+Tateauthor=W.+Xiaauthor=J.+L.+Ivesauthor=M.+A.+Findeisauthor=B.+S.+Bronk&title=Initial+optimization+of+a+new+series+of+%CE%B3-secretase+modulators+derived+from+a+triterpene+glycoside&doi=10.1021%2Fml300256p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Initial Optimization of a New Series of γ-Secretase Modulators Derived from a Triterpene Glycoside</span></div><div class="casAuthors">Fuller, Nathan O.; Hubbs, Jed L.; Austin, Wesley F.; Creaser, Steffen P.; McKee, Timothy D.; Loureiro, Robyn M. B.; Tate, Barbara; Xia, Weiming; Ives, Jeffrey L.; Findeis, Mark A.; Bronk, Brian S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">908-913</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of a new series of γ-secretase modulators is disclosed.  Starting from a triterpene glycoside γ-secretase modulator that gave a very low brain-to-plasma ratio, initial SAR and optimization involved replacement of a pendant sugar with a series of morpholines.  This modification led to two compds. with significantly improved central nervous system (CNS) exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSMG2H-MfULLVg90H21EOLACvtfcHk0liXtOH3dkpnfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjO&md5=998a73e5df368087af6c75038cd74eaa</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fml300256p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300256p%26sid%3Dliteratum%253Aachs%26aulast%3DFuller%26aufirst%3DN.%2BO.%26aulast%3DHubbs%26aufirst%3DJ.%2BL.%26aulast%3DAustin%26aufirst%3DW.%2BF.%26aulast%3DCreaser%26aufirst%3DS.%2BP.%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DLoureiro%26aufirst%3DR.%2BM.%2BB.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DIves%26aufirst%3DJ.%2BL.%26aulast%3DFindeis%26aufirst%3DM.%2BA.%26aulast%3DBronk%26aufirst%3DB.%2BS.%26atitle%3DInitial%2520optimization%2520of%2520a%2520new%2520series%2520of%2520%25CE%25B3-secretase%2520modulators%2520derived%2520from%2520a%2520triterpene%2520glycoside%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D908%26epage%3D913%26doi%3D10.1021%2Fml300256p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Austin, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creaser, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, R. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findeis, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ives, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronk, B. S.</span><span> </span><span class="NLM_article-title">Sar investigations on a novel class of gamma-secretase modulators based on a unique scaffold</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span><span class="refDoi"> DOI: 10.1039/c3md20357c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1039%2Fc3md20357c" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=569-574&author=W.+F.+Austinauthor=J.+L.+Hubbsauthor=N.+O.+Fullerauthor=S.+P.+Creaserauthor=T.+D.+McKeeauthor=R.+M.+B.+Loureiroauthor=M.+A.+Findeisauthor=B.+Tateauthor=J.+L.+Ivesauthor=B.+S.+Bronk&title=Sar+investigations+on+a+novel+class+of+gamma-secretase+modulators+based+on+a+unique+scaffold&doi=10.1039%2Fc3md20357c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1039%2Fc3md20357c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md20357c%26sid%3Dliteratum%253Aachs%26aulast%3DAustin%26aufirst%3DW.%2BF.%26aulast%3DHubbs%26aufirst%3DJ.%2BL.%26aulast%3DFuller%26aufirst%3DN.%2BO.%26aulast%3DCreaser%26aufirst%3DS.%2BP.%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DLoureiro%26aufirst%3DR.%2BM.%2BB.%26aulast%3DFindeis%26aufirst%3DM.%2BA.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DIves%26aufirst%3DJ.%2BL.%26aulast%3DBronk%26aufirst%3DB.%2BS.%26atitle%3DSar%2520investigations%2520on%2520a%2520novel%2520class%2520of%2520gamma-secretase%2520modulators%2520based%2520on%2520a%2520unique%2520scaffold%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D569%26epage%3D574%26doi%3D10.1039%2Fc3md20357c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Loureiro, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ives, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronk, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span> </span><span class="NLM_article-title">Efficacy of spi-1865, a novel gamma-secretase modulator, in multiple rodent models</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="refDoi"> DOI: 10.1186/alzrt173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1186%2Falzrt173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXos1Oltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=19&author=R.+M.+Loureiroauthor=J.+A.+Duminauthor=T.+D.+McKeeauthor=W.+F.+Austinauthor=N.+O.+Fullerauthor=J.+L.+Hubbsauthor=R.+Shenauthor=J.+Jonkerauthor=J.+Ivesauthor=B.+S.+Bronkauthor=B.+Tate&title=Efficacy+of+spi-1865%2C+a+novel+gamma-secretase+modulator%2C+in+multiple+rodent+models&doi=10.1186%2Falzrt173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models</span></div><div class="casAuthors">Loureiro, Robyn M.; Dumin, Jo Ann; McKee, Timothy D.; Austin, Wesley F.; Fuller, Nathan O.; Hubbs, Jed L.; Shen, Ruichao; Jonker, Jeff; Ives, Jeff; Bronk, Brian S.; Tate, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">19</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Introduction: Modulation of the gamma-secretase enzyme, which reduces the prodn. of the amyloidogenic Aβ42 peptide while sparing the prodn. of other Aβ species, is a promising therapeutic approach for the treatment of Alzheimer's disease.  Satori has identified a unique class of small mol. gamma-secretase modulators (GSMs) capable of decreasing Aβ42 levels in cellular and rodent model systems.  The compd. class exhibits potency in the nM range in vitro and is selective for lowering Aβ42 and Aβ38 while sparing Aβ40 and total Aβ levels.  In vivo , a compd. from the series, SPI-1865, demonstrates similar pharmacol. in wild-type CD1 mice, Tg2576 mice and Sprague Dawley rats.  Methods: Animals were orally administered either a single dose of SPI-1865 or dosed for multiple days.  Aβ levels were measured using a sensitive plate-based ELISA system (MSD) and brain and plasma exposure of drug were assessed by LC/MS/MS.  Results: In wild-type mice using either dosing regimen, brain Aβ42 and Aβ38 levels were decreased upon treatment with SPI-1865 and little to no statistically meaningful effect on Aβ40 was obsd., reflecting the changes obsd. in vitro.  In rats, brain Aβ levels were examd. and similar to the mouse studies, brain Aβ42 and Aβ38 were lowered.  Comparable changes were also obsd. in the Tg2576 mice, where Aβ levels were measured in brain as well as plasma and CSF.  Conclusions: Taken together, these data indicate that SPI-1865 is orally bioavailable, brain penetrant, and effective at lowering Aβ42 in a dose responsive manner.  With this unique profile, the class of compds. represented by SPI-1865 may be a promising new therapy for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1X_YHlxYm6rVg90H21EOLACvtfcHk0liXtOH3dkpnfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXos1Oltbc%253D&md5=f452b63f5a006a1bd8f379c64e14f6a4</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1186%2Falzrt173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt173%26sid%3Dliteratum%253Aachs%26aulast%3DLoureiro%26aufirst%3DR.%2BM.%26aulast%3DDumin%26aufirst%3DJ.%2BA.%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DAustin%26aufirst%3DW.%2BF.%26aulast%3DFuller%26aufirst%3DN.%2BO.%26aulast%3DHubbs%26aufirst%3DJ.%2BL.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DJonker%26aufirst%3DJ.%26aulast%3DIves%26aufirst%3DJ.%26aulast%3DBronk%26aufirst%3DB.%2BS.%26aulast%3DTate%26aufirst%3DB.%26atitle%3DEfficacy%2520of%2520spi-1865%252C%2520a%2520novel%2520gamma-secretase%2520modulator%252C%2520in%2520multiple%2520rodent%2520models%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2013%26volume%3D5%26spage%3D19%26doi%3D10.1186%2Falzrt173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><a href="http://www.alzforum.org/news/research-news/satori-pharmaceuticals-shuts-down-abandons-g-secretase-modulators" class="extLink">http://www.alzforum.org/news/research-news/satori-pharmaceuticals-shuts-down-abandons-g-secretase-modulators</a> (accessed Dec 1, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.alzforum.org%2Fnews%2Fresearch-news%2Fsatori-pharmaceuticals-shuts-down-abandons-g-secretase-modulators+%28accessed+Dec+1%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Jung, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsenstein, K. M.</span><span> </span><span class="NLM_article-title">Steroids as γ-secretase modulators</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3775</span><span class="NLM_x">–</span> <span class="NLM_lpage">3785</span><span class="refDoi"> DOI: 10.1096/fj.12-225649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1096%2Ffj.12-225649" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=3775-3785&author=J.+I.+Jungauthor=T.+B.+Laddauthor=T.+Kukarauthor=A.+R.+Priceauthor=B.+D.+Mooreauthor=E.+H.+Kooauthor=T.+E.+Goldeauthor=K.+M.+Felsenstein&title=Steroids+as+%CE%B3-secretase+modulators&doi=10.1096%2Ffj.12-225649"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1096%2Ffj.12-225649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.12-225649%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DJ.%2BI.%26aulast%3DLadd%26aufirst%3DT.%2BB.%26aulast%3DKukar%26aufirst%3DT.%26aulast%3DPrice%26aufirst%3DA.%2BR.%26aulast%3DMoore%26aufirst%3DB.%2BD.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26atitle%3DSteroids%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DFASEB%2520J.%26date%3D2013%26volume%3D27%26spage%3D3775%26epage%3D3785%26doi%3D10.1096%2Ffj.12-225649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro adme, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.1021/cn100007x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+adme%2C+and+safety+attributes&doi=10.1021%2Fcn100007x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0liCK0o5itjQrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520adme%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434%26doi%3D10.1021%2Fcn100007x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 82 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ángel Santiago, Dulce C. Guzmán-Ocampo, Rodrigo Aguayo-Ortiz, <span class="NLM_string-name hlFld-ContribAuthor">Laura Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Characterizing the Chemical Space of γ-Secretase Inhibitors and Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (15)
                                     , 2765-2775. <a href="https://doi.org/10.1021/acschemneuro.1c00313" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00313%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DCharacterizing%252Bthe%252BChemical%252BSpace%252Bof%252B%2525CE%2525B3-Secretase%252BInhibitors%252Band%252BModulators%26aulast%3DSantiago%26aufirst%3D%25C3%2581ngel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21052021%26date%3D09072021%26date%3D22072021%26volume%3D12%26issue%3D15%26spage%3D2765%26epage%3D2775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bryan Li, Richard W. Barnhart, Amelie Dion, Steven Guinness, Alan Happe, Cheryl M. Hayward, Jeffrey Kohrt, Teresa Makowski, Mark Maloney, Jade D. Nelson, Asaad Nematalla, J. Christopher McWilliams, Zhihui Peng, Jeffrey Raggon, John Sagal, Gerald A. Weisenburger, Denghui Bao, Miguel Gonzalez, Jiangping Lu, Mark D. McLaws, Jian Tao, <span class="NLM_string-name hlFld-ContribAuthor">Baolin Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor—Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (6)
                                     , 1440-1453. <a href="https://doi.org/10.1021/acs.oprd.1c00126" title="DOI URL">https://doi.org/10.1021/acs.oprd.1c00126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.1c00126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.1c00126%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DProcess%252BDevelopment%252Bof%252Ba%252BSecond%252BGeneration%252B%2525CE%2525B2-Amyloid-Cleaving%252BEnzyme%252BInhibitor%2525E2%252580%252594Improving%252Bthe%252BRobustness%252Bof%252Ba%252BHalogen-Metal%252BExchange%252BUsing%252BContinuous%252BStirred-Tank%252BReactors%26aulast%3DLi%26aufirst%3DBryan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12042021%26date%3D24052021%26volume%3D25%26issue%3D6%26spage%3D1440%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Biao Zhang, Donghan Liu, Yulin Sun, Yajing Zhang, Jiayi Feng, <span class="NLM_string-name hlFld-ContribAuthor">Fuchao Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of Thiazole-2-thiones through TBPB-Promoted Oxidative Cascade Cyclization of Enaminones with Elemental Sulfur. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (8)
                                     , 3076-3082. <a href="https://doi.org/10.1021/acs.orglett.1c00751" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00751%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPreparation%252Bof%252BThiazole-2-thiones%252Bthrough%252BTBPB-Promoted%252BOxidative%252BCascade%252BCyclization%252Bof%252BEnaminones%252Bwith%252BElemental%252BSulfur%26aulast%3DZhang%26aufirst%3DBiao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04032021%26date%3D26032021%26volume%3D23%26issue%3D8%26spage%3D3076%26epage%3D3082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wenjie Luo, Fanny C. F. Ip, Guangmiao Fu, Kit Cheung, Yuan Tian, Yueqing Hu, Anjana Sinha, Elaine Y. L. Cheng, Xianzhong Wu, Victor Bustos, Paul Greengard, Yue-Ming Li, Subhash C. Sinha, <span class="NLM_string-name hlFld-ContribAuthor">Nancy Y. Ip</span>. </span><span class="cited-content_cbyCitation_article-title">A Pentacyclic Triterpene from Ligustrum lucidum Targets γ-Secretase. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (18)
                                     , 2827-2835. <a href="https://doi.org/10.1021/acschemneuro.0c00389" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00389%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DA%252BPentacyclic%252BTriterpene%252Bfrom%252BLigustrum%252Blucidum%252BTargets%252B%2525CE%2525B3-Secretase%26aulast%3DLuo%26aufirst%3DWenjie%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23062020%26date%3D10082020%26date%3D03092020%26date%3D10082020%26volume%3D11%26issue%3D18%26spage%3D2827%26epage%3D2835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rosa María Rodríguez
Sarmiento, Caterina Bissantz, Johan Bylund, Anja Limberg, Werner Neidhart, Roland Jakob-Roetne, Lisha Wang, <span class="NLM_string-name hlFld-ContribAuthor">Karlheinz Baumann</span>. </span><span class="cited-content_cbyCitation_article-title">Stepwise Design of γ-Secretase Modulators with an Advanced Profile by Judicious Coordinated Structural Replacements and an Unconventional Phenyl Ring Bioisostere. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8534-8553. <a href="https://doi.org/10.1021/acs.jmedchem.0c00909" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00909</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00909%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStepwise%252BDesign%252Bof%252B%2525CE%2525B3-Secretase%252BModulators%252Bwith%252Ban%252BAdvanced%252BProfile%252Bby%252BJudicious%252BCoordinated%252BStructural%252BReplacements%252Band%252Ban%252BUnconventional%252BPhenyl%252BRing%252BBioisostere%26aulast%3DRodr%25C3%25ADguez%2BSarmiento%26aufirst%3DRosa%2BMar%25C3%25ADa%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28052020%26date%3D04082020%26date%3D24072020%26volume%3D63%26issue%3D15%26spage%3D8534%26epage%3D8553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hasane Ratni, Andre Alker, Bjoern Bartels, Caterina Bissantz, Weichun Chen, Irene Gerlach, Anja Limberg, Mingqiu Lu, Werner Neidhart, Solen Pichereau, Michael Reutlinger, Rosa-Maria Rodriguez-Sarmiento, Roland Jakob-Roetne, Georg Schmitt, Eric Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Karlheinz Baumann</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of RO7185876, a Highly Potent γ-Secretase Modulator (GSM) as a Potential Treatment for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1257-1268. <a href="https://doi.org/10.1021/acsmedchemlett.0c00109" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00109%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BRO7185876%25252C%252Ba%252BHighly%252BPotent%252B%2525CE%2525B3-Secretase%252BModulator%252B%252528GSM%252529%252Bas%252Ba%252BPotential%252BTreatment%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DRatni%26aufirst%3DHasane%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03032020%26date%3D27042020%26date%3D01052020%26date%3D27042020%26volume%3D11%26issue%3D6%26spage%3D1257%26epage%3D1268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hester
A. Beard, Marta Barniol-Xicota, Jian Yang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. L. Verhelst</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Cellular Roles of Intramembrane Proteases. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (11)
                                     , 2372-2388. <a href="https://doi.org/10.1021/acschembio.9b00404" title="DOI URL">https://doi.org/10.1021/acschembio.9b00404</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00404%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDiscovery%252Bof%252BCellular%252BRoles%252Bof%252BIntramembrane%252BProteases%26aulast%3DBeard%26aufirst%3DHester%2BA.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20052019%26date%3D09072019%26date%3D24072019%26date%3D09072019%26volume%3D14%26issue%3D11%26spage%3D2372%26epage%3D2388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Michael S. Wolfe</span>. </span><span class="cited-content_cbyCitation_article-title">Structure and Function of the γ-Secretase Complex. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (27)
                                     , 2953-2966. <a href="https://doi.org/10.1021/acs.biochem.9b00401" title="DOI URL">https://doi.org/10.1021/acs.biochem.9b00401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.9b00401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.9b00401%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DStructure%252Band%252BFunction%252Bof%252Bthe%252B%2525CE%2525B3-Secretase%252BComplex%26aulast%3DWolfe%26aufirst%3DMichael%2BS.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02052019%26date%3D13062019%26date%3D25062019%26date%3D14062019%26volume%3D58%26issue%3D27%26spage%3D2953%26epage%3D2966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kenneth M. Boy, Jason M. Guernon, Dmitry S. Zuev, Li Xu, Yunhui Zhang, Jianliang Shi, Lawrence R. Marcin, Mendi A. Higgins, Yong-Jin Wu, Subramaniam Krishnananthan, Jianqing Li, Ashok Trehan, Daniel Smith, Jeremy H. Toyn, Jere E. Meredith, Catherine R. Burton, S. Roy Kimura, Tatyana Zvyaga, Xiaoliang Zhuo, Kimberley A. Lentz, James E. Grace, Rex Denton, John S. Morrison, Arvind Mathur, Charles F. Albright, Michael K. Ahlijanian, Richard E. Olson, Lorin A. Thompson, <span class="NLM_string-name hlFld-ContribAuthor">John E. Macor</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 312-317. <a href="https://doi.org/10.1021/acsmedchemlett.8b00541" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00541%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Band%252BPreclinical%252BEvaluation%252Bof%252Bthe%252BBicyclic%252BPyrimidine%252B%2525CE%2525B3-Secretase%252BModulator%252BBMS-932481%26aulast%3DBoy%26aufirst%3DKenneth%2BM.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D09112018%26date%3D04022019%26date%3D17022019%26volume%3D10%26issue%3D3%26spage%3D312%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ning Tang, Arun K. Somavarapu, <span class="NLM_string-name hlFld-ContribAuthor">Kasper P. Kepp</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Recipe for γ-Secretase Modulation from Computational Analysis of 60 Active Compounds. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (12)
                                     , 18078-18088. <a href="https://doi.org/10.1021/acsomega.8b02196" title="DOI URL">https://doi.org/10.1021/acsomega.8b02196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b02196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b02196%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DMolecular%252BRecipe%252Bfor%252B%2525CE%2525B3-Secretase%252BModulation%252Bfrom%252BComputational%252BAnalysis%252Bof%252B60%252BActive%252BCompounds%26aulast%3DTang%26aufirst%3DNing%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D28082018%26date%3D10122018%26volume%3D3%26issue%3D12%26spage%3D18078%26epage%3D18088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kenji Nakahara, Kouki Fuchino, Kazuo Komano, Naoya Asada, Genta Tadano, Tsuyoshi Hasegawa, Takahiko Yamamoto, Yusuke Sako, Masayoshi Ogawa, Chie Unemura, Motoko Hosono, Hisanori Ito, Gaku Sakaguchi, Shigeru Ando, Shuichi Ohnishi, Yasuto Kido, Tamio Fukushima, Deborah Dhuyvetter, Herman Borghys, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (13)
                                     , 5525-5546. <a href="https://doi.org/10.1021/acs.jmedchem.8b00011" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BCentrally%252BActive%252B6-Substituted%252B5-Fluoro-1%25252C3-dihydro-oxazine%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%252Bvia%252BActive%252BConformation%252BStabilization%26aulast%3DNakahara%26aufirst%3DKenji%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04012018%26date%3D14062018%26date%3D18052018%26volume%3D61%26issue%3D13%26spage%3D5525%26epage%3D5546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kouki Fuchino, Yasunori Mitsuoka, Moriyasu Masui, Noriyuki Kurose, Shuhei Yoshida, Kazuo Komano, Takahiko Yamamoto, Masayoshi Ogawa, Chie Unemura, Motoko Hosono, Hisanori Ito, Gaku Sakaguchi, Shigeru Ando, Shuichi Ohnishi, Yasuto Kido, Tamio Fukushima, Hirofumi Miyajima, Shuichi Hiroyama, Kiyotaka Koyabu, Deborah Dhuyvetter, Herman Borghys, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (12)
                                     , 5122-5137. <a href="https://doi.org/10.1021/acs.jmedchem.8b00002" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252BNovel%252B1%25252C3-Oxazine%252BBased%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%25253A%252BIncorporation%252Bof%252Ba%252BDouble%252BBond%252BTo%252BReduce%252BP-gp%252BEfflux%252BLeading%252Bto%252BRobust%252BA%2525CE%2525B2%252BReduction%252Bin%252Bthe%252BBrain%26aulast%3DFuchino%26aufirst%3DKouki%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D01012018%26date%3D23052018%26date%3D07052018%26volume%3D61%26issue%3D12%26spage%3D5122%26epage%3D5137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danica A.  Rankic</span>, <span class="hlFld-ContribAuthor ">Cory M.  Stiff</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, and <span class="hlFld-ContribAuthor ">John M.  Humphrey</span>  . </span><span class="cited-content_cbyCitation_article-title">Protocol for the Direct Conversion of Lactones to Lactams Mediated by 1,5,7-Triazabicyclo[4.4.0]dec-5-ene: Synthesis of Pyridopyrazine-1,6-diones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (23)
                                     , 12791-12797. <a href="https://doi.org/10.1021/acs.joc.7b02079" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02079%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DProtocol%252Bfor%252Bthe%252BDirect%252BConversion%252Bof%252BLactones%252Bto%252BLactams%252BMediated%252Bby%252B1%25252C5%25252C7-Triazabicyclo%25255B4.4.0%25255Ddec-5-ene%25253A%252BSynthesis%252Bof%252BPyridopyrazine-1%25252C6-diones%26aulast%3DRankic%26aufirst%3DDanica%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D16082017%26date%3D01112017%26date%3D01122017%26date%3D19102017%26volume%3D82%26issue%3D23%26spage%3D12791%26epage%3D12797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abhijeet  Srivastava</span>, <span class="hlFld-ContribAuthor ">Gaurav  Shukla</span>, <span class="hlFld-ContribAuthor ">Dhananjay  Yadav</span>, and <span class="hlFld-ContribAuthor ">Maya Shankar  Singh</span>  . </span><span class="cited-content_cbyCitation_article-title">Access to Fully Substituted Thiazoles and 2,3-Dihydrothiazoles via Copper-Catalyzed [4 + 1] Heterocyclization of α-(N-Hydroxy/aryl)imino-β-oxodithioesters with α-Diazocarbonyls. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (20)
                                     , 10846-10854. <a href="https://doi.org/10.1021/acs.joc.7b01601" title="DOI URL">https://doi.org/10.1021/acs.joc.7b01601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b01601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b01601%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAccess%252Bto%252BFully%252BSubstituted%252BThiazoles%252Band%252B2%25252C3-Dihydrothiazoles%252Bvia%252BCopper-Catalyzed%252B%25255B4%252B%25252B%252B1%25255D%252BHeterocyclization%252Bof%252B%2525CE%2525B1-%252528N-Hydroxy%25252Faryl%252529imino-%2525CE%2525B2-oxodithioesters%252Bwith%252B%2525CE%2525B1-Diazocarbonyls%26aulast%3DSrivastava%26aufirst%3DAbhijeet%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28062017%26date%3D02102017%26date%3D20102017%26date%3D25092017%26volume%3D82%26issue%3D20%26spage%3D10846%26epage%3D10854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiqiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Dmitri A.  Pissarnitski</span>, <span class="hlFld-ContribAuthor ">Xianhai  Huang</span>, <span class="hlFld-ContribAuthor ">Anandan  Palani</span>, <span class="hlFld-ContribAuthor ">Zhaoning  Zhu</span>, <span class="hlFld-ContribAuthor ">William J.  Greenlee</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Lixin  Song</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Terracina</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, and <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 1002-1006. <a href="https://doi.org/10.1021/acsmedchemlett.7b00178" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00178%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BTetrahydrobenzisoxazole%252BSeries%252Bof%252B%2525CE%2525B3-Secretase%252BModulators%26aulast%3DZhao%26aufirst%3DZhiqiang%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23042017%26date%3D19092017%26date%3D26092017%26date%3D12102017%26date%3D19092017%26volume%3D8%26issue%3D10%26spage%3D1002%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew G.  Bursavich</span>, <span class="hlFld-ContribAuthor ">Bryce A.  Harrison</span>, <span class="hlFld-ContribAuthor ">Raksha  Acharya</span>, <span class="hlFld-ContribAuthor ">Donald E.  Costa</span>, <span class="hlFld-ContribAuthor ">Emily A.  Freeman</span>, <span class="hlFld-ContribAuthor ">Hilliary E.  Hodgdon</span>, <span class="hlFld-ContribAuthor ">Lori A.  Hrdlicka</span>, <span class="hlFld-ContribAuthor ">Hong  Jin</span>, <span class="hlFld-ContribAuthor ">Sudarshan  Kapadnis</span>, <span class="hlFld-ContribAuthor ">Jeffrey S.  Moffit</span>, <span class="hlFld-ContribAuthor ">Deirdre A.  Murphy</span>, <span class="hlFld-ContribAuthor ">Scott  Nolan</span>, <span class="hlFld-ContribAuthor ">Holger  Patzke</span>, <span class="hlFld-ContribAuthor ">Cuyue  Tang</span>, <span class="hlFld-ContribAuthor ">Melody  Wen</span>, <span class="hlFld-ContribAuthor ">Gerhard  Koenig</span>, <span class="hlFld-ContribAuthor ">Jean-François  Blain</span>, and <span class="hlFld-ContribAuthor ">Duane A.  Burnett</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (6)
                                     , 2383-2400. <a href="https://doi.org/10.1021/acs.jmedchem.6b01620" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01620</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01620%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BOxadiazine%252BGamma%252BSecretase%252BModulators%252Bfor%252BFamilial%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DBursavich%26aufirst%3DMatthew%2BG.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D22112016%26date%3D10032017%26date%3D23032017%26date%3D23022017%26volume%3D60%26issue%3D6%26spage%3D2383%26epage%3D2400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Boris  Decourt</span>, <span class="hlFld-ContribAuthor ">Fadel  Boumelhem</span>, <span class="hlFld-ContribAuthor ">Evans D.  Pope</span>, <span class="hlFld-ContribAuthor ">Jiong  Shi</span>, <span class="hlFld-ContribAuthor ">Zoltan  Mari</span>, <span class="hlFld-ContribAuthor ">Marwan Noel  Sabbagh</span>. </span><span class="cited-content_cbyCitation_article-title">Critical Appraisal of Amyloid Lowering Agents in AD. </span><span class="cited-content_cbyCitation_journal-name">Current Neurology and Neuroscience Reports</span><span> <strong>2021,</strong> <em>21 </em>
                                    (8)
                                     <a href="https://doi.org/10.1007/s11910-021-01125-y" title="DOI URL">https://doi.org/10.1007/s11910-021-01125-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11910-021-01125-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11910-021-01125-y%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Neurology%2520and%2520Neuroscience%2520Reports%26atitle%3DCritical%252BAppraisal%252Bof%252BAmyloid%252BLowering%252BAgents%252Bin%252BAD%26aulast%3DDecourt%26aufirst%3DBoris%26date%3D2021%26date%3D2021%26volume%3D21%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milan  Stoiljkovic</span>, <span class="hlFld-ContribAuthor ">Tamas L.  Horvath</span>, <span class="hlFld-ContribAuthor ">Mihály  Hajós</span>. </span><span class="cited-content_cbyCitation_article-title">Therapy for Alzheimer’s disease: Missing targets and functional markers?. </span><span class="cited-content_cbyCitation_journal-name">Ageing Research Reviews</span><span> <strong>2021,</strong> <em>68 </em>, 101318. <a href="https://doi.org/10.1016/j.arr.2021.101318" title="DOI URL">https://doi.org/10.1016/j.arr.2021.101318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arr.2021.101318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arr.2021.101318%26sid%3Dliteratum%253Aachs%26jtitle%3DAgeing%2520Research%2520Reviews%26atitle%3DTherapy%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252BMissing%252Btargets%252Band%252Bfunctional%252Bmarkers%25253F%26aulast%3DStoiljkovic%26aufirst%3DMilan%26date%3D2021%26volume%3D68%26spage%3D101318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael S.  Wolfe</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting γ-secretase for familial Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (7)
                                     , 1321-1327. <a href="https://doi.org/10.1007/s00044-021-02744-3" title="DOI URL">https://doi.org/10.1007/s00044-021-02744-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-021-02744-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-021-02744-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DTargeting%252B%2525CE%2525B3-secretase%252Bfor%252Bfamilial%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DWolfe%26aufirst%3DMichael%2BS.%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D7%26spage%3D1321%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kejing  Lao</span>, <span class="hlFld-ContribAuthor ">Ruisan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuxuan  Dai</span>, <span class="hlFld-ContribAuthor ">Jing  Luan</span>, <span class="hlFld-ContribAuthor ">Na  Guo</span>, <span class="hlFld-ContribAuthor ">Xi  Xu</span>, <span class="hlFld-ContribAuthor ">Yuelin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xingchun  Gou</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel Aβ-LilrB2 inhibitors as potential therapeutic agents for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Neuroscience</span><span> <strong>2021,</strong> <em>114 </em>, 103630. <a href="https://doi.org/10.1016/j.mcn.2021.103630" title="DOI URL">https://doi.org/10.1016/j.mcn.2021.103630</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mcn.2021.103630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mcn.2021.103630%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Neuroscience%26atitle%3DIdentification%252Bof%252Bnovel%252BA%2525CE%2525B2-LilrB2%252Binhibitors%252Bas%252Bpotential%252Btherapeutic%252Bagents%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DLao%26aufirst%3DKejing%26date%3D2021%26volume%3D114%26spage%3D103630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominika  Nowak</span>, <span class="hlFld-ContribAuthor ">Wojciech  Słupski</span>, <span class="hlFld-ContribAuthor ">Maria  Rutkowska</span>. </span><span class="cited-content_cbyCitation_article-title">New therapeutic strategies for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Postępy Higieny i Medycyny Doświadczalnej</span><span> <strong>2021,</strong> <em>75 </em>, 474-490. <a href="https://doi.org/10.5604/01.3001.0014.9532" title="DOI URL">https://doi.org/10.5604/01.3001.0014.9532</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5604/01.3001.0014.9532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5604%2F01.3001.0014.9532%26sid%3Dliteratum%253Aachs%26jtitle%3DPost%25C4%2599py%2520Higieny%2520i%2520Medycyny%2520Do%25C5%259Bwiadczalnej%26atitle%3DNew%252Btherapeutic%252Bstrategies%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DNowak%26aufirst%3DDominika%26date%3D2021%26volume%3D75%26spage%3D474%26epage%3D490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rukmankesh  Mehra</span>, <span class="hlFld-ContribAuthor ">Kasper Planeta  Kepp</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding familial Alzheimer's disease: The fit‐stay‐trim mechanism of γ‐secretase. </span><span class="cited-content_cbyCitation_journal-name">WIREs Computational Molecular Science</span><span> <strong>2021,</strong> <em>15 </em><a href="https://doi.org/10.1002/wcms.1556" title="DOI URL">https://doi.org/10.1002/wcms.1556</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1556%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Computational%2520Molecular%2520Science%26atitle%3DUnderstanding%252Bfamilial%252BAlzheimer%252527s%252Bdisease%25253A%252BThe%252Bfit%2525E2%252580%252590stay%2525E2%252580%252590trim%252Bmechanism%252Bof%252B%2525CE%2525B3%2525E2%252580%252590secretase%26aulast%3DMehra%26aufirst%3DRukmankesh%26date%3D2021%26date%3D2021%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Ratni</span>, <span class="hlFld-ContribAuthor ">K.  Baumann</span>, <span class="hlFld-ContribAuthor ">P.  Bellotti</span>, <span class="hlFld-ContribAuthor ">X. A.  Cook</span>, <span class="hlFld-ContribAuthor ">L. G.  Green</span>, <span class="hlFld-ContribAuthor ">T.  Luebbers</span>, <span class="hlFld-ContribAuthor ">M.  Reutlinger</span>, <span class="hlFld-ContribAuthor ">A. F.  Stepan</span>, <span class="hlFld-ContribAuthor ">W.  Vifian</span>. </span><span class="cited-content_cbyCitation_article-title">Phenyl bioisosteres in medicinal chemistry: discovery of novel γ-secretase modulators as a potential treatment for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 758-766. <a href="https://doi.org/10.1039/D1MD00043H" title="DOI URL">https://doi.org/10.1039/D1MD00043H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00043H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00043H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPhenyl%252Bbioisosteres%252Bin%252Bmedicinal%252Bchemistry%25253A%252Bdiscovery%252Bof%252Bnovel%252B%2525CE%2525B3-secretase%252Bmodulators%252Bas%252Ba%252Bpotential%252Btreatment%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DRatni%26aufirst%3DH.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D5%26spage%3D758%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alvaro  Miranda</span>, <span class="hlFld-ContribAuthor ">Enrique  Montiel</span>, <span class="hlFld-ContribAuthor ">Henning  Ulrich</span>, <span class="hlFld-ContribAuthor ">Cristian  Paz</span>, . </span><span class="cited-content_cbyCitation_article-title">Selective Secretase Targeting for Alzheimer’s Disease Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2021,</strong> <em>81 </em>
                                    (1)
                                     , 1-17. <a href="https://doi.org/10.3233/JAD-201027" title="DOI URL">https://doi.org/10.3233/JAD-201027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-201027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-201027%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DSelective%252BSecretase%252BTargeting%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%26aulast%3DMiranda%26aufirst%3DAlvaro%26date%3D2021%26volume%3D81%26issue%3D1%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Saretz</span>, <span class="hlFld-ContribAuthor ">Gabriele  Basset</span>, <span class="hlFld-ContribAuthor ">Liridona  Useini</span>, <span class="hlFld-ContribAuthor ">Markus  Laube</span>, <span class="hlFld-ContribAuthor ">Jens  Pietzsch</span>, <span class="hlFld-ContribAuthor ">Dijana  Drača</span>, <span class="hlFld-ContribAuthor ">Danijela  Maksimović-Ivanić</span>, <span class="hlFld-ContribAuthor ">Johannes  Trambauer</span>, <span class="hlFld-ContribAuthor ">Harald  Steiner</span>, <span class="hlFld-ContribAuthor ">Evamarie  Hey-Hawkins</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (10)
                                     , 2843. <a href="https://doi.org/10.3390/molecules26102843" title="DOI URL">https://doi.org/10.3390/molecules26102843</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26102843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26102843%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DModulation%252Bof%252B%2525CE%2525B3-Secretase%252BActivity%252Bby%252Ba%252BCarborane-Based%252BFlurbiprofen%252BAnalogue%26aulast%3DSaretz%26aufirst%3DStefan%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D10%26spage%3D2843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tetsuo  Cai</span>, <span class="hlFld-ContribAuthor ">Taisuke  Tomita</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential conformational changes in transmembrane domains of presenilin 1 in Aβ42 downregulation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Biochemistry</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.1093/jb/mvab033" title="DOI URL">https://doi.org/10.1093/jb/mvab033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jb/mvab033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjb%2Fmvab033%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Biochemistry%26atitle%3DSequential%252Bconformational%252Bchanges%252Bin%252Btransmembrane%252Bdomains%252Bof%252Bpresenilin%252B1%252Bin%252BA%2525CE%2525B242%252Bdownregulation%26aulast%3DCai%26aufirst%3DTetsuo%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kejing  Lao</span>, <span class="hlFld-ContribAuthor ">Ruisan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Luan</span>, <span class="hlFld-ContribAuthor ">Yuelin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xingchun  Gou</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2021,</strong> <em>79 </em>
                                    (4)
                                     , 1429-1442. <a href="https://doi.org/10.3233/JAD-200851" title="DOI URL">https://doi.org/10.3233/JAD-200851</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-200851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-200851%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DTherapeutic%252BStrategies%252BTargeting%252BAmyloid-%2525CE%2525B2%252BReceptors%252Band%252BTransporters%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DLao%26aufirst%3DKejing%26date%3D2021%26volume%3D79%26issue%3D4%26spage%3D1429%26epage%3D1442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samarpan  Majumder</span>, <span class="hlFld-ContribAuthor ">Judy S.  Crabtree</span>, <span class="hlFld-ContribAuthor ">Todd E.  Golde</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Minter</span>, <span class="hlFld-ContribAuthor ">Barbara A.  Osborne</span>, <span class="hlFld-ContribAuthor ">Lucio  Miele</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Notch in oncology: the path forward. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2021,</strong> <em>20 </em>
                                    (2)
                                     , 125-144. <a href="https://doi.org/10.1038/s41573-020-00091-3" title="DOI URL">https://doi.org/10.1038/s41573-020-00091-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-020-00091-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-020-00091-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DTargeting%252BNotch%252Bin%252Boncology%25253A%252Bthe%252Bpath%252Bforward%26aulast%3DMajumder%26aufirst%3DSamarpan%26date%3D2021%26date%3D2020%26volume%3D20%26issue%3D2%26spage%3D125%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rukmankesh  Mehra</span>, <span class="hlFld-ContribAuthor ">Kasper P.  Kepp</span>. </span><span class="cited-content_cbyCitation_article-title">Computational prediction and molecular mechanism of γ-secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2021,</strong> <em>157 </em>, 105626. <a href="https://doi.org/10.1016/j.ejps.2020.105626" title="DOI URL">https://doi.org/10.1016/j.ejps.2020.105626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2020.105626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2020.105626%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DComputational%252Bprediction%252Band%252Bmolecular%252Bmechanism%252Bof%252B%2525CE%2525B3-secretase%252Bmodulators%26aulast%3DMehra%26aufirst%3DRukmankesh%26date%3D2021%26volume%3D157%26spage%3D105626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanghui  Yang</span>, <span class="hlFld-ContribAuthor ">Rui  Zhou</span>, <span class="hlFld-ContribAuthor ">Xuefei  Guo</span>, <span class="hlFld-ContribAuthor ">Chuangye  Yan</span>, <span class="hlFld-ContribAuthor ">Jianlin  Lei</span>, <span class="hlFld-ContribAuthor ">Yigong  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis of γ-secretase inhibition and modulation by small molecule drugs. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2021,</strong> <em>184 </em>
                                    (2)
                                     , 521-533.e14. <a href="https://doi.org/10.1016/j.cell.2020.11.049" title="DOI URL">https://doi.org/10.1016/j.cell.2020.11.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2020.11.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2020.11.049%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3DStructural%252Bbasis%252Bof%252B%2525CE%2525B3-secretase%252Binhibition%252Band%252Bmodulation%252Bby%252Bsmall%252Bmolecule%252Bdrugs%26aulast%3DYang%26aufirst%3DGuanghui%26date%3D2021%26volume%3D184%26issue%3D2%26spage%3D521%26epage%3D533.e14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael S.  Wolfe</span>. </span><span class="cited-content_cbyCitation_article-title">Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (2)
                                     , 388. <a href="https://doi.org/10.3390/molecules26020388" title="DOI URL">https://doi.org/10.3390/molecules26020388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26020388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26020388%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DProbing%252BMechanisms%252Band%252BTherapeutic%252BPotential%252Bof%252B%2525CE%2525B3-Secretase%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWolfe%26aufirst%3DMichael%2BS.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D2%26spage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frédéric  Checler</span>, <span class="hlFld-ContribAuthor ">Elissa  Afram</span>, <span class="hlFld-ContribAuthor ">Raphaëlle  Pardossi-Piquard</span>, <span class="hlFld-ContribAuthor ">Inger  Lauritzen</span>. </span><span class="cited-content_cbyCitation_article-title">Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100489. <a href="https://doi.org/10.1016/j.jbc.2021.100489" title="DOI URL">https://doi.org/10.1016/j.jbc.2021.100489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jbc.2021.100489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jbc.2021.100489%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DIs%252B%2525CE%2525B3-secretase%252Ba%252Bbeneficial%252Binactivating%252Benzyme%252Bof%252Bthe%252Btoxic%252BAPP%252BC-terminal%252Bfragment%252BC99%25253F%26aulast%3DChecler%26aufirst%3DFr%25C3%25A9d%25C3%25A9ric%26date%3D2021%26volume%3D296%26spage%3D100489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristi  Henjum</span>, <span class="hlFld-ContribAuthor ">Vibeke  Årskog</span>, <span class="hlFld-ContribAuthor ">Charlotte B.  Jendresen</span>, <span class="hlFld-ContribAuthor ">Tormod  Fladby</span>, <span class="hlFld-ContribAuthor ">Reidun  Torp</span>, <span class="hlFld-ContribAuthor ">Lars N. G.  Nilsson</span>. </span><span class="cited-content_cbyCitation_article-title">Analyzing microglial-associated Aβ in Alzheimer’s disease transgenic mice with a novel mid-domain Aβ-antibody. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-67419-2" title="DOI URL">https://doi.org/10.1038/s41598-020-67419-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-67419-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-67419-2%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAnalyzing%252Bmicroglial-associated%252BA%2525CE%2525B2%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Btransgenic%252Bmice%252Bwith%252Ba%252Bnovel%252Bmid-domain%252BA%2525CE%2525B2-antibody%26aulast%3DHenjum%26aufirst%3DKristi%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shekar  Mekala</span>, <span class="hlFld-ContribAuthor ">Grady  Nelson</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments of small molecule γ-secretase modulators for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (9)
                                     , 1003-1022. <a href="https://doi.org/10.1039/D0MD00196A" title="DOI URL">https://doi.org/10.1039/D0MD00196A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00196A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00196A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopments%252Bof%252Bsmall%252Bmolecule%252B%2525CE%2525B3-secretase%252Bmodulators%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DMekala%26aufirst%3DShekar%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D9%26spage%3D1003%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Lei</span>, <span class="hlFld-ContribAuthor ">Jia  Xu</span>, <span class="hlFld-ContribAuthor ">Dian-Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Jing-Wei  Shao</span>, <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhi-Gang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">A concise and unexpected one-pot methodology for the synthesis of pyrazinone-fused pyridones. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (18)
                                     , 2657-2663. <a href="https://doi.org/10.1039/D0QO00590H" title="DOI URL">https://doi.org/10.1039/D0QO00590H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00590H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00590H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DA%252Bconcise%252Band%252Bunexpected%252Bone-pot%252Bmethodology%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bpyrazinone-fused%252Bpyridones%26aulast%3DLei%26aufirst%3DJie%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D18%26spage%3D2657%26epage%3D2663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher  Lee</span>, <span class="hlFld-ContribAuthor ">Stephanie M.  Willerth</span>, <span class="hlFld-ContribAuthor ">Haakon B.  Nygaard</span>. </span><span class="cited-content_cbyCitation_article-title">The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer’s Disease Modeling. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neurobiology</span><span> <strong>2020,</strong> <em>192 </em>, 101804. <a href="https://doi.org/10.1016/j.pneurobio.2020.101804" title="DOI URL">https://doi.org/10.1016/j.pneurobio.2020.101804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pneurobio.2020.101804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pneurobio.2020.101804%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neurobiology%26atitle%3DThe%252BUse%252Bof%252BPatient-Derived%252BInduced%252BPluripotent%252BStem%252BCells%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BModeling%26aulast%3DLee%26aufirst%3DChristopher%26date%3D2020%26volume%3D192%26spage%3D101804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akio  Fukumori</span>, <span class="hlFld-ContribAuthor ">Lukas P.  Feilen</span>, <span class="hlFld-ContribAuthor ">Harald  Steiner</span>. </span><span class="cited-content_cbyCitation_article-title">Substrate recruitment by γ-secretase. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cell & Developmental Biology</span><span> <strong>2020,</strong> <em>105 </em>, 54-63. <a href="https://doi.org/10.1016/j.semcdb.2020.03.006" title="DOI URL">https://doi.org/10.1016/j.semcdb.2020.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcdb.2020.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcdb.2020.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cell%2520%2526%2520Developmental%2520Biology%26atitle%3DSubstrate%252Brecruitment%252Bby%252B%2525CE%2525B3-secretase%26aulast%3DFukumori%26aufirst%3DAkio%26date%3D2020%26volume%3D105%26spage%3D54%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srishti  Sharma</span>, <span class="hlFld-ContribAuthor ">Manoj Kumar  Banjare</span>, <span class="hlFld-ContribAuthor ">Namrata  Singh</span>, <span class="hlFld-ContribAuthor ">Jan  Korábečný</span>, <span class="hlFld-ContribAuthor ">Zdeněk  Fišar</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuča</span>, <span class="hlFld-ContribAuthor ">Kallol K.  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring spectroscopic insights into molecular recognition of potential anti-Alzheimer's drugs within the hydrophobic pockets of β-cycloamylose. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Liquids</span><span> <strong>2020,</strong> <em>311 </em>, 113269. <a href="https://doi.org/10.1016/j.molliq.2020.113269" title="DOI URL">https://doi.org/10.1016/j.molliq.2020.113269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molliq.2020.113269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molliq.2020.113269%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Liquids%26atitle%3DExploring%252Bspectroscopic%252Binsights%252Binto%252Bmolecular%252Brecognition%252Bof%252Bpotential%252Banti-Alzheimer%252527s%252Bdrugs%252Bwithin%252Bthe%252Bhydrophobic%252Bpockets%252Bof%252B%2525CE%2525B2-cycloamylose%26aulast%3DSharma%26aufirst%3DSrishti%26date%3D2020%26volume%3D311%26spage%3D113269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Adel  Youssef</span>, <span class="hlFld-ContribAuthor ">Siva S.  Panda</span>, <span class="hlFld-ContribAuthor ">Riham A.  El-Shiekh</span>, <span class="hlFld-ContribAuthor ">ElSayed M.  Shalaby</span>, <span class="hlFld-ContribAuthor ">Dalia R.  Aboshouk</span>, <span class="hlFld-ContribAuthor ">Walid  Fayad</span>, <span class="hlFld-ContribAuthor ">Nehmedo G.  Fawzy</span>, <span class="hlFld-ContribAuthor ">Adel S.  Girgis</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and molecular modeling studies of cholinesterase inhibitor dispiro[indoline-3,2′-pyrrolidine-3′,3′′-pyrrolidines]. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (37)
                                     , 21830-21838. <a href="https://doi.org/10.1039/D0RA03064C" title="DOI URL">https://doi.org/10.1039/D0RA03064C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA03064C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA03064C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bmolecular%252Bmodeling%252Bstudies%252Bof%252Bcholinesterase%252Binhibitor%252Bdispiro%25255Bindoline-3%25252C2%2525E2%252580%2525B2-pyrrolidine-3%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2%2525E2%252580%2525B2-pyrrolidines%25255D%26aulast%3DYoussef%26aufirst%3DM.%2BAdel%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D37%26spage%3D21830%26epage%3D21838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinyue  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Yingkai  Zhang</span>, <span class="hlFld-ContribAuthor ">Iban  Ubarretxena-Belandia</span>, <span class="hlFld-ContribAuthor ">Scott  Forth</span>, <span class="hlFld-ContribAuthor ">Raquel L.  Lieberman</span>, <span class="hlFld-ContribAuthor ">Chunyu  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Substrate–Enzyme Interactions in Intramembrane Proteolysis: γ-Secretase as the Prototype. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Neuroscience</span><span> <strong>2020,</strong> <em>13 </em><a href="https://doi.org/10.3389/fnmol.2020.00065" title="DOI URL">https://doi.org/10.3389/fnmol.2020.00065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnmol.2020.00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnmol.2020.00065%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Neuroscience%26atitle%3DSubstrate%2525E2%252580%252593Enzyme%252BInteractions%252Bin%252BIntramembrane%252BProteolysis%25253A%252B%2525CE%2525B3-Secretase%252Bas%252Bthe%252BPrototype%26aulast%3DLiu%26aufirst%3DXinyue%26date%3D2020%26date%3D2020%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md. Sahab  Uddin</span>, <span class="hlFld-ContribAuthor ">Md. Tanvir  Kabir</span>, <span class="hlFld-ContribAuthor ">Philippe  Jeandet</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>, <span class="hlFld-ContribAuthor ">Ghulam Md  Ashraf</span>, <span class="hlFld-ContribAuthor ">Asma  Perveen</span>, <span class="hlFld-ContribAuthor ">May N.  Bin-Jumah</span>, <span class="hlFld-ContribAuthor ">Shaker A.  Mousa</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Abdel-Daim</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing. </span><span class="cited-content_cbyCitation_journal-name">Oxidative Medicine and Cellular Longevity</span><span> <strong>2020,</strong> <em>2020 </em>, 1-19. <a href="https://doi.org/10.1155/2020/7039138" title="DOI URL">https://doi.org/10.1155/2020/7039138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2020/7039138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2020%2F7039138%26sid%3Dliteratum%253Aachs%26jtitle%3DOxidative%2520Medicine%2520and%2520Cellular%2520Longevity%26atitle%3DNovel%252BAnti-Alzheimer%2525E2%252580%252599s%252BTherapeutic%252BMolecules%252BTargeting%252BAmyloid%252BPrecursor%252BProtein%252BProcessing%26aulast%3DUddin%26aufirst%3DMd.%2BSahab%26date%3D2020%26volume%3D2020%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aida  Iraji</span>, <span class="hlFld-ContribAuthor ">Mahsima  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Omidreza  Firuzi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Najmeh  Edraki</span>. </span><span class="cited-content_cbyCitation_article-title">Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103649. <a href="https://doi.org/10.1016/j.bioorg.2020.103649" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103649%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Bsmall%252Bmolecule%252Btherapeutic%252Bagents%252Bfor%252BAlzheimer%252Bdisease%25253A%252BFocusing%252Bon%252BBACE1%252Band%252Bmulti-target%252Bdirected%252Bligands%26aulast%3DIraji%26aufirst%3DAida%26date%3D2020%26volume%3D97%26spage%3D103649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johannes  Trambauer</span>, <span class="hlFld-ContribAuthor ">Akio  Fukumori</span>, <span class="hlFld-ContribAuthor ">Harald  Steiner</span>. </span><span class="cited-content_cbyCitation_article-title">Pathogenic Aβ generation in familial Alzheimer’s disease: novel mechanistic insights and therapeutic implications. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Neurobiology</span><span> <strong>2020,</strong> <em>61 </em>, 73-81. <a href="https://doi.org/10.1016/j.conb.2020.01.011" title="DOI URL">https://doi.org/10.1016/j.conb.2020.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.conb.2020.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.conb.2020.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Neurobiology%26atitle%3DPathogenic%252BA%2525CE%2525B2%252Bgeneration%252Bin%252Bfamilial%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Bnovel%252Bmechanistic%252Binsights%252Band%252Btherapeutic%252Bimplications%26aulast%3DTrambauer%26aufirst%3DJohannes%26date%3D2020%26volume%3D61%26spage%3D73%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johannes  Trambauer</span>, <span class="hlFld-ContribAuthor ">Rosa María  Rodríguez Sarmiento</span>, <span class="hlFld-ContribAuthor ">Akio  Fukumori</span>, <span class="hlFld-ContribAuthor ">Regina  Feederle</span>, <span class="hlFld-ContribAuthor ">Karlheinz  Baumann</span>, <span class="hlFld-ContribAuthor ">Harald  Steiner</span>. </span><span class="cited-content_cbyCitation_article-title">Aβ43‐producing
              PS
              1
              FAD
              mutants cause altered substrate interactions and respond to γ‐secretase modulation. </span><span class="cited-content_cbyCitation_journal-name">EMBO reports</span><span> <strong>2020,</strong> <em>21 </em>
                                    (1)
                                     <a href="https://doi.org/10.15252/embr.201947996" title="DOI URL">https://doi.org/10.15252/embr.201947996</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15252/embr.201947996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15252%2Fembr.201947996%26sid%3Dliteratum%253Aachs%26jtitle%3DEMBO%2520reports%26atitle%3DA%2525CE%2525B243%2525E2%252580%252590producing%252BPS%252B1%252BFAD%252Bmutants%252Bcause%252Baltered%252Bsubstrate%252Binteractions%252Band%252Brespond%252Bto%252B%2525CE%2525B3%2525E2%252580%252590secretase%252Bmodulation%26aulast%3DTrambauer%26aufirst%3DJohannes%26date%3D2020%26date%3D2019%26volume%3D21%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jae Eun  Ahn</span>, <span class="hlFld-ContribAuthor ">Charles  Carrieri</span>, <span class="hlFld-ContribAuthor ">Fernando  Dela Cruz</span>, <span class="hlFld-ContribAuthor ">Terence  Fullerton</span>, <span class="hlFld-ContribAuthor ">Eva  Hajos‐Korcsok</span>, <span class="hlFld-ContribAuthor ">Ping  He</span>, <span class="hlFld-ContribAuthor ">Constantino  Kantaridis</span>, <span class="hlFld-ContribAuthor ">Claire  Leurent</span>, <span class="hlFld-ContribAuthor ">Richann  Liu</span>, <span class="hlFld-ContribAuthor ">Jessica  Mancuso</span>, <span class="hlFld-ContribAuthor ">Laure  Mendes da Costa</span>, <span class="hlFld-ContribAuthor ">Ruolun  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator,
              PF
              ‐06648671, on
              CSF
              Amyloid‐β Peptides in Randomized Phase I Studies. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>107 </em>
                                    (1)
                                     , 211-220. <a href="https://doi.org/10.1002/cpt.1570" title="DOI URL">https://doi.org/10.1002/cpt.1570</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpt.1570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpt.1570%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DPharmacokinetic%252Band%252BPharmacodynamic%252BEffects%252Bof%252Ba%252B%2525CE%2525B3%2525E2%252580%252590Secretase%252BModulator%25252C%252BPF%252B%2525E2%252580%25259006648671%25252C%252Bon%252BCSF%252BAmyloid%2525E2%252580%252590%2525CE%2525B2%252BPeptides%252Bin%252BRandomized%252BPhase%252BI%252BStudies%26aulast%3DAhn%26aufirst%3DJae%2BEun%26date%3D2020%26date%3D2019%26volume%3D107%26issue%3D1%26spage%3D211%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gerhard  Multhaup</span>, <span class="hlFld-ContribAuthor ">Filip  Liebsch</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-6. <a href="https://doi.org/10.1007/978-3-030-21573-6_262-1" title="DOI URL">https://doi.org/10.1007/978-3-030-21573-6_262-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-21573-6_262-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-21573-6_262-1%26sid%3Dliteratum%253Aachs%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DMulthaup%26aufirst%3DGerhard%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D6%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEncyclopedia%252Bof%252BMolecular%252BPharmacology%26aulast%3DOffermanns%26aufirst%3DStefan%26date%3D2020%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. Prakash  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmaceutical applications of organofluorine compounds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 133-214. <a href="https://doi.org/10.1016/B978-0-12-813286-9.00005-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-813286-9.00005-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-813286-9.00005-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-813286-9.00005-5%26sid%3Dliteratum%253Aachs%26atitle%3DPharmaceutical%252Bapplications%252Bof%252Borganofluorine%252Bcompounds%26aulast%3DReddy%26aufirst%3DV.%2BPrakash%26date%3D2020%26spage%3D133%26epage%3D214%26pub%3DElsevier%26atitle%3DOrganofluorine%252BChemistry%26date%3D2020%26volume%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fausta  Ciccocioppo</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Bologna</span>, <span class="hlFld-ContribAuthor ">Eva  Ercolino</span>, <span class="hlFld-ContribAuthor ">Laura  Pierdomenico</span>, <span class="hlFld-ContribAuthor ">Pasquale  Simeone</span>, <span class="hlFld-ContribAuthor ">Paola  Lanuti</span>, <span class="hlFld-ContribAuthor ">Damiana  Pieragostino</span>, <span class="hlFld-ContribAuthor ">Piero  Del Boccio</span>, <span class="hlFld-ContribAuthor ">Marco  Marchisio</span>, <span class="hlFld-ContribAuthor ">Sebastiano  Miscia</span>. </span><span class="cited-content_cbyCitation_article-title">Neurodegenerative diseases as proteinopathies-driven immune disorders. </span><span class="cited-content_cbyCitation_journal-name">Neural Regeneration Research</span><span> <strong>2020,</strong> <em>15 </em>
                                    (5)
                                     , 850. <a href="https://doi.org/10.4103/1673-5374.268971" title="DOI URL">https://doi.org/10.4103/1673-5374.268971</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/1673-5374.268971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2F1673-5374.268971%26sid%3Dliteratum%253Aachs%26jtitle%3DNeural%2520Regeneration%2520Research%26atitle%3DNeurodegenerative%252Bdiseases%252Bas%252Bproteinopathies-driven%252Bimmune%252Bdisorders%26aulast%3DCiccocioppo%26aufirst%3DFausta%26date%3D2020%26volume%3D15%26issue%3D5%26spage%3D850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth  Joe</span>, <span class="hlFld-ContribAuthor ">John M  Ringman</span>. </span><span class="cited-content_cbyCitation_article-title">Cognitive symptoms of Alzheimer’s disease: clinical management and prevention. </span><span class="cited-content_cbyCitation_journal-name">BMJ</span><span> <strong>2019,</strong> <em>25 </em>, l6217. <a href="https://doi.org/10.1136/bmj.l6217" title="DOI URL">https://doi.org/10.1136/bmj.l6217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1136/bmj.l6217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1136%2Fbmj.l6217%26sid%3Dliteratum%253Aachs%26jtitle%3DBMJ%26atitle%3DCognitive%252Bsymptoms%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Bclinical%252Bmanagement%252Band%252Bprevention%26aulast%3DJoe%26aufirst%3DElizabeth%26date%3D2019%26date%3D2019%26volume%3D25%26spage%3Dl6217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Vanda</span>, <span class="hlFld-ContribAuthor ">Paweł  Zajdel</span>, <span class="hlFld-ContribAuthor ">Miroslav  Soural</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>181 </em>, 111569. <a href="https://doi.org/10.1016/j.ejmech.2019.111569" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111569%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImidazopyridine-based%252Bselective%252Band%252Bmultifunctional%252Bligands%252Bof%252Bbiological%252Btargets%252Bassociated%252Bwith%252Bpsychiatric%252Band%252Bneurodegenerative%252Bdiseases%26aulast%3DVanda%26aufirst%3DDavid%26date%3D2019%26volume%3D181%26spage%3D111569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  de Sena M. Pinheiro</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Rodolfo  do Couto Maia</span>, <span class="hlFld-ContribAuthor ">Sreekanth  Thota</span>, <span class="hlFld-ContribAuthor ">Carlos A.M.  Fraga</span>. </span><span class="cited-content_cbyCitation_article-title">The Use of Conformational Restriction in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (19)
                                     , 1712-1733. <a href="https://doi.org/10.2174/1568026619666190712205025" title="DOI URL">https://doi.org/10.2174/1568026619666190712205025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190712205025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190712205025%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DThe%252BUse%252Bof%252BConformational%252BRestriction%252Bin%252BMedicinal%252BChemistry%26aulast%3Dde%2BSena%2BM.%2BPinheiro%26aufirst%3DPedro%26date%3D2019%26volume%3D19%26issue%3D19%26spage%3D1712%26epage%3D1733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlo  Cusulin</span>, <span class="hlFld-ContribAuthor ">Isabelle  Wells</span>, <span class="hlFld-ContribAuthor ">Solveig  Badillo</span>, <span class="hlFld-ContribAuthor ">Gonzalo Christian  Duran-Pacheco</span>, <span class="hlFld-ContribAuthor ">Karlheinz  Baumann</span>, <span class="hlFld-ContribAuthor ">Christoph  Patsch</span>. </span><span class="cited-content_cbyCitation_article-title">Gamma secretase modulators and BACE inhibitors reduce Aβ production without altering gene expression in Alzheimer's disease iPSC-derived neurons and mice. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Neuroscience</span><span> <strong>2019,</strong> <em>100 </em>, 103392. <a href="https://doi.org/10.1016/j.mcn.2019.103392" title="DOI URL">https://doi.org/10.1016/j.mcn.2019.103392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mcn.2019.103392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mcn.2019.103392%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Neuroscience%26atitle%3DGamma%252Bsecretase%252Bmodulators%252Band%252BBACE%252Binhibitors%252Breduce%252BA%2525CE%2525B2%252Bproduction%252Bwithout%252Baltering%252Bgene%252Bexpression%252Bin%252BAlzheimer%252527s%252Bdisease%252BiPSC-derived%252Bneurons%252Band%252Bmice%26aulast%3DCusulin%26aufirst%3DCarlo%26date%3D2019%26volume%3D100%26spage%3D103392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nalini  Schaduangrat</span>, <span class="hlFld-ContribAuthor ">Veda  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Saowapak  Choomwattana</span>, <span class="hlFld-ContribAuthor ">Prapimpun  Wongchitrat</span>, <span class="hlFld-ContribAuthor ">Kamonrat  Phopin</span>, <span class="hlFld-ContribAuthor ">Wilasinee  Suwanjang</span>, <span class="hlFld-ContribAuthor ">Aijaz Ahmad  Malik</span>, <span class="hlFld-ContribAuthor ">Bruno  Vincent</span>, <span class="hlFld-ContribAuthor ">Chanin  Nantasenamat</span>. </span><span class="cited-content_cbyCitation_article-title">Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (5)
                                     , 1730-1778. <a href="https://doi.org/10.1002/med.21563" title="DOI URL">https://doi.org/10.1002/med.21563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21563%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMultidisciplinary%252Bapproaches%252Bfor%252Btargeting%252Bthe%252Bsecretase%252Bprotein%252Bfamily%252Bas%252Ba%252Btherapeutic%252Broute%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DSchaduangrat%26aufirst%3DNalini%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D5%26spage%3D1730%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David S.  Reynolds</span>. </span><span class="cited-content_cbyCitation_article-title">A short perspective on the long road to effective treatments for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2019,</strong> <em>176 </em>
                                    (18)
                                     , 3636-3648. <a href="https://doi.org/10.1111/bph.14581" title="DOI URL">https://doi.org/10.1111/bph.14581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14581%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DA%252Bshort%252Bperspective%252Bon%252Bthe%252Blong%252Broad%252Bto%252Beffective%252Btreatments%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DReynolds%26aufirst%3DDavid%2BS.%26date%3D2019%26date%3D2019%26volume%3D176%26issue%3D18%26spage%3D3636%26epage%3D3648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilherme Martins  Silva</span>, <span class="hlFld-ContribAuthor ">Mariana Pegrucci  Barcelos</span>, <span class="hlFld-ContribAuthor ">João Gabriel Curtolo  Poiani</span>, <span class="hlFld-ContribAuthor ">Lorane Izabel da Silva  Hage‐Melim</span>, <span class="hlFld-ContribAuthor ">Carlos Henrique Tomich de Paula  da Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (16)
                                     , 1467-1483. <a href="https://doi.org/10.1002/cmdc.201900299" title="DOI URL">https://doi.org/10.1002/cmdc.201900299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900299%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAllosteric%252BModulators%252Bof%252BPotential%252BTargets%252BRelated%252Bto%252BAlzheimer%252527s%252BDisease%25253A%252Ba%252BReview%26aulast%3DSilva%26aufirst%3DGuilherme%2BMartins%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D16%26spage%3D1467%26epage%3D1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel A.  Castro</span>, <span class="hlFld-ContribAuthor ">Arina  Hadziselimovic</span>, <span class="hlFld-ContribAuthor ">Charles R.  Sanders</span>. </span><span class="cited-content_cbyCitation_article-title">The vexing complexity of the amyloidogenic pathway. </span><span class="cited-content_cbyCitation_journal-name">Protein Science</span><span> <strong>2019,</strong> <em>24 </em><a href="https://doi.org/10.1002/pro.3606" title="DOI URL">https://doi.org/10.1002/pro.3606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pro.3606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpro.3606%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Science%26atitle%3DThe%252Bvexing%252Bcomplexity%252Bof%252Bthe%252Bamyloidogenic%252Bpathway%26aulast%3DCastro%26aufirst%3DManuel%2BA.%26date%3D2019%26date%3D2019%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosa Anna  Vacca</span>, <span class="hlFld-ContribAuthor ">Sweta  Bawari</span>, <span class="hlFld-ContribAuthor ">Daniela  Valenti</span>, <span class="hlFld-ContribAuthor ">Devesh  Tewari</span>, <span class="hlFld-ContribAuthor ">Seyed Fazel  Nabavi</span>, <span class="hlFld-ContribAuthor ">Samira  Shirooie</span>, <span class="hlFld-ContribAuthor ">Archana N.  Sah</span>, <span class="hlFld-ContribAuthor ">Mariateresa  Volpicella</span>, <span class="hlFld-ContribAuthor ">Nady  Braidy</span>, <span class="hlFld-ContribAuthor ">Seyed Mohammad  Nabavi</span>. </span><span class="cited-content_cbyCitation_article-title">Down syndrome: Neurobiological alterations and therapeutic targets. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience & Biobehavioral Reviews</span><span> <strong>2019,</strong> <em>98 </em>, 234-255. <a href="https://doi.org/10.1016/j.neubiorev.2019.01.001" title="DOI URL">https://doi.org/10.1016/j.neubiorev.2019.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neubiorev.2019.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neubiorev.2019.01.001%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520%2526%2520Biobehavioral%2520Reviews%26atitle%3DDown%252Bsyndrome%25253A%252BNeurobiological%252Balterations%252Band%252Btherapeutic%252Btargets%26aulast%3DVacca%26aufirst%3DRosa%2BAnna%26date%3D2019%26volume%3D98%26spage%3D234%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miguel  Maia</span>, <span class="hlFld-ContribAuthor ">Emília  Sousa</span>. </span><span class="cited-content_cbyCitation_article-title">BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2019,</strong> <em>12 </em>
                                    (1)
                                     , 41. <a href="https://doi.org/10.3390/ph12010041" title="DOI URL">https://doi.org/10.3390/ph12010041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph12010041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph12010041%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DBACE-1%252Band%252B%2525CE%2525B3-Secretase%252Bas%252BTherapeutic%252BTargets%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DMaia%26aufirst%3DMiguel%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D1%26spage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kejing  Lao</span>, <span class="hlFld-ContribAuthor ">Naichun  Ji</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenwei  Qiao</span>, <span class="hlFld-ContribAuthor ">Zhishu  Tang</span>, <span class="hlFld-ContribAuthor ">Xingchun  Gou</span>. </span><span class="cited-content_cbyCitation_article-title">Drug development for Alzheimer’s disease: review. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Targeting</span><span> <strong>2019,</strong> <em>27 </em>
                                    (2)
                                     , 164-173. <a href="https://doi.org/10.1080/1061186X.2018.1474361" title="DOI URL">https://doi.org/10.1080/1061186X.2018.1474361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1061186X.2018.1474361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1061186X.2018.1474361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Targeting%26atitle%3DDrug%252Bdevelopment%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Breview%26aulast%3DLao%26aufirst%3DKejing%26date%3D2019%26date%3D2018%26volume%3D27%26issue%3D2%26spage%3D164%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noralyn Basco  Mañucat-Tan</span>, <span class="hlFld-ContribAuthor ">Khalil  Saadipour</span>, <span class="hlFld-ContribAuthor ">Yan-Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Larisa  Bobrovskaya</span>, <span class="hlFld-ContribAuthor ">Xin-Fu  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurobiology</span><span> <strong>2019,</strong> <em>56 </em>
                                    (2)
                                     , 812-830. <a href="https://doi.org/10.1007/s12035-018-1106-9" title="DOI URL">https://doi.org/10.1007/s12035-018-1106-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12035-018-1106-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12035-018-1106-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurobiology%26atitle%3DCellular%252BTrafficking%252Bof%252BAmyloid%252BPrecursor%252BProtein%252Bin%252BAmyloidogenesis%252BPhysiological%252Band%252BPathological%252BSignificance%26aulast%3DMa%25C3%25B1ucat-Tan%26aufirst%3DNoralyn%2BBasco%26date%3D2019%26date%3D2018%26volume%3D56%26issue%3D2%26spage%3D812%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael S.  Wolfe</span>. </span><span class="cited-content_cbyCitation_article-title">Dysfunctional γ-Secretase in Familial Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Neurochemical Research</span><span> <strong>2019,</strong> <em>44 </em>
                                    (1)
                                     , 5-11. <a href="https://doi.org/10.1007/s11064-018-2511-1" title="DOI URL">https://doi.org/10.1007/s11064-018-2511-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11064-018-2511-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11064-018-2511-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemical%2520Research%26atitle%3DDysfunctional%252B%2525CE%2525B3-Secretase%252Bin%252BFamilial%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWolfe%26aufirst%3DMichael%2BS.%26date%3D2019%26date%3D2018%26volume%3D44%26issue%3D1%26spage%3D5%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ram W.  Sabnis</span>. </span><span class="cited-content_cbyCitation_article-title">Patents on Natural Products for Diagnosing/Preventing/Treating Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 85-141. <a href="https://doi.org/10.1016/B978-0-444-64183-0.00003-8" title="DOI URL">https://doi.org/10.1016/B978-0-444-64183-0.00003-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-64183-0.00003-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-64183-0.00003-8%26sid%3Dliteratum%253Aachs%26atitle%3DPatents%252Bon%252BNatural%252BProducts%252Bfor%252BDiagnosing%25252FPreventing%25252FTreating%252BAlzheimer%252527s%252BDisease%26aulast%3DSabnis%26aufirst%3DRam%2BW.%26date%3D2019%26spage%3D85%26epage%3D141%26pub%3DElsevier%26date%3D2019%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Z.  Kounnas</span>, <span class="hlFld-ContribAuthor ">Murat S.  Durakoglugil</span>, <span class="hlFld-ContribAuthor ">Joachim  Herz</span>, <span class="hlFld-ContribAuthor ">William T.  Comer</span>. </span><span class="cited-content_cbyCitation_article-title">NGP 555, a γ‐secretase modulator, shows a beneficial shift in the ratio of amyloid biomarkers in human cerebrospinal fluid at safe doses. </span><span class="cited-content_cbyCitation_journal-name">Alzheimer's & Dementia: Translational Research & Clinical Interventions</span><span> <strong>2019,</strong> <em>5 </em>
                                    (1)
                                     , 458-467. <a href="https://doi.org/10.1016/j.trci.2019.06.006" title="DOI URL">https://doi.org/10.1016/j.trci.2019.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trci.2019.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trci.2019.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520%2526%2520Dementia%253A%2520Translational%2520Research%2520%2526%2520Clinical%2520Interventions%26atitle%3DNGP%252B555%25252C%252Ba%252B%2525CE%2525B3%2525E2%252580%252590secretase%252Bmodulator%25252C%252Bshows%252Ba%252Bbeneficial%252Bshift%252Bin%252Bthe%252Bratio%252Bof%252Bamyloid%252Bbiomarkers%252Bin%252Bhuman%252Bcerebrospinal%252Bfluid%252Bat%252Bsafe%252Bdoses%26aulast%3DKounnas%26aufirst%3DMaria%2BZ.%26date%3D2019%26date%3D2019%26volume%3D5%26issue%3D1%26spage%3D458%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evgeniy  Salnikov</span>, <span class="hlFld-ContribAuthor ">Binia  Drung</span>, <span class="hlFld-ContribAuthor ">Gabin  Fabre</span>, <span class="hlFld-ContribAuthor ">Anna  Itkin</span>, <span class="hlFld-ContribAuthor ">Michal  Otyepka</span>, <span class="hlFld-ContribAuthor ">Norbert A.  Dencher</span>, <span class="hlFld-ContribAuthor ">Boris  Schmidt</span>, <span class="hlFld-ContribAuthor ">Thomas  Hauß</span>, <span class="hlFld-ContribAuthor ">Patrick  Trouillas</span>, <span class="hlFld-ContribAuthor ">Burkhard  Bechinger</span>. </span><span class="cited-content_cbyCitation_article-title">Lipid bilayer position and orientation of novel carprofens, modulators of γ-secretase in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Biomembranes</span><span> <strong>2018,</strong> <em>1860 </em>
                                    (11)
                                     , 2224-2233. <a href="https://doi.org/10.1016/j.bbamem.2018.09.003" title="DOI URL">https://doi.org/10.1016/j.bbamem.2018.09.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamem.2018.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamem.2018.09.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Biomembranes%26atitle%3DLipid%252Bbilayer%252Bposition%252Band%252Borientation%252Bof%252Bnovel%252Bcarprofens%25252C%252Bmodulators%252Bof%252B%2525CE%2525B3-secretase%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DSalnikov%26aufirst%3DEvgeniy%26date%3D2018%26volume%3D1860%26issue%3D11%26spage%3D2224%26epage%3D2233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepti  Goyal</span>, <span class="hlFld-ContribAuthor ">Amandeep  Kaur</span>, <span class="hlFld-ContribAuthor ">Bhupesh  Goyal</span>. </span><span class="cited-content_cbyCitation_article-title">Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (13)
                                     , 1275-1299. <a href="https://doi.org/10.1002/cmdc.201800156" title="DOI URL">https://doi.org/10.1002/cmdc.201800156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800156%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DBenzofuran%252Band%252BIndole%25253A%252BPromising%252BScaffolds%252Bfor%252BDrug%252BDevelopment%252Bin%252BAlzheimer%252527s%252BDisease%26aulast%3DGoyal%26aufirst%3DDeepti%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D13%26spage%3D1275%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Gerlach</span>, <span class="hlFld-ContribAuthor ">Scott  Hobson</span>, <span class="hlFld-ContribAuthor ">Christian  Eickmeier</span>, <span class="hlFld-ContribAuthor ">Ulrike  Groß</span>, <span class="hlFld-ContribAuthor ">Clemens  Braun</span>, <span class="hlFld-ContribAuthor ">Peter  Sieger</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Stefan  Hoerer</span>, <span class="hlFld-ContribAuthor ">Niklas  Heine</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3227-3241. <a href="https://doi.org/10.1016/j.bmc.2018.04.053" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Btetrahydroindazoles%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bpotent%252Band%252Bin%252Bvivo%252Befficacious%252Bgamma%252Bsecretase%252Bmodulators%26aulast%3DGerlach%26aufirst%3DKai%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3227%26epage%3D3241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Devendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Ankit  Ganeshpurkar</span>, <span class="hlFld-ContribAuthor ">Dileep  Kumar</span>, <span class="hlFld-ContribAuthor ">Gyan  Modi</span>, <span class="hlFld-ContribAuthor ">Sanjeev Kumar  Gupta</span>, <span class="hlFld-ContribAuthor ">Sushil Kumar  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>148 </em>, 436-452. <a href="https://doi.org/10.1016/j.ejmech.2018.02.035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.02.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.02.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSecretase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%25253A%252BLong%252Broad%252Bahead%26aulast%3DKumar%26aufirst%3DDevendra%26date%3D2018%26volume%3D148%26spage%3D436%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ean-Jeong  Seo</span>, <span class="hlFld-ContribAuthor ">Nicolas  Fischer</span>, <span class="hlFld-ContribAuthor ">Thomas  Efferth</span>. </span><span class="cited-content_cbyCitation_article-title">Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2018,</strong> <em>129 </em>, 262-273. <a href="https://doi.org/10.1016/j.phrs.2017.11.030" title="DOI URL">https://doi.org/10.1016/j.phrs.2017.11.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2017.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2017.11.030%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DPhytochemicals%252Bas%252Binhibitors%252Bof%252BNF-%2525CE%2525BAB%252Bfor%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSeo%26aufirst%3DEan-Jeong%26date%3D2018%26volume%3D129%26spage%3D262%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akio  Fukumori</span>, <span class="hlFld-ContribAuthor ">Johannes  Trambauer</span>, <span class="hlFld-ContribAuthor ">Lukas P.  Feilen</span>, <span class="hlFld-ContribAuthor ">Harald  Steiner</span>. </span><span class="cited-content_cbyCitation_article-title">Identifizierung von Substratbindestellen in der γ-Sekretase. </span><span class="cited-content_cbyCitation_journal-name">BIOspektrum</span><span> <strong>2018,</strong> <em>24 </em>
                                    (1)
                                     , 34-36. <a href="https://doi.org/10.1007/s12268-018-0888-7" title="DOI URL">https://doi.org/10.1007/s12268-018-0888-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12268-018-0888-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12268-018-0888-7%26sid%3Dliteratum%253Aachs%26jtitle%3DBIOspektrum%26atitle%3DIdentifizierung%252Bvon%252BSubstratbindestellen%252Bin%252Bder%252B%2525CE%2525B3-Sekretase%26aulast%3DFukumori%26aufirst%3DAkio%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D1%26spage%3D34%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna Marta  Zoltowska</span>, <span class="hlFld-ContribAuthor ">Masato  Maesako</span>, <span class="hlFld-ContribAuthor ">Iryna  Lushnikova</span>, <span class="hlFld-ContribAuthor ">Shuko  Takeda</span>, <span class="hlFld-ContribAuthor ">Laura J.  Keller</span>, <span class="hlFld-ContribAuthor ">Galina  Skibo</span>, <span class="hlFld-ContribAuthor ">Bradley T.  Hyman</span>, <span class="hlFld-ContribAuthor ">Oksana  Berezovska</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamic presenilin 1 and synaptotagmin 1 interaction modulates exocytosis and amyloid β production. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurodegeneration</span><span> <strong>2017,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13024-017-0159-y" title="DOI URL">https://doi.org/10.1186/s13024-017-0159-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13024-017-0159-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13024-017-0159-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurodegeneration%26atitle%3DDynamic%252Bpresenilin%252B1%252Band%252Bsynaptotagmin%252B1%252Binteraction%252Bmodulates%252Bexocytosis%252Band%252Bamyloid%252B%2525CE%2525B2%252Bproduction%26aulast%3DZoltowska%26aufirst%3DKatarzyna%2BMarta%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan S.  Robertson</span>, <span class="hlFld-ContribAuthor ">Lawrence G.  Iben</span>, <span class="hlFld-ContribAuthor ">Cong  Wei</span>, <span class="hlFld-ContribAuthor ">Jere E.  Meredith</span>, <span class="hlFld-ContribAuthor ">Dieter M.  Drexler</span>, <span class="hlFld-ContribAuthor ">Martyn  Banks</span>, <span class="hlFld-ContribAuthor ">Gregory D.  Vite</span>, <span class="hlFld-ContribAuthor ">Richard E.  Olson</span>, <span class="hlFld-ContribAuthor ">Lorin A.  Thompson</span>, <span class="hlFld-ContribAuthor ">Charles F.  Albright</span>, <span class="hlFld-ContribAuthor ">Michael K.  Ahlijanian</span>, <span class="hlFld-ContribAuthor ">Jeremy H.  Toyn</span>. </span><span class="cited-content_cbyCitation_article-title">Synergistic inhibition of Aβ production by combinations of γ-secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2017,</strong> <em>812 </em>, 104-112. <a href="https://doi.org/10.1016/j.ejphar.2017.07.019" title="DOI URL">https://doi.org/10.1016/j.ejphar.2017.07.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2017.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2017.07.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DSynergistic%252Binhibition%252Bof%252BA%2525CE%2525B2%252Bproduction%252Bby%252Bcombinations%252Bof%252B%2525CE%2525B3-secretase%252Bmodulators%26aulast%3DRobertson%26aufirst%3DAlan%2BS.%26date%3D2017%26volume%3D812%26spage%3D104%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nguyen Quoc  Thai</span>, <span class="hlFld-ContribAuthor ">Hoang Linh  Nguyen</span>, <span class="hlFld-ContribAuthor ">Huynh Quang  Linh</span>, <span class="hlFld-ContribAuthor ">Mai Suan  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Protocol for fast screening of multi-target drug candidates: Application to Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2017,</strong> <em>77 </em>, 121-129. <a href="https://doi.org/10.1016/j.jmgm.2017.08.002" title="DOI URL">https://doi.org/10.1016/j.jmgm.2017.08.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2017.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2017.08.002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DProtocol%252Bfor%252Bfast%252Bscreening%252Bof%252Bmulti-target%252Bdrug%252Bcandidates%25253A%252BApplication%252Bto%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DThai%26aufirst%3DNguyen%2BQuoc%26date%3D2017%26volume%3D77%26spage%3D121%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayesha  Khan</span>, <span class="hlFld-ContribAuthor ">Anne  Corbett</span>, <span class="hlFld-ContribAuthor ">Clive  Ballard</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging amyloid and tau targeting treatments for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Neurotherapeutics</span><span> <strong>2017,</strong> <em>17 </em>
                                    (7)
                                     , 697-711. <a href="https://doi.org/10.1080/14737175.2017.1326819" title="DOI URL">https://doi.org/10.1080/14737175.2017.1326819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737175.2017.1326819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737175.2017.1326819%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Neurotherapeutics%26atitle%3DEmerging%252Bamyloid%252Band%252Btau%252Btargeting%252Btreatments%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DKhan%26aufirst%3DAyesha%26date%3D2017%26date%3D2017%26volume%3D17%26issue%3D7%26spage%3D697%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo  Aguayo-Ortiz</span>, <span class="hlFld-ContribAuthor ">Laura  Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of Amyloid-β Peptides by γ-Secretase. </span><span class="cited-content_cbyCitation_journal-name">Israel Journal of Chemistry</span><span> <strong>2017,</strong> <em>57 </em>
                                    (7-8)
                                     , 574-585. <a href="https://doi.org/10.1002/ijch.201600073" title="DOI URL">https://doi.org/10.1002/ijch.201600073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijch.201600073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijch.201600073%26sid%3Dliteratum%253Aachs%26jtitle%3DIsrael%2520Journal%2520of%2520Chemistry%26atitle%3DGeneration%252Bof%252BAmyloid-%2525CE%2525B2%252BPeptides%252Bby%252B%2525CE%2525B3-Secretase%26aulast%3DAguayo-Ortiz%26aufirst%3DRodrigo%26date%3D2017%26date%3D2016%26volume%3D57%26issue%3D7-8%26spage%3D574%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven H. L.  Verhelst</span>. </span><span class="cited-content_cbyCitation_article-title">Intramembrane proteases as drug targets. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2017,</strong> <em>284 </em>
                                    (10)
                                     , 1489-1502. <a href="https://doi.org/10.1111/febs.13979" title="DOI URL">https://doi.org/10.1111/febs.13979</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.13979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.13979%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DIntramembrane%252Bproteases%252Bas%252Bdrug%252Btargets%26aulast%3DVerhelst%26aufirst%3DSteven%2BH.%2BL.%26date%3D2017%26date%3D2017%26volume%3D284%26issue%3D10%26spage%3D1489%26epage%3D1502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dieter  Langosch</span>, <span class="hlFld-ContribAuthor ">Harald  Steiner</span>. </span><span class="cited-content_cbyCitation_article-title">Substrate processing in intramembrane proteolysis by γ-secretase – the role of protein dynamics. </span><span class="cited-content_cbyCitation_journal-name">Biological Chemistry</span><span> <strong>2017,</strong> <em>398 </em>
                                    (4)
                                     , 441-453. <a href="https://doi.org/10.1515/hsz-2016-0269" title="DOI URL">https://doi.org/10.1515/hsz-2016-0269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hsz-2016-0269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhsz-2016-0269%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Chemistry%26atitle%3DSubstrate%252Bprocessing%252Bin%252Bintramembrane%252Bproteolysis%252Bby%252B%2525CE%2525B3-secretase%252B%2525E2%252580%252593%252Bthe%252Brole%252Bof%252Bprotein%252Bdynamics%26aulast%3DLangosch%26aufirst%3DDieter%26date%3D2017%26volume%3D398%26issue%3D4%26spage%3D441%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Hall</span>, <span class="hlFld-ContribAuthor ">A.I.  Velter</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting γ-Secretase for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 280-325. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13789-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13789-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13789-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13789-8%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252B%2525CE%2525B3-Secretase%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHall%26aufirst%3DA.%26date%3D2017%26spage%3D280%26epage%3D325%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Trambauer</span>, <span class="hlFld-ContribAuthor ">A.  Fukumori</span>, <span class="hlFld-ContribAuthor ">B.  Kretner</span>, <span class="hlFld-ContribAuthor ">H.  Steiner</span>. </span><span class="cited-content_cbyCitation_article-title">Analyzing Amyloid-β Peptide Modulation Profiles and Binding Sites of γ-Secretase Modulators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 157-183. <a href="https://doi.org/10.1016/bs.mie.2016.10.013" title="DOI URL">https://doi.org/10.1016/bs.mie.2016.10.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.mie.2016.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.mie.2016.10.013%26sid%3Dliteratum%253Aachs%26atitle%3DAnalyzing%252BAmyloid-%2525CE%2525B2%252BPeptide%252BModulation%252BProfiles%252Band%252BBinding%252BSites%252Bof%252B%2525CE%2525B3-Secretase%252BModulators%26aulast%3DTrambauer%26aufirst%3DJ.%26date%3D2017%26spage%3D157%26epage%3D183%26pub%3DElsevier%26atitle%3DEnzymology%252Bat%252Bthe%252BMembrane%252BInterface%25253A%252BIntramembrane%252BProteases%26date%3D2017%26volume%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Z.  Kounnas</span>, <span class="hlFld-ContribAuthor ">Courtney  Lane-Donovan</span>, <span class="hlFld-ContribAuthor ">Dan W.  Nowakowski</span>, <span class="hlFld-ContribAuthor ">Joachim  Herz</span>, <span class="hlFld-ContribAuthor ">William T.  Comer</span>. </span><span class="cited-content_cbyCitation_article-title">NGP 555, a γ-secretase modulator, lowers the amyloid biomarker, Aβ
              42,
              in cerebrospinal fluid while preventing Alzheimer's disease cognitive decline in rodents. </span><span class="cited-content_cbyCitation_journal-name">Alzheimer's & Dementia: Translational Research & Clinical Interventions</span><span> <strong>2017,</strong> <em>3 </em>
                                    (1)
                                     , 65-73. <a href="https://doi.org/10.1016/j.trci.2016.09.003" title="DOI URL">https://doi.org/10.1016/j.trci.2016.09.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trci.2016.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trci.2016.09.003%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520%2526%2520Dementia%253A%2520Translational%2520Research%2520%2526%2520Clinical%2520Interventions%26atitle%3DNGP%252B555%25252C%252Ba%252B%2525CE%2525B3-secretase%252Bmodulator%25252C%252Blowers%252Bthe%252Bamyloid%252Bbiomarker%25252C%252BA%2525CE%2525B2%252B42%25252C%252Bin%252Bcerebrospinal%252Bfluid%252Bwhile%252Bpreventing%252BAlzheimer%252527s%252Bdisease%252Bcognitive%252Bdecline%252Bin%252Brodents%26aulast%3DKounnas%26aufirst%3DMaria%2BZ.%26date%3D2017%26date%3D2016%26volume%3D3%26issue%3D1%26spage%3D65%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Myung-Hoon  Han</span>, <span class="hlFld-ContribAuthor ">Eun-Hye  Lee</span>, <span class="hlFld-ContribAuthor ">Seong-Ho  Koh</span>. </span><span class="cited-content_cbyCitation_article-title">Current Opinion on the Role of Neurogenesis in the Therapeutic Strategies for Alzheimer Disease, Parkinson Disease, and Ischemic Stroke; Considering Neuronal Voiding Function. </span><span class="cited-content_cbyCitation_journal-name">International Neurourology Journal</span><span> <strong>2016,</strong> <em>20 </em>
                                    (4)
                                     , 276-287. <a href="https://doi.org/10.5213/inj.1632776.388" title="DOI URL">https://doi.org/10.5213/inj.1632776.388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5213/inj.1632776.388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5213%2Finj.1632776.388%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Neurourology%2520Journal%26atitle%3DCurrent%252BOpinion%252Bon%252Bthe%252BRole%252Bof%252BNeurogenesis%252Bin%252Bthe%252BTherapeutic%252BStrategies%252Bfor%252BAlzheimer%252BDisease%25252C%252BParkinson%252BDisease%25252C%252Band%252BIschemic%252BStroke%25253B%252BConsidering%252BNeuronal%252BVoiding%252BFunction%26aulast%3DHan%26aufirst%3DMyung-Hoon%26date%3D2016%26volume%3D20%26issue%3D4%26spage%3D276%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-François  Blain</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Bursavich</span>, <span class="hlFld-ContribAuthor ">Emily A.  Freeman</span>, <span class="hlFld-ContribAuthor ">Lori A.  Hrdlicka</span>, <span class="hlFld-ContribAuthor ">Hilliary E.  Hodgdon</span>, <span class="hlFld-ContribAuthor ">Ting  Chen</span>, <span class="hlFld-ContribAuthor ">Don E.  Costa</span>, <span class="hlFld-ContribAuthor ">Bryce A.  Harrison</span>, <span class="hlFld-ContribAuthor ">Sudarshan  Kapadnis</span>, <span class="hlFld-ContribAuthor ">Deirdre A.  Murphy</span>, <span class="hlFld-ContribAuthor ">Scott  Nolan</span>, <span class="hlFld-ContribAuthor ">Zhiming  Tu</span>, <span class="hlFld-ContribAuthor ">Cuyue  Tang</span>, <span class="hlFld-ContribAuthor ">Duane A.  Burnett</span>, <span class="hlFld-ContribAuthor ">Holger  Patzke</span>, <span class="hlFld-ContribAuthor ">Gerhard  Koenig</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Alzheimer's Research & Therapy</span><span> <strong>2016,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13195-016-0199-5" title="DOI URL">https://doi.org/10.1186/s13195-016-0199-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13195-016-0199-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13195-016-0199-5%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520Research%2520%2526%2520Therapy%26atitle%3DCharacterization%252Bof%252BFRM-36143%252Bas%252Ba%252Bnew%252B%2525CE%2525B3-secretase%252Bmodulator%252Bfor%252Bthe%252Bpotential%252Btreatment%252Bof%252Bfamilial%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DBlain%26aufirst%3DJean-Fran%25C3%25A7ois%26date%3D2016%26date%3D2016%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Processing of APP. (a) In step 1, APP is processed by BACE1, which releases the soluble APPβ, leaving C99 (Aβ plus AICD) in the membrane. (b) In step 2, GS releases AICD by cleaving C99 at the ε cleavage site (endopeptidase activity). This is followed by ζ and γ cleavages (carboxypeptidase activities), which further process the Aβ substrate into peptides of different lengths (see <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> for details).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Stepwise cleavage model for Aβ generation and potential effect of PS FAD mutations and GSMs. (a) In a normal situation, C99 is sequentially cleaved by GS ε, ζ, and γ cleavages. The first cleavage cycle (ε) between amino acids 50 and 49 or 49 and 48 determines the Aβ peptide production line (49 → 46 → 43 → 40 or 48 → 45 → 42). (b) Many PS mutations affect the fourth cleavage cycle of the complex, leading to the increased Aβ42:Aβ40 ratio observed in FAD. (c) GSMs increase the processivity of the complex, leading to increased production of the shorter, non-amyloidogenic peptides Aβ37 and Aβ38. The thickness of the arrows depicts the cleavage efficiency.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. GSIs: semagacestat and avagacestat.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Early NSAID GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0007.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. NSAID-based GSMs investigated in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0008.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Eisai GSMs investigated in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0009.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Schering-Plough oxadiazoline GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0010.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Schering-Plough oxadiazine GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0011.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Schering-Plough oxadiazine and oxadiazepine GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0012.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Janssen aniline GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0013.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Other Janssen aniline GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0014.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Optimized Janssen aniline GSM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0015.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Boehringer Ingelheim pyrimidine GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0016.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. FORUM N-substituted pyrimidomorpholine GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0017.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. FORUM N-substituted pyrimidomorpholines with increased sp<sup>3</sup> character.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0018.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. FORUM C-substituted pyrimidomorpholines with increased sp<sup>3</sup> character.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0019.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Bristol-Meyers Squibb aniline GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0020.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Bristol-Meyers Squibb tricyclic thiazole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0021.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Bristol-Meyers Squibb tricyclic pyrazole and imidazole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0022.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Bristol-Meyers Squibb tricyclic pyridine GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0023.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Amgen aniline GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0024.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Torrey Pines early GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0025.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Improvements to the early thiazole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0026.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Merck triazole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0027.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Merck triazole GSMs with improved drug metabolism and pharmacokinetic properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0028.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Takeda piperazine GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0029.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Dainippon Sumitomo piperidine amide GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0030.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Janssen triazole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0031.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Janssen triazole GSMs with improved properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0032.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Janssen cyanoindole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0033.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Takeda oxazole GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0034.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Pfizer amide GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0035.jpeg" id="rightTab-gr33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Pfizer pyridopyrazine-1,6-dione GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0036.jpeg" id="rightTab-gr34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Pfizer pyridopyrazine-1,6-dione GSMs with conformational restrictions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig35" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0037.jpeg" id="rightTab-gr35" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. Janssen pyridopyrazine-1,6-dione GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig36" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0038.jpeg" id="rightTab-gr36" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. Satori natural product GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig37" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/medium/jm-2015-01960f_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0039.jpeg" id="rightTab-gr37" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 37. University of Florida steroid GSMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.5b01960/20160819/images/large/jm-2015-01960f_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01960&amp;id=fig37"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i16">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13347" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13347" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 140 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><a href="http://www.alz.org/facts/overview.asp" class="extLink">http://www.alz.org/facts/overview.asp</a> (accessed Dec 1, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.alz.org%2Ffacts%2Foverview.asp+%28accessed+Dec+1%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morstorf, T.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=K.+Zhongauthor=T.+Morstorf&title=Alzheimer%E2%80%99s+disease+drug-development+pipeline%3A+Few+candidates%2C+frequent+failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eZXTQ1DxCUoarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DZhong%26aufirst%3DK.%26aulast%3DMorstorf%26aufirst%3DT.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug-development%2520pipeline%253A%2520Few%2520candidates%252C%2520frequent%2520failures%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chartier-Harlin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mant, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roques, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pericak-Vance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roses, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span> </span><span class="NLM_article-title">Segregation of a missense mutation in the amyloid precursor protein gene with familial alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span><span class="refDoi"> DOI: 10.1038/349704a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F349704a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1671712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFyhu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=1991&pages=704-706&author=A.+Goateauthor=M.+C.+Chartier-Harlinauthor=M.+Mullanauthor=J.+Brownauthor=F.+Crawfordauthor=L.+Fidaniauthor=L.+Giuffraauthor=A.+Haynesauthor=N.+Irvingauthor=L.+Jamesauthor=R.+Mantauthor=P.+Newtonauthor=K.+Rookeauthor=P.+Roquesauthor=C.+Talbotauthor=M.+Pericak-Vanceauthor=A.+Rosesauthor=R.+Williamsonauthor=M.+Rossorauthor=M.+Owenauthor=J.+Hardy&title=Segregation+of+a+missense+mutation+in+the+amyloid+precursor+protein+gene+with+familial+alzheimer%E2%80%99s+disease&doi=10.1038%2F349704a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease</span></div><div class="casAuthors">Goate, Alison; Chartier-Harlin, Marie Christine; Mullan, Mike; Brown, Jeremy; Crawford, Fiona; Fidani, Liana; Giuffra, Luis; Haynes, Andrew; Irving, Nick; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">6311</span>),
    <span class="NLM_cas:pages">704-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">To avoid the problems that heterogeneity poses for genetic anal., the authors examd. the cosegregation of Alzheimer's disease (AD) and markers along the long arm of chromosome 21 in a single family with AD confirmed by autopsy.  In this kindred, which shows linkage to chromosome 21 markers, there is a point mutation in the APP gene.  This mutation causes an amino-acid substitution (Val→Ile) close to the carboxy terminus of the β-amyloid peptide.  Screening other cases of familial AD revealed a second unrelated family in which this variant occurs.  This suggests that some cases of AD could be caused by mutations in the APP gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv7EvQ1MkXVbVg90H21EOLACvtfcHk0lhSdQzFfwBG3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFyhu7k%253D&md5=5b27eb7cea61e5121c8d9f3d27fc2c0b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F349704a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F349704a0%26sid%3Dliteratum%253Aachs%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DChartier-Harlin%26aufirst%3DM.%2BC.%26aulast%3DMullan%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DCrawford%26aufirst%3DF.%26aulast%3DFidani%26aufirst%3DL.%26aulast%3DGiuffra%26aufirst%3DL.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DIrving%26aufirst%3DN.%26aulast%3DJames%26aufirst%3DL.%26aulast%3DMant%26aufirst%3DR.%26aulast%3DNewton%26aufirst%3DP.%26aulast%3DRooke%26aufirst%3DK.%26aulast%3DRoques%26aufirst%3DP.%26aulast%3DTalbot%26aufirst%3DC.%26aulast%3DPericak-Vance%26aufirst%3DM.%26aulast%3DRoses%26aufirst%3DA.%26aulast%3DWilliamson%26aufirst%3DR.%26aulast%3DRossor%26aufirst%3DM.%26aulast%3DOwen%26aufirst%3DM.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DSegregation%2520of%2520a%2520missense%2520mutation%2520in%2520the%2520amyloid%2520precursor%2520protein%2520gene%2520with%2520familial%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1991%26volume%3D349%26spage%3D704%26epage%3D706%26doi%3D10.1038%2F349704a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Amyloid deposition as the central event in the aetiology of alzheimer’s disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1016/0165-6147(91)90609-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2F0165-6147%2891%2990609-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1763432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383-388&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+deposition+as+the+central+event+in+the+aetiology+of+alzheimer%E2%80%99s+disease&doi=10.1016%2F0165-6147%2891%2990609-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid deposition as the central event in the etiology of Alzheimer's disease</span></div><div class="casAuthors">Hardy, John; Allsop, David</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">383-8</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A review with 50 refs. of pathol. and etiol. of Alzheimer's disease; the function of β-amyloid precursor protein and the mechanism of formation of cerebrovascular amyloid peptide β/A4; and the progression of the disease from amyloid formation to neurofibrillary tangles and cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRPqP0OKB5rVg90H21EOLACvtfcHk0lizZ3zUBm2KfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D&md5=7756055cd27bec2821c9926267a93872</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2891%2990609-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252891%252990609-V%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520deposition%2520as%2520the%2520central%2520event%2520in%2520the%2520aetiology%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D383%26epage%3D388%26doi%3D10.1016%2F0165-6147%2891%2990609-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: The amyloid cascade hypothesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+The+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lizZ3zUBm2KfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520The%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The molecular pathology of alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span><span class="refDoi"> DOI: 10.1016/0896-6273(91)90052-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2F0896-6273%2891%2990052-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1673054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK3MXltlartrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=487-498&author=D.+J.+Selkoe&title=The+molecular+pathology+of+alzheimer%E2%80%99s+disease&doi=10.1016%2F0896-6273%2891%2990052-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular pathology of Alzheimer's disease</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">487-98</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    </div><div class="casAbstract">A review with 123 refs.  The salient features of the altered biochem. of Alzheimer's disease brain tissue and the possible role of these changes in the pathogenesis of this complex disease are reviewed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo89M2XS8q9lLVg90H21EOLACvtfcHk0lizZ3zUBm2KfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXltlartrk%253D&md5=4745e85e182053674cb6a67fe4b1cfb8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2891%2990052-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252891%252990052-2%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520molecular%2520pathology%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D1991%26volume%3D6%26spage%3D487%26epage%3D498%26doi%3D10.1016%2F0896-6273%2891%2990052-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Benilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The toxic abeta oligomer and alzheimer’s disease: An emperor in need of clothes</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span><span class="refDoi"> DOI: 10.1038/nn.3028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Fnn.3028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22286176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlOltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=349-357&author=I.+Benilovaauthor=E.+Karranauthor=B.+De+Strooper&title=The+toxic+abeta+oligomer+and+alzheimer%E2%80%99s+disease%3A+An+emperor+in+need+of+clothes&doi=10.1038%2Fnn.3028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes</span></div><div class="casAuthors">Benilova, Iryna; Karran, Eric; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-357</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'toxic Aβ oligomer' hypothesis has attracted considerable attention among Alzheimer's disease researchers as a way of resolving the lack of correlation between deposited amyloid-β (Aβ) in amyloid plaques-in terms of both amt. and location-and cognitive impairment or neurodegeneration.  However, the lack of a common, agreed-upon exptl. description of the toxic Aβ oligomer makes interpretation and direct comparison of data between different research groups impossible.  Here we critically review the evidence supporting toxic Aβ oligomers as drivers of neurodegeneration and make some suggestions that might facilitate progress in this complex field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov5Kqo0wOIJ7Vg90H21EOLACvtfcHk0lhNTPdzGPPrAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlOltrc%253D&md5=071f3c9b1e0fe9b2e66363c44d87e381</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnn.3028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3028%26sid%3Dliteratum%253Aachs%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520toxic%2520abeta%2520oligomer%2520and%2520alzheimer%25E2%2580%2599s%2520disease%253A%2520An%2520emperor%2520in%2520need%2520of%2520clothes%26jtitle%3DNat.%2520Neurosci.%26date%3D2012%26volume%3D15%26spage%3D349%26epage%3D357%26doi%3D10.1038%2Fnn.3028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A mutation in app protects against alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Jonssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+app+protects+against+alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lhNTPdzGPPrAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJonsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520app%2520protects%2520against%2520alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for alzheimer’s disease: An appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span><span class="refDoi"> DOI: 10.1038/nrd3505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Fnrd3505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=21852788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+alzheimer%E2%80%99s+disease%3A+An+appraisal+for+the+development+of+therapeutics&doi=10.1038%2Fnrd3505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics</span></div><div class="casAuthors">Karran, Eric; Mercken, Marc; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">698-712</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the brain is a central event in Alzheimer's disease pathol., has dominated research for the past twenty years.  Several therapeutics that were purported to reduce amyloid-β prodn. or aggregation have failed in Phase III clin. testing, and many others are in various stages of development.  Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clin. trials will constitute a valid test of this hypothesis and explore whether amyloid-β-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-zjcfHaQ87Vg90H21EOLACvtfcHk0lhNTPdzGPPrAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L&md5=cf2824a56a4c3df6e265d8788970729d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3505%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520alzheimer%25E2%2580%2599s%2520disease%253A%2520An%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712%26doi%3D10.1038%2Fnrd3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smirnov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klafki, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyrks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruther, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornhuber, J.</span><span> </span><span class="NLM_article-title">Highly conserved and disease-specific patterns of carboxyterminally truncated abeta peptides 1–37/38/39 in addition to 1–40/42 in alzheimer’s disease and in patients with chronic neuroinflammation</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.00818.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1046%2Fj.1471-4159.2002.00818.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=12065657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFGktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2002&pages=481-496&author=J.+Wiltfangauthor=H.+Esselmannauthor=M.+Biblauthor=A.+Smirnovauthor=M.+Ottoauthor=S.+Paulauthor=B.+Schmidtauthor=H.+W.+Klafkiauthor=M.+Malerauthor=T.+Dyrksauthor=M.+Bienertauthor=M.+Beyermannauthor=E.+Rutherauthor=J.+Kornhuber&title=Highly+conserved+and+disease-specific+patterns+of+carboxyterminally+truncated+abeta+peptides+1%E2%80%9337%2F38%2F39+in+addition+to+1%E2%80%9340%2F42+in+alzheimer%E2%80%99s+disease+and+in+patients+with+chronic+neuroinflammation&doi=10.1046%2Fj.1471-4159.2002.00818.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Highly conserved and disease-specific patterns of carboxyterminally truncated Aβ peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation</span></div><div class="casAuthors">Wiltfang, J.; Esselmann, H.; Bibl, M.; Smirnov, A.; Otto, M.; Paul, S.; Schmidt, B.; Klafki, H.-W.; Maler, M.; Dyrks, T.; Bienert, M.; Beyermann, M.; Ruther, E.; Kornhuber, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">481-496</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Human lumbar CSF patterns of Aβ peptides were analyzed by urea-based β-amyloid SDS-PAGE with western immunoblot (Aβ-SDS-PAGE/immunoblot).  A highly conserved pattern of C-terminally truncated Aβ1-37/38/39 was found in addn. to Aβ1-40 and Aβ1-42.  Remarkably, Aβ1-38 was present at a higher concn. than Aβ1-42, being the second prominent Aβ peptide species in CSF.  Patients with Alzheimer's disease (AD) and patients with chronic inflammatory CNS disease (CID) were differentiated by unique CSF Aβ peptide patterns from patients with other neuropsychiatric diseases (OND).  This became evident only when the authors investigated the amt. of Aβ peptides relative to their total Aβ peptide concn. (Aβ1-x%, fractional Aβ peptide pattern), which may reflect disease-specific υ-secretase activities.  Remarkably, patients with AD and CID shared elevated Aβ1-38% values, whereas otherwise the patterns were distinct, allowing sepn. of AD from CID or OND patients without overlap.  The presence of one or two ApoE ε4 alleles resulted in an overall redn. of CSF Aβ peptides, which was pronounced for Aβ1-42.  The severity of dementia was significantly correlated to the fractional Aβ peptide pattern but not to the abs. Aβ peptide concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8ATekdr8UGrVg90H21EOLACvtfcHk0ljTG8MaKO65nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFGktrc%253D&md5=896100941428364397314e7b5af9831b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.00818.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.00818.x%26sid%3Dliteratum%253Aachs%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DEsselmann%26aufirst%3DH.%26aulast%3DBibl%26aufirst%3DM.%26aulast%3DSmirnov%26aufirst%3DA.%26aulast%3DOtto%26aufirst%3DM.%26aulast%3DPaul%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DKlafki%26aufirst%3DH.%2BW.%26aulast%3DMaler%26aufirst%3DM.%26aulast%3DDyrks%26aufirst%3DT.%26aulast%3DBienert%26aufirst%3DM.%26aulast%3DBeyermann%26aufirst%3DM.%26aulast%3DRuther%26aufirst%3DE.%26aulast%3DKornhuber%26aufirst%3DJ.%26atitle%3DHighly%2520conserved%2520and%2520disease-specific%2520patterns%2520of%2520carboxyterminally%2520truncated%2520abeta%2520peptides%25201%25E2%2580%259337%252F38%252F39%2520in%2520addition%2520to%25201%25E2%2580%259340%252F42%2520in%2520alzheimer%25E2%2580%2599s%2520disease%2520and%2520in%2520patients%2520with%2520chronic%2520neuroinflammation%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D81%26spage%3D481%26epage%3D496%26doi%3D10.1046%2Fj.1471-4159.2002.00818.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Portelius, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westman-Brinkmalm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span> </span><span class="NLM_article-title">Determination of β-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry</span> <span class="citation_source-journal">J. Proteome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1010</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span><span class="refDoi"> DOI: 10.1021/pr050475v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr050475v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFOiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1010-1016&author=E.+Porteliusauthor=A.+Westman-Brinkmalmauthor=H.+Zetterbergauthor=K.+Blennow&title=Determination+of+%CE%B2-amyloid+peptide+signatures+in+cerebrospinal+fluid+using+immunoprecipitation-mass+spectrometry&doi=10.1021%2Fpr050475v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of β-Amyloid Peptide Signatures in Cerebrospinal Fluid Using Immunoprecipitation-Mass Spectrometry</span></div><div class="casAuthors">Portelius, Erik; Westman-Brinkmalm, Ann; Zetterberg, Henrik; Blennow, Kaj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1010-1016</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Early pathogenic events in Alzheimer's disease (AD) involve increased prodn. and/or reduced clearance of β-amyloid (Aβ), esp. the 42 amino acid fragment Aβ1-42.  The Aβ1-42 peptide is generated through cleavage of the amyloid precursor protein by β- and γ-secretase and is catabolized by a variety of proteolytic enzymes such as insulin-degrading enzyme and neprilysin.  Here, the authors describe a method that employs immunopptn. combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to det. the pattern of C-terminally truncated Aβ peptides in cerebrospinal fluid (CSF).  Using antibodies coupled to magnetic beads, the authors have detected 18 C-terminally and 2 N-terminally truncated Aβ peptides in CSF.  By detg. the identity and profile of the truncated Aβ peptides, more insight may be gained about differences in the metab. and structural properties of Aβ in AD.  Finally, the Aβ fragment signatures may prove useful as a diagnostic test for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxSKih56iERrVg90H21EOLACvtfcHk0ljTG8MaKO65nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFOiur8%253D&md5=1927c8e4b3d609915546a68956144e01</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fpr050475v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr050475v%26sid%3Dliteratum%253Aachs%26aulast%3DPortelius%26aufirst%3DE.%26aulast%3DWestman-Brinkmalm%26aufirst%3DA.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DBlennow%26aufirst%3DK.%26atitle%3DDetermination%2520of%2520%25CE%25B2-amyloid%2520peptide%2520signatures%2520in%2520cerebrospinal%2520fluid%2520using%2520immunoprecipitation-mass%2520spectrometry%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2006%26volume%3D5%26spage%3D1010%26epage%3D1016%26doi%3D10.1021%2Fpr050475v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bentahir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyabi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhamme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horre, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Presenilin clinical mutations can affect γ-secretase activity by different mechanisms</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">732</span><span class="NLM_x">–</span> <span class="NLM_lpage">742</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2005.03578.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1111%2Fj.1471-4159.2005.03578.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=16405513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFCnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2006&pages=732-742&author=M.+Bentahirauthor=O.+Nyabiauthor=J.+Verhammeauthor=A.+Toliaauthor=K.+Horreauthor=J.+Wiltfangauthor=H.+Esselmannauthor=B.+De+Strooper&title=Presenilin+clinical+mutations+can+affect+%CE%B3-secretase+activity+by+different+mechanisms&doi=10.1111%2Fj.1471-4159.2005.03578.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Presenilin clinical mutations can affect γ-secretase activity by different mechanisms</span></div><div class="casAuthors">Bentahir, Mostafa; Nyabi, Omar; Verhamme, Jan; Tolia, Alexandra; Horre, Katrien; Wiltfang, Jens; Esselmann, Hermann; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">732-742</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Mutations in human presenilin (PS) genes cause aggressive forms of familial Alzheimer's disease.  Presenilins are polytopic proteins that harbor the catalytic site of the γ-secretase complex and cleave many type I transmembrane proteins including β-amyloid precursor protein (APP), Notch and syndecan 3.  Contradictory results have been published concerning whether PS mutations cause 'abnormal' gain or (partial) loss of function of γ-secretase.  To avoid the possibility that wild-type PS confounds the interpretation of the results, we used presenilin-deficient cells to analyze the effects of different clin. mutations on APP, Notch, syndecan 3 and N-cadherin substrate processing, and on γ-secretase complex formation.  A loss in APP and Notch substrate processing at ε and S3 cleavage sites was obsd. with all presenilin mutants, whereas APP processing at the γ site was affected in variable ways.  PS1-Δ9 and PS1-L166P mutations caused a redn. in β-amyloid peptide (Aβ)40 prodn. whereas PS1-G384A mutant significantly increased Aβ42.  Interestingly PS2, a close homolog of PS1, appeared to be a less efficient producer of Aβ than PS1.  Finally, subtle differences in γ-secretase complex assembly were obsd.  Overall, our results indicate that the different mutations in PS affect γ-secretase structure or function in multiple ways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptpHnflldicLVg90H21EOLACvtfcHk0ljTG8MaKO65nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFCnurY%253D&md5=d6023fb0564be7d6d2a29848a7fdc68e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03578.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03578.x%26sid%3Dliteratum%253Aachs%26aulast%3DBentahir%26aufirst%3DM.%26aulast%3DNyabi%26aufirst%3DO.%26aulast%3DVerhamme%26aufirst%3DJ.%26aulast%3DTolia%26aufirst%3DA.%26aulast%3DHorre%26aufirst%3DK.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DEsselmann%26aufirst%3DH.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DPresenilin%2520clinical%2520mutations%2520can%2520affect%2520%25CE%25B3-secretase%2520activity%2520by%2520different%2520mechanisms%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D96%26spage%3D732%26epage%3D742%26doi%3D10.1111%2Fj.1471-4159.2005.03578.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wolfe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostaszewski, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimberly, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">398</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span><span class="refDoi"> DOI: 10.1038/19077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F19077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10206644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK1MXisFGqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=1999&pages=513-517&author=M.+S.+Wolfeauthor=W.+Xiaauthor=B.+L.+Ostaszewskiauthor=T.+S.+Diehlauthor=W.+T.+Kimberlyauthor=D.+J.+Selkoe&title=Two+transmembrane+aspartates+in+presenilin-1+required+for+presenilin+endoproteolysis+and+gamma-secretase+activity&doi=10.1038%2F19077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity</span></div><div class="casAuthors">Wolfe, Michael S.; Xia, Weiming; Ostaszewski, Beth L.; Diehl, Thekla S.; Kimberly, W. Taylor; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">398</span>
        (<span class="NLM_cas:issue">6727</span>),
    <span class="NLM_cas:pages">513-517</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Accumulation of the amyloid-β protein (Aβ) in the cerebral cortex is an early and invariant event in the pathogenesis of Alzheimer's disease.  The final step in the generation of Aβ from the β-amyloid precursor protein is an apparently intra-membranous proteolysis by the elusive γ-secretase(s).  The most common cause of familial Alzheimer's disease is mutation of the genes encoding presenilins 1 and 2, which alters γ-secretase activity to increase the prodn. of the highly amyloidogenic Aβ42 isoform.  Moreover, deletion of presenilin-1 in mice greatly reduces γ-secretase activity, indicating that presenilin-1 mediates most of this proteolytic event.  Here we report that mutation of either of two conserved transmembrane (TM) aspartate residues in presenilin-1, Asp 257 (in TM6) and Asp 385 (in TM7), substantially reduces Aβ prodn. and increases the amts. of the carboxy-terminal fragments of 1-amyloid precursor protein that are the substrates of γ-secretase.  We obsd. these effects in three different cell lines as well as in cell-free microsomes.  Either of the Asp → Ala mutations also prevented the normal endoproteolysis of presenilin-1 in the TM6 → TM7 cytoplasmic loop.  In a functional presenilin-1 variant (carrying a deletion in exon 9) that is assocd. with familial Alzheimer's disease and which does not require this cleavage, the Asp 385 → Ala mutation still inhibited γ-secretase activity.  Our results indicate that the two transmembrane aspartate residues are crit. for both presenilin-1 endoproteolysis and γ-secretase activity, and suggest that presenilin 1 is either a unique di-aspartyl cofactor for γ-secretase or is itself γ-secretase, an auto-activated intra-membranous aspartyl protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIBUrgEzFHtbVg90H21EOLACvtfcHk0lj_aNrD7iykOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisFGqt7g%253D&md5=c7b52439e0e35003e8c20242b21da860</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2F19077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F19077%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DOstaszewski%26aufirst%3DB.%2BL.%26aulast%3DDiehl%26aufirst%3DT.%2BS.%26aulast%3DKimberly%26aufirst%3DW.%2BT.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DTwo%2520transmembrane%2520aspartates%2520in%2520presenilin-1%2520required%2520for%2520presenilin%2520endoproteolysis%2520and%2520gamma-secretase%2520activity%26jtitle%3DNature%26date%3D1999%26volume%3D398%26spage%3D513%26epage%3D517%26doi%3D10.1038%2F19077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craessaerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumm, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeter, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrijvers, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopan, R.</span><span> </span><span class="NLM_article-title">A presenilin-1-dependent gamma-secretase-like protease mediates release of notch intracellular domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">398</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span><span class="refDoi"> DOI: 10.1038/19083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F19083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10206645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK1MXisFGqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=1999&pages=518-522&author=B.+De+Strooperauthor=W.+Annaertauthor=P.+Cupersauthor=P.+Saftigauthor=K.+Craessaertsauthor=J.+S.+Mummauthor=E.+H.+Schroeterauthor=V.+Schrijversauthor=M.+S.+Wolfeauthor=W.+J.+Rayauthor=A.+Goateauthor=R.+Kopan&title=A+presenilin-1-dependent+gamma-secretase-like+protease+mediates+release+of+notch+intracellular+domain&doi=10.1038%2F19083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain</span></div><div class="casAuthors">De Strooper, Bart; Annaert, Wim; Cupers, Philippe; Saftig, Paul; Craessaerts, Katleen; Mumm, Jeffrey S.; Schroeter, Eric H.; Schrijvers, Vincent; Wolfe, Michael S.; Ray, William J.; Goate, Alison; Kopan, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">398</span>
        (<span class="NLM_cas:issue">6727</span>),
    <span class="NLM_cas:pages">518-522</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Signaling through the receptor protein Notch, which is involved in crucial cell-fate decisions during development, requires ligand-induced cleavage of Notch.  This cleavage occurs within the predicted transmembrane domain, releasing the Notch intra-cellular domain (NICD), and is reminiscent of γ-secretase-mediated cleavage of β-amyloid precursor protein (APP), a crit. event in the pathogenesis of Alzheimer's disease.  A deficiency in presenilin-1 (PS1) inhibits processing of APP by γ-secretase in mammalian cells, and genetic interactions between Notch and PS1 homologs in Caenorhabditis elegans indicate that the presenilins may modulate the Notch signaling pathway.  Here we report that, in mammalian cells, PS1 deficiency also reduces the proteolytic release of NICD from a truncated Notch construct, thus identifying the specific biochem. step of the Notch signaling pathway that is affected by PS1.  Moreover, several γ-secretase inhibitors block this same step in Notch processing, indicating that related protease activities are responsible for cleavage within the predicted transmembrane domains of Notch and APP.  Thus the targeting of γ-secretase for the treatment of Alzheimer's disease may risk toxicity caused by reduced Notch signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQagjvTdUe8rVg90H21EOLACvtfcHk0lj_aNrD7iykOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisFGqt7k%253D&md5=b42222d870cb32d3093addb8ccb2a5a2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F19083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F19083%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DAnnaert%26aufirst%3DW.%26aulast%3DCupers%26aufirst%3DP.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DCraessaerts%26aufirst%3DK.%26aulast%3DMumm%26aufirst%3DJ.%2BS.%26aulast%3DSchroeter%26aufirst%3DE.%2BH.%26aulast%3DSchrijvers%26aufirst%3DV.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DKopan%26aufirst%3DR.%26atitle%3DA%2520presenilin-1-dependent%2520gamma-secretase-like%2520protease%2520mediates%2520release%2520of%2520notch%2520intracellular%2520domain%26jtitle%3DNature%26date%3D1999%26volume%3D398%26spage%3D518%26epage%3D522%26doi%3D10.1038%2F19083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Sherrington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaev, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaeva, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foncin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruni, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montesi, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainero, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinessi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumakov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanseau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polinsky, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasco, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Silva, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haines, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pericak-Vance, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roses, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St George-Hyslop, P. H.</span><span> </span><span class="NLM_article-title">Cloning of a gene bearing missense mutations in early-onset familial alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">754</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span><span class="refDoi"> DOI: 10.1038/375754a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F375754a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=7596406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVymtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=1995&pages=754-760&author=R.+Sherringtonauthor=E.+I.+Rogaevauthor=Y.+Liangauthor=E.+A.+Rogaevaauthor=G.+Levesqueauthor=M.+Ikedaauthor=H.+Chiauthor=C.+Linauthor=G.+Liauthor=K.+Holmanauthor=T.+Tsudaauthor=L.+Marauthor=J.+F.+Foncinauthor=A.+C.+Bruniauthor=M.+P.+Montesiauthor=S.+Sorbiauthor=I.+Raineroauthor=L.+Pinessiauthor=L.+Neeauthor=I.+Chumakovauthor=D.+Pollenauthor=A.+Brookesauthor=P.+Sanseauauthor=R.+J.+Polinskyauthor=W.+Wascoauthor=H.+A.+Da+Silvaauthor=J.+L.+Hainesauthor=M.+A.+Pericak-Vanceauthor=R.+E.+Tanziauthor=A.+D.+Rosesauthor=P.+E.+Fraserauthor=J.+M.+Rommensauthor=P.+H.+St+George-Hyslop&title=Cloning+of+a+gene+bearing+missense+mutations+in+early-onset+familial+alzheimer%E2%80%99s+disease&doi=10.1038%2F375754a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease</span></div><div class="casAuthors">Sherrington, R.; Rogaev, E. I.; Liang, Y.; Rogaeva, E. A.; Levesque, G.; Ikeda, M.; Chi, H.; Lin, C.; Li, G.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">375</span>
        (<span class="NLM_cas:issue">6534</span>),
    <span class="NLM_cas:pages">754-60</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Some cases of Alzheimer's disease are inherited as an autosomal dominant trait.  Genetic linkage studies have mapped a locus (AD3) assocd. with susceptibility to a very aggressive form of Alzheimer's disease to chromosome 14q24.3.  The authors have defined a minimal cosegregating region contg. the AD3 gene, and isolated at least 19 different transcripts encoded within this region.  One of these transcripts (S182) corresponds to a novel gene whose product is predicted to contain multiple transmembrane domains and resembles an integral membrane protein.  Five different missense mutations have been found that cosegregate with early-onset familial Alzheimer's disease.  Because these changes occurred in conserved domains of the gene, and are not present in normal controls, they are likely to be causative of AD3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp49ubD8AKFQ7Vg90H21EOLACvtfcHk0lhYbJyLirQPPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVymtbo%253D&md5=c68c5ca80245a13604d3710cb5e3ab28</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2F375754a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F375754a0%26sid%3Dliteratum%253Aachs%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DRogaev%26aufirst%3DE.%2BI.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DRogaeva%26aufirst%3DE.%2BA.%26aulast%3DLevesque%26aufirst%3DG.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DChi%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DHolman%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DT.%26aulast%3DMar%26aufirst%3DL.%26aulast%3DFoncin%26aufirst%3DJ.%2BF.%26aulast%3DBruni%26aufirst%3DA.%2BC.%26aulast%3DMontesi%26aufirst%3DM.%2BP.%26aulast%3DSorbi%26aufirst%3DS.%26aulast%3DRainero%26aufirst%3DI.%26aulast%3DPinessi%26aufirst%3DL.%26aulast%3DNee%26aufirst%3DL.%26aulast%3DChumakov%26aufirst%3DI.%26aulast%3DPollen%26aufirst%3DD.%26aulast%3DBrookes%26aufirst%3DA.%26aulast%3DSanseau%26aufirst%3DP.%26aulast%3DPolinsky%26aufirst%3DR.%2BJ.%26aulast%3DWasco%26aufirst%3DW.%26aulast%3DDa%2BSilva%26aufirst%3DH.%2BA.%26aulast%3DHaines%26aufirst%3DJ.%2BL.%26aulast%3DPericak-Vance%26aufirst%3DM.%2BA.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DRoses%26aufirst%3DA.%2BD.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26aulast%3DRommens%26aufirst%3DJ.%2BM.%26aulast%3DSt%2BGeorge-Hyslop%26aufirst%3DP.%2BH.%26atitle%3DCloning%2520of%2520a%2520gene%2520bearing%2520missense%2520mutations%2520in%2520early-onset%2520familial%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1995%26volume%3D375%26spage%3D754%26epage%3D760%26doi%3D10.1038%2F375754a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Rogaev, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaeva, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacmias, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piacentini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaducci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumakov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannfelt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George-Hyslop, P. H.</span><span> </span><span class="NLM_article-title">Familial alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the alzheimer’s disease type 3 gene</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span><span class="refDoi"> DOI: 10.1038/376775a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F376775a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=7651536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=775-778&author=E.+I.+Rogaevauthor=R.+Sherringtonauthor=E.+A.+Rogaevaauthor=G.+Levesqueauthor=M.+Ikedaauthor=Y.+Liangauthor=H.+Chiauthor=C.+Linauthor=K.+Holmanauthor=T.+Tsudaauthor=L.+Marauthor=S.+Sorbiauthor=B.+Nacmiasauthor=S.+Piacentiniauthor=L.+Amaducciauthor=I.+Chumakovauthor=D.+Cohenauthor=P.+Lannfeltauthor=P.+E.+Fraserauthor=J.+M.+Rommensauthor=P.+H.+St.+George-Hyslop&title=Familial+alzheimer%E2%80%99s+disease+in+kindreds+with+missense+mutations+in+a+gene+on+chromosome+1+related+to+the+alzheimer%E2%80%99s+disease+type+3+gene&doi=10.1038%2F376775a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene</span></div><div class="casAuthors">Rogaev, E. I.; Sherrington, R.; Rogaeva, E. A.; Levesque, G.; Ikeda, M.; Liang, Y.; Chi, H.; Lin, C.; Holman, K.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">6543</span>),
    <span class="NLM_cas:pages">775-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">We report the cloning of a novel gene (E5-1) encoded on chromosome 1 which has substantial nucleotide and amino-acid sequence similarity to the S182 gene on chromosome 14q24.3.  Mutations, including three new missense mutations in the S182 gene, are assocd. with the AD3 subtype of early-onset familial Alzheimer's disease (AD).  Both the E5-1 and the S182 proteins are predicted to be integral membrane proteins with seven-membrane-spanning domains, and a large exposed loop between the sixth and seventh transmembrane domains.  Anal. of the nucleotide sequence of the open reading frame (ORF) of the E5-1 gene led to the discovery of two missense substitutions at conserved amino-acid residues in affected members of pedigrees with a form of familial AD that has a later age of onset than the AD3 subtype (50-70 yr vs. 30-60 yr for AD3).  These observations imply that the E5-1 gene on chromosome 1 and the S182 gene on chromosome 14q24.3 are members of a family of genes (presenilins) with related functions, and indicates that mutations in conserved residues of E5-1 could also play a role in the genesis of AD.  The authors results also indicate that still other AD susceptibility genes exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopES5CZyuo6LVg90H21EOLACvtfcHk0liIovjyusMKNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFChsL4%253D&md5=8566f773f8d12ab5339a9fb16cb8dfd5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2F376775a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F376775a0%26sid%3Dliteratum%253Aachs%26aulast%3DRogaev%26aufirst%3DE.%2BI.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DRogaeva%26aufirst%3DE.%2BA.%26aulast%3DLevesque%26aufirst%3DG.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DChi%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DHolman%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DT.%26aulast%3DMar%26aufirst%3DL.%26aulast%3DSorbi%26aufirst%3DS.%26aulast%3DNacmias%26aufirst%3DB.%26aulast%3DPiacentini%26aufirst%3DS.%26aulast%3DAmaducci%26aufirst%3DL.%26aulast%3DChumakov%26aufirst%3DI.%26aulast%3DCohen%26aufirst%3DD.%26aulast%3DLannfelt%26aufirst%3DP.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26aulast%3DRommens%26aufirst%3DJ.%2BM.%26aulast%3DSt.%2BGeorge-Hyslop%26aufirst%3DP.%2BH.%26atitle%3DFamilial%2520alzheimer%25E2%2580%2599s%2520disease%2520in%2520kindreds%2520with%2520missense%2520mutations%2520in%2520a%2520gene%2520on%2520chromosome%25201%2520related%2520to%2520the%2520alzheimer%25E2%2580%2599s%2520disease%2520type%25203%2520gene%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D775%26epage%3D778%26doi%3D10.1038%2F376775a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span> </span><span class="NLM_article-title">Nonpeptide bace1 inhibitors: Design and synthesis</span> <span class="citation_source-journal">Methods Princ. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span><span class="refDoi"> DOI: 10.1002/9783527630943.ch17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1002%2F9783527630943.ch17" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2011&pages=481-509&author=D.+C.+Coleauthor=M.+G.+Bursavich&title=Nonpeptide+bace1+inhibitors%3A+Design+and+synthesis&doi=10.1002%2F9783527630943.ch17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F9783527630943.ch17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9783527630943.ch17%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26atitle%3DNonpeptide%2520bace1%2520inhibitors%253A%2520Design%2520and%2520synthesis%26jtitle%3DMethods%2520Princ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D45%26spage%3D481%26epage%3D509%26doi%3D10.1002%2F9783527630943.ch17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopcova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J.</span><span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant bace1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2045</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+bace1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0liIovjyusMKNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520bace1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemma, S.</span><span> </span><span class="NLM_article-title">The structural evolution of beta-secretase inhibitors: A focus on the development of small-molecule inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1787</span><span class="NLM_x">–</span> <span class="NLM_lpage">1807</span><span class="refDoi"> DOI: 10.2174/15680266113139990137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.2174%2F15680266113139990137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23931442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1787-1807&author=S.+Butiniauthor=S.+Brogiauthor=E.+Novellinoauthor=G.+Campianiauthor=A.+K.+Ghoshauthor=M.+Brindisiauthor=S.+Gemma&title=The+structural+evolution+of+beta-secretase+inhibitors%3A+A+focus+on+the+development+of+small-molecule+inhibitors&doi=10.2174%2F15680266113139990137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Structural Evolution of β-Secretase Inhibitors: A Focus on the Development of Small-Molecule Inhibitors</span></div><div class="casAuthors">Butini, Stefania; Brogi, Simone; Novellino, Ettore; Campiani, Giuseppe; Ghosh, Arun K.; Brindisi, Margherita; Gemma, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1787-1807</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Effective treatment of Alzheimer's disease (AD) remains a crit. unmet need in medicine.  The lack of useful treatment for AD led to an intense search for novel therapies based on the amyloid hypothesis, which states that amyloid β-42 (Aβ 42) plays an early and crucial role in all cases of AD. β-Secretase (also known as BACE-1 β-site APP-cleaving enzyme, Asp-2 or memapsin-2) is an aspartyl protease representing the rate limiting step in the generation of Aβ peptide fragments, therefore it could represent an important target in the steady hunt for a disease-modifying treatment.  Generally, β-secretase inhibitors are grouped into two families: peptidomimetic and nonpeptidomimetic inhibitors.  However, irresp. of the class, serious challenges with respect to blood-brain barrier (BBB) penetration and selectivity still remain.  Discovering a small mol. inhibitor of β-secretase represents an unnerving challenge but, due to its significant potential as a therapeutic target, growing efforts in this task are evident from both academic and industrial labs.  In this frame, the rising availability of crystal structures of β-secretase-inhibitor complexes represents an invaluable opportunity for optimization.  Nevertheless, beyond the inhibitory activity, the major issue of the current research approaches is about problems assocd. with BBB penetration and pharmacokinetic properties.  This review follows the structural evolution of the early β-secretase inhibitors and gives a snap-shot of the hottest chem. templates in the literature of the last five years, showing research progress in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9SkCa5mjCv7Vg90H21EOLACvtfcHk0lgC1V05h2RMCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsLrI&md5=05e8126a28f1d7560530a0a67304864f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990137%26sid%3Dliteratum%253Aachs%26aulast%3DButini%26aufirst%3DS.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DGemma%26aufirst%3DS.%26atitle%3DThe%2520structural%2520evolution%2520of%2520beta-secretase%2520inhibitors%253A%2520A%2520focus%2520on%2520the%2520development%2520of%2520small-molecule%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1787%26epage%3D1807%26doi%3D10.2174%2F15680266113139990137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendran, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span> </span><span class="NLM_article-title">Function, therapeutic potential and cell biology of bace proteases: Current status and future prospects</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1111/jnc.12715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1111%2Fjnc.12715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24646365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2014&pages=4-28&author=R.+Vassarauthor=P.+H.+Kuhnauthor=C.+Haassauthor=M.+E.+Kennedyauthor=L.+Rajendranauthor=P.+C.+Wongauthor=S.+F.+Lichtenthaler&title=Function%2C+therapeutic+potential+and+cell+biology+of+bace+proteases%3A+Current+status+and+future+prospects&doi=10.1111%2Fjnc.12715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects</span></div><div class="casAuthors">Vassar, Robert; Kuhn, Peer-Hendrik; Haass, Christian; Kennedy, Matthew E.; Rajendran, Lawrence; Wong, Philip C.; Lichtenthaler, Stefan F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-28</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The β-site APP cleaving enzymes 1 and 2 (BACE1 and BACE2) were initially identified as transmembrane aspartyl proteases cleaving the amyloid precursor protein (APP).  BACE1 is a major drug target for Alzheimer's disease because BACE1-mediated cleavage of APP is the first step in the generation of the pathogenic amyloid-β peptides.  BACE1, which is highly expressed in the nervous system, is also required for myelination by cleaving neuregulin 1.  Several recent proteomic and in vivo studies using BACE1- and BACE2-deficient mice demonstrate a much wider range of physiol. substrates and functions for both proteases within and outside of the nervous system.  For BACE1 this includes axon guidance, neurogenesis, muscle spindle formation, and neuronal network functions, whereas BACE2 was shown to be involved in pigmentation and pancreatic β-cell function.  This review highlights the recent progress in understanding cell biol., substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer's disease.  The protease BACE1 is a major drug target in Alzheimer disease.  Together with its homolog BACE2, both proteases have an increasing no. of functions within and outside of the nervous system.  This review highlights recent progress in understanding cell biol., substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxkCRjc9dYMLVg90H21EOLACvtfcHk0lgC1V05h2RMCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtL7M&md5=79e394bb720ad6639f8efc86138fcd60</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12715%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKuhn%26aufirst%3DP.%2BH.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DRajendran%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26atitle%3DFunction%252C%2520therapeutic%2520potential%2520and%2520cell%2520biology%2520of%2520bace%2520proteases%253A%2520Current%2520status%2520and%2520future%2520prospects%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D130%26spage%3D4%26epage%3D28%26doi%3D10.1111%2Fjnc.12715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Doody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieburtz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethuraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R.</span><span> </span><span class="NLM_article-title">A phase 3 trial of semagacestat for treatment of alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span><span class="refDoi"> DOI: 10.1056/NEJMoa1210951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1056%2FNEJMoa1210951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23883379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2nur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=341-350&author=R.+S.+Doodyauthor=R.+Ramanauthor=M.+Farlowauthor=T.+Iwatsuboauthor=B.+Vellasauthor=S.+Joffeauthor=K.+Kieburtzauthor=F.+Heauthor=X.+Sunauthor=R.+G.+Thomasauthor=P.+S.+Aisenauthor=E.+Siemersauthor=G.+Sethuramanauthor=R.+Mohs&title=A+phase+3+trial+of+semagacestat+for+treatment+of+alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1210951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 3 trial of semagacestat for treatment of Alzheimer's disease</span></div><div class="casAuthors">Doody, Rachelle S.; Raman, Rema; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; He, Feng; Sun, Xiaoying; Thomas, Ronald G.; Aisen, Paul S.; Siemers, Eric; Sethuraman, Gopalan; Mohs, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-350</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease is characterized by the presence of cortical amyloid-beta (Aβ) protein plaques, which result from the sequential action of β-secretase and γ-secretase on amyloid precursor protein.  Semagacestat is a small-mol. γ-secretase inhibitor that was developed as a potential treatment for Alzheimer's disease.  Methods: We conducted a double-blind, placebo-controlled trial in which 1537 patients with probable Alzheimer's disease underwent randomization to receive 100 mg of semagacestat, 140 mg of semagacestat, or placebo daily.  Changes in cognition from baseline to week 76 were assessed with the use of the cognitive subscale of the Alzheimer's Disease Assessment Scale for cognition (ADAS-cog), on which scores range from 0 to 70 and higher scores indicate greater cognitive impairment, and changes in functioning were assessed with the Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) scale, on which scores range from 0 to 78 and higher scores indicate better functioning.  A mixed-model repeated-measures anal. was used.  Results: The trial was terminated before completion on the basis of a recommendation by the data and safety monitoring board.  At termination, there were 189 patients in the group receiving placebo, 153 patients in the group receiving 100 mg of semagacestat, and 121 patients in the group receiving 140 mg of semagacestat.  The ADAS-cog scores worsened in all three groups (mean change, 6.4 points in the placebo group, 7.5 points in the group receiving 100 mg of the study drug, and 7.8 points in the group receiving 140 mg; P = 0.15 and P = 0.07, resp., for the comparison with placebo).  The ADCS-ADL scores also worsened in all groups (mean change at week 76, -9.0 points in the placebo group, -10.5 points in the 100-mg group, and -12.6 points in the 140-mg group; P = 0.14 and P<0.001, resp., for the comparison with placebo).  Patients treated with semagacestat lost more wt. and had more skin cancers and infections, treatment discontinuations due to adverse events, and serious adverse events (P<0.001 for all comparisons with placebo).  Lab. abnormalities included reduced levels of lymphocytes, T cells, Igs, albumin, total protein, and uric acid and elevated levels of eosinophils, monocytes, and cholesterol; the urine pH was also elevated.  Conclusions: As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability.  Semagacestat was assocd. with more adverse events, including skin cancers and infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMQCX6dUTyl7Vg90H21EOLACvtfcHk0liDEKi2qTOO8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2nur7L&md5=366f2545b2156100af31993c809feac1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1210951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1210951%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DJoffe%26aufirst%3DS.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DSethuraman%26aufirst%3DG.%26aulast%3DMohs%26aufirst%3DR.%26atitle%3DA%2520phase%25203%2520trial%2520of%2520semagacestat%2520for%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D341%26epage%3D350%26doi%3D10.1056%2FNEJMoa1210951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Henley, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundell, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethuraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span> </span><span class="NLM_article-title">Safety profile of semagacestat, a gamma-secretase inhibitor: Identity trial findings</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2032</span><span class="refDoi"> DOI: 10.1185/03007995.2014.939167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1185%2F03007995.2014.939167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24983746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Oktb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=2021-2032&author=D.+B.+Henleyauthor=K.+L.+Sundellauthor=G.+Sethuramanauthor=S.+A.+Dowsettauthor=P.+C.+May&title=Safety+profile+of+semagacestat%2C+a+gamma-secretase+inhibitor%3A+Identity+trial+findings&doi=10.1185%2F03007995.2014.939167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings</span></div><div class="casAuthors">Henley, David B.; Sundell, Karen L.; Sethuraman, Gopalan; Dowsett, Sherie A.; May, Patrick C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2021-2032</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Objective: Semagacestat, a γ-secretase inhibitor, demonstrated an unfavorable risk-benefit profile in a Phase 3 study of patients with Alzheimer's disease (IDENTITY trials), and clin. development was halted.  To assist in future development of γ-secretase inhibitors, we report detailed safety findings from the IDENTITY study, with emphasis on those that might be mechanistically linked to γ-secretase inhibition.  Research design and methods: The IDENTITY trial was a double-blind, placebo-controlled trial of semagacestat (100 mg and 140 mg), in which 1537 patients age 55 years and older with probable Alzheimer's disease were randomized.  Treatment-emergent adverse events (TEAEs) are reported by body system along with pertinent lab., vital sign, and ECG findings.  Results: Semagacestat treatment was assocd. with increased reporting of suspected Notch-related adverse events (gastrointestinal, infection, and skin cancer related).  Other relevant safety findings assocd. with semagacestat treatment included cognitive and functional worsening, skin-related TEAEs, renal and hepatic changes, increased QT interval, and wt. loss.  With few exceptions, differences between semagacestat and placebo treatment groups were no longer significant after cessation of treatment with active drug.  Conclusions: Many of these safety findings can be attributed to γ-secretase inhibition, and may be valuable to researchers developing γ-secretase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC2ZGLarufNrVg90H21EOLACvtfcHk0liDEKi2qTOO8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Oktb3N&md5=7c2d61aafe7bbf26ce9d853d8b5f590a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1185%2F03007995.2014.939167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F03007995.2014.939167%26sid%3Dliteratum%253Aachs%26aulast%3DHenley%26aufirst%3DD.%2BB.%26aulast%3DSundell%26aufirst%3DK.%2BL.%26aulast%3DSethuraman%26aufirst%3DG.%26aulast%3DDowsett%26aufirst%3DS.%2BA.%26aulast%3DMay%26aufirst%3DP.%2BC.%26atitle%3DSafety%2520profile%2520of%2520semagacestat%252C%2520a%2520gamma-secretase%2520inhibitor%253A%2520Identity%2520trial%2520findings%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2014%26volume%3D30%26spage%3D2021%26epage%3D2032%26doi%3D10.1185%2F03007995.2014.939167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Lessons from a failed gamma-secretase alzheimer trial</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.cell.2014.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.cell.2014.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=25417150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2msrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2014&pages=721-726&author=B.+De+Strooper&title=Lessons+from+a+failed+gamma-secretase+alzheimer+trial&doi=10.1016%2Fj.cell.2014.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from a Failed γ-Secretase Alzheimer Trial</span></div><div class="casAuthors">De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">721-726</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  γ-Secretase proteases have been assocd. with pathol. in Alzheimer disease (AD), but we are just beginning to understand their basic mechanisms and physiol. roles.  A neg. drug trial with a broad spectrum γ-secretase inhibitor in AD patients has severely dampened enthusiasm for the potential of pursuing γ-secretase research therapeutically.  This pessimism is unwarranted: anal. of available information presented here demonstrates significant confounds for interpreting the outcome of the trial and argues that the major lessons pertain to broad knowledge gaps that are imperative to fill.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoltWoN44tWybVg90H21EOLACvtfcHk0ljNUAA28JtQyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2msrnI&md5=9d19644a7135552c6c4ef2b812b4b665</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DLessons%2520from%2520a%2520failed%2520gamma-secretase%2520alzheimer%2520trial%26jtitle%3DCell%26date%3D2014%26volume%3D159%26spage%3D721%26epage%3D726%26doi%3D10.1016%2Fj.cell.2014.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Sterling, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">A subset of nsaids lower amyloidogenic abeta42 independently of cyclooxygenase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1038/35102591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F35102591" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=212-216&author=S.+Weggenauthor=J.+L.+Eriksenauthor=P.+Dasauthor=S.+A.+Sagiauthor=R.+Wangauthor=C.+U.+Pietrzikauthor=K.+A.+Findlayauthor=T.+E.+Smithauthor=M.+P.+Murphyauthor=T.+Bulterauthor=D.+E.+Kangauthor=N.+Marquez-Sterlingauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A+subset+of+nsaids+lower+amyloidogenic+abeta42+independently+of+cyclooxygenase+activity&doi=10.1038%2F35102591"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2F35102591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35102591%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DFindlay%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DBulter%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%2BE.%26aulast%3DMarquez-Sterling%26aufirst%3DN.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%2520subset%2520of%2520nsaids%2520lower%2520amyloidogenic%2520abeta42%2520independently%2520of%2520cyclooxygenase%2520activity%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D212%26epage%3D216%26doi%3D10.1038%2F35102591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Sato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title">Active gamma-secretase complexes contain only one of each component</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">33985</span><span class="NLM_x">–</span> <span class="NLM_lpage">33993</span><span class="refDoi"> DOI: 10.1074/jbc.M705248200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M705248200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=33985-33993&author=T.+Satoauthor=T.+S.+Diehlauthor=S.+Narayananauthor=S.+Funamotoauthor=Y.+Iharaauthor=B.+De+Strooperauthor=H.+Steinerauthor=C.+Haassauthor=M.+S.+Wolfe&title=Active+gamma-secretase+complexes+contain+only+one+of+each+component&doi=10.1074%2Fjbc.M705248200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M705248200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M705248200%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DT.%26aulast%3DDiehl%26aufirst%3DT.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DFunamoto%26aufirst%3DS.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3DActive%2520gamma-secretase%2520complexes%2520contain%2520only%2520one%2520of%2520each%2520component%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D33985%26epage%3D33993%26doi%3D10.1074%2Fjbc.M705248200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><a href="http://www.alzforum.org/mutations" class="extLink">http://www.alzforum.org/mutations</a> (accessed Dec 1, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.alzforum.org%2Fmutations+%28accessed+Dec+1%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Brunkan, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goate, A. M.</span><span> </span><span class="NLM_article-title">Presenilin endoproteolysis is an intramolecular cleavage</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1016/j.mcn.2004.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.mcn.2004.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=15866047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslKitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2005&pages=65-73&author=A.+L.+Brunkanauthor=M.+Martinezauthor=E.+S.+Walkerauthor=A.+M.+Goate&title=Presenilin+endoproteolysis+is+an+intramolecular+cleavage&doi=10.1016%2Fj.mcn.2004.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Presenilin endoproteolysis is an intramolecular cleavage</span></div><div class="casAuthors">Brunkan, Anne L.; Martinez, Maribel; Walker, Emily S.; Goate, Alison M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-73</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mutations in the presenilin genes (PS) account for most cases of familial Alzheimer's disease.  PS contain the active site of the γ-secretase complex that cleaves within the transmembrane domain of β-amyloid precursor protein (APP).  Full-length PS undergoes regulated endoproteolysis to produce fragments that comprise the active form of PS.  The "presenilinase" responsible for endoproteolysis is unknown but may be the same presenilin-dependent γ-secretase activity that cleaves APP.  To investigate the mechanism of endoproteolysis, the authors examd. sequence specificity at the cleavage site and tested whether PS dimers are important for endoproteolysis as well as γ-secretase activity.  No single point mutation, or a double mutation M292D/V293K, was able to completely abolish endoproteolysis and all mutants supported γ-secretase activity.  When wtPS1 was co-expressed with either M292D/V293K or D257A, it was unable to restore normal endoproteolysis to either mutant.  Lack of transcleavage by wtPS1 suggests that PS1 endoproteolysis occurs via intramol. cleavage and does not require dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxjlxGVNZNabVg90H21EOLACvtfcHk0lglIMtUJuJ0bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslKitr0%253D&md5=3c9873361ff2690a9b076dfc0e4f0c62</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2004.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2004.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DBrunkan%26aufirst%3DA.%2BL.%26aulast%3DMartinez%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DE.%2BS.%26aulast%3DGoate%26aufirst%3DA.%2BM.%26atitle%3DPresenilin%2520endoproteolysis%2520is%2520an%2520intramolecular%2520cleavage%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2005%26volume%3D29%26spage%3D65%26epage%3D73%26doi%3D10.1016%2Fj.mcn.2004.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Chavez-Gutierrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Strooper, B.</span><span> </span><span class="NLM_article-title">Glu(332) in the nicastrin ectodomain is essential for gamma-secretase complex maturation but not for its activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">20096</span><span class="NLM_x">–</span> <span class="NLM_lpage">20105</span><span class="refDoi"> DOI: 10.1074/jbc.M803040200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M803040200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=20096-20105&author=L.+Chavez-Gutierrezauthor=A.+Toliaauthor=E.+Maesauthor=T.+Liauthor=P.+C.+Wongauthor=B.+de+Strooper&title=Glu%28332%29+in+the+nicastrin+ectodomain+is+essential+for+gamma-secretase+complex+maturation+but+not+for+its+activity&doi=10.1074%2Fjbc.M803040200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803040200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803040200%26sid%3Dliteratum%253Aachs%26aulast%3DChavez-Gutierrez%26aufirst%3DL.%26aulast%3DTolia%26aufirst%3DA.%26aulast%3DMaes%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3Dde%2BStrooper%26aufirst%3DB.%26atitle%3DGlu%2528332%2529%2520in%2520the%2520nicastrin%2520ectodomain%2520is%2520essential%2520for%2520gamma-secretase%2520complex%2520maturation%2520but%2520not%2520for%2520its%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D20096%26epage%3D20105%26doi%3D10.1074%2Fjbc.M803040200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlant, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dann, C. E.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudhof, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G.</span><span> </span><span class="NLM_article-title">Nicastrin functions as a gamma-secretase-substrate receptor</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span><span class="refDoi"> DOI: 10.1016/j.cell.2005.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.cell.2005.05.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2005&pages=435-447&author=S.+Shahauthor=S.+F.+Leeauthor=K.+Tabuchiauthor=Y.+H.+Haoauthor=C.+Yuauthor=Q.+LaPlantauthor=H.+Ballauthor=C.+E.+Dannauthor=T.+Sudhofauthor=G.+Yu&title=Nicastrin+functions+as+a+gamma-secretase-substrate+receptor&doi=10.1016%2Fj.cell.2005.05.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BF.%26aulast%3DTabuchi%26aufirst%3DK.%26aulast%3DHao%26aufirst%3DY.%2BH.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DLaPlant%26aufirst%3DQ.%26aulast%3DBall%26aufirst%3DH.%26aulast%3DDann%26aufirst%3DC.%2BE.%26aulast%3DSudhof%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DG.%26atitle%3DNicastrin%2520functions%2520as%2520a%2520gamma-secretase-substrate%2520receptor%26jtitle%3DCell%26date%3D2005%26volume%3D122%26spage%3D435%26epage%3D447%26doi%3D10.1016%2Fj.cell.2005.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Xie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Crystal structure of the gamma-secretase component nicastrin</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">13349</span><span class="NLM_x">–</span> <span class="NLM_lpage">13354</span><span class="refDoi"> DOI: 10.1073/pnas.1414837111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1073%2Fpnas.1414837111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=13349-13354&author=T.+Xieauthor=C.+Yanauthor=R.+Zhouauthor=Y.+Zhaoauthor=L.+Sunauthor=G.+Yangauthor=P.+Luauthor=D.+Maauthor=Y.+Shi&title=Crystal+structure+of+the+gamma-secretase+component+nicastrin&doi=10.1073%2Fpnas.1414837111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1414837111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1414837111%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DCrystal%2520structure%2520of%2520the%2520gamma-secretase%2520component%2520nicastrin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D13349%26epage%3D13354%26doi%3D10.1073%2Fpnas.1414837111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Pardossi-Piquard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanemoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevalle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Checler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt-Ulms, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George-Hyslop, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span> </span><span class="NLM_article-title">Aph1 polar transmembrane residues regulate the assembly and activity of presenilin complexes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">16298</span><span class="NLM_x">–</span> <span class="NLM_lpage">16307</span><span class="refDoi"> DOI: 10.1074/jbc.M109.000067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M109.000067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=16298-16307&author=R.+Pardossi-Piquardauthor=S.+P.+Yangauthor=S.+Kanemotoauthor=Y.+Guauthor=F.+Chenauthor=C.+Bohmauthor=J.+Sevalleauthor=T.+Liauthor=P.+C.+Wongauthor=F.+Checlerauthor=G.+Schmitt-Ulmsauthor=P.+St.+George-Hyslopauthor=P.+E.+Fraser&title=Aph1+polar+transmembrane+residues+regulate+the+assembly+and+activity+of+presenilin+complexes&doi=10.1074%2Fjbc.M109.000067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.000067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.000067%26sid%3Dliteratum%253Aachs%26aulast%3DPardossi-Piquard%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DS.%2BP.%26aulast%3DKanemoto%26aufirst%3DS.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DBohm%26aufirst%3DC.%26aulast%3DSevalle%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DSchmitt-Ulms%26aufirst%3DG.%26aulast%3DSt.%2BGeorge-Hyslop%26aufirst%3DP.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26atitle%3DAph1%2520polar%2520transmembrane%2520residues%2520regulate%2520the%2520assembly%2520and%2520activity%2520of%2520presenilin%2520complexes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D16298%26epage%3D16307%26doi%3D10.1074%2Fjbc.M109.000067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Biervliet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craessaerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dejaegere, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horre, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Houtvin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezovska, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprangers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciot, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moons, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jucker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Hooge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Gamma-secretase heterogeneity in the aph1 subunit: Relevance for alzheimer’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span><span class="refDoi"> DOI: 10.1126/science.1171176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1126%2Fscience.1171176" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=639-642&author=L.+Serneelsauthor=J.+Van+Biervlietauthor=K.+Craessaertsauthor=T.+Dejaegereauthor=K.+Horreauthor=T.+Van+Houtvinauthor=H.+Esselmannauthor=S.+Paulauthor=M.+K.+Schaferauthor=O.+Berezovskaauthor=B.+T.+Hymanauthor=B.+Sprangersauthor=R.+Sciotauthor=L.+Moonsauthor=M.+Juckerauthor=Z.+Yangauthor=P.+C.+Mayauthor=E.+Karranauthor=J.+Wiltfangauthor=R.+D%E2%80%99Hoogeauthor=B.+De+Strooper&title=Gamma-secretase+heterogeneity+in+the+aph1+subunit%3A+Relevance+for+alzheimer%E2%80%99s+disease&doi=10.1126%2Fscience.1171176"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscience.1171176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1171176%26sid%3Dliteratum%253Aachs%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DVan%2BBiervliet%26aufirst%3DJ.%26aulast%3DCraessaerts%26aufirst%3DK.%26aulast%3DDejaegere%26aufirst%3DT.%26aulast%3DHorre%26aufirst%3DK.%26aulast%3DVan%2BHoutvin%26aufirst%3DT.%26aulast%3DEsselmann%26aufirst%3DH.%26aulast%3DPaul%26aufirst%3DS.%26aulast%3DSchafer%26aufirst%3DM.%2BK.%26aulast%3DBerezovska%26aufirst%3DO.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DSprangers%26aufirst%3DB.%26aulast%3DSciot%26aufirst%3DR.%26aulast%3DMoons%26aufirst%3DL.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DD%25E2%2580%2599Hooge%26aufirst%3DR.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DGamma-secretase%2520heterogeneity%2520in%2520the%2520aph1%2520subunit%253A%2520Relevance%2520for%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D639%26epage%3D642%26doi%3D10.1126%2Fscience.1171176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Bammens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez-Gutierrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwijsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Functional and topological analysis of pen-2, the fourth subunit of the gamma-secretase complex</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">12271</span><span class="NLM_x">–</span> <span class="NLM_lpage">12282</span><span class="refDoi"> DOI: 10.1074/jbc.M110.216978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M110.216978" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=12271-12282&author=L.+Bammensauthor=L.+Chavez-Gutierrezauthor=A.+Toliaauthor=A.+Zwijsenauthor=B.+De+Strooper&title=Functional+and+topological+analysis+of+pen-2%2C+the+fourth+subunit+of+the+gamma-secretase+complex&doi=10.1074%2Fjbc.M110.216978"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.216978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.216978%26sid%3Dliteratum%253Aachs%26aulast%3DBammens%26aufirst%3DL.%26aulast%3DChavez-Gutierrez%26aufirst%3DL.%26aulast%3DTolia%26aufirst%3DA.%26aulast%3DZwijsen%26aufirst%3DA.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DFunctional%2520and%2520topological%2520analysis%2520of%2520pen-2%252C%2520the%2520fourth%2520subunit%2520of%2520the%2520gamma-secretase%2520complex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D12271%26epage%3D12282%26doi%3D10.1074%2Fjbc.M110.216978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Holmes, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paturi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title">Pen-2 is essential for gamma-secretase complex stability and trafficking but partially dispensable for endoproteolysis</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4393</span><span class="NLM_x">–</span> <span class="NLM_lpage">4406</span><span class="refDoi"> DOI: 10.1021/bi500489j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi500489j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=4393-4406&author=O.+Holmesauthor=S.+Paturiauthor=D.+J.+Selkoeauthor=M.+S.+Wolfe&title=Pen-2+is+essential+for+gamma-secretase+complex+stability+and+trafficking+but+partially+dispensable+for+endoproteolysis&doi=10.1021%2Fbi500489j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fbi500489j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi500489j%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DO.%26aulast%3DPaturi%26aufirst%3DS.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3DPen-2%2520is%2520essential%2520for%2520gamma-secretase%2520complex%2520stability%2520and%2520trafficking%2520but%2520partially%2520dispensable%2520for%2520endoproteolysis%26jtitle%3DBiochemistry%26date%3D2014%26volume%3D53%26spage%3D4393%26epage%3D4406%26doi%3D10.1021%2Fbi500489j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Edbauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regula, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesold, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Reconstitution of gamma-secretase activity</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><span class="refDoi"> DOI: 10.1038/ncb960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Fncb960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=12679784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlamu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=486-488&author=D.+Edbauerauthor=E.+Winklerauthor=J.+T.+Regulaauthor=B.+Pesoldauthor=H.+Steinerauthor=C.+Haass&title=Reconstitution+of+gamma-secretase+activity&doi=10.1038%2Fncb960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Reconstitution of γ-secretase activity</span></div><div class="casAuthors">Edbauer, Dieter; Winkler, Edith; Regula, Joerg T.; Pesold, Brigitte; Steiner, Harald; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">486-488</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">γ-Secretase is a membrane protein complex with an unusual aspartyl protease activity that catalyzes the regulated intramembranous cleavage of the β-amyloid precursor protein (APP) to release the Alzheimer's disease (AD)-assocd. amyloid β-peptide (Aβ) and the APP intracellular domain (AICD).  Here we show the reconstitution of γ-secretase activity in the yeast Saccharomyces cerevisiae, which lacks endogenous γ-secretase activity.  Reconstituted γ-secretase activity depends on the presence of four complex components including presenilin (PS), nicastrin (Nct), APH-1, and PEN-2, is assocd. with endoproteolysis of PS, and produces Aβ and AICD in vitro.  Thus, the biol. activity of γ-secretase is reconstituted by the co-expression of human PS, Nct, APH-1 and PEN-2 in yeast.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTsRxQt_Ugb7Vg90H21EOLACvtfcHk0ljVFbSBBxKlMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlamu70%253D&md5=60b187dcd89c3400b62724eaecbf8fe0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fncb960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb960%26sid%3Dliteratum%253Aachs%26aulast%3DEdbauer%26aufirst%3DD.%26aulast%3DWinkler%26aufirst%3DE.%26aulast%3DRegula%26aufirst%3DJ.%2BT.%26aulast%3DPesold%26aufirst%3DB.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DReconstitution%2520of%2520gamma-secretase%2520activity%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D486%26epage%3D488%26doi%3D10.1038%2Fncb960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Bai, X.-c.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheres, S. H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">An atomic structure of human γ-secretase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">525</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span><span class="refDoi"> DOI: 10.1038/nature14892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Fnature14892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=26280335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGgurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=212-217&author=X.-c.+Baiauthor=C.+Yanauthor=G.+Yangauthor=P.+Luauthor=D.+Maauthor=L.+Sunauthor=R.+Zhouauthor=S.+H.+W.+Scheresauthor=Y.+Shi&title=An+atomic+structure+of+human+%CE%B3-secretase&doi=10.1038%2Fnature14892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">An atomic structure of human γ-secretase</span></div><div class="casAuthors">Bai, Xiao-chen; Yan, Chuangye; Yang, Guanghui; Lu, Peilong; Ma, Dan; Sun, Linfeng; Zhou, Rui; Scheres, Sjors H. W.; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">525</span>
        (<span class="NLM_cas:issue">7568</span>),
    <span class="NLM_cas:pages">212-217</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Dysfunction of the intramembrane protease γ-secretase is thought to cause Alzheimer's disease, with most mutations derived from Alzheimer's disease mapping to the catalytic subunit presenilin 1 (PS1).  Here we report an at. structure of human γ-secretase at 3.4 Å resoln., detd. by single-particle cryo-electron microscopy.  Mutations derived from Alzheimer's disease affect residues at two hotspots in PS1, each located at the center of a distinct four transmembrane segment (TM) bundle.  TM2 and, to a lesser extent, TM6 exhibit considerable flexibility, yielding a plastic active site and adaptable surrounding elements.  The active site of PS1 is accessible from the convex side of the TM horseshoe, suggesting considerable conformational changes in nicastrin extracellular domain after substrate recruitment.  Component protein APH-1 serves as a scaffold, anchoring the lone transmembrane helix from nicastrin and supporting the flexible conformation of PS1.  Ordered phospholipids stabilize the complex inside the membrane.  Our structure serves as a mol. basis for mechanistic understanding of γ-secretase function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGo99dE6LPbbVg90H21EOLACvtfcHk0lguUAObeVIsvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGgurfM&md5=68dd390cae90f02f8c6a3d6d9c503326</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature14892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14892%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DX.-c.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DScheres%26aufirst%3DS.%2BH.%2BW.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DAn%2520atomic%2520structure%2520of%2520human%2520%25CE%25B3-secretase%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D212%26epage%3D217%26doi%3D10.1038%2Fnature14892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Jurisch-Yaksi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannerud, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, W.</span><span> </span><span class="NLM_article-title">A fast growing spectrum of biological functions of gamma-secretase in development and disease</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1828</span><span class="NLM_x">, </span> <span class="NLM_fpage">2815</span><span class="NLM_x">–</span> <span class="NLM_lpage">2827</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2013.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bbamem.2013.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24099003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOgtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1828&publication_year=2013&pages=2815-2827&author=N.+Jurisch-Yaksiauthor=R.+Sannerudauthor=W.+Annaert&title=A+fast+growing+spectrum+of+biological+functions+of+gamma-secretase+in+development+and+disease&doi=10.1016%2Fj.bbamem.2013.04.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A fast growing spectrum of biological functions of γ-secretase in development and disease</span></div><div class="casAuthors">Jurisch-Yaksi, Nathalie; Sannerud, Ragna; Annaert, Wim</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1828</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2815-2827</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase, which assembles as a tetrameric complex, is an aspartic protease that proteolytically cleaves substrate proteins within their membrane-spanning domain; a process also known as regulated intramembrane proteolysis (RIP).  RIP regulates signaling pathways by abrogating or releasing signaling mols.  Since the discovery, already >15 years ago, of its catalytic component, presenilin, and even much earlier with the identification of amyloid precursor protein as its first substrate, γ-secretase has been commonly assocd. with Alzheimer's disease.  However, starting with Notch protein and thereafter a continuously increasing no. of novel substrates, γ-secretase is becoming linked to an equally broader range of biol. processes.  Here, the authors present an updated overview of current knowledge on the diverse mol. mechanisms and signaling pathways controlled by γ-secretase, with a focus on organ development, homeostasis, and dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp38duZNEtDLLVg90H21EOLACvtfcHk0lguUAObeVIsvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOgtLfE&md5=a5c48288df0911551e1f3c17f378d846</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DJurisch-Yaksi%26aufirst%3DN.%26aulast%3DSannerud%26aufirst%3DR.%26aulast%3DAnnaert%26aufirst%3DW.%26atitle%3DA%2520fast%2520growing%2520spectrum%2520of%2520biological%2520functions%2520of%2520gamma-secretase%2520in%2520development%2520and%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2013%26volume%3D1828%26spage%3D2815%26epage%3D2827%26doi%3D10.1016%2Fj.bbamem.2013.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Kopan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilagan, M. X.</span><span> </span><span class="NLM_article-title">Gamma-secretase: Proteasome of the membrane?</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1038/nrm1406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Fnrm1406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=15173829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVarsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=499-504&author=R.+Kopanauthor=M.+X.+Ilagan&title=Gamma-secretase%3A+Proteasome+of+the+membrane%3F&doi=10.1038%2Fnrm1406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Opinion: γ-Secretase: proteasome of the membrane?</span></div><div class="casAuthors">Kopan, Raphael; Ilagan, Ma. Xenia G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">499-504</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review and discussion.  γ-Secretase (I), a protease that cleaves within the membrane, was 1st recognized for its role in the prodn. of amyloidogenic Aβ peptides, but was subsequently found to mediate Notch signaling by releasing the Notch-receptor intracellular domain.  Many other I substrates have recently been identified, which indicates a broader biol. function for this unusual protease.  Emerging evidence implies that whereas some intracellular cleavage products of I function as signaling mols., others might simply be intermediates that are destined for degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAA7vqYqos2bVg90H21EOLACvtfcHk0ljyDFwhHSB05A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVarsbw%253D&md5=06767583dd746f5a41664a615534ebd8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrm1406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1406%26sid%3Dliteratum%253Aachs%26aulast%3DKopan%26aufirst%3DR.%26aulast%3DIlagan%26aufirst%3DM.%2BX.%26atitle%3DGamma-secretase%253A%2520Proteasome%2520of%2520the%2520membrane%253F%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D499%26epage%3D504%26doi%3D10.1038%2Fnrm1406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Chavez-Gutierrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bammens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandersteen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benurwar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lismont, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Cleynenbreugel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schymkowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The mechanism of gamma-secretase dysfunction in familial alzheimer disease</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2261</span><span class="NLM_x">–</span> <span class="NLM_lpage">2274</span><span class="refDoi"> DOI: 10.1038/emboj.2012.79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Femboj.2012.79" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22505025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFWjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=2261-2274&author=L.+Chavez-Gutierrezauthor=L.+Bammensauthor=I.+Benilovaauthor=A.+Vandersteenauthor=M.+Benurwarauthor=M.+Borgersauthor=S.+Lismontauthor=L.+Zhouauthor=S.+Van+Cleynenbreugelauthor=H.+Esselmannauthor=J.+Wiltfangauthor=L.+Serneelsauthor=E.+Karranauthor=H.+Gijsenauthor=J.+Schymkowitzauthor=F.+Rousseauauthor=K.+Broersenauthor=B.+De+Strooper&title=The+mechanism+of+gamma-secretase+dysfunction+in+familial+alzheimer+disease&doi=10.1038%2Femboj.2012.79"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of γ-secretase dysfunction in familial Alzheimer disease</span></div><div class="casAuthors">Chavez-Gutierrez, Lucia; Bammens, Leen; Benilova, Iryna; Vandersteen, Annelies; Benurwar, Manasi; Borgers, Marianne; Lismont, Sam; Zhou, Lujia; Van Cleynenbreugel, Simon; Esselmann, Hermann; Wiltfang, Jens; Serneels, Lutgarde; Karran, Eric; Gijsen, Harrie; Schymkowitz, Joost; Rousseau, Frederic; Broersen, Kerensa; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2261-2274</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanisms by which mutations in the presenilins (PSEN) or the amyloid precursor protein (APP) genes cause familial Alzheimer disease (FAD) are controversial.  FAD mutations increase the release of amyloid β (Aβ)42 relative to Aβ40 by an unknown, possibly gain-of-toxic-function, mechanism.  However, many PSEN mutations paradoxically impair γ-secretase and loss-of-function' mechanisms have also been postulated.  Here, we use kinetic studies to demonstrate that FAD mutations affect Aβ generation via three different mechanisms, resulting in qual. changes in the Aβ profiles, which are not limited to Aβ42.  Loss of ε-cleavage function is not generally obsd. among FAD mutants.  On the other hand, γ-secretase inhibitors used in the clinic appear to block the initial ε-cleavage step, but unexpectedly affect more selectively Notch than APP processing, while modulators act as activators of the carboxypeptidase-like (γ) activity.  Overall, we provide a coherent explanation for the effect of different FAD mutations, demonstrating the importance of qual. rather than quant. changes in the Aβ products, and suggest fundamental improvements for current drug development efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkaq2xb4Rkd7Vg90H21EOLACvtfcHk0ljyDFwhHSB05A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFWjsbg%253D&md5=75a7fd9dbecf3d24739426545aa3f6b8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Femboj.2012.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2012.79%26sid%3Dliteratum%253Aachs%26aulast%3DChavez-Gutierrez%26aufirst%3DL.%26aulast%3DBammens%26aufirst%3DL.%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DVandersteen%26aufirst%3DA.%26aulast%3DBenurwar%26aufirst%3DM.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3DLismont%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DVan%2BCleynenbreugel%26aufirst%3DS.%26aulast%3DEsselmann%26aufirst%3DH.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DSchymkowitz%26aufirst%3DJ.%26aulast%3DRousseau%26aufirst%3DF.%26aulast%3DBroersen%26aufirst%3DK.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520mechanism%2520of%2520gamma-secretase%2520dysfunction%2520in%2520familial%2520alzheimer%2520disease%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D2261%26epage%3D2274%26doi%3D10.1038%2Femboj.2012.79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title">Processive proteolysis by gamma-secretase and the mechanism of alzheimer’s disease</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">905</span><span class="refDoi"> DOI: 10.1515/hsz-2012-0140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1515%2Fhsz-2012-0140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22944690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGiurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2012&pages=899-905&author=M.+S.+Wolfe&title=Processive+proteolysis+by+gamma-secretase+and+the+mechanism+of+alzheimer%E2%80%99s+disease&doi=10.1515%2Fhsz-2012-0140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Processive proteolysis by γ-secretase and the mechanism of Alzheimer's disease</span></div><div class="casAuthors">Wolfe, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">899-905</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  γ-Secretase is a membrane-embedded protease complex with presenilin as the catalytic component.  Cleavage within the transmembrane domain of the amyloid β-protein precursor (APP) by γ-secretase produces the C-terminus of the amyloid β-peptide (Aβ), a proteolytic product prone to aggregation and strongly linked to Alzheimer's disease (AD).  Presenilin mutations are assocd. with early-onset AD, but their pathogenic mechanisms are unclear.  One hypothesis is that these mutations cause AD through a toxic gain of function, changing γ-secretase activity to increase the proportion of 42-residue Aβ over the more sol. 40-residue form.  A competing hypothesis is that the mutations cause AD through a loss of function, by reducing γ-secretase activity.  However, γ-secretase apparently has two types of activities, an endoproteolytic function that first cuts APP to generate a 48/49-residue form of Aβ, and a carboxypeptidase activity that processively trims these longer Aβ intermediates approx. every three residues to form shorter, secreted forms.  Recent studies suggest a resoln. of the gain-of-function vs. loss-of-function debate: presenilin mutations may increase the proportion of longer, more aggregation-prone Aβ by specifically decreasing the trimming activity of γ-secretase.  That is, the redn. of this particular proteolytic function of presenilin, not its endoproteolytic activity, may lead to the neurotoxic gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyz5nTenrC7bVg90H21EOLACvtfcHk0ljyDFwhHSB05A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGiurrM&md5=fcc7ed67a1127168594af1200f5943e3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2012-0140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2012-0140%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3DProcessive%2520proteolysis%2520by%2520gamma-secretase%2520and%2520the%2520mechanism%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiol.%2520Chem.%26date%3D2012%26volume%3D393%26spage%3D899%26epage%3D905%26doi%3D10.1515%2Fhsz-2012-0140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Weidemann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhard, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paliga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baier, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyreuther, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evin, G.</span><span> </span><span class="NLM_article-title">A novel epsilon-cleavage within the transmembrane domain of the alzheimer amyloid precursor protein demonstrates homology with notch processing</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2825</span><span class="NLM_x">–</span> <span class="NLM_lpage">2835</span><span class="refDoi"> DOI: 10.1021/bi015794o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi015794o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2825-2835&author=A.+Weidemannauthor=S.+Eggertauthor=F.+B.+Reinhardauthor=M.+Vogelauthor=K.+Paligaauthor=G.+Baierauthor=C.+L.+Mastersauthor=K.+Beyreutherauthor=G.+Evin&title=A+novel+epsilon-cleavage+within+the+transmembrane+domain+of+the+alzheimer+amyloid+precursor+protein+demonstrates+homology+with+notch+processing&doi=10.1021%2Fbi015794o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fbi015794o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi015794o%26sid%3Dliteratum%253Aachs%26aulast%3DWeidemann%26aufirst%3DA.%26aulast%3DEggert%26aufirst%3DS.%26aulast%3DReinhard%26aufirst%3DF.%2BB.%26aulast%3DVogel%26aufirst%3DM.%26aulast%3DPaliga%26aufirst%3DK.%26aulast%3DBaier%26aufirst%3DG.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBeyreuther%26aufirst%3DK.%26aulast%3DEvin%26aufirst%3DG.%26atitle%3DA%2520novel%2520epsilon-cleavage%2520within%2520the%2520transmembrane%2520domain%2520of%2520the%2520alzheimer%2520amyloid%2520precursor%2520protein%2520demonstrates%2520homology%2520with%2520notch%2520processing%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D2825%26epage%3D2835%26doi%3D10.1021%2Fbi015794o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span> </span><span class="NLM_article-title">Gamma-cleavage is dependent on zeta-cleavage during the proteolytic processing of amyloid precursor protein within its transmembrane domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">37689</span><span class="NLM_x">–</span> <span class="NLM_lpage">37697</span><span class="refDoi"> DOI: 10.1074/jbc.M507993200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M507993200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=37689-37697&author=G.+Zhaoauthor=M.+Z.+Cuiauthor=G.+Maoauthor=Y.+Dongauthor=J.+Tanauthor=L.+Sunauthor=X.+Xu&title=Gamma-cleavage+is+dependent+on+zeta-cleavage+during+the+proteolytic+processing+of+amyloid+precursor+protein+within+its+transmembrane+domain&doi=10.1074%2Fjbc.M507993200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M507993200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M507993200%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DM.%2BZ.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DGamma-cleavage%2520is%2520dependent%2520on%2520zeta-cleavage%2520during%2520the%2520proteolytic%2520processing%2520of%2520amyloid%2520precursor%2520protein%2520within%2520its%2520transmembrane%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D37689%26epage%3D37697%26doi%3D10.1074%2Fjbc.M507993200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Funamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirotani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span> </span><span class="NLM_article-title">Truncated carboxyl-terminal fragments of beta-amyloid precursor protein are processed to amyloid beta-proteins 40 and 42</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">13532</span><span class="NLM_x">–</span> <span class="NLM_lpage">13540</span><span class="refDoi"> DOI: 10.1021/bi049399k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi049399k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=13532-13540&author=S.+Funamotoauthor=M.+Morishima-Kawashimaauthor=Y.+Tanimuraauthor=N.+Hirotaniauthor=T.+C.+Saidoauthor=Y.+Ihara&title=Truncated+carboxyl-terminal+fragments+of+beta-amyloid+precursor+protein+are+processed+to+amyloid+beta-proteins+40+and+42&doi=10.1021%2Fbi049399k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi049399k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049399k%26sid%3Dliteratum%253Aachs%26aulast%3DFunamoto%26aufirst%3DS.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DTanimura%26aufirst%3DY.%26aulast%3DHirotani%26aufirst%3DN.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DIhara%26aufirst%3DY.%26atitle%3DTruncated%2520carboxyl-terminal%2520fragments%2520of%2520beta-amyloid%2520precursor%2520protein%2520are%2520processed%2520to%2520amyloid%2520beta-proteins%252040%2520and%252042%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D13532%26epage%3D13540%26doi%3D10.1021%2Fbi049399k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Yagishita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span> </span><span class="NLM_article-title">Abeta46 is processed to abeta40 and abeta43, but not to abeta42, in the low density membrane domains</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span><span class="refDoi"> DOI: 10.1074/jbc.M707103200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M707103200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=733-738&author=S.+Yagishitaauthor=M.+Morishima-Kawashimaauthor=S.+Ishiuraauthor=Y.+Ihara&title=Abeta46+is+processed+to+abeta40+and+abeta43%2C+but+not+to+abeta42%2C+in+the+low+density+membrane+domains&doi=10.1074%2Fjbc.M707103200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M707103200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M707103200%26sid%3Dliteratum%253Aachs%26aulast%3DYagishita%26aufirst%3DS.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DIshiura%26aufirst%3DS.%26aulast%3DIhara%26aufirst%3DY.%26atitle%3DAbeta46%2520is%2520processed%2520to%2520abeta40%2520and%2520abeta43%252C%2520but%2520not%2520to%2520abeta42%252C%2520in%2520the%2520low%2520density%2520membrane%2520domains%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D733%26epage%3D738%26doi%3D10.1074%2Fjbc.M707103200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Takami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagashima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span> </span><span class="NLM_article-title">Gamma-secretase: Successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">13042</span><span class="NLM_x">–</span> <span class="NLM_lpage">13052</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2362-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1523%2FJNEUROSCI.2362-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=19828817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSitL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=13042-13052&author=M.+Takamiauthor=Y.+Nagashimaauthor=Y.+Sanoauthor=S.+Ishiharaauthor=M.+Morishima-Kawashimaauthor=S.+Funamotoauthor=Y.+Ihara&title=Gamma-secretase%3A+Successive+tripeptide+and+tetrapeptide+release+from+the+transmembrane+domain+of+beta-carboxyl+terminal+fragment&doi=10.1523%2FJNEUROSCI.2362-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of β-carboxyl terminal fragment</span></div><div class="casAuthors">Takami, Mako; Nagashima, Yu; Sano, Yoshihisa; Ishihara, Seiko; Morishima-Kawashima, Maho; Funamoto, Satoru; Ihara, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">13042-13052</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid β protein (Aβ), a pathogenic mol. assocd. with Alzheimer's disease, is produced by γ-secretase, which cleaves the β-carboxyl terminal fragment (βCTF) of β-amyloid precursor protein (APP) in the middle of its transmembrane domain.  How the cleavage proceeds within the membrane has long been enigmatic.  We hypothesized previously that βCTF is cleaved first at the membrane-cytoplasm boundary, producing two long Aβs, Aβ48 and Aβ49, which are processed further by releasing three residues at each step to produce Aβ42 and Aβ40, resp.  To test this hypothesis, we used liq. chromatog. tandem mass spectrometry (LC-MS/MS) to quantify the specific tripeptides that are postulated to be released.  Using CHAPSO (3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxyl-1-propanesulfonate)-reconstituted γ-secretase system, we confirmed that Aβ49 is converted to Aβ43/40 by successively releasing two or three tripeptides and that Aβ48 is converted to Aβ42/38 by successively releasing two tripeptides or these plus an addnl. tetrapeptide.  Most unexpectedly, LC-MS/MS quantification revealed an induction period, 3-4 min, in the generation of peptides.  When extrapolated, each time line for each tripeptide appears to intercept the same point on the x-axis.  According to numerical simulation based on the successive reaction kinetics, the induction period exists.  These results strongly suggest that Aβ is generated through the stepwise processing of βCTF by γ-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYC-g_Nhz9QrVg90H21EOLACvtfcHk0ljEgSW-7A23aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSitL%252FM&md5=7123eb2419feeace3500a2ba4f42de43</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2362-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2362-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DTakami%26aufirst%3DM.%26aulast%3DNagashima%26aufirst%3DY.%26aulast%3DSano%26aufirst%3DY.%26aulast%3DIshihara%26aufirst%3DS.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DFunamoto%26aufirst%3DS.%26aulast%3DIhara%26aufirst%3DY.%26atitle%3DGamma-secretase%253A%2520Successive%2520tripeptide%2520and%2520tetrapeptide%2520release%2520from%2520the%2520transmembrane%2520domain%2520of%2520beta-carboxyl%2520terminal%2520fragment%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D13042%26epage%3D13052%26doi%3D10.1523%2FJNEUROSCI.2362-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Qi-Takahara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolios, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirotani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikoshi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kametani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span> </span><span class="NLM_article-title">Longer forms of amyloid beta protein: Implications for the mechanism of intramembrane cleavage by gamma-secretase</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1575-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1523%2FJNEUROSCI.1575-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=15647487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptV2isw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=436-445&author=Y.+Qi-Takaharaauthor=M.+Morishima-Kawashimaauthor=Y.+Tanimuraauthor=G.+Doliosauthor=N.+Hirotaniauthor=Y.+Horikoshiauthor=F.+Kametaniauthor=M.+Maedaauthor=T.+C.+Saidoauthor=R.+Wangauthor=Y.+Ihara&title=Longer+forms+of+amyloid+beta+protein%3A+Implications+for+the+mechanism+of+intramembrane+cleavage+by+gamma-secretase&doi=10.1523%2FJNEUROSCI.1575-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Longer forms of amyloid β protein: Implications for the mechanism of intramembrane cleavage by γ-secretase</span></div><div class="casAuthors">Qi-Takahara, Yue; Morishima-Kawashima, Maho; Tanimura, Yu; Dolios, Georgia; Hirotani, Naoko; Horikoshi, Yuko; Kametani, Fuyuki; Maeda, Masahiro; Saido, Takaomi C.; Wang, Rong; Ihara, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">436-445</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">γ-Cleavage of β-amyloid precursor protein (APP) in the middle of the cell membrane generates amyloid β protein (Aβ), and ε-cleavage, ∼10 residues downstream of the γ-cleavage site, releases the APP intracellular domain (AICD).  A significant link between generation of Aβ and AICD and failure to detect AICD41-99 led us to hypothesize that ε-cleavage generates longer Aβs, which are then processed to Aβ40/42.  Using newly developed gel systems and an N-end-specific monoclonal antibody, the authors have identified the longer Aβs (Aβ1-43, Aβ1-45, Aβ1-46, and Aβ1-48) within the cells and in brain tissues.  The prodn. of these longer Aβs as well as Aβ40/42 is presenilin dependent and is suppressed by {1S-benzyl-4R-[1S-carbamoyl-2-phenylethylcarbamoyl-1S-3-methylbutylcarbamoyl]-2R-hydroxy-5-phenylpentyl}carbamic acid tert-Bu ester, a transition state analog inhibitor for aspartyl protease.  In contrast, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-Bu ester, a potent dipeptide γ-secretase inhibitor, builds up Aβ1-43 and Aβ1-46 intracellularly, which was also confirmed by mass spectrometry.  Notably, suppression of Aβ40 appeared to lead to an increase in Aβ43, which in turn brings an increase in Aβ46, in a dose-dependent manner.  We therefore propose an α-helical model in which longer Aβ species generated by ε-cleavage is cleaved at every 3 residues in its carboxyl portion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZa3fdqQdlBbVg90H21EOLACvtfcHk0ljOobe62FgmJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptV2isw%253D%253D&md5=0fc17e80b8e775421ed5d521c80e1a30</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1575-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1575-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DQi-Takahara%26aufirst%3DY.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DTanimura%26aufirst%3DY.%26aulast%3DDolios%26aufirst%3DG.%26aulast%3DHirotani%26aufirst%3DN.%26aulast%3DHorikoshi%26aufirst%3DY.%26aulast%3DKametani%26aufirst%3DF.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DIhara%26aufirst%3DY.%26atitle%3DLonger%2520forms%2520of%2520amyloid%2520beta%2520protein%253A%2520Implications%2520for%2520the%2520mechanism%2520of%2520intramembrane%2520cleavage%2520by%2520gamma-secretase%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D436%26epage%3D445%26doi%3D10.1523%2FJNEUROSCI.1575-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Matsumura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada-Kakuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span> </span><span class="NLM_article-title">Gamma-secretase associated with lipid rafts: Multiple interactive pathways in the stepwise processing of beta-carboxyl-terminal fragment</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">5109</span><span class="NLM_x">–</span> <span class="NLM_lpage">5121</span><span class="refDoi"> DOI: 10.1074/jbc.M113.510131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M113.510131" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=5109-5121&author=N.+Matsumuraauthor=M.+Takamiauthor=M.+Okochiauthor=S.+Wada-Kakudaauthor=H.+Fujiwaraauthor=S.+Tagamiauthor=S.+Funamotoauthor=Y.+Iharaauthor=M.+Morishima-Kawashima&title=Gamma-secretase+associated+with+lipid+rafts%3A+Multiple+interactive+pathways+in+the+stepwise+processing+of+beta-carboxyl-terminal+fragment&doi=10.1074%2Fjbc.M113.510131"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.510131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.510131%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DN.%26aulast%3DTakami%26aufirst%3DM.%26aulast%3DOkochi%26aufirst%3DM.%26aulast%3DWada-Kakuda%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DTagami%26aufirst%3DS.%26aulast%3DFunamoto%26aufirst%3DS.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26atitle%3DGamma-secretase%2520associated%2520with%2520lipid%2520rafts%253A%2520Multiple%2520interactive%2520pathways%2520in%2520the%2520stepwise%2520processing%2520of%2520beta-carboxyl-terminal%2520fragment%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D5109%26epage%3D5121%26doi%3D10.1074%2Fjbc.M113.510131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Shimojo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizoroki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichinose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span> </span><span class="NLM_article-title">Enzymatic characteristics of i213t mutant presenilin-1/gamma-secretase in cell models and knock-in mouse brains: Familial alzheimer disease-linked mutation impairs gamma-site cleavage of amyloid precursor protein c-terminal fragment beta</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">16488</span><span class="NLM_x">–</span> <span class="NLM_lpage">16496</span><span class="refDoi"> DOI: 10.1074/jbc.M801279200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M801279200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=16488-16496&author=M.+Shimojoauthor=N.+Saharaauthor=T.+Mizorokiauthor=S.+Funamotoauthor=M.+Morishima-Kawashimaauthor=T.+Kudoauthor=M.+Takedaauthor=Y.+Iharaauthor=H.+Ichinoseauthor=A.+Takashima&title=Enzymatic+characteristics+of+i213t+mutant+presenilin-1%2Fgamma-secretase+in+cell+models+and+knock-in+mouse+brains%3A+Familial+alzheimer+disease-linked+mutation+impairs+gamma-site+cleavage+of+amyloid+precursor+protein+c-terminal+fragment+beta&doi=10.1074%2Fjbc.M801279200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M801279200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M801279200%26sid%3Dliteratum%253Aachs%26aulast%3DShimojo%26aufirst%3DM.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DMizoroki%26aufirst%3DT.%26aulast%3DFunamoto%26aufirst%3DS.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DKudo%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DIchinose%26aufirst%3DH.%26aulast%3DTakashima%26aufirst%3DA.%26atitle%3DEnzymatic%2520characteristics%2520of%2520i213t%2520mutant%2520presenilin-1%252Fgamma-secretase%2520in%2520cell%2520models%2520and%2520knock-in%2520mouse%2520brains%253A%2520Familial%2520alzheimer%2520disease-linked%2520mutation%2520impairs%2520gamma-site%2520cleavage%2520of%2520amyloid%2520precursor%2520protein%2520c-terminal%2520fragment%2520beta%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D16488%26epage%3D16496%26doi%3D10.1074%2Fjbc.M801279200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Okochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span> </span><span class="NLM_article-title">Gamma-secretase modulators and presenilin 1 mutants act differently on presenilin/gamma-secretase function to cleave abeta42 and abeta43</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1016/j.celrep.2012.11.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.celrep.2012.11.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23291095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=42-51&author=M.+Okochiauthor=S.+Tagamiauthor=K.+Yanagidaauthor=M.+Takamiauthor=T.+S.+Kodamaauthor=K.+Moriauthor=T.+Nakayamaauthor=Y.+Iharaauthor=M.+Takeda&title=Gamma-secretase+modulators+and+presenilin+1+mutants+act+differently+on+presenilin%2Fgamma-secretase+function+to+cleave+abeta42+and+abeta43&doi=10.1016%2Fj.celrep.2012.11.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators and Presenilin 1 Mutants Act Differently on Presenilin/γ-Secretase Function to Cleave Aβ42 and Aβ43</span></div><div class="casAuthors">Okochi, Masayasu; Tagami, Shinji; Yanagida, Kanta; Takami, Mako; Kodama, Takashi S.; Mori, Kohji; Nakayama, Taisuke; Ihara, Yasuo; Takeda, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-51</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Deciphering the mechanism by which the relative Aβ42(43) to total Aβ ratio is regulated is central to understanding Alzheimer disease (AD) etiol.; however, the mechanisms underlying changes in the Aβ42(43) ratio caused by familial mutations and γ-secretase modulators (GSMs) are unclear.  Here, we show in vitro and in living cells that presenilin (PS)/γ-secretase cleaves Aβ42 into Aβ38, and Aβ43 into Aβ40 or Aβ38.  Approx. 40% of Aβ38 is derived from Aβ43.  Aβ42(43) cleavage is involved in the regulation of the Aβ42(43) ratio in living cells.  GSMs increase the cleavage of PS/γ-secretase-bound Aβ42 (increase kcat) and slow its dissocn. from the enzyme (decrease kb), whereas PS1 mutants and inverse GSMs show the opposite effects.  Therefore, we suggest a concept to describe the Aβ42(43) prodn. process and propose how GSMs act, and we suggest that a loss of PS/γ-secretase function to cleave Aβ42(43) may initiate AD and might represent a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJEYS_49n8hbVg90H21EOLACvtfcHk0lj3QDyzGcBoFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSrsLo%253D&md5=ca7695ce5fd0d6506b27ec00cd3a4918</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.11.028%26sid%3Dliteratum%253Aachs%26aulast%3DOkochi%26aufirst%3DM.%26aulast%3DTagami%26aufirst%3DS.%26aulast%3DYanagida%26aufirst%3DK.%26aulast%3DTakami%26aufirst%3DM.%26aulast%3DKodama%26aufirst%3DT.%2BS.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DM.%26atitle%3DGamma-secretase%2520modulators%2520and%2520presenilin%25201%2520mutants%2520act%2520differently%2520on%2520presenilin%252Fgamma-secretase%2520function%2520to%2520cleave%2520abeta42%2520and%2520abeta43%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D42%26epage%3D51%26doi%3D10.1016%2Fj.celrep.2012.11.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Szaruga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veugelen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benurwar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lismont, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez-Gutierrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepulveda-Falla, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lleo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lashley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Qualitative changes in human γ-secretase underlie familial alzheimer’s disease</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">2003</span><span class="NLM_x">–</span> <span class="NLM_lpage">2013</span><span class="refDoi"> DOI: 10.1084/jem.20150892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1084%2Fjem.20150892" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2015&pages=2003-2013&author=M.+Szarugaauthor=S.+Veugelenauthor=M.+Benurwarauthor=S.+Lismontauthor=L.+Chavez-Gutierrezauthor=D.+Sepulveda-Fallaauthor=A.+Lleoauthor=N.+S.+Ryanauthor=N.+C.+Foxauthor=T.+Lashleyauthor=S.+Murayamaauthor=H.+Gijsenauthor=B.+De+Strooper&title=Qualitative+changes+in+human+%CE%B3-secretase+underlie+familial+alzheimer%E2%80%99s+disease&doi=10.1084%2Fjem.20150892"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1084%2Fjem.20150892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20150892%26sid%3Dliteratum%253Aachs%26aulast%3DSzaruga%26aufirst%3DM.%26aulast%3DVeugelen%26aufirst%3DS.%26aulast%3DBenurwar%26aufirst%3DM.%26aulast%3DLismont%26aufirst%3DS.%26aulast%3DChavez-Gutierrez%26aufirst%3DL.%26aulast%3DSepulveda-Falla%26aufirst%3DD.%26aulast%3DLleo%26aufirst%3DA.%26aulast%3DRyan%26aufirst%3DN.%2BS.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DLashley%26aufirst%3DT.%26aulast%3DMurayama%26aufirst%3DS.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DQualitative%2520changes%2520in%2520human%2520%25CE%25B3-secretase%2520underlie%2520familial%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2015%26volume%3D212%26spage%3D2003%26epage%3D2013%26doi%3D10.1084%2Fjem.20150892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Kretner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutsmiedl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span> </span><span class="NLM_article-title">Attenuated aβ42 responses to low potency γ-secretase modulators can be overcome for many pathogenic presenilin mutants by second-generation compounds</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">15240</span><span class="NLM_x">–</span> <span class="NLM_lpage">15251</span><span class="refDoi"> DOI: 10.1074/jbc.M110.213587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M110.213587" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=15240-15251&author=B.+Kretnerauthor=A.+Fukumoriauthor=A.+Gutsmiedlauthor=R.+M.+Pageauthor=T.+Luebbersauthor=G.+Galleyauthor=K.+Baumannauthor=C.+Haassauthor=H.+Steiner&title=Attenuated+a%CE%B242+responses+to+low+potency+%CE%B3-secretase+modulators+can+be+overcome+for+many+pathogenic+presenilin+mutants+by+second-generation+compounds&doi=10.1074%2Fjbc.M110.213587"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.213587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.213587%26sid%3Dliteratum%253Aachs%26aulast%3DKretner%26aufirst%3DB.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DGutsmiedl%26aufirst%3DA.%26aulast%3DPage%26aufirst%3DR.%2BM.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DGalley%26aufirst%3DG.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DAttenuated%2520a%25CE%25B242%2520responses%2520to%2520low%2520potency%2520%25CE%25B3-secretase%2520modulators%2520can%2520be%2520overcome%2520for%2520many%2520pathogenic%2520presenilin%2520mutants%2520by%2520second-generation%2520compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D15240%26epage%3D15251%26doi%3D10.1074%2Fjbc.M110.213587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Coric, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dyck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brody, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soininen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiovitz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portelius, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, R. M.</span><span> </span><span class="NLM_article-title">Safety and tolerability of the gamma-secretase inhibitor avagacestat in a phase 2 study of mild to moderate alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1430</span><span class="NLM_x">–</span> <span class="NLM_lpage">1440</span><span class="refDoi"> DOI: 10.1001/archneurol.2012.2194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1001%2Farchneurol.2012.2194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22892585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A280%3ADC%252BC38fotVSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2012&pages=1430-1440&author=V.+Coricauthor=C.+H.+van+Dyckauthor=S.+Sallowayauthor=N.+Andreasenauthor=M.+Brodyauthor=R.+W.+Richterauthor=H.+Soininenauthor=S.+Theinauthor=T.+Shiovitzauthor=G.+Pilcherauthor=S.+Colbyauthor=L.+Rollinauthor=R.+Dockensauthor=C.+Pachaiauthor=E.+Porteliusauthor=U.+Andreassonauthor=K.+Blennowauthor=H.+Soaresauthor=C.+Albrightauthor=H.+H.+Feldmanauthor=R.+M.+Berman&title=Safety+and+tolerability+of+the+gamma-secretase+inhibitor+avagacestat+in+a+phase+2+study+of+mild+to+moderate+alzheimer+disease&doi=10.1001%2Farchneurol.2012.2194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease</span></div><div class="casAuthors">Coric Vladimir; van Dyck Christopher H; Salloway Stephen; Andreasen Niels; Brody Mark; Richter Ralph W; Soininen Hilkka; Thein Stephen; Shiovitz Thomas; Pilcher Gary; Colby Susan; Rollin Linda; Dockens Randy; Pachai Chahin; Portelius Erik; Andreasson Ulf; Blennow Kaj; Soares Holly; Albright Charles; Feldman Howard H; Berman Robert M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1430-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To assess the safety, tolerability, and pharmacokinetic and pharmacodynamic effects of the -secretase inhibitor avagacestat in patients with mild to moderate Alzheimer disease (AD).  DESIGN:  Randomized, double-blind, placebo-controlled,24-week phase 2 study.  SETTING:  Global, multicenter trial.  PATIENTS:  A total of 209 outpatients with mild to moderate AD were randomized into the double-blind treatment phase.  The median age of the patients was 75 years,58.9% were APOE ε4 carriers, and baseline measures of disease severity were similar among groups.  INTERVENTION:  Avagacestat, 25, 50, 100, or 125 mg daily,or placebo administered orally daily.  MAIN OUTCOME MEASURES:  Safety and tolerability of avagacestat.  RESULTS:  Discontinuation rates for the 25-mg and 50-mg doses of avagacestat were comparable with placebo but were higher in the 100-mg and 125-mg dose groups.Trends for worsening cognition, as measured by change from baseline Alzheimer Disease Assessment Scale cognitive subscale score, were observed in the 100-mg and125-mg dose groups.  Treatment-emergent serious adverse events were similar across placebo and treatment groups.  The most common reason for discontinuation was adverse events, predominantly gastrointestinal anddermatologic.  Other adverse events occurring more frequentlyin patients undergoing treatment included reversibleglycosuria (without associated serum glucose changes), nonmelanoma skin cancer, and asymptomaticmagnetic resonance imaging findings.  Exploratory cerebrospinal fluid amyloid isoforms and tau biomarker analysis demonstrated dose-dependent but not statistically significant reductions in a small subset of patients.  CONCLUSIONS:  Avagacestat dosed at 25 and 50 mg daily was relatively well tolerated and had low discontinuation rates.  The 100-mg and 125-mg dose arms were poorly tolerated with trends for cognitive worsening.  Exploratory cerebrospinal fluid biomarker substudies provide preliminary support for -secretase target engagement,but additional studies are warranted to better characterize pharmacodynamic effects at the 25- and 50-mg doses.This study establishes an acceptable safety and tolerability dose range for future avagacestat studies in AD.  TRIAL REGISTRATION:  clinicaltrials.gov Identifier: NCT00810147</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuwXa-F7HH9okFb3mqPUYDfW6udTcc2eYitcPvkG_Q07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fotVSgtw%253D%253D&md5=b0935144b0569050bd45f25029694282</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2012.2194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2012.2194%26sid%3Dliteratum%253Aachs%26aulast%3DCoric%26aufirst%3DV.%26aulast%3Dvan%2BDyck%26aufirst%3DC.%2BH.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DBrody%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DR.%2BW.%26aulast%3DSoininen%26aufirst%3DH.%26aulast%3DThein%26aufirst%3DS.%26aulast%3DShiovitz%26aufirst%3DT.%26aulast%3DPilcher%26aufirst%3DG.%26aulast%3DColby%26aufirst%3DS.%26aulast%3DRollin%26aufirst%3DL.%26aulast%3DDockens%26aufirst%3DR.%26aulast%3DPachai%26aufirst%3DC.%26aulast%3DPortelius%26aufirst%3DE.%26aulast%3DAndreasson%26aufirst%3DU.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DSoares%26aufirst%3DH.%26aulast%3DAlbright%26aufirst%3DC.%26aulast%3DFeldman%26aufirst%3DH.%2BH.%26aulast%3DBerman%26aufirst%3DR.%2BM.%26atitle%3DSafety%2520and%2520tolerability%2520of%2520the%2520gamma-secretase%2520inhibitor%2520avagacestat%2520in%2520a%2520phase%25202%2520study%2520of%2520mild%2520to%2520moderate%2520alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2012%26volume%3D69%26spage%3D1430%26epage%3D1440%26doi%3D10.1001%2Farchneurol.2012.2194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Schroeter, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisslinger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopan, R.</span><span> </span><span class="NLM_article-title">Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span><span class="refDoi"> DOI: 10.1038/30756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2F30756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=9620803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFKgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=1998&pages=382-386&author=E.+H.+Schroeterauthor=J.+A.+Kisslingerauthor=R.+Kopan&title=Notch-1+signalling+requires+ligand-induced+proteolytic+release+of+intracellular+domain&doi=10.1038%2F30756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Notch-1 signaling requires ligand-induced proteolytic release of intracellular domain</span></div><div class="casAuthors">Schroeter, Eric H.; Kisslinger, Jeffrey A.; Kopan, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">6683</span>),
    <span class="NLM_cas:pages">382-386</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Notch proteins are ligand-activated transmembranes receptors involved in cell-fate selection throughout development.  No known enzymic activity is contained within Notch and the mol. mechanism by which it transduces signals across the cell membrane is poorly understood.  In many instances, Notch activation results in transcriptional changes in the nucleus through an assocn. with membranes of the CSL family of DNA-binding proteins (where CSL stands for CBF1, Su(H), Lag-1).  As Notch is located in the plasma membrane and CSL is a nuclear protein, two models have been proposed to explain how they interact.  The first suggests that the two interact transiently at the membrane.  The second postulates the Notch is cleaved by a protease, enabling the cleaved fragment to enter the nucleus.  Here we show that signaling by a constitutively active membrane-bound Notch-1 protein requires the proteolytic release of the Notch intracellular domain (NICD), which interacts preferentially with CSL.  Very small amts. of NICD are active, explaining why it is hard to detect in the nucleus in vivo.  We also show that it is ligand binding that induces release of NICD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn9GiDcGKFZLVg90H21EOLACvtfcHk0lh8b_gE3G6rSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFKgt78%253D&md5=57c820844266305f1624a6e71e06d44f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2F30756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F30756%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeter%26aufirst%3DE.%2BH.%26aulast%3DKisslinger%26aufirst%3DJ.%2BA.%26aulast%3DKopan%26aufirst%3DR.%26atitle%3DNotch-1%2520signalling%2520requires%2520ligand-induced%2520proteolytic%2520release%2520of%2520intracellular%2520domain%26jtitle%3DNature%26date%3D1998%26volume%3D393%26spage%3D382%26epage%3D386%26doi%3D10.1038%2F30756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Mitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarimizu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akashiba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shitaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, N.</span><span> </span><span class="NLM_article-title">Differential effects between gamma-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2037</span><span class="NLM_x">–</span> <span class="NLM_lpage">2050</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4264-11.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1523%2FJNEUROSCI.4264-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22323718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFantbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=2037-2050&author=Y.+Mitaniauthor=J.+Yarimizuauthor=K.+Saitaauthor=H.+Uchinoauthor=H.+Akashibaauthor=Y.+Shitakaauthor=K.+Niauthor=N.+Matsuoka&title=Differential+effects+between+gamma-secretase+inhibitors+and+modulators+on+cognitive+function+in+amyloid+precursor+protein-transgenic+and+nontransgenic+mice&doi=10.1523%2FJNEUROSCI.4264-11.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice</span></div><div class="casAuthors">Mitani, Yasuyuki; Yarimizu, Junko; Saita, Kyoko; Uchino, Hiroshi; Akashiba, Hiroki; Shitaka, Yoshitsugu; Ni, Keni; Matsuoka, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2037-2050</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">γ-Secretase inhibitors (GSIs) reduce amyloid-β (Aβ) peptides but inevitably increase the β-C-terminal fragment (β-CTF) of amyloid precursor protein (APP), potentially having undesirable effects on synapses.  In contrast, γ-secretase modulators (GSMs) reduce Aβ42 without increasing β-CTF.  Although the Aβ-lowering effects of these compds. have been extensively studied, little effort has been made to investigate their effects on cognition.  Here, we compared the effects of two GSIs-(2S)-2-hydroxy-3-methyl-N-[(2S)-1-{[(1S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl]amino}-1-oxopropan-2-yl]butanamide (LY450139, semagacestat) and (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxazol-3-yl)phenyl]methyl]amino-5,5,5-trifluoropentanamide (BMS-708163)-and a second-generation GSM [{(2S,4R)-1-[(4R)-1,1,1-trifluoro-7-methyloctan-4-yl]-2-[4-(trifluoromethyl)phenyl]piperidin-4-yl}acetic acid (GSM-2)] on spatial working memory in APP-transgenic (Tg2576) and nontransgenic mice using the Y-maze task.  While acute dosing with either GSI ameliorated memory deficits in 5.5-mo-old Tg2576 mice, these effects disappeared after 8 d subchronic dosing.  Subchronic dosing with either GSI rather impaired normal cognition in 3-mo-old Tg2576 mice, with no inhibition on the processing of other γ-secretase substrates, such as Notch, N-cadherin, or EphA4, in the brain.  LY450139 also impaired normal cognition in wild-type mice; however, the potency was 10-fold lower than that in Tg2576 mice, indicating an APP-dependent mechanism likely with β-CTF accumulation.  Immunofluorescence studies revealed that the β-CTF accumulation was localized in the presynaptic terminals of the hippocampal stratum lucidum and dentate hilus, implying an effect on presynaptic function in the mossy fibers.  In contrast, both acute and subchronic dosing with GSM-2 significantly ameliorated memory deficits in Tg2576 mice and did not affect normal cognition in wild-type mice.  We demonstrated a clear difference between GSI and GSM in effects on functional consequences, providing new insights into strategies for developing these drugs against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCQSvDeM5057Vg90H21EOLACvtfcHk0liH-gZfhcD0iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFantbw%253D&md5=8b822c8ce2e99faaf881dde88c50224b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4264-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4264-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DMitani%26aufirst%3DY.%26aulast%3DYarimizu%26aufirst%3DJ.%26aulast%3DSaita%26aufirst%3DK.%26aulast%3DUchino%26aufirst%3DH.%26aulast%3DAkashiba%26aufirst%3DH.%26aulast%3DShitaka%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DN.%26atitle%3DDifferential%2520effects%2520between%2520gamma-secretase%2520inhibitors%2520and%2520modulators%2520on%2520cognitive%2520function%2520in%2520amyloid%2520precursor%2520protein-transgenic%2520and%2520nontransgenic%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D2037%26epage%3D2050%26doi%3D10.1523%2FJNEUROSCI.4264-11.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Inoue, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguchi-Tawarada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katahira-Tayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takai, Y.</span><span> </span><span class="NLM_article-title">Synaptic activity prompts gamma-secretase-mediated cleavage of epha4 and dendritic spine formation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1083/jcb.200809151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1083%2Fjcb.200809151" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2009&pages=551-564&author=E.+Inoueauthor=M.+Deguchi-Tawaradaauthor=A.+Togawaauthor=C.+Matsuiauthor=K.+Aritaauthor=S.+Katahira-Tayamaauthor=T.+Satoauthor=E.+Yamauchiauthor=Y.+Odaauthor=Y.+Takai&title=Synaptic+activity+prompts+gamma-secretase-mediated+cleavage+of+epha4+and+dendritic+spine+formation&doi=10.1083%2Fjcb.200809151"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200809151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200809151%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DE.%26aulast%3DDeguchi-Tawarada%26aufirst%3DM.%26aulast%3DTogawa%26aufirst%3DA.%26aulast%3DMatsui%26aufirst%3DC.%26aulast%3DArita%26aufirst%3DK.%26aulast%3DKatahira-Tayama%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DYamauchi%26aufirst%3DE.%26aulast%3DOda%26aufirst%3DY.%26aulast%3DTakai%26aufirst%3DY.%26atitle%3DSynaptic%2520activity%2520prompts%2520gamma-secretase-mediated%2520cleavage%2520of%2520epha4%2520and%2520dendritic%2520spine%2520formation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2009%26volume%3D185%26spage%3D551%26epage%3D564%26doi%3D10.1083%2Fjcb.200809151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Lanz, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karmilowicz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, K. E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebbinghaus, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spracklin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, L.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auperin, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachter, J. B.</span><span> </span><span class="NLM_article-title">Concentration-dependent modulation of amyloid-β in vivo and in vitro using the γ-secretase inhibitor, ly-450139</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">924</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span><span class="refDoi"> DOI: 10.1124/jpet.106.110700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1124%2Fjpet.106.110700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=16920992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOkurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=924-933&author=T.+A.+Lanzauthor=M.+J.+Karmilowiczauthor=K.+M.+Woodauthor=N.+Pozdnyakovauthor=P.+Duauthor=M.+A.+Piotrowskiauthor=T.+M.+Brownauthor=C.+E.+Nolanauthor=K.+E.+G.+Richterauthor=J.+E.+Finleyauthor=Q.+Feiauthor=C.+F.+Ebbinghausauthor=Y.+L.+Chenauthor=D.+K.+Spracklinauthor=B.+Tateauthor=K.+F.+Geogheganauthor=L.-F.+Lauauthor=D.+D.+Auperinauthor=J.+B.+Schachter&title=Concentration-dependent+modulation+of+amyloid-%CE%B2+in+vivo+and+in+vitro+using+the+%CE%B3-secretase+inhibitor%2C+ly-450139&doi=10.1124%2Fjpet.106.110700"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Concentration-dependent modulation of amyloid-β in vivo and in vitro using the γ-secretase inhibitor, LY-450139</span></div><div class="casAuthors">Lanz, Thomas A.; Karmilowicz, Michael J.; Wood, Kathleen M.; Pozdnyakov, Nikolay; Du, Ping; Piotrowski, Mary A.; Brown, Tracy M.; Nolan, Charles E.; Richter, Karl E. G.; Finley, James E.; Fei, Qing; Ebbinghaus, Charles F.; Chen, Yuhpyng L.; Spracklin, Douglas K.; Tate, Barbara; Geoghegan, Kieran F.; Lau, Lit-Fui; Auperin, David D.; Schachter, Joel B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">924-933</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">LY-450139 is a γ-secretase inhibitor shown to have efficacy in multiple cellular and animal models.  Paradoxically, robust elevations of plasma amyloid-β (Aβ) have been reported in dogs and humans after administration of subefficacious doses.  The present study sought to further evaluate Aβ responses to LY-450139 in the guinea pig, a nontransgenic model that has an Aβ sequence identical to that of human.  Male guinea pigs were treated with LY-450139 (0.2-60 mg/kg), and brain, cerebrospinal fluid, and plasma Aβ levels were characterized at 1, 3, 6, 9, and 14 h postdose.  Low doses significantly elevated plasma Aβ levels at early time points, with return to baseline within hours.  Higher doses inhibited Aβ levels in all compartments at early time points, but elevated plasma Aβ levels at later time points.  To det. whether this phenomenon occurs under steady-state drug exposure, guinea pigs were implanted with s.c. minipumps delivering LY-450139 (0.3-30 mg/kg/day) for 5 days.  Plasma Aβ was significantly inhibited at 10-30 mg/kg/day, but significantly elevated at 1 mg/kg/day.  To further understand the mechanism of Aβ elevation by LY-450139, H4 cells overexpressing the Swedish mutant of amyloid-precursor protein and a mouse embryonic stem cell-derived neuronal cell line were studied.  In both cellular models, elevated levels of secreted Aβ were obsd. at subefficacious concns., whereas dose-responsive inhibition was obsd. at higher concns.  These results suggest that LY-450139 modulates the γ-secretase complex, eliciting Aβ lowering at high concns. but Aβ elevation at low concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2z_DmwmXT1LVg90H21EOLACvtfcHk0li8xtjqTWLAww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOkurnN&md5=682602abb67f2b36d7d802a14b3b24de</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.110700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.110700%26sid%3Dliteratum%253Aachs%26aulast%3DLanz%26aufirst%3DT.%2BA.%26aulast%3DKarmilowicz%26aufirst%3DM.%2BJ.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DDu%26aufirst%3DP.%26aulast%3DPiotrowski%26aufirst%3DM.%2BA.%26aulast%3DBrown%26aufirst%3DT.%2BM.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DRichter%26aufirst%3DK.%2BE.%2BG.%26aulast%3DFinley%26aufirst%3DJ.%2BE.%26aulast%3DFei%26aufirst%3DQ.%26aulast%3DEbbinghaus%26aufirst%3DC.%2BF.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DLau%26aufirst%3DL.-F.%26aulast%3DAuperin%26aufirst%3DD.%2BD.%26aulast%3DSchachter%26aufirst%3DJ.%2BB.%26atitle%3DConcentration-dependent%2520modulation%2520of%2520amyloid-%25CE%25B2%2520in%2520vivo%2520and%2520in%2520vitro%2520using%2520the%2520%25CE%25B3-secretase%2520inhibitor%252C%2520ly-450139%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D924%26epage%3D933%26doi%3D10.1124%2Fjpet.106.110700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Gillman, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starrett, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcin, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElhone, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mate, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span> </span><span class="NLM_article-title">Discovery and evaluation of BMS-708163, a potent, selective and orally bioavailable gamma-secretase inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1021/ml1000239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1000239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=120-124&author=K.+W.+Gillmanauthor=J.+E.+Starrettauthor=M.+F.+Parkerauthor=K.+Xieauthor=J.+J.+Bronsonauthor=L.+R.+Marcinauthor=K.+E.+McElhoneauthor=C.+P.+Bergstromauthor=R.+A.+Mateauthor=R.+Williamsauthor=J.+E.+Meredithauthor=C.+R.+Burtonauthor=D.+M.+Bartenauthor=J.+H.+Toynauthor=S.+B.+Robertsauthor=K.+A.+Lentzauthor=J.+G.+Houstonauthor=R.+Zaczekauthor=C.+F.+Albrightauthor=C.+P.+Deciccoauthor=J.+E.+Macorauthor=R.+E.+Olson&title=Discovery+and+evaluation+of+BMS-708163%2C+a+potent%2C+selective+and+orally+bioavailable+gamma-secretase+inhibitor&doi=10.1021%2Fml1000239"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fml1000239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000239%26sid%3Dliteratum%253Aachs%26aulast%3DGillman%26aufirst%3DK.%2BW.%26aulast%3DStarrett%26aufirst%3DJ.%2BE.%26aulast%3DParker%26aufirst%3DM.%2BF.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMarcin%26aufirst%3DL.%2BR.%26aulast%3DMcElhone%26aufirst%3DK.%2BE.%26aulast%3DBergstrom%26aufirst%3DC.%2BP.%26aulast%3DMate%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DHouston%26aufirst%3DJ.%2BG.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520BMS-708163%252C%2520a%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520gamma-secretase%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D120%26epage%3D124%26doi%3D10.1021%2Fml1000239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slemmon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denton, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhyne, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raybon, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guss, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simutis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillman, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starrett, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sverdlov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaneda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coric, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, G.</span><span> </span><span class="NLM_article-title">Pharmacodynamics of selective inhibition of gamma-secretase by avagacestat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span><span class="refDoi"> DOI: 10.1124/jpet.112.199356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1124%2Fjpet.112.199356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23275065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVaisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2013&pages=686-695&author=C.+F.+Albrightauthor=R.+C.+Dockensauthor=J.+E.+Meredithauthor=R.+E.+Olsonauthor=R.+Slemmonauthor=K.+A.+Lentzauthor=J.+S.+Wangauthor=R.+R.+Dentonauthor=G.+Pilcherauthor=P.+W.+Rhyneauthor=J.+J.+Raybonauthor=D.+M.+Bartenauthor=C.+Burtonauthor=J.+H.+Toynauthor=S.+Sankaranarayananauthor=C.+Polsonauthor=V.+Gussauthor=R.+Whiteauthor=F.+Simutisauthor=T.+Sandersonauthor=K.+W.+Gillmanauthor=J.+E.+Starrettauthor=J.+Bronsonauthor=O.+Sverdlovauthor=S.+P.+Huangauthor=L.+Castanedaauthor=H.+Feldmanauthor=V.+Coricauthor=R.+Zaczekauthor=J.+E.+Macorauthor=J.+Houstonauthor=R.+M.+Bermanauthor=G.+Tong&title=Pharmacodynamics+of+selective+inhibition+of+gamma-secretase+by+avagacestat&doi=10.1124%2Fjpet.112.199356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamics of selective inhibition of γ-secretase by avagacestat</span></div><div class="casAuthors">Albright, Charles F.; Dockens, Randy C.; Meredith, Jere E., Jr.; Olson, Richard E.; Slemmon, Randy; Lentz, Kimberley A.; Wang, Jun-Sheng; Denton, R. Rex; Pilcher, Gary; Rhyne, Paul W.; Raybon, Joseph J.; Barten, Donna M.; Burton, Catherine; Toyn, Jeremy H.; Sankaranarayanan, Sethu; Polson, Craig; Guss, Valerie; White, Randy; Simutis, Frank; Sanderson, Thomas; Gillman, Kevin W.; Starrett, John E., Jr.; Bronson, Joanne; Sverdlov, Oleksandr; Huang, Shu-Pang; Castaneda, Loma; Feldman, Howard; Coric, Vlad; Zaczek, Robert; Macor, John E.; Houston, John; Berman, Robert M.; Tong, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">686-695</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A hallmark of Alzheimer's disease (AD) pathol. is the accumulation of brain amyloid β-peptide (Aβ), generated by γ-secretase-mediated cleavage of the amyloid precursor protein (APP).  Therefore, γ-secretase inhibitors (GSIs) may lower brain Aβ and offer a potential new approach to treat AD.  As γ-secretase also cleaves Notch proteins, GSIs can have undesirable effects due to interference with Notch signaling.  Avagacestat (BMS-708163) is a GSI developed for selective inhibition of APP over Notch cleavage.  Avagacestat inhibition of APP and Notch cleavage was evaluated in cell culture by measuring levels of Aβ and human Notch proteins.  In rats, dogs, and humans, selectivity was evaluated by measuring plasma blood concns. in relation to effects on cerebrospinal fluid (CSF) Aβ levels and Notch-related toxicities.  Measurements of Notch-related toxicity included goblet cell metaplasia in the gut, marginal-zone depletion in the spleen, redns. in B cells, and changes in expression of the Notch-regulated hairy and enhancer of split homolog-1 from blood cells.  In rats and dogs, acute administration of avagacestat robustly reduced CSF Aβ40 and Aβ42 levels similarly.  Chronic administration in rats and dogs, and 28-day, single- and multiple-ascending-dose administration in healthy human subjects caused similar exposure-dependent redns. in CSF Aβ40.  Consistent with the 137-fold selectivity measured in cell culture, we identified doses of avagacestat that reduce CSF Aβ levels without causing Notch-related toxicities.  Our results demonstrate the selectivity of avagacestat for APP over Notch cleavage, supporting further evaluation of avagacestat for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5fAxZamNybbVg90H21EOLACvtfcHk0lglPijGJByFzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVaisr8%253D&md5=91241c812b36909ea783288520bc6af5</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.199356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.199356%26sid%3Dliteratum%253Aachs%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DDockens%26aufirst%3DR.%2BC.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DSlemmon%26aufirst%3DR.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DJ.%2BS.%26aulast%3DDenton%26aufirst%3DR.%2BR.%26aulast%3DPilcher%26aufirst%3DG.%26aulast%3DRhyne%26aufirst%3DP.%2BW.%26aulast%3DRaybon%26aufirst%3DJ.%2BJ.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DBurton%26aufirst%3DC.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DPolson%26aufirst%3DC.%26aulast%3DGuss%26aufirst%3DV.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DSimutis%26aufirst%3DF.%26aulast%3DSanderson%26aufirst%3DT.%26aulast%3DGillman%26aufirst%3DK.%2BW.%26aulast%3DStarrett%26aufirst%3DJ.%2BE.%26aulast%3DBronson%26aufirst%3DJ.%26aulast%3DSverdlov%26aufirst%3DO.%26aulast%3DHuang%26aufirst%3DS.%2BP.%26aulast%3DCastaneda%26aufirst%3DL.%26aulast%3DFeldman%26aufirst%3DH.%26aulast%3DCoric%26aufirst%3DV.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DHouston%26aufirst%3DJ.%26aulast%3DBerman%26aufirst%3DR.%2BM.%26aulast%3DTong%26aufirst%3DG.%26atitle%3DPharmacodynamics%2520of%2520selective%2520inhibition%2520of%2520gamma-secretase%2520by%2520avagacestat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D344%26spage%3D686%26epage%3D695%26doi%3D10.1124%2Fjpet.112.199356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">McKee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, R. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarayskiy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span> </span><span class="NLM_article-title">An improved cell-based method for determining the γ-secretase enzyme activity against both notch and app substrates</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">213</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.1016/j.jneumeth.2012.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.jneumeth.2012.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23219895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Krurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2013&pages=14-21&author=T.+D.+McKeeauthor=R.+M.+B.+Loureiroauthor=J.+A.+Duminauthor=V.+Zarayskiyauthor=B.+Tate&title=An+improved+cell-based+method+for+determining+the+%CE%B3-secretase+enzyme+activity+against+both+notch+and+app+substrates&doi=10.1016%2Fj.jneumeth.2012.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates</span></div><div class="casAuthors">McKee, Timothy D.; Loureiro, Robyn M. B.; Dumin, Jo Ann; Zarayskiy, Vladislav; Tate, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-21</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">γ-Secretase modulators (GSM), which reduce amyloidogenic Aβ42 prodn. while maintaining total Aβ levels, and Notch-sparing γ-secretase inhibitors (GSIs) are promising therapies for the treatment of Alzheimer's Disease (AD).  To have a safety margin for therapeutic use, GSMs and GSIs need to allow Notch intracellular domain (NICD) prodn., while preventing neurotoxic Aβ peptide prodn.  Typically, GSI and GSM effects on these substrates are detd. using two different cell lines, one for the measurement of enzyme activity against each substrate.  However, predicting selectivity for different substrates across cell systems may reduce the reliability of such ratios such that the in vitro data are not useful for predicting in vivo safety margins.  This is esp. concerning since the IC50's of some GSIs vary depending upon the level of APP expression in a cell line.  To circumvent this problem, we utilized the SUP-T1 cell line which expresses a truncated Notch receptor fragment that does not need sheddase cleavage to be a γ-secretase substrate.  When combined with a sensitive method of measuring Aβ prodn., this assay system allows both substrates to be measured simultaneously, reducing the potential to calc. imprecise selectivity margins.  To demonstrate the value of this system, known GSIs and GSMs were examd. in the SUP-T1 dual substrate assay.  IC50's were detd. for both substrates and the in vitro selectivity margin was calcd.  These data suggest using a single cell line is a more accurate prediction of the fold difference between NICD inhibition and Aβ42 lowering for therapeutically promising GSIs and GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6-E8Ymt3CbVg90H21EOLACvtfcHk0ljgDb2z5UcVLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Krurs%253D&md5=3bd99971c4f9015d4ccd7c5a2e5980d6</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2012.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2012.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DLoureiro%26aufirst%3DR.%2BM.%2BB.%26aulast%3DDumin%26aufirst%3DJ.%2BA.%26aulast%3DZarayskiy%26aufirst%3DV.%26aulast%3DTate%26aufirst%3DB.%26atitle%3DAn%2520improved%2520cell-based%2520method%2520for%2520determining%2520the%2520%25CE%25B3-secretase%2520enzyme%2520activity%2520against%2520both%2520notch%2520and%2520app%2520substrates%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2013%26volume%3D213%26spage%3D14%26epage%3D21%26doi%3D10.1016%2Fj.jneumeth.2012.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span> </span><span class="NLM_article-title">BMS-708,163 targets presenilin and lacks notch-sparing activity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7209</span><span class="NLM_x">–</span> <span class="NLM_lpage">7211</span><span class="refDoi"> DOI: 10.1021/bi301137h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi301137h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ymsrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=7209-7211&author=C.+J.+Crumpauthor=S.+V.+Castroauthor=F.+Wangauthor=N.+Pozdnyakovauthor=T.+E.+Ballardauthor=S.+S.+Sisodiaauthor=K.+R.+Balesauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=BMS-708%2C163+targets+presenilin+and+lacks+notch-sparing+activity&doi=10.1021%2Fbi301137h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">BMS-708,163 Targets Presenilin and Lacks Notch-Sparing Activity</span></div><div class="casAuthors">Crump, Christina J.; Castro, Suita V.; Wang, Feng; Pozdnyakov, Nikolay; Ballard, T. Eric; Sisodia, Sangram S.; Bales, Kelly R.; Johnson, Douglas S.; Li, Yue-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">7209-7211</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Notch-sparing γ-secretase inhibitor (GSI) BMS-708,163 (Avagacestat) is currently in phase II clin. trials for Alzheimer's disease.  Unlike previously failed GSIs, BMS-708,163 is considered to be a promising drug candidate because of its reported Notch-sparing activity for the inhibition of Aβ prodn. over Notch cleavage.  We now report that BMS-708,163 binds directly to the presenilin-1 N-terminal fragment and that binding can be challenged by other pan-GSIs, but not by γ-secretase modulators.  Furthermore, BMS-708,163 blocks the binding of four different active site-directed GSI photoaffinity probes.  We therefore report that this compd. acts as a nonselective γ-secretase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbN7OtNj8yxLVg90H21EOLACvtfcHk0ljgDb2z5UcVLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ymsrzL&md5=c473842172969f3260e33ca758f08778</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fbi301137h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi301137h%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DCastro%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DBMS-708%252C163%2520targets%2520presenilin%2520and%2520lacks%2520notch-sparing%2520activity%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D7209%26epage%3D7211%26doi%3D10.1021%2Fbi301137h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Kuperstein, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozenski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonckheere, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debulpaep, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandersteen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segers-Nolten, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Werf, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramaniam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braeken, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callewaert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Hooge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schymkowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Neurotoxicity of alzheimer’s disease abeta peptides is induced by small changes in the abeta42 to abeta40 ratio</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">3408</span><span class="NLM_x">–</span> <span class="NLM_lpage">3420</span><span class="refDoi"> DOI: 10.1038/emboj.2010.211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Femboj.2010.211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=20818335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSmsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=3408-3420&author=I.+Kupersteinauthor=K.+Broersenauthor=I.+Benilovaauthor=J.+Rozenskiauthor=W.+Jonckheereauthor=M.+Debulpaepauthor=A.+Vandersteenauthor=I.+Segers-Noltenauthor=K.+Van+Der+Werfauthor=V.+Subramaniamauthor=D.+Braekenauthor=G.+Callewaertauthor=C.+Barticauthor=R.+D%E2%80%99Hoogeauthor=I.+C.+Martinsauthor=F.+Rousseauauthor=J.+Schymkowitzauthor=B.+De+Strooper&title=Neurotoxicity+of+alzheimer%E2%80%99s+disease+abeta+peptides+is+induced+by+small+changes+in+the+abeta42+to+abeta40+ratio&doi=10.1038%2Femboj.2010.211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotoxicity of Alzheimer's disease A peptides is induced by small changes in the A42 to A40 ratio</span></div><div class="casAuthors">Kuperstein, Inna; Broersen, Kerensa; Benilova, Iryna; Rozenski, Jef; Jonckheere, Wim; Debulpaep, Maja; Vandersteen, Annelies; Segers-Nolten, Ine; Van Der Werf, Kees; Subramaniam, Vinod; Braeken, Dries; Callewaert, Geert; Bartic, Carmen; D'Hooge, Rudi; Martins, Ivo Cristiano; Rousseau, Frederic; Schymkowitz, Joost; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3408-3420</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The amyloid peptides A40 and A42 of Alzheimer's disease are thought to contribute differentially to the disease process.  Although A42 seems more pathogenic than A40, the reason for this is not well understood.  We show here that small alterations in the A42:A40 ratio dramatically affect the biophys. and biol. properties of the A mixts. reflected in their aggregation kinetics, the morphol. of the resulting amyloid fibrils and synaptic function tested in vitro and in vivo.  A minor increase in the A42:A40 ratio stabilizes toxic oligomeric species with intermediate conformations.  The initial toxic impact of these A species is synaptic in nature, but this can spread into the cells leading to neuronal cell death.  The fact that the relative ratio of A peptides is more crucial than the abs. amts. of peptides for the induction of neurotoxic conformations has important implications for anti-amyloid therapy.  Our work also suggests the dynamic nature of the equil. between toxic and non-toxic intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR-22pazffF7Vg90H21EOLACvtfcHk0lixoO0JSoesvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSmsbzP&md5=1048db62830cd821652c6337364d067d</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Femboj.2010.211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2010.211%26sid%3Dliteratum%253Aachs%26aulast%3DKuperstein%26aufirst%3DI.%26aulast%3DBroersen%26aufirst%3DK.%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DRozenski%26aufirst%3DJ.%26aulast%3DJonckheere%26aufirst%3DW.%26aulast%3DDebulpaep%26aufirst%3DM.%26aulast%3DVandersteen%26aufirst%3DA.%26aulast%3DSegers-Nolten%26aufirst%3DI.%26aulast%3DVan%2BDer%2BWerf%26aufirst%3DK.%26aulast%3DSubramaniam%26aufirst%3DV.%26aulast%3DBraeken%26aufirst%3DD.%26aulast%3DCallewaert%26aufirst%3DG.%26aulast%3DBartic%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Hooge%26aufirst%3DR.%26aulast%3DMartins%26aufirst%3DI.%2BC.%26aulast%3DRousseau%26aufirst%3DF.%26aulast%3DSchymkowitz%26aufirst%3DJ.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DNeurotoxicity%2520of%2520alzheimer%25E2%2580%2599s%2520disease%2520abeta%2520peptides%2520is%2520induced%2520by%2520small%2520changes%2520in%2520the%2520abeta42%2520to%2520abeta40%2520ratio%26jtitle%3DEMBO%2520J.%26date%3D2010%26volume%3D29%26spage%3D3408%26epage%3D3420%26doi%3D10.1038%2Femboj.2010.211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onstead, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwizinski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span> </span><span class="NLM_article-title">Abeta40 inhibits amyloid deposition in vivo</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4849-06.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1523%2FJNEUROSCI.4849-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=17234594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSkurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=627-633&author=J.+Kimauthor=L.+Onsteadauthor=S.+Randleauthor=R.+Priceauthor=L.+Smithsonauthor=C.+Zwizinskiauthor=D.+W.+Dicksonauthor=T.+Goldeauthor=E.+McGowan&title=Abeta40+inhibits+amyloid+deposition+in+vivo&doi=10.1523%2FJNEUROSCI.4849-06.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ40 inhibits amyloid deposition in vivo</span></div><div class="casAuthors">Kim, Jungsu; Onstead, Luisa; Randle, Suzanne; Price, Robert; Smithson, Lisa; Zwizinski, Craig; Dickson, Dennis W.; Golde, Todd; McGowan, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">627-633</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Numerous studies have established a pivotal role for Aβ42 in Alzheimer's disease (AD) pathogenesis.  In contrast, although Aβ40 is the predominant form of amyloid β (Aβ) produced and accumulates to a variable degree in the human AD brain, its role in AD pathogenesis has not been established.  It has generally been assumed that an increase in Aβ40 would accelerate amyloid plaque formation in vivo.  We have crossed BRI-Aβ40 mice that selectively express high levels of Aβ40 with both Tg2576 (APPswe, K670N + M671L) mice and BRI-Aβ42A mice expressing Aβ42 selectively and analyzed parenchymal and cerebrovascular Aβ deposition in the bitransgenic mice compared with their singly transgenic littermates.  In the bitransgenic mice, the increased steady-state levels of Aβ40 decreased Aβ deposition by 60-90%.  These results demonstrate that Aβ42 and Aβ40 have opposing effects on amyloid deposition: Aβ42 promotes amyloid deposition but Aβ40 inhibits it.  In addn., increasing Aβ40 levels protected BRI-Aβ40/Tg2576 mice from the premature-death phenotype obsd. in Tg2576 mice.  The protective properties of Aβ40 with respect to amyloid deposition suggest that strategies that preferentially target Aβ40 may actually worsen the disease course and that selective increases in Aβ40 levels may actually reduce the risk for development of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBkk_HKSaW0bVg90H21EOLACvtfcHk0lixoO0JSoesvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSkurg%253D&md5=503d71263bf85911413a264fe360490a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4849-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4849-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DOnstead%26aufirst%3DL.%26aulast%3DRandle%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DR.%26aulast%3DSmithson%26aufirst%3DL.%26aulast%3DZwizinski%26aufirst%3DC.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DGolde%26aufirst%3DT.%26aulast%3DMcGowan%26aufirst%3DE.%26atitle%3DAbeta40%2520inhibits%2520amyloid%2520deposition%2520in%2520vivo%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D627%26epage%3D633%26doi%3D10.1523%2FJNEUROSCI.4849-06.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-secretase modulators: A review of patents from 2008 to 2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span><span class="refDoi"> DOI: 10.1517/13543776.2011.547479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1517%2F13543776.2011.547479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=21231889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=205-226&author=M.+Petterssonauthor=G.+W.+Kauffmanauthor=C.+W.+am+Endeauthor=N.+C.+Patelauthor=C.+Stiffauthor=T.+P.+Tranauthor=D.+S.+Johnson&title=Novel+%CE%B3-secretase+modulators%3A+A+review+of+patents+from+2008+to+2010&doi=10.1517%2F13543776.2011.547479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span></div><div class="casAuthors">Pettersson, Martin; Kauffman, Gregory W.; am Ende, Christopher W.; Patel, Nandini C.; Stiff, Cory; Tran, Tuan P.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-226</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The amyloid precursor protein is first cleaved by β-secretase to generate a 99-residue membrane-bound CTF (C99 or β-CTF), which is subsequently cleaved by γ-secretase to generate amyloid β (Aβ) peptides and the APP intracellular domain.  The amyloidogenic Aβ42 has attracted considerable attention because it is thought to be the most pathogenic species assocd. with Alzheimer's disease progression.  New classes of compds., called γ-secretase modulators (GSMs), have been shown to selectively lower Aβ42 prodn. without shutting down key γ-secretase-dependent signaling pathways.  This has become an important therapeutic strategy aimed at modulating Aβ prodn.  The progress on the clin. development of γ-secretase inhibitors is briefly covered in this review, followed by a discussion of the potential differentiating attributes of GSMs.  Then, the patent literature covering novel GSMs is reviewed, focusing on patents from 2008 to 2010.  Much progress has been made in the past 2 years on developing GSMs with improved potency for lowering the prodn. of Aβ42.  However, many of these chemotypes are in a challenging chem. space and generally possess higher lipophilicity than most CNS drugs.  It will be important to gain a better understanding of the specific target(s) that these GSMs interact with in order to facilitate future drug design efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocCQHiTfGSILVg90H21EOLACvtfcHk0lh5mL3h48ozRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D&md5=9e52482a492eea96f9f88b59742e38ce</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.547479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.547479%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520modulators%253A%2520A%2520review%2520of%2520patents%2520from%25202008%2520to%25202010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D205%26epage%3D226%26doi%3D10.1517%2F13543776.2011.547479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Garofalo, A. W.</span><span> </span><span class="NLM_article-title">Patents targeting γ-secretase inhibition and modulation for the treatment of alzheimer’s disease: 2004 - 2008</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span><span class="refDoi"> DOI: 10.1517/13543776.18.7.693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1517%2F13543776.18.7.693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntlGgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=693-703&author=A.+W.+Garofalo&title=Patents+targeting+%CE%B3-secretase+inhibition+and+modulation+for+the+treatment+of+alzheimer%E2%80%99s+disease%3A+2004+-+2008&doi=10.1517%2F13543776.18.7.693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Patents targeting γ-secretase inhibition and modulation for the treatment of Alzheimer's disease: 2004 - 2008</span></div><div class="casAuthors">Garofalo, Albert W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">693-703</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Although Alzheimer's disease has been defined for over a century, at present there is no effective treatment.  Amyloid deposition and plaque formation are widely believed to contribute to the pathol. of the disease.  As the etiol. of plaque formation has become better understood, the search for therapies has bred small mols. capable of inhibiting or regulating the activity of γ-secretase.  This paper reviews patents from the past 4 years claiming modulators or inhibitors of γ-secretase as a treatment for Alzheimer's disease.  One or two compds. from each patent were selected to represent the claimed chem. space.  Compd. selection was influenced by literature accounts, which are also discussed.  Although an attempt has been made to include major contributions in the field, the list of patents reviewed should not be considered exhaustive.  This review seeks to expand upon a previous review covering patents from 2000-2004.  Since then there has been an increase in the no. of structural and mechanistic approaches being pursued and several compds. have entered the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptzyUbNbn4uLVg90H21EOLACvtfcHk0lh5mL3h48ozRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntlGgu78%253D&md5=a26891676fdd05b0b3c2501824ced28f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.7.693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.7.693%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26atitle%3DPatents%2520targeting%2520%25CE%25B3-secretase%2520inhibition%2520and%2520modulation%2520for%2520the%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%253A%25202004%2520-%25202008%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D693%26epage%3D703%26doi%3D10.1517%2F13543776.18.7.693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span> </span><span class="NLM_article-title">Development and mechanism of γ-secretase modulators for alzheimer’s disease</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3197</span><span class="NLM_x">–</span> <span class="NLM_lpage">3216</span><span class="refDoi"> DOI: 10.1021/bi400377p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi400377p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVCnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=3197-3216&author=C.+J.+Crumpauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=Development+and+mechanism+of+%CE%B3-secretase+modulators+for+alzheimer%E2%80%99s+disease&doi=10.1021%2Fbi400377p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Mechanism of γ-Secretase Modulators for Alzheimer's Disease</span></div><div class="casAuthors">Crump, Christina J.; Johnson, Douglas S.; Li, Yue-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3197-3216</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  γ-Secretase is an aspartyl intramembranal protease composed of presenilin, Nicastrin, Aph1, and Pen2 with 19 transmembrane domains.  γ-Secretase cleaves the amyloid precursor proteins (APP) to release Aβ peptides that likely play a causative role in the pathogenesis of Alzheimer's disease (AD).  In addn., γ-secretase cleaves Notch and other type I membrane proteins.  γ-Secretase inhibitors (GSIs) have been developed and used for clin. studies.  However, clin. trials have shown adverse effects of GSIs that are potentially linked with nondiscriminatory inhibition of Notch signaling, overall APP processing, and other substrate cleavages.  Therefore, these findings call for the development of disease-modifying agents that target γ-secretase activity to lower levels of Aβ42 prodn. without blocking the overall processing of γ-secretase substrates.  γ-Secretase modulators (GSMs) originally derived from nonsteroidal anti-inflammatory drugs (NSAIDs) display such characteristics and are the focus of this review.  However, first-generation GSMs have limited potential because of the low potency and undesired neuropharmacokinetic properties.  This generation of GSMs has been suggested to interact with the APP substrate, γ-secretase, or both.  To improve the potency and brain availability, second-generation GSMs, including NSAID-derived carboxylic acid and non-NSAID-derived heterocyclic chemotypes, as well as natural product-derived GSMs have been developed.  Animal studies of this generation of GSMs have shown encouraging preclin. profiles.  Moreover, using potent GSM photoaffinity probes, multiple studies unambiguously have showed that both carboxylic acid and heterocyclic GSMs specifically target presenilin, the catalytic subunit of γ-secretase.  In addn., two types of GSMs have distinct binding sites within the γ-secretase complex and exhibit different Aβ profiles.  GSMs induce a conformational change of γ-secretase to achieve modulation.  Various models are proposed and discussed.  Despite the progress of GSM research, many outstanding issues remain to be investigated to achieve the ultimate goal of developing GSMs as effective AD therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplaHViKcHC17Vg90H21EOLACvtfcHk0lh5mL3h48ozRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVCnt7w%253D&md5=7210c05b5624c85078accf40a7cf76ac</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fbi400377p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400377p%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DDevelopment%2520and%2520mechanism%2520of%2520%25CE%25B3-secretase%2520modulators%2520for%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D3197%26epage%3D3216%26doi%3D10.1021%2Fbi400377p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrigley, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churcher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">43419</span><span class="NLM_x">–</span> <span class="NLM_lpage">43426</span><span class="refDoi"> DOI: 10.1074/jbc.M404937200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M404937200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=43419-43426&author=D.+Beherauthor=E.+E.+Clarkeauthor=J.+D.+Wrigleyauthor=A.+C.+Martinauthor=A.+Nadinauthor=I.+Churcherauthor=M.+S.+Shearman&title=Selected+non-steroidal+anti-inflammatory+drugs+and+their+derivatives+target+gamma-secretase+at+a+novel+site.+Evidence+for+an+allosteric+mechanism&doi=10.1074%2Fjbc.M404937200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M404937200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M404937200%26sid%3Dliteratum%253Aachs%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DE.%2BE.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%26aulast%3DMartin%26aufirst%3DA.%2BC.%26aulast%3DNadin%26aufirst%3DA.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DSelected%2520non-steroidal%2520anti-inflammatory%2520drugs%2520and%2520their%2520derivatives%2520target%2520gamma-secretase%2520at%2520a%2520novel%2520site.%2520Evidence%2520for%2520an%2520allosteric%2520mechanism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D43419%26epage%3D43426%26doi%3D10.1074%2Fjbc.M404937200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, D.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gertsik, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M.</span><span> </span><span class="NLM_article-title">Piperidine acetic acid based γ-secretase modulators directly bind to presenilin-1</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span><span class="refDoi"> DOI: 10.1021/cn200098p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200098p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaqtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=705-710&author=C.+J.+Crumpauthor=B.+A.+Fishauthor=S.+V.+Castroauthor=D.-M.+Chauauthor=N.+Gertsikauthor=K.+Ahnauthor=C.+Stiffauthor=N.+Pozdnyakovauthor=K.+R.+Balesauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=Piperidine+acetic+acid+based+%CE%B3-secretase+modulators+directly+bind+to+presenilin-1&doi=10.1021%2Fcn200098p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Piperidine Acetic Acid Based γ-Secretase Modulators Directly Bind to Presenilin-1</span></div><div class="casAuthors">Crump, Christina J.; Fish, Benjamin A.; Castro, Suita V.; Chau, De-Ming; Gertsik, Natalya; Ahn, Kwangwook; Stiff, Cory; Pozdnyakov, Nikolay; Bales, Kelly R.; Johnson, Douglas S.; Li, Yue-Ming</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">705-710</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aβ42 is believed to play a causative role in Alzheimer's disease (AD) pathogenesis.  γ-Secretase modulators (GSMs) are actively being pursued as potential AD therapeutics because they selectively alter the cleavage site of the amyloid precursor protein (APP) to reduce the formation of Aβ42.  However, the binding partner of acid based GSMs was unresolved until now.  We have developed clickable photoaffinity probes based on piperidine acetic acid GSM-1 and identified PS1 as the target within the γ-secretase complex.  Furthermore, we provide evidence that allosteric interaction of GSMs with PS1 results in a conformational change in the active site of the γ-secretase complex leading to the obsd. modulation of γ-secretase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYLOY1hkibKrVg90H21EOLACvtfcHk0lhLGAvfbow3Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaqtrbM&md5=6129b8b4d150647165a04d2dd40e9ba9</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fcn200098p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200098p%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DCastro%26aufirst%3DS.%2BV.%26aulast%3DChau%26aufirst%3DD.-M.%26aulast%3DGertsik%26aufirst%3DN.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3DPiperidine%2520acetic%2520acid%2520based%2520%25CE%25B3-secretase%2520modulators%2520directly%2520bind%2520to%2520presenilin-1%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D705%26epage%3D710%26doi%3D10.1021%2Fcn200098p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Ohki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uemura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezovska, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoshima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span> </span><span class="NLM_article-title">Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4815</span><span class="NLM_x">–</span> <span class="NLM_lpage">4824</span><span class="refDoi"> DOI: 10.1038/emboj.2011.372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1038%2Femboj.2011.372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22002539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWltb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=4815-4824&author=Y.+Ohkiauthor=T.+Higoauthor=K.+Uemuraauthor=N.+Shimadaauthor=S.+Osawaauthor=O.+Berezovskaauthor=S.+Yokoshimaauthor=T.+Fukuyamaauthor=T.+Tomitaauthor=T.+Iwatsubo&title=Phenylpiperidine-type+%CE%B3-secretase+modulators+target+the+transmembrane+domain+1+of+presenilin+1&doi=10.1038%2Femboj.2011.372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1</span></div><div class="casAuthors">Ohki, Yu; Higo, Takuya; Uemura, Kengo; Shimada, Naoaki; Osawa, Satoko; Berezovska, Oksana; Yokoshima, Satoshi; Fukuyama, Tohru; Tomita, Taisuke; Iwatsubo, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4815-4824</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Amyloid-β peptide ending at the 42nd residue (Aβ42) is implicated in the pathogenesis of Alzheimer's disease (AD).  Small compds. that exhibit selective lowering effects on Aβ42 prodn. are termed γ-secretase modulators (GSMs) and are deemed promising therapeutic agents against AD, although the mol. target as well as the mechanism of action remains controversial.  Here, we show that a phenylpiperidine-type compd. GSM-1 directly targets the transmembrane domain (TMD) 1 of presenilin 1 (PS1) by photoaffinity labeling expts. combined with limited digestion.  Binding of GSM-1 affected the structure of the initial substrate binding and the catalytic sites of the γ-secretase, thereby decreasing prodn. of Aβ42, possibly by enhancing its conversion to Aβ38.  These data indicate an allosteric action of GSM-1 by directly binding to the TMD1 of PS1, pinpointing the target structure of the phenylpiperidine-type GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt9j8QNf1pW7Vg90H21EOLACvtfcHk0lika2U0NYSnxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWltb3N&md5=e7635158068cd931a820529f43790b09</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Femboj.2011.372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2011.372%26sid%3Dliteratum%253Aachs%26aulast%3DOhki%26aufirst%3DY.%26aulast%3DHigo%26aufirst%3DT.%26aulast%3DUemura%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DN.%26aulast%3DOsawa%26aufirst%3DS.%26aulast%3DBerezovska%26aufirst%3DO.%26aulast%3DYokoshima%26aufirst%3DS.%26aulast%3DFukuyama%26aufirst%3DT.%26aulast%3DTomita%26aufirst%3DT.%26aulast%3DIwatsubo%26aufirst%3DT.%26atitle%3DPhenylpiperidine-type%2520%25CE%25B3-secretase%2520modulators%2520target%2520the%2520transmembrane%2520domain%25201%2520of%2520presenilin%25201%26jtitle%3DEMBO%2520J.%26date%3D2011%26volume%3D30%26spage%3D4815%26epage%3D4824%26doi%3D10.1038%2Femboj.2011.372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Ebke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirotani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span> </span><span class="NLM_article-title">Novel gamma-secretase enzyme modulators directly target presenilin protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">37181</span><span class="NLM_x">–</span> <span class="NLM_lpage">37186</span><span class="refDoi"> DOI: 10.1074/jbc.C111.276972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.C111.276972" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=37181-37186&author=A.+Ebkeauthor=T.+Luebbersauthor=A.+Fukumoriauthor=K.+Shirotaniauthor=C.+Haassauthor=K.+Baumannauthor=H.+Steiner&title=Novel+gamma-secretase+enzyme+modulators+directly+target+presenilin+protein&doi=10.1074%2Fjbc.C111.276972"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C111.276972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C111.276972%26sid%3Dliteratum%253Aachs%26aulast%3DEbke%26aufirst%3DA.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DShirotani%26aufirst%3DK.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DNovel%2520gamma-secretase%2520enzyme%2520modulators%2520directly%2520target%2520presenilin%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D37181%26epage%3D37186%26doi%3D10.1074%2Fjbc.C111.276972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Rennhack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jumpertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ness, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baches, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulic, B.</span><span> </span><span class="NLM_article-title">Synthesis of a potent photoreactive acidic gamma-secretase modulator for target identification in cells</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6532</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmc.2012.08.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6523-6532&author=A.+Rennhackauthor=T.+Jumpertzauthor=J.+Nessauthor=S.+Bachesauthor=C.+U.+Pietrzikauthor=S.+Weggenauthor=B.+Bulic&title=Synthesis+of+a+potent+photoreactive+acidic+gamma-secretase+modulator+for+target+identification+in+cells&doi=10.1016%2Fj.bmc.2012.08.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DRennhack%26aufirst%3DA.%26aulast%3DJumpertz%26aufirst%3DT.%26aulast%3DNess%26aufirst%3DJ.%26aulast%3DBaches%26aufirst%3DS.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DBulic%26aufirst%3DB.%26atitle%3DSynthesis%2520of%2520a%2520potent%2520photoreactive%2520acidic%2520gamma-secretase%2520modulator%2520for%2520target%2520identification%2520in%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6523%26epage%3D6532%26doi%3D10.1016%2Fj.bmc.2012.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Jumpertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennhack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ness, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baches, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span> </span><span class="NLM_article-title">Presenilin is the molecular target of acidic γ-secretase modulators in living cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e30484</span><span class="refDoi"> DOI: 10.1371/journal.pone.0030484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1371%2Fjournal.pone.0030484" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30484&author=T.+Jumpertzauthor=A.+Rennhackauthor=J.+Nessauthor=S.+Bachesauthor=C.+U.+Pietrzikauthor=B.+Bulicauthor=S.+Weggen&title=Presenilin+is+the+molecular+target+of+acidic+%CE%B3-secretase+modulators+in+living+cells&doi=10.1371%2Fjournal.pone.0030484"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030484%26sid%3Dliteratum%253Aachs%26aulast%3DJumpertz%26aufirst%3DT.%26aulast%3DRennhack%26aufirst%3DA.%26aulast%3DNess%26aufirst%3DJ.%26aulast%3DBaches%26aufirst%3DS.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DWeggen%26aufirst%3DS.%26atitle%3DPresenilin%2520is%2520the%2520molecular%2520target%2520of%2520acidic%2520%25CE%25B3-secretase%2520modulators%2520in%2520living%2520cells%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30484%26doi%3D10.1371%2Fjournal.pone.0030484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Gamma-secretase modulator (gsm) photoaffinity probes reveal distinct allosteric binding sites on presenilin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">9710</span><span class="NLM_x">–</span> <span class="NLM_lpage">9720</span><span class="refDoi"> DOI: 10.1074/jbc.M112.398602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1074%2Fjbc.M112.398602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23396974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsVGgsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=9710-9720&author=N.+Pozdnyakovauthor=H.+E.+Murreyauthor=C.+J.+Crumpauthor=M.+Petterssonauthor=T.+E.+Ballardauthor=C.+W.+Am+Endeauthor=K.+Ahnauthor=Y.+M.+Liauthor=K.+R.+Balesauthor=D.+S.+Johnson&title=Gamma-secretase+modulator+%28gsm%29+photoaffinity+probes+reveal+distinct+allosteric+binding+sites+on+presenilin&doi=10.1074%2Fjbc.M112.398602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulator (GSM) Photoaffinity Probes Reveal Distinct Allosteric Binding Sites on Presenilin</span></div><div class="casAuthors">Pozdnyakov, Nikolay; Murrey, Heather E.; Crump, Christina J.; Pettersson, Martin; Ballard, T. Eric; am Ende, Christopher W.; Ahn, Kwangwook; Li, Yue-Ming; Bales, Kelly R.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9710-9720</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">γ-Secretase is an intramembrane aspartyl protease that cleaves the amyloid precursor protein to produce neurotoxic β-amyloid peptides (i.e. Aβ42) that have been implicated in the pathogenesis of Alzheimer disease.  Small mol. γ-secretase modulators (GSMs) have emerged as potential disease-modifying treatments for Alzheimer disease because they reduce the formation of Aβ42 while not blocking the processing of γ-secretase substrates.  We developed clickable GSM photoaffinity probes with the goal of identifying the target of various classes of GSMs and to better understand their mechanism of action.  Here, we demonstrate that the photoaffinity probe E2012-BPyne specifically labels the N-terminal fragment of presenilin-1 (PS1-NTF) in cell membranes as well as in live cells and primary neuronal cultures.  The labeling is competed in the presence of the parent imidazole GSM E2012, but not with acid GSM-1, allosteric GSI (γ-secretase inhibitor) BMS-708163, or substrate docking site peptide inhibitor pep11, providing evidence that these compds. have distinct binding sites.  Surprisingly, we found that the crosslinking of E2012-BPyne to PS1-NTF is significantly enhanced in the presence of the active site-directed GSI L-685,458 (L458).  In contrast, L458 does not affect the labeling of the acid GSM photoprobe GSM-5.  We also obsd. that E2012-BPyne specifically labels PS1-NTF (active γ-secretase) but not full-length PS1 (inactive γ-secretase) in ANP.24 cells.  Taken together, our results support the hypothesis that multiple binding sites within the γ-secretase complex exist, each of which may contribute to different modes of modulatory action.  Furthermore, the enhancement of PS1-NTF labeling by E2012-BPyne in the presence of L458 suggests a degree of cooperativity between the active site of γ-secretase and the modulatory binding site of certain GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotm37CD1tAKbVg90H21EOLACvtfcHk0ljh8H7nnDcxSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsVGgsrc%253D&md5=ee09863af8a589d8a8bbe6e4920474fb</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.398602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.398602%26sid%3Dliteratum%253Aachs%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DMurrey%26aufirst%3DH.%2BE.%26aulast%3DCrump%26aufirst%3DC.%2BJ.%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DAm%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DGamma-secretase%2520modulator%2520%2528gsm%2529%2520photoaffinity%2520probes%2520reveal%2520distinct%2520allosteric%2520binding%2520sites%2520on%2520presenilin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D9710%26epage%3D9720%26doi%3D10.1074%2Fjbc.M112.398602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Takeo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahariev, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takegami, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishizuka-Katsura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi-Niidome, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura-Someya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirouzu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoshima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span> </span><span class="NLM_article-title">Allosteric regulation of gamma-secretase activity by a phenylimidazole-type gamma-secretase modulator</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">10544</span><span class="NLM_x">–</span> <span class="NLM_lpage">10549</span><span class="refDoi"> DOI: 10.1073/pnas.1402171111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1073%2Fpnas.1402171111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=10544-10549&author=K.+Takeoauthor=S.+Tanimuraauthor=T.+Shinodaauthor=S.+Osawaauthor=I.+K.+Zaharievauthor=N.+Takegamiauthor=Y.+Ishizuka-Katsuraauthor=N.+Shinyaauthor=S.+Takagi-Niidomeauthor=A.+Tominagaauthor=N.+Ohsawaauthor=T.+Kimura-Someyaauthor=M.+Shirouzuauthor=S.+Yokoshimaauthor=S.+Yokoyamaauthor=T.+Fukuyamaauthor=T.+Tomitaauthor=T.+Iwatsubo&title=Allosteric+regulation+of+gamma-secretase+activity+by+a+phenylimidazole-type+gamma-secretase+modulator&doi=10.1073%2Fpnas.1402171111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1402171111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1402171111%26sid%3Dliteratum%253Aachs%26aulast%3DTakeo%26aufirst%3DK.%26aulast%3DTanimura%26aufirst%3DS.%26aulast%3DShinoda%26aufirst%3DT.%26aulast%3DOsawa%26aufirst%3DS.%26aulast%3DZahariev%26aufirst%3DI.%2BK.%26aulast%3DTakegami%26aufirst%3DN.%26aulast%3DIshizuka-Katsura%26aufirst%3DY.%26aulast%3DShinya%26aufirst%3DN.%26aulast%3DTakagi-Niidome%26aufirst%3DS.%26aulast%3DTominaga%26aufirst%3DA.%26aulast%3DOhsawa%26aufirst%3DN.%26aulast%3DKimura-Someya%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DYokoshima%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DFukuyama%26aufirst%3DT.%26aulast%3DTomita%26aufirst%3DT.%26aulast%3DIwatsubo%26aufirst%3DT.%26atitle%3DAllosteric%2520regulation%2520of%2520gamma-secretase%2520activity%2520by%2520a%2520phenylimidazole-type%2520gamma-secretase%2520modulator%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D10544%26epage%3D10549%26doi%3D10.1073%2Fpnas.1402171111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from flatland: Increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span><span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+Increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0ljURnCd5xdjww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520Increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span>The JChem Cartridge was used for structure-based property calculation and reporting from Oracle: JChem, version 5.9.0; <span class="NLM_publisher-name">ChemAxon</span>: <span class="NLM_publisher-loc">Budapest, Hungary</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+JChem+Cartridge+was+used+for+structure-based+property+calculation+and+reporting+from+Oracle%3A+JChem%2C+version+5.9.0%3B+ChemAxon%3A+Budapest%2C+Hungary%2C+2012%3B+http%3A%2F%2Fwww.chemaxon.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DJChem%26pub%3DChemAxon%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: The development of a central nervous system multiparameter optimization (cns mpo) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+The+development+of+a+central+nervous+system+multiparameter+optimization+%28cns+mpo%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0ljURnCd5xdjww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520The%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528cns%2520mpo%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">Γ-secretase modulators as potential disease modifying anti-alzheimer’s drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span><span class="refDoi"> DOI: 10.1021/jm101168r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101168r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=669-698&author=D.+Oehlrichauthor=D.+J.+C.+Berthelotauthor=H.+J.+M.+Gijsen&title=%CE%93-secretase+modulators+as+potential+disease+modifying+anti-alzheimer%E2%80%99s+drugs&doi=10.1021%2Fjm101168r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer's Drugs</span></div><div class="casAuthors">Oehlrich, Daniel; Berthelot, Didier J.-C.; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">669-698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvn89jnxR8U7Vg90H21EOLACvtfcHk0ljCEG67U6cNEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbfO&md5=91dfeb6984c718e941635e7b3f60f59f</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101168r%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.%2BC.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3D%25CE%2593-secretase%2520modulators%2520as%2520potential%2520disease%2520modifying%2520anti-alzheimer%25E2%2580%2599s%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D669%26epage%3D698%26doi%3D10.1021%2Fjm101168r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-secretase modulators for the treatment of alzheimer’s disease: A review focusing on patents from 2010 to 2012</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1349</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span><span class="refDoi"> DOI: 10.1517/13543776.2013.821465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1517%2F13543776.2013.821465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23875696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1349-1366&author=M.+Petterssonauthor=A.+F.+Stepanauthor=G.+W.+Kauffmanauthor=D.+S.+Johnson&title=Novel+%CE%B3-secretase+modulators+for+the+treatment+of+alzheimer%E2%80%99s+disease%3A+A+review+focusing+on+patents+from+2010+to+2012&doi=10.1517%2F13543776.2013.821465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012</span></div><div class="casAuthors">Pettersson, Martin; Stepan, Antonia F.; Kauffman, Gregory W.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1349-1366</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: γ-Secretase is the enzyme responsible for the final step of amyloid precursor protein proteolysis to generate Aβ peptides including Aβ42 which is believed to be a toxic species involved in Alzheimer's disease (AD) progression. γ-Secretase modulators (GSMs) have been shown to selectively lower Aβ42 prodn. without affecting total Aβ levels or the formation of γ-secretase substrate intracellular domains such as APP intracellular domain and Notch intracellular domain.  Therefore, GSMs have emerged as an important therapeutic strategy for the treatment of AD.  Areas covered: The literature covering novel GSMs will be reviewed focusing on patents from 2010 to 2012.  Expert opinion: During the last review period (2008 - 2010) considerable progress was made developing GSMs with improved potency for lowering Aβ42 levels, but most of the compds. resided in unfavorable central nervous system (CNS) drug space.  In this review period (2010 - 2012), there is a higher percentage of potent GSM chem. matter that resides in favorable CNS drug space.  It is anticipated that clin. candidates will emerge out of this cohort that will be able to test the GSM mechanism of action in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFLi5hAAdKc7Vg90H21EOLACvtfcHk0ljCEG67U6cNEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fP&md5=6b43a8feb210fa87ded92a26397b754f</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.821465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.821465%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520modulators%2520for%2520the%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%253A%2520A%2520review%2520focusing%2520on%2520patents%2520from%25202010%2520to%25202012%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D1349%26epage%3D1366%26doi%3D10.1517%2F13543776.2013.821465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F. P.</span><span> </span><span class="NLM_article-title">Secretase inhibitors and modulators as a disease-modifying approach against alzheimer’s disease</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span><span class="refDoi"> DOI: 10.1016/B978-0-12-396492-2.00005-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2FB978-0-12-396492-2.00005-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=55-69&author=H.+J.+M.+Gijsenauthor=F.+P.+Bischoff&title=Secretase+inhibitors+and+modulators+as+a+disease-modifying+approach+against+alzheimer%E2%80%99s+disease&doi=10.1016%2FB978-0-12-396492-2.00005-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-396492-2.00005-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-396492-2.00005-9%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26atitle%3DSecretase%2520inhibitors%2520and%2520modulators%2520as%2520a%2520disease-modifying%2520approach%2520against%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D55%26epage%3D69%26doi%3D10.1016%2FB978-0-12-396492-2.00005-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenacchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottonello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, A.</span><span> </span><span class="NLM_article-title">In vitro and in vivo profiling of chf5022 and chf5074 two beta-amyloid1–42 lowering agents</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span><span class="refDoi"> DOI: 10.1016/j.phrs.2006.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.phrs.2006.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=17292621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=318-328&author=B.+P.+Imbimboauthor=E.+Del+Giudiceauthor=V.+Cenacchiauthor=R.+Voltaauthor=G.+Villettiauthor=F.+Facchinettiauthor=B.+Riccardiauthor=P.+Pucciniauthor=N.+Morettoauthor=F.+Grassiauthor=S.+Ottonelloauthor=A.+Leon&title=In+vitro+and+in+vivo+profiling+of+chf5022+and+chf5074+two+beta-amyloid1%E2%80%9342+lowering+agents&doi=10.1016%2Fj.phrs.2006.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo profiling of CHF5022 and CHF5074: Two β-amyloid1-42 lowering agents</span></div><div class="casAuthors">Imbimbo, Bruno P.; Del Giudice, Elda; Cenacchi, Valentina; Volta, Roberta; Villetti, Gino; Facchinetti, Fabrizio; Riccardi, Benedetta; Puccini, Paola; Moretto, Nadia; Grassi, Francesca; Ottonello, Simone; Leon, Alberta</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">318-328</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) may delay or prevent the onset of Alzheimer's disease (AD).  A subset of NSAIDs, including flurbiprofen, has been shown to selectively inhibit the prodn. of β-amyloid1-42 (Aβ42), independently from their cyclooxygenase (COX) inhibiting activity.  We evaluated the in vitro and in vivo profiles of CHF5022 and CHF5074, two flurbiprofen analogs.  The in vitro Aβ inhibiting activity was evaluated in a human neuroglioma cell line (H4) carrying the double Swedish mutation (K595N/M596L) of the human amyloid precursor protein (APPsw).  The in vitro anti-COX activity was evaluated using human recombinant enzymes isolated from transfected Sf-9 cells.  The in vivo pharmacokinetic and pharmacodynamic profiles of the two compds. were evaluated in young APPsw transgenic mice (Tg2576) after oral gavage (100 or 300 mg kg-1 day-1 for 4-5 days) and after medicated diet (375 ppm for 4 wk).  R-Flurbiprofen was used as comparator.  In vitro, CHF5022 and CHF5074 were found to be 3- and 7-fold more potent than R-flurbiprofen in inhibiting Aβ42 secretion (IC50s of 92, 40 and 268 μM, resp.).  Differently from R-flurbiprofen, CHF5022 and CHF5074 did not affect COX-1 (at 100 μM) and COX-2 (at 300 μM) activity.  Similarly to R-flurbiprofen, no significant alteration in the expression profile of a subset of Notch intracellular domain-responsive genes was obsd. with either CHF5022 or CHF5074.  In Tg2576 mice, CHF5022 was well tolerated when administered by oral gavage (100 mg kg-1 day-1 for 5 days) or by medicated diet (56 mg kg-1 day-1 for 4 wk).  R-Flurbiprofen was poorly tolerated in the diet (32 mg kg-1 day-1) with 55% of the animals dying during the first week of treatment.  After 4-5 days of oral gavage, CHF5022 and CHF5074 plasma and brain levels at 3 h were found to increase with the dose, leading to brain concns. of about 10% and 5% of the corresponding plasma concns., resp.  In animals fed for 4 wk with compd.-supplemented diet, mean plasma (580 μM) and brain (20 μ[n.1052]) concns. of CHF5022 were 8 and 15 times higher than those of R-flurbiprofen.  Plasma Aβ42 concn. was dose-dependently decreased by CHF5022 and CHF5074.  Brain Aβ levels (formic acid-extractable) were not significantly affected by either compd., although Aβ42 levels tended to inversely correlate (P = 0.105) with CHF5022 concn. in the brain.  CHF5022 and CHF5074 thus appear to have a promising in vitro and in vivo profile.  This warrants further evaluation of their long-term effects on Aβ brain pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqOFdo5MZ1r7Vg90H21EOLACvtfcHk0ljWAG1IwWbMvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGnsbY%253D&md5=dbcb906a0f3ed14249a65783b3718a70</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2006.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2006.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DDel%2BGiudice%26aufirst%3DE.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DVolta%26aufirst%3DR.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DRiccardi%26aufirst%3DB.%26aulast%3DPuccini%26aufirst%3DP.%26aulast%3DMoretto%26aufirst%3DN.%26aulast%3DGrassi%26aufirst%3DF.%26aulast%3DOttonello%26aufirst%3DS.%26aulast%3DLeon%26aufirst%3DA.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520profiling%2520of%2520chf5022%2520and%2520chf5074%2520two%2520beta-amyloid1%25E2%2580%259342%2520lowering%2520agents%26jtitle%3DPharmacol.%2520Res.%26date%3D2007%26volume%3D55%26spage%3D318%26epage%3D328%26doi%3D10.1016%2Fj.phrs.2006.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Rogers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsenstein, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrdlicka, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albayya, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaulding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgdon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blain, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulsteke, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scrocchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portelius, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlijanian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flood, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patzke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, G.</span><span> </span><span class="NLM_article-title">Modulation of gamma-secretase by evp-0015962 reduces amyloid deposition and behavioral deficits in tg2576 mice</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="refDoi"> DOI: 10.1186/1750-1326-7-61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1186%2F1750-1326-7-61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23249765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFyqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=61&author=K.+Rogersauthor=K.+M.+Felsensteinauthor=L.+Hrdlickaauthor=Z.+Tuauthor=F.+Albayyaauthor=W.+Leeauthor=S.+Hoppauthor=M.+J.+Millerauthor=D.+Spauldingauthor=Z.+Yangauthor=H.+Hodgdonauthor=S.+Nolanauthor=M.+Wenauthor=D.+Costaauthor=J.+F.+Blainauthor=E.+Freemanauthor=B.+De+Strooperauthor=V.+Vulstekeauthor=L.+Scrocchiauthor=H.+Zetterbergauthor=E.+Porteliusauthor=B.+Hutter-Paierauthor=D.+Havasauthor=M.+Ahlijanianauthor=D.+Floodauthor=L.+Leventhalauthor=G.+Shapiroauthor=H.+Patzkeauthor=R.+Chesworthauthor=G.+Koenig&title=Modulation+of+gamma-secretase+by+evp-0015962+reduces+amyloid+deposition+and+behavioral+deficits+in+tg2576+mice&doi=10.1186%2F1750-1326-7-61"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of γ-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 mice</span></div><div class="casAuthors">Rogers, Kathryn; Felsenstein, Kevin M.; Hrdlicka, Lori; Tu, Zhiming; Albayya, Faris; Lee, Winnie; Hopp, Sarah; Miller, Mary-Jo; Spaulding, Darcie; Yang, Zhiyong; Hodgdon, Hilliary; Nolan, Scott; Wen, Melody; Costa, Don; Blain, Jean-Francois; Freeman, Emily; De Strooper, Bart; Vulsteke, Veerle; Scrocchi, Louise; Zetterberg, Henrik; Portelius, Erik; Hutter-Paier, Birgit; Havas, Daniel; Ahlijanian, Michael; Flood, Dorothy; Leventhal, Liza; Shapiro, Gideon; Patzke, Holger; Chesworth, Richard; Koenig, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: A hallmark of Alzheimer's disease is the presence of senile plaques in human brain primarily contg. the amyloid peptides Aβ42 and Aβ40.  Many drug discovery efforts have focused on decreasing the prodn. of Aβ42 through γ-secretase inhibition.  However, identification of γ-secretase inhibitors has also uncovered mechanism-based side effects.  One approach to circumvent these side effects has been modulation of γ-secretase to shift Aβ prodn. to favor shorter, less amyloidogenic peptides than Aβ42, without affecting the overall cleavage efficiency of the enzyme.  This approach, frequently called γ-secretase modulation, appears more promising and has lead to the development of new therapeutic candidates for disease modification in Alzheimer's disease.  Results: Here we describe EVP-0015962, a novel small mol. γ-secretase modulator.  EVP-0015962 decreased Aβ42 in H4 cells (IC50 = 67 nM) and increased the shorter Aβ38 by 1.7 fold at the IC50 for lowering of Aβ42.  AβTotal, as well as other carboxyl-terminal fragments of amyloid precursor protein, were not changed.  EVP-0015962 did not cause the accumulation of other γ-secretase substrates, such as the Notch and ephrin A4 receptors, whereas a γ-secretase inhibitor reduced processing of both.  A single oral dose of EVP-0015962 (30 mg/kg) decreased Aβ42 and did not alter AβTotal peptide levels in a dose-dependent manner in Tg2576 mouse brain at an age when overt Aβ deposition was not present.  In Tg2576 mice, chronic treatment with EVP-0015962 (20 or 60 mg/kg/day in a food formulation) reduced Aβ aggregates, amyloid plaques, inflammatory markers and cognitive deficits.  Conclusions: EVP-0015962 is orally bioavailable, detected in brain and a potent, selective γ-secretase modulator in vitro and in vivo.  Chronic treatment with EVP-0015962 was well tolerated in mice and lowered the prodn. of Aβ42, attenuated memory deficits and reduced Aβ plaque formation and inflammation in Tg2576 transgenic animals.  In summary, these data suggest that γ-secretase modulation with EVP-0015962 represents a viable therapeutic alternative for disease modification in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrawar6w5ZKrrVg90H21EOLACvtfcHk0lhMvihXCF5D-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFyqt78%253D&md5=cc1497b9c84ac2a5de368c81d99789c6</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-7-61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-7-61%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DK.%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26aulast%3DHrdlicka%26aufirst%3DL.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DAlbayya%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DHopp%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26aulast%3DSpaulding%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DHodgdon%26aufirst%3DH.%26aulast%3DNolan%26aufirst%3DS.%26aulast%3DWen%26aufirst%3DM.%26aulast%3DCosta%26aufirst%3DD.%26aulast%3DBlain%26aufirst%3DJ.%2BF.%26aulast%3DFreeman%26aufirst%3DE.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVulsteke%26aufirst%3DV.%26aulast%3DScrocchi%26aufirst%3DL.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DPortelius%26aufirst%3DE.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DHavas%26aufirst%3DD.%26aulast%3DAhlijanian%26aufirst%3DM.%26aulast%3DFlood%26aufirst%3DD.%26aulast%3DLeventhal%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DG.%26aulast%3DPatzke%26aufirst%3DH.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DModulation%2520of%2520gamma-secretase%2520by%2520evp-0015962%2520reduces%2520amyloid%2520deposition%2520and%2520behavioral%2520deficits%2520in%2520tg2576%2520mice%26jtitle%3DMol.%2520Neurodegener.%26date%3D2012%26volume%3D7%26spage%3D61%26doi%3D10.1186%2F1750-1326-7-61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Ross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franceschi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigerio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivilia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicirello, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casula, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Chf5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: A 12-week, double-blind, placebo- controlled study</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span><span class="refDoi"> DOI: 10.2174/13892037113149990144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.2174%2F13892037113149990144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23968157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVylt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=742-753&author=J.+Rossauthor=S.+Sharmaauthor=J.+Winstonauthor=M.+Nunezauthor=G.+Bottiniauthor=M.+Franceschiauthor=E.+Scarpiniauthor=E.+Frigerioauthor=F.+Fiorentiniauthor=M.+Fernandezauthor=S.+Siviliaauthor=L.+Giardinoauthor=L.+Calzaauthor=D.+Norrisauthor=H.+Cicirelloauthor=D.+Casulaauthor=B.+P.+Imbimbo&title=Chf5074+reduces+biomarkers+of+neuroinflammation+in+patients+with+mild+cognitive+impairment%3A+A+12-week%2C+double-blind%2C+placebo-+controlled+study&doi=10.2174%2F13892037113149990144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study</span></div><div class="casAuthors">Ross, Joel; Sharma, Sanjiv; Winston, Jaron; Nunez, Margarita; Bottini, Gabriella; Franceschi, Massimo; Scarpini, Elio; Frigerio, Enrico; Fiorentini, Francesco; Fernandez, Mercedes; Sivilia, Sandra; Giardino, Luciana; Calza, Laura; Norris, Dottie; Cicirello, Helen; Casula, Daniela; Imbimbo, Bruno P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">742-753</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">As neuroinflammation is an early event in the pathogenesis of Alzheimer' s disease, new selective antiinflammatory drugs could lead to promising preventive strategies.  We evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of CHF5074, a new microglial modulator, in a 12-wk, double-blind, placebo-controlled, parallel groups, ascending dose study involving 96 MCI patients.  Subjects were allocated into three successive study cohorts to receive ascending, titrated doses of CHF5074 (200, 400 or 600 mg/day) or placebo.  Vital signs, cardiac safety, neuropsychol. performance and safety clin. lab. parameters were assessed on all subjects.  Plasma samples were collected throughout the study for measuring drug concns., sol. CD40 ligand (sCD40L) and TNF-α.  At the end of treatment, cerebrospinal fluid (CSF) samples were optionally collected after the last dose to measure drug levels, β- amyloid1-42 (Aβ42), tau, phospho-tau181, sCD40L and TNF-α.  Ten patients did not complete the study: one in the placebo group (consent withdrawn), two in the 200-mg/day treatment group (consent withdrawn and unable to comply) and seven in the 400-mg/day treatment group (five AEs, one consent withdrawn and one unable to comply).  The most frequent treatment-emergent adverse events were diarrhea, dizziness and back pain.  There were no clin. significant treatment related clin. lab., vital sign or ECG abnormalities.  CHF5074 total body clearance depended by gender, age and glomerular filtration rate.  CHF5074 CSF concns. increased in a dose-dependent manner.  At the end of treatment, mean sCD40L and TNF-α levels in CSF were found to be inversely related to the CHF5074 dose (p=0.037 and p=0.001, resp.).  Plasma levels of sCD40L in the 600-mg/day group were significantly lower than those measured in the placebo group (p=0.010).  No significant differences between treatment groups were found in neuropsychol. tests but a pos. dose-response trend was found on executive function in APOE4 carriers.  This study shows that CHF5074 is well tolerated in MCI patients after a 12-wk titrated treatment up to 600 mg/day and dose-dependently affects central nervous system biomarkers of neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqolNg5CMCXW7Vg90H21EOLACvtfcHk0lhMvihXCF5D-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVylt7vJ&md5=2120581a5f9fe47f85cf140d7ccdb942</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.2174%2F13892037113149990144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13892037113149990144%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DJ.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DWinston%26aufirst%3DJ.%26aulast%3DNunez%26aufirst%3DM.%26aulast%3DBottini%26aufirst%3DG.%26aulast%3DFranceschi%26aufirst%3DM.%26aulast%3DScarpini%26aufirst%3DE.%26aulast%3DFrigerio%26aufirst%3DE.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DFernandez%26aufirst%3DM.%26aulast%3DSivilia%26aufirst%3DS.%26aulast%3DGiardino%26aufirst%3DL.%26aulast%3DCalza%26aufirst%3DL.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DCicirello%26aufirst%3DH.%26aulast%3DCasula%26aufirst%3DD.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DChf5074%2520reduces%2520biomarkers%2520of%2520neuroinflammation%2520in%2520patients%2520with%2520mild%2520cognitive%2520impairment%253A%2520A%252012-week%252C%2520double-blind%252C%2520placebo-%2520controlled%2520study%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2013%26volume%3D10%26spage%3D742%26epage%3D753%26doi%3D10.2174%2F13892037113149990144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigerio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivilia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casula, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenouda, M.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of chf5074 after short-term administration in healthy subjects</span> <span class="citation_source-journal">Alzheimer Dis. Assoc. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1097/WAD.0b013e3182622ace</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1097%2FWAD.0b013e3182622ace" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22922591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSgt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=278-286&author=B.+P.+Imbimboauthor=E.+Frigerioauthor=M.+Bredaauthor=F.+Fiorentiniauthor=M.+Fernandezauthor=S.+Siviliaauthor=L.+Giardinoauthor=L.+Calzaauthor=D.+Norrisauthor=D.+Casulaauthor=M.+Shenouda&title=Pharmacokinetics+and+pharmacodynamics+of+chf5074+after+short-term+administration+in+healthy+subjects&doi=10.1097%2FWAD.0b013e3182622ace"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects</span></div><div class="casAuthors">Imbimbo, Bruno P.; Frigerio, Enrico; Breda, Massimo; Fiorentini, Francesco; Fernandez, Mercedes; Sivilia, Sandra; Giardino, Luciana; Calza, Laura; Norris, Dottie; Casula, Daniela; Shenouda, Magdy</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease & Associated Disorders</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">278-286</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">CHF5074 has been shown to inhibit brain β-amyloid deposition and attenuate memory deficits in different transgenic mice models of Alzheimer disease.  We evaluated the safety, pharmacokinetics, and pharmacodynamics of 3 ascending dose regimens of CHF5074 (200, 400, and 600 mg/d for 14 d) in a double-blind, placebo-controlled, parallel group study involving 48 healthy subjects.  Plasma, urine, and cerebrospinal fluid (CSF) samples were collected for measuring drug and main metabolite concns. and potential biomarkers of pharmacodynamic activity (β-amyloid1-40, β-amyloid1-42, sol. CD40 ligand, and tumor necrosis factor-α).  All subjects completed the study, and no serious or severe adverse events were reported.  The max. tolerated dose was close to 600 mg/d with mild diarrhea being the most frequent adverse event at this dose.  CHF5074 reached peak plasma levels 2 to 3 h after drug administration and then was slowly eliminated (t1/2z=30 h) in the urine as glucoronide.  Systemic exposure to the drug appeared to be dose-proportional with a 2-fold accumulation ratio at steady state.  Metabolite plasma levels peaked at 4 to 5 h and accounted for about 25% of the parent compd.  Drug levels in the CSF were dose-proportional.  The drug dose-dependently lowered the levels of the sol. CD40 ligand, a marker of microglia activation, in both plasma and CSF samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJYz4mSBAT_LVg90H21EOLACvtfcHk0lhDfGuEkZ4TjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSgt7rF&md5=3ba56b2989731174e5dc1d4d571bc333</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1097%2FWAD.0b013e3182622ace&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWAD.0b013e3182622ace%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DFrigerio%26aufirst%3DE.%26aulast%3DBreda%26aufirst%3DM.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DFernandez%26aufirst%3DM.%26aulast%3DSivilia%26aufirst%3DS.%26aulast%3DGiardino%26aufirst%3DL.%26aulast%3DCalza%26aufirst%3DL.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DCasula%26aufirst%3DD.%26aulast%3DShenouda%26aufirst%3DM.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520chf5074%2520after%2520short-term%2520administration%2520in%2520healthy%2520subjects%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2013%26volume%3D27%26spage%3D278%26epage%3D286%26doi%3D10.1097%2FWAD.0b013e3182622ace" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Kimura, T.; Kawano, K.; Doi, E.; Kitazawa, N.; Shin, K.; Miyagawa, T.; Kaneko, T.; Ito, K.; Takaishi, M.; Sasaki, T.; Hagiwara, H.</span><span> </span><span class="NLM_article-title">Preparation of cinnamide, 3-benzylidenepiperidin-2-one, phenylpropynamide compounds as amyloid β production inhibitors</span>. WO2005115990A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=K.+Shin&author=T.+Miyagawa&author=T.+Kaneko&author=K.+Ito&author=M.+Takaishi&author=T.+Sasaki&author=H.+Hagiwara&title=Preparation+of+cinnamide%2C+3-benzylidenepiperidin-2-one%2C+phenylpropynamide+compounds+as+amyloid+%CE%B2+production+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520cinnamide%252C%25203-benzylidenepiperidin-2-one%252C%2520phenylpropynamide%2520compounds%2520as%2520amyloid%2520%25CE%25B2%2520production%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagawa, T.</span><span> </span><span class="NLM_article-title">E2012: A novel gamma-secretase modulator-pharmacology part</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">S242</span><span class="refDoi"> DOI: 10.1016/j.jalz.2010.05.787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.jalz.2010.05.787" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S242&author=T.+Hashimotoauthor=A.+Ishibashiauthor=H.+Hagiwaraauthor=Y.+Murataauthor=O.+Takenakaauthor=T.+Miyagawa&title=E2012%3A+A+novel+gamma-secretase+modulator-pharmacology+part&doi=10.1016%2Fj.jalz.2010.05.787"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.05.787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.05.787%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DIshibashi%26aufirst%3DA.%26aulast%3DHagiwara%26aufirst%3DH.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DTakenaka%26aufirst%3DO.%26aulast%3DMiyagawa%26aufirst%3DT.%26atitle%3DE2012%253A%2520A%2520novel%2520gamma-secretase%2520modulator-pharmacology%2520part%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS242%26doi%3D10.1016%2Fj.jalz.2010.05.787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Nakano-Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinjo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suganuma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukidate, K.</span><span> </span><span class="NLM_article-title">E2012-induced cataract and its predictive biomarkers</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1093/toxsci/kft224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1093%2Ftoxsci%2Fkft224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24085193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslKj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2014&pages=249-258&author=K.+Nakano-Itoauthor=Y.+Fujikawaauthor=T.+Hiharaauthor=H.+Shinjoauthor=S.+Kotaniauthor=A.+Suganumaauthor=T.+Aokiauthor=K.+Tsukidate&title=E2012-induced+cataract+and+its+predictive+biomarkers&doi=10.1093%2Ftoxsci%2Fkft224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">E2012-Induced Cataract and Its Predictive Biomarkers</span></div><div class="casAuthors">Nakano-Ito, Kyoko; Fujikawa, Yasuhiro; Hihara, Taro; Shinjo, Hiroko; Kotani, Sadaharu; Suganuma, Akiyoshi; Aoki, Toyohiko; Tsukidate, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">249-258</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">E2012, a gamma secretase modulator without affecting Notch processing, aimed at Alzheimer's disease by redn. of amyloid β-42, induced cataract following repeated doses in the rat.  Cataract appeared first at week 10-11 of treatment as a posterior subcapsular area with granular/punctate opaque or shiny dots along the suture line, characterized histol. as lenticular fiber degeneration, which eventually coalesced to form a triangular or circular opacity.  It was assocd. with prolonged and sustained elevation of lenticular desmosterol (24-dehydrocholesterol), the final precursor of cholesterol, and decrease in lenticular cholesterol.  In vitro studies to investigate the effect of E2012 on cholesterol metab. demonstrated that E2012 inhibits 3β-hydroxysterol Δ24-reductase (DHCR24) at the final step in the cholesterol biosynthesis.  In vivo lenticular concn. of E2012 after 13-wk repeated dose with cataract was well above those where inhibition was obsd. in vitro.  There was no cataract formation at doses where desmosterol did not accumulate in the lens.  The elevation of desmosterol and decreased cholesterol levels were also seen in the liver and plasma and preceded those in the lens.  These results demonstrate that E2012 induces cataract in the rat by inhibiting DHCR24 at the final step of cholesterol synthesis with assocd. elevation in desmosterol within the lens, preceded by desmosterol changes that would serve as a predictive safety biomarker for lenticular opacity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvv1PlcqriILVg90H21EOLACvtfcHk0lgTHwz7aexEbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslKj&md5=db86f359b417db36786a7538f2c43a7d</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkft224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkft224%26sid%3Dliteratum%253Aachs%26aulast%3DNakano-Ito%26aufirst%3DK.%26aulast%3DFujikawa%26aufirst%3DY.%26aulast%3DHihara%26aufirst%3DT.%26aulast%3DShinjo%26aufirst%3DH.%26aulast%3DKotani%26aufirst%3DS.%26aulast%3DSuganuma%26aufirst%3DA.%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DTsukidate%26aufirst%3DK.%26atitle%3DE2012-induced%2520cataract%2520and%2520its%2520predictive%2520biomarkers%26jtitle%3DToxicol.%2520Sci.%26date%3D2014%26volume%3D137%26spage%3D249%26epage%3D258%26doi%3D10.1093%2Ftoxsci%2Fkft224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Nagy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rege, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logovinsky, V.</span><span> </span><span class="NLM_article-title">E2012, a novel gamma-secretase modulator, decreases plasma amyloid-beta (aβ) levels in humans</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">S574</span><span class="refDoi"> DOI: 10.1016/j.jalz.2010.05.1958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.jalz.2010.05.1958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S574&author=C.+Nagyauthor=E.+Schuckauthor=A.+Ishibashiauthor=Y.+Nakataniauthor=B.+Regeauthor=V.+Logovinsky&title=E2012%2C+a+novel+gamma-secretase+modulator%2C+decreases+plasma+amyloid-beta+%28a%CE%B2%29+levels+in+humans&doi=10.1016%2Fj.jalz.2010.05.1958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.05.1958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.05.1958%26sid%3Dliteratum%253Aachs%26aulast%3DNagy%26aufirst%3DC.%26aulast%3DSchuck%26aufirst%3DE.%26aulast%3DIshibashi%26aufirst%3DA.%26aulast%3DNakatani%26aufirst%3DY.%26aulast%3DRege%26aufirst%3DB.%26aulast%3DLogovinsky%26aufirst%3DV.%26atitle%3DE2012%252C%2520a%2520novel%2520gamma-secretase%2520modulator%252C%2520decreases%2520plasma%2520amyloid-beta%2520%2528a%25CE%25B2%2529%2520levels%2520in%2520humans%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS574%26doi%3D10.1016%2Fj.jalz.2010.05.1958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logovinsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, J.</span><span> </span><span class="NLM_article-title">Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel gamma-secretase modulator, e2212, in healthy human subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span><span class="refDoi"> DOI: 10.1002/jcph.249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1002%2Fjcph.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24343761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFOltr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=528-536&author=Y.+Yuauthor=V.+Logovinskyauthor=E.+Schuckauthor=J.+Kaplowauthor=M.+K.+Changauthor=T.+Miyagawaauthor=N.+Wongauthor=J.+Ferry&title=Safety%2C+tolerability%2C+pharmacokinetics%2C+and+pharmacodynamics+of+the+novel+gamma-secretase+modulator%2C+e2212%2C+in+healthy+human+subjects&doi=10.1002%2Fjcph.249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel γ-secretase modulator, E2212, in healthy human subjects</span></div><div class="casAuthors">Yu, Yanke; Logovinsky, Veronika; Schuck, Edgar; Kaplow, June; Chang, Min-kun; Miyagawa, Takehiko; Wong, Nancy; Ferry, Jim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">528-536</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">E2212, a novel γ-secretase modulator, is under development for the treatment of Alzheimer's disease.  The safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending oral doses (10-250 mg, double-blind, placebo-controlled, randomized) of E2212 were evaluated.  In this phase I clin. trial, E2212 was found to be well tolerated in single doses.  Maximum tolerated dose was not achieved up to 250 mg.  Most AEs were mild to moderate in severity with no identifiable dose related pattern.  There were no clin. significant findings on phys. and ophthalmol. examns. as well as vital signs, lab., ECG and C-SSRS assessments.  E2212 was rapidly absorbed, with median tmax values ranging from 0.5 to 1.0 h.  E2212 exhibited biphasic disposition with the terminal t1/2 of 12.5-19.0 h.  Renal excretion was the minor pathway for E2212 elimination.  Increased PD response (redn. in plasma concns. of Aβ(x-42)) was obsd. with increasing doses.  The max. PD response was obsd. in the highest dose 250 mg cohort, with ΔAUAC(0-24 h) of 44.1% and Amax of 53.6%.  These results support further clin. development of E2212.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPOIqz7T9957Vg90H21EOLACvtfcHk0lgTHwz7aexEbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFOltr3J&md5=2a7f24b32e99f4ea41082cc438319e8c</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1002%2Fjcph.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcph.249%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DLogovinsky%26aufirst%3DV.%26aulast%3DSchuck%26aufirst%3DE.%26aulast%3DKaplow%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DM.%2BK.%26aulast%3DMiyagawa%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DN.%26aulast%3DFerry%26aufirst%3DJ.%26atitle%3DSafety%252C%2520tolerability%252C%2520pharmacokinetics%252C%2520and%2520pharmacodynamics%2520of%2520the%2520novel%2520gamma-secretase%2520modulator%252C%2520e2212%252C%2520in%2520healthy%2520human%2520subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2014%26volume%3D54%26spage%3D528%26epage%3D536%26doi%3D10.1002%2Fjcph.249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, T. R.</span><span> </span><span class="NLM_article-title">Γ-secretase modulators: Current status and future directions</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1016/B978-0-444-63380-4.00003-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2FB978-0-444-63380-4.00003-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24418609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=101-145&author=A.+Hallauthor=T.+R.+Patel&title=%CE%93-secretase+modulators%3A+Current+status+and+future+directions&doi=10.1016%2FB978-0-444-63380-4.00003-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase modulators: current status and future directions</span></div><div class="casAuthors">Hall, Adrian; Patel, Toshal R.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-145</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  This article provides an overview of recent progress in the development of γ-secretase modulator (GSMs), focusing mainly on the peer reviewed literature, but drawing on the patent literature where necessary.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq01MNt_SYGrVg90H21EOLACvtfcHk0liufsD3lTqNIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWnt7Y%253D&md5=4f59015d982e3d5cf1ff090c105eb471</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-63380-4.00003-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-63380-4.00003-2%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DT.%2BR.%26atitle%3D%25CE%2593-secretase%2520modulators%253A%2520Current%2520status%2520and%2520future%2520directions%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D53%26spage%3D101%26epage%3D145%26doi%3D10.1016%2FB978-0-444-63380-4.00003-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Kamada, A.; Sasaki, T.; Uemura, T.</span><span> </span><span class="NLM_article-title">Method for producing 2-[(<i>E</i>)-2-(pyridin-2-yl)vinyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-<i>a</i>]pyridine compound and its intermediates</span>. JP2012121809A,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Kamada&author=T.+Sasaki&author=T.+Uemura&title=Method+for+producing+2-%5B%28E%29-2-%28pyridin-2-yl%29vinyl%5D-5%2C6%2C7%2C8-tetrahydro-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyridine+compound+and+its+intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKamada%26aufirst%3DA.%26atitle%3DMethod%2520for%2520producing%25202-%255B%2528E%2529-2-%2528pyridin-2-yl%2529vinyl%255D-5%252C6%252C7%252C8-tetrahydro-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyridine%2520compound%2520and%2520its%2520intermediates%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Nakamura, T.; Matsuda, M.; Hu, Y.; Hasegawa, D.; Hoshino, Y.; Inanaga, K.; Isomura, M.; Sato, N.; Yoshizawa, K.; Moniz, G. A.; Wilkie, G. D.; Fang, F. G.; Nishikawa, Y.</span><span> </span><span class="NLM_article-title">Process for preparing stereoisomeric cinnamide derivatives</span>. WO2010025197A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Nakamura&author=M.+Matsuda&author=Y.+Hu&author=D.+Hasegawa&author=Y.+Hoshino&author=K.+Inanaga&author=M.+Isomura&author=N.+Sato&author=K.+Yoshizawa&author=G.+A.+Moniz&author=G.+D.+Wilkie&author=F.+G.+Fang&author=Y.+Nishikawa&title=Process+for+preparing+stereoisomeric+cinnamide+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DT.%26atitle%3DProcess%2520for%2520preparing%2520stereoisomeric%2520cinnamide%2520derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Minamisono, T.; Kitazawa, N.; Kushida, I.</span><span> </span><span class="NLM_article-title">Preparation of salts of (8<i>S</i>)-2-[(<i>E</i>)-2-[6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyridin-2-yl]vinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-1,2,4-triazolo[1,5-<i>a</i>]pyridine</span>. WO2010098490A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Minamisono&author=N.+Kitazawa&author=I.+Kushida&title=Preparation+of+salts+of+%288S%29-2-%5B%28E%29-2-%5B6-methoxy-5-%284-methyl-1H-imidazol-1-yl%29pyridin-2-yl%5Dvinyl%5D-8-%5B2-%28trifluoromethyl%29phenyl%5D-5%2C6%2C7%2C8-tetrahydro-1%2C2%2C4-triazolo%5B1%2C5-a%5Dpyridine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMinamisono%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520salts%2520of%2520%25288S%2529-2-%255B%2528E%2529-2-%255B6-methoxy-5-%25284-methyl-1H-imidazol-1-yl%2529pyridin-2-yl%255Dvinyl%255D-8-%255B2-%2528trifluoromethyl%2529phenyl%255D-5%252C6%252C7%252C8-tetrahydro-1%252C2%252C4-triazolo%255B1%252C5-a%255Dpyridine%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Kamada, A.; Sasaki, T.; Uemura, T.</span><span> </span><span class="NLM_article-title">Method for producing 2-[(<i>E</i>)-2-(pyridin-2-yl)vinyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-<i>a</i>]pyridine compound and its intermediates</span>. WO2010098332A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=A.+Kamada&author=T.+Sasaki&author=T.+Uemura&title=Method+for+producing+2-%5B%28E%29-2-%28pyridin-2-yl%29vinyl%5D-5%2C6%2C7%2C8-tetrahydro-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyridine+compound+and+its+intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKamada%26aufirst%3DA.%26atitle%3DMethod%2520for%2520producing%25202-%255B%2528E%2529-2-%2528pyridin-2-yl%2529vinyl%255D-5%252C6%252C7%252C8-tetrahydro-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyridine%2520compound%2520and%2520its%2520intermediates%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Sun, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCracken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicarel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span> </span><span class="NLM_article-title">Cyclic hydroxyamidines as amide isosteres: Discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span><span class="refDoi"> DOI: 10.1021/jm201407j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201407j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=489-502&author=Z.-Y.+Sunauthor=T.+Asberomauthor=T.+Baraauthor=C.+Bennettauthor=D.+Burnettauthor=I.+Chuauthor=J.+Claderauthor=M.+Cohen-Williamsauthor=D.+Coleauthor=M.+Czarnieckiauthor=J.+Durkinauthor=G.+Galloauthor=W.+Greenleeauthor=H.+Josienauthor=X.+Huangauthor=L.+Hydeauthor=N.+Jonesauthor=I.+Kazakevichauthor=H.+Liauthor=X.+Liuauthor=J.+Leeauthor=M.+MacCossauthor=M.+B.+Mandalauthor=T.+McCrackenauthor=A.+Nomeirauthor=R.+Mazzolaauthor=A.+Palaniauthor=E.+M.+Parkerauthor=D.+A.+Pissarnitskiauthor=J.+Qinauthor=L.+Songauthor=G.+Terracinaauthor=M.+Vicarelauthor=J.+Voigtauthor=R.+Xuauthor=L.+Zhangauthor=Q.+Zhangauthor=Z.+Zhaoauthor=X.+Zhuauthor=Z.+Zhu&title=Cyclic+hydroxyamidines+as+amide+isosteres%3A+Discovery+of+oxadiazolines+and+oxadiazines+as+potent+and+highly+efficacious+%CE%B3-secretase+modulators+in+vivo&doi=10.1021%2Fjm201407j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in Vivo</span></div><div class="casAuthors">Sun, Zhong-Yue; Asberom, Theodros; Bara, Thomas; Bennett, Chad; Burnett, Duane; Chu, Inhou; Clader, John; Cohen-Williams, Mary; Cole, David; Czarniecki, Michael; Durkin, James; Gallo, Gioconda; Greenlee, William; Josien, Hubert; Huang, Xianhai; Hyde, Lynn; Jones, Nicholas; Kazakevich, Irina; Li, Hongmei; Liu, Xiaoxiang; Lee, Julie; MacCoss, Malcolm; Mandal, Mihir B.; McCracken, Troy; Nomeir, Amin; Mazzola, Robert; Palani, Anandan; Parker, Eric M.; Pissarnitski, Dmitri A.; Qin, Jun; Song, Lixin; Terracina, Giuseppe; Vicarel, Monica; Voigt, Johannes; Xu, Ruo; Zhang, Lili; Zhang, Qi; Zhao, Zhiqiang; Zhu, Xiaohong; Zhu, Zhaoning</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">489-502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic hydroxyamidines were designed and validated as isosteric replacements of the amide functionality.  Compds. with these structural motifs were found to be metabolically stable and to possess highly desirable pharmacokinetic profiles.  These designs were applied in the identification of γ-secretase modulators leading to highly efficacious agents for redn. of central nervous system Aβ42 in various animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowGuNLMGYzw7Vg90H21EOLACvtfcHk0lhR_GXsLvB-1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbbL&md5=5f64483cba26060a60de990fa423014e</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm201407j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201407j%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.-Y.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMandal%26aufirst%3DM.%2BB.%26aulast%3DMcCracken%26aufirst%3DT.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DPissarnitski%26aufirst%3DD.%2BA.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DCyclic%2520hydroxyamidines%2520as%2520amide%2520isosteres%253A%2520Discovery%2520of%2520oxadiazolines%2520and%2520oxadiazines%2520as%2520potent%2520and%2520highly%2520efficacious%2520%25CE%25B3-secretase%2520modulators%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D489%26epage%3D502%26doi%3D10.1021%2Fjm201407j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicarel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCraken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span> </span><span class="NLM_article-title">Synthesis and sar studies of fused oxadiazines as γ-secretase modulators for treatment of alzheimer’s disease</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span><span class="refDoi"> DOI: 10.1021/ml300209g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300209g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12itr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=931-935&author=X.+Huangauthor=W.+Zhouauthor=X.+Liuauthor=H.+Liauthor=G.+Sunauthor=M.+Mandalauthor=M.+Vicarelauthor=X.+Zhuauthor=C.+Bennettauthor=T.+McCrakenauthor=D.+Pissarnitskiauthor=Z.+Zhaoauthor=D.+Coleauthor=G.+Galloauthor=Z.+Zhuauthor=A.+Palaniauthor=R.+Aslanianauthor=J.+Claderauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=D.+Burnettauthor=M.+Cohen-Williamsauthor=L.+Hydeauthor=L.+Songauthor=L.+Zhangauthor=I.+Chuauthor=A.+Buevich&title=Synthesis+and+sar+studies+of+fused+oxadiazines+as+%CE%B3-secretase+modulators+for+treatment+of+alzheimer%E2%80%99s+disease&doi=10.1021%2Fml300209g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Huang, Xianhai; Zhou, Wei; Liu, Xiaoxiang; Li, Hongmei; Sun, George; Mandal, Mihirbaran; Vicarel, Monica; Zhu, Xiaohong; Bennett, Chad; McCraken, Troy; Pissarnitski, Dmitri; Zhao, Zhiqiang; Cole, David; Gallo, Gioconda; Zhu, Zhaoning; Palani, Anandan; Aslanian, Robert; Clader, John; Czarniecki, Michael; Greenlee, William; Burnett, Duane; Cohen-Williams, Mary; Hyde, Lynn; Song, Lixin; Zhang, Lili; Chu, Inhou; Buevich, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">931-935</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fused oxadiazines such as imidazolylbenzylidene pyridooxadiazines I (R = Cl, F; R1 = H, F; R2 = H; X = CH2) and imidazolylbenzylidene oxazinooxadiazines I (R = F; R1 = H, F; R2 = Me; X = O) were prepd. as selective and orally bioavailable γ-secretase modulators (GSMs) derived by analogy from pyridooxadiazoline GSMs.  The effect of structural modifications on pyridooxadiazoline GSMs differed significantly from the effects of modifications to pyridooxadiazine GSMs.  I (R = Cl, F; R1 = H, F; R2 = H; X = CH2) were found to be highly efficacious in vitro and in vivo in a no. of animal models with highly desirable phys. and pharmacol. properties.  Fused morpholine oxadiazines such as I (R = F; R1 = H, F; R2 = Me; X = O) showed improved in vitro activities and selectivities as GSMs.  The shift in specificity of APP cleavage rather than a redn. in overall γ-secretase activity and the lack of changes in substrate accumulation and Notch processing as obsd. in the animal studies of compd. I (R = R1 = F; R2 = H; X = CH2) confirm that imidazolylbenzylidene pyridooxadiazines are potent GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrLJKqS8YPSLVg90H21EOLACvtfcHk0lgT8djEw6W6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12itr3L&md5=42883463705abaa95287df4ea07f8936</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fml300209g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300209g%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DG.%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DMcCraken%26aufirst%3DT.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DBuevich%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520sar%2520studies%2520of%2520fused%2520oxadiazines%2520as%2520%25CE%25B3-secretase%2520modulators%2520for%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D931%26epage%3D935%26doi%3D10.1021%2Fml300209g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhondi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicarel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">The discovery of fused oxadiazepines as gamma secretase modulators for treatment of alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2012.11.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=23253441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVOrurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=466-471&author=H.+Liauthor=J.+Qinauthor=P.+Dhondiauthor=W.+Zhouauthor=M.+Vicarelauthor=T.+Baraauthor=D.+Coleauthor=H.+Josienauthor=D.+Pissarnitskiauthor=Z.+Zhuauthor=A.+Palaniauthor=R.+Aslanianauthor=J.+Claderauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=M.+Cohen-Williamsauthor=L.+Hydeauthor=L.+Songauthor=L.+Zhangauthor=I.+Chuauthor=X.+Huang&title=The+discovery+of+fused+oxadiazepines+as+gamma+secretase+modulators+for+treatment+of+alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2012.11.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's disease</span></div><div class="casAuthors">Li, Hongmei; Qin, Jun; Dhondi, Pawan; Zhou, Wei; Vicarel, Monica; Bara, Thomas; Cole, David; Josien, Hubert; Pissarnitski, Dmitri; Zhu, Zhaoning; Palani, Anandan; Aslanian, Robert; Clader, John; Czarniecki, Michael; Greenlee, William; Cohen-Williams, Mary; Hyde, Lynn; Song, Lixin; Zhang, Lili; Chu, Inhou; Huang, Xianhai</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">466-471</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In an attempt to further improve overall profiles of the oxadiazine series of GSMs, in particular the hERG activity, conformational modifications of the core structure resulted in the identification of fused oxadiazepines such as 7i (I) which had an improved hERG inhibition profile and was a highly efficacious GSM in vitro and in vivo in rats.  These SAR explorations offer opportunities to identify potential drugs to treat Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJUUyjEiaFDbVg90H21EOLACvtfcHk0lgT8djEw6W6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVOrurrI&md5=d2c0ec5773714fe62e9056a98823343e</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.055%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DThe%2520discovery%2520of%2520fused%2520oxadiazepines%2520as%2520gamma%2520secretase%2520modulators%2520for%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D466%26epage%3D471%26doi%3D10.1016%2Fj.bmcl.2012.11.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Henderson, R. F.</span><span> </span><span class="NLM_article-title">Species differences in the metabolism of olefins. Implications for risk assessment</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">135–136</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/S0009-2797(01)00170-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2FS0009-2797%2801%2900170-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=11397381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktV2ltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135%E2%80%93136&publication_year=2001&pages=53-64&author=R.+F.+Henderson&title=Species+differences+in+the+metabolism+of+olefins.+Implications+for+risk+assessment&doi=10.1016%2FS0009-2797%2801%2900170-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in the metabolism of olefins. Implications for risk assessment</span></div><div class="casAuthors">Henderson, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">135-136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-64</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 22 refs.  Olefinic compds. are com. valuable because they form useful polymeric substances.  The same chem. property (presence of double bonds) that makes the olefins useful may also cause them to be toxic in the body.  The double bonds of olefins can be oxidized by cytochrome P 450 enzymes to epoxides, which are electrophiles that can react with DNA and may cause alterations in the genetic information carried by that macromol.  Epoxides can be rendered inactive toward DNA by binding to proteins, by hydrolysis to diols through epoxide hydrolase enzymes (EHs), or by forming conjugates with glutathione via glutathione S-transferase (GST) activities.  The balance between the oxidizing enzymic activities and the hydrolyzing or conjugating enzymic activities in the livers of different species can influence the potential toxicity of the olefins.  The location of the enzymes and the potential for concerted reactions in which epoxides are inactivated immediately after formation will also influence the potential toxicity of the olefins.  Cytochrome P 450 enzymes and EHs are in microsomes located in the rough endoplasmic reticulum surrounding the nucleus where the DNA is located.  GST is in the cytoplasm of the cell.  In the case of 1,3-butadiene (BD), such enzymic differences may strongly influence the toxicity in different species.  The mouse, in which BD is a potent multi-site carcinogen, has the lowest microsomal EH activity of any species.  This allows the monoepoxides formed in the microsomes by cytochrome P 450 enzymes to be further oxidized to the highly genotoxic diepoxide (DEB), and both epoxides can either be released into the blood for distribution throughout the body or can react with DNA in the nucleus.  The rat, in which BD is a weak carcinogen, has much higher levels of microsomal EH, and only trace amts. of DEB enter the bloodstream.  Major BD metabolites in primates suggest that the hydrolysis pathway is even more prominent in primates than in rats.  Data suggest that BD will be much less toxic in primates than in mice.  Considering these quant. differences in metab. may help to reduce the uncertainties in extrapolating animal data on olefin toxicity to health risk assessments for humans exposed to the compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQf50n60n2iLVg90H21EOLACvtfcHk0lgT8djEw6W6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktV2ltb0%253D&md5=050db0848b3020f59c9d58f5774db520</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2801%2900170-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252801%252900170-3%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DR.%2BF.%26atitle%3DSpecies%2520differences%2520in%2520the%2520metabolism%2520of%2520olefins.%2520Implications%2520for%2520risk%2520assessment%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2001%26volume%3D135%25E2%2580%2593136%26spage%3D53%26epage%3D64%26doi%3D10.1016%2FS0009-2797%2801%2900170-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Bischoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masungi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9089</span><span class="NLM_x">–</span> <span class="NLM_lpage">9106</span><span class="refDoi"> DOI: 10.1021/jm201710f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201710f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9089-9106&author=F.+Bischoffauthor=D.+Berthelotauthor=M.+De+Cleynauthor=G.+MacDonaldauthor=G.+Minneauthor=D.+Oehlrichauthor=S.+Pietersauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=S.+Van+Brandtauthor=I.+Velterauthor=M.+Zajaauthor=H.+Borghysauthor=C.+Masungiauthor=M.+Merckenauthor=H.+J.+M.+Gijsen&title=Design+and+synthesis+of+a+novel+series+of+bicyclic+heterocycles+as+potent+%CE%B3-secretase+modulators&doi=10.1021%2Fjm201710f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators</span></div><div class="casAuthors">Bischoff, Francois; Berthelot, Didier; De Cleyn, Michel; MacDonald, Gregor; Minne, Garrett; Oehlrich, Daniel; Pieters, Serge; Surkyn, Michel; Trabanco, Andres A.; Tresadern, Gary; Van Brandt, Sven; Velter, Ingrid; Zaja, Mirko; Borghys, Herman; Masungi, Chantal; Mercken, Marc; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9089-9106</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and the synthesis of several chem. subclasses of imidazole contg. γ-secretase modulators (GSMs) is described.  Conformational restriction of an aminopyridone into bicyclic pyridone isosteres has led to compds. with high in vitro and in vivo potency.  This has resulted in the identification of benzimidazole I as a GSM with low nanomolar potency in vitro.  In mouse, rat, and dog, this compd. displayed the typical γ-secretase modulatory profile by lowering Aβ42 and Aβ40 levels combined with an esp. pronounced increase in Aβ38 and Aβ37 levels while leaving the total levels of amyloid peptides unchanged.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtfwoI1AvXwLVg90H21EOLACvtfcHk0liMhuKwNChSyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGrurw%253D&md5=8edaf14f066220910e0d510a563ce02f</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm201710f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201710f%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DMacDonald%26aufirst%3DG.%26aulast%3DMinne%26aufirst%3DG.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVelter%26aufirst%3DI.%26aulast%3DZaja%26aufirst%3DM.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DMasungi%26aufirst%3DC.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520novel%2520series%2520of%2520bicyclic%2520heterocycles%2520as%2520potent%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9089%26epage%3D9106%26doi%3D10.1021%2Fjm201710f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Gerlach, K.; Heine, N.; Hobson, S.; Hoenke, C.; Weber, A.</span><span> </span><span class="NLM_article-title">Preparation of dihydrothienopyrimidines γ-secretase modulators</span>. WO2013020992A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+Gerlach&author=N.+Heine&author=S.+Hobson&author=C.+Hoenke&author=A.+Weber&title=Preparation+of+dihydrothienopyrimidines+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520dihydrothienopyrimidines%2520%25CE%25B3-secretase%2520modulators%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Gerlach, K.; Eickmeier, C.; Heine, C.; Heine, N.; Weber, A.</span><span> </span><span class="NLM_article-title">Preparation of dihydropteridinones as modulators of γ-secretase for treating Alzheimer’s disease</span>. US20130225549A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+Gerlach&author=C.+Eickmeier&author=C.+Heine&author=N.+Heine&author=A.+Weber&title=Preparation+of+dihydropteridinones+as+modulators+of+%CE%B3-secretase+for+treating+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520dihydropteridinones%2520as%2520modulators%2520of%2520%25CE%25B3-secretase%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Eickmeier, C.; Gerlach, K.; Heine, N.; Weber, A.; Gross, U.</span><span> </span><span class="NLM_article-title">Preparation of spiroheterocyclodihydropteridinones as modulators of γ-secretase for treating Alzheimer’s disease</span>. US20130225593A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Eickmeier&author=K.+Gerlach&author=N.+Heine&author=A.+Weber&author=U.+Gross&title=Preparation+of+spiroheterocyclodihydropteridinones+as+modulators+of+%CE%B3-secretase+for+treating+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEickmeier%26aufirst%3DC.%26atitle%3DPreparation%2520of%2520spiroheterocyclodihydropteridinones%2520as%2520modulators%2520of%2520%25CE%25B3-secretase%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Burnett, D. A.; Bursavich, M. G.; McRiner, A. J.</span><span> </span><span class="NLM_article-title">Preparation of fused morpholinopyrimidines for treating neurodegenerative diseases</span>. WO2015066697A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+A.+Burnett&author=M.+G.+Bursavich&author=A.+J.+McRiner&title=Preparation+of+fused+morpholinopyrimidines+for+treating+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26atitle%3DPreparation%2520of%2520fused%2520morpholinopyrimidines%2520for%2520treating%2520neurodegenerative%2520diseases%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Burnett, D. A.; Bursavich, M. G.; McRiner, A. J.</span><span> </span><span class="NLM_article-title">Preparation of fused morpholinopyrimidines for treating neurodegenerative diseases</span>. WO2015066696A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+A.+Burnett&author=M.+G.+Bursavich&author=A.+J.+McRiner&title=Preparation+of+fused+morpholinopyrimidines+for+treating+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26atitle%3DPreparation%2520of%2520fused%2520morpholinopyrimidines%2520for%2520treating%2520neurodegenerative%2520diseases%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Burnett, D. A.; Bursavich, M. G.; McRiner, A. J.</span><span> </span><span class="NLM_article-title">Fused morpholinopyrimidines as beta-amyloid inhibitors and their preparation</span>. WO2015109109A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+A.+Burnett&author=M.+G.+Bursavich&author=A.+J.+McRiner&title=Fused+morpholinopyrimidines+as+beta-amyloid+inhibitors+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26atitle%3DFused%2520morpholinopyrimidines%2520as%2520beta-amyloid%2520inhibitors%2520and%2520their%2520preparation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranararyanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guss, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iben, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierdomenico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlijanian, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerritz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcin, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denton, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raybon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanabha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harden, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prack, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvyaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantone, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drexler, D. M.</span><span> </span><span class="NLM_article-title">Identification and preclinical pharmacology of the γ-secretase modulator BMS-869780</span> <span class="citation_source-journal">Int. J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2014</span><span class="NLM_x">, </span> <span class="NLM_fpage">431858</span><span class="refDoi"> DOI: 10.1155/2014/431858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1155%2F2014%2F431858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=25097793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A280%3ADC%252BC2cbptlKmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=431858&author=J.+H.+Toynauthor=J.+E.+Meredithauthor=C.+R.+Burtonauthor=S.+Sankaranararyananauthor=V.+Gussauthor=L.+G.+Ibenauthor=C.+M.+Krauseauthor=R.+Krauseauthor=X.-A.+Linauthor=M.+Pierdomenicoauthor=C.+Polsonauthor=A.+S.+Robertsonauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=L.+A.+Thompsonauthor=S.+Gerritzauthor=L.+R.+Marcinauthor=M.+A.+Higginsauthor=J.+Shiauthor=J.+E.+Macorauthor=R.+E.+Olsonauthor=K.+A.+Lentzauthor=R.+R.+Dentonauthor=J.+E.+Graceauthor=J.+Morrisonauthor=J.+Raybonauthor=X.+Zhuoauthor=K.+Snowauthor=T.+Hallauthor=R.+Padmanabhaauthor=K.+Espositoauthor=D.+Hardenauthor=M.+Prackauthor=T.+Zvyagaauthor=M.+Aglerauthor=S.+Varmaauthor=V.+Wongauthor=Y.+Zhuauthor=C.+Weiauthor=J.+L.+Cantoneauthor=D.+M.+Drexler&title=Identification+and+preclinical+pharmacology+of+the+%CE%B3-secretase+modulator+BMS-869780&doi=10.1155%2F2014%2F431858"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780</span></div><div class="casAuthors">Toyn Jeremy H; Meredith Jere E Jr; Burton Catherine R; Sankaranararyanan Sethu; Guss Valerie; Iben Lawrence G; Krause Carol M; Krause Rudy; Lin Xu-Alan; Pierdomenico Maria; Polson Craig; Robertson Alan S; Ahlijanian Michael K; Albright Charles F; Thompson Lorin A; Gerritz Samuel; Marcin Lawrence R; Higgins Mendi A; Shi Jianliang; Macor John E; Olson Richard E; Lentz Kimberley A; Denton R Rex; Grace James E; Morrison John; Raybon Joseph; Zhuo Xiaoliang; Snow Kimberly; Hall Tracey; Padmanabha Ramesh; Esposito Kim; Harden David; Prack Margaret; Zvyaga Tatyana; Agler Michele; Varma Sam; Wong Victoria; Zhu Yingjie; Wei Cong; Cantone Joseph L; Drexler Dieter M</div><div class="citationInfo"><span class="NLM_cas:title">International journal of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">431858</span>
        ISSN:<span class="NLM_cas:issn">2090-8024</span>.
    </div><div class="casAbstract">Alzheimer's disease is the most prevalent cause of dementia and is associated with accumulation of amyloid-β peptide (Aβ), particularly the 42-amino acid Aβ1-42, in the brain.  Aβ1-42 levels can be decreased by γ-secretase modulators (GSM), which are small molecules that modulate γ-secretase, an enzyme essential for Aβ production.  BMS-869780 is a potent GSM that decreased Aβ1-42 and Aβ1-40 and increased Aβ1-37 and Aβ1-38, without inhibiting overall levels of Aβ peptides or other APP processing intermediates.  BMS-869780 also did not inhibit Notch processing by γ-secretase and lowered brain Aβ1-42 without evidence of Notch-related side effects in rats.  Human pharmacokinetic (PK) parameters were predicted through allometric scaling of PK in rat, dog, and monkey and were combined with the rat pharmacodynamic (PD) parameters to predict the relationship between BMS-869780 dose, exposure and Aβ1-42 levels in human.  Off-target and safety margins were then based on comparisons to the predicted exposure required for robust Aβ1-42 lowering.  Because of insufficient safety predictions and the relatively high predicted human daily dose of 700 mg, further evaluation of BMS-869780 as a potential clinical candidate was discontinued.  Nevertheless, BMS-869780 demonstrates the potential of the GSM approach for robust lowering of brain Aβ1-42 without Notch-related side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRiQzrKw3yQB--MdeMhXAHkfW6udTcc2eaPeE55rtLEQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbptlKmsg%253D%253D&md5=c5da43b0bd60d8bc739651d39e6216f7</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1155%2F2014%2F431858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F431858%26sid%3Dliteratum%253Aachs%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DSankaranararyanan%26aufirst%3DS.%26aulast%3DGuss%26aufirst%3DV.%26aulast%3DIben%26aufirst%3DL.%2BG.%26aulast%3DKrause%26aufirst%3DC.%2BM.%26aulast%3DKrause%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DX.-A.%26aulast%3DPierdomenico%26aufirst%3DM.%26aulast%3DPolson%26aufirst%3DC.%26aulast%3DRobertson%26aufirst%3DA.%2BS.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DGerritz%26aufirst%3DS.%26aulast%3DMarcin%26aufirst%3DL.%2BR.%26aulast%3DHiggins%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DDenton%26aufirst%3DR.%2BR.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DMorrison%26aufirst%3DJ.%26aulast%3DRaybon%26aufirst%3DJ.%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DSnow%26aufirst%3DK.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DPadmanabha%26aufirst%3DR.%26aulast%3DEsposito%26aufirst%3DK.%26aulast%3DHarden%26aufirst%3DD.%26aulast%3DPrack%26aufirst%3DM.%26aulast%3DZvyaga%26aufirst%3DT.%26aulast%3DAgler%26aufirst%3DM.%26aulast%3DVarma%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DCantone%26aufirst%3DJ.%2BL.%26aulast%3DDrexler%26aufirst%3DD.%2BM.%26atitle%3DIdentification%2520and%2520preclinical%2520pharmacology%2520of%2520the%2520%25CE%25B3-secretase%2520modulator%2520BMS-869780%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2014%26volume%3D2014%26spage%3D431858%26doi%3D10.1155%2F2014%2F431858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Boy, K. M.; Guernon, J. M.; Zhang, Y.; Zuev, D.; Mandal, S. K.; Chandrashekharappa, S.; K, S. D.; Baligar, V.; Wu, Y.-J.; Marcin, L.; Higgins, M.; Shi, J.; Xu, L.; Toyn, J. H.; Meredith, J. E.,  Jr.; Burton, C. R.; Albright, C. F.; Lentz, K. A.; Grace, J. E.; Denton, R.; Morrison, J. S.; Kimura, R.; Ahlijanian, M. K.; Olson, R. E.; Macor, J. E.; Thompson, L. A.,  III.</span><span> </span><span class="NLM_article-title">Bicyclic pyrimidine modulators of Abeta production for the treatment of Alzheimer’s disease</span>. Presented at the 248th National Meeting of the American Chemical Society, San Francisco, CA, Aug 10–14,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Paper  <span class="NLM_fpage">MEDI-265</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Boy%2C+K.+M.%3B+Guernon%2C+J.+M.%3B+Zhang%2C+Y.%3B+Zuev%2C+D.%3B+Mandal%2C+S.+K.%3B+Chandrashekharappa%2C+S.%3B+K%2C+S.+D.%3B+Baligar%2C+V.%3B+Wu%2C+Y.-J.%3B+Marcin%2C+L.%3B+Higgins%2C+M.%3B+Shi%2C+J.%3B+Xu%2C+L.%3B+Toyn%2C+J.+H.%3B+Meredith%2C+J.+E.%2C+Jr.%3B+Burton%2C+C.+R.%3B+Albright%2C+C.+F.%3B+Lentz%2C+K.+A.%3B+Grace%2C+J.+E.%3B+Denton%2C+R.%3B+Morrison%2C+J.+S.%3B+Kimura%2C+R.%3B+Ahlijanian%2C+M.+K.%3B+Olson%2C+R.+E.%3B+Macor%2C+J.+E.%3B+Thompson%2C+L.+A.%2C+III.+Bicyclic+pyrimidine+modulators+of+Abeta+production+for+the+treatment+of+Alzheimer%E2%80%99s+disease.+Presented+at+the+248th+National+Meeting+of+the+American+Chemical+Society%2C+San+Francisco%2C+CA%2C+Aug+10%E2%80%9314%2C+2014%3B+Paper+MEDI-265."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBoy%26aufirst%3DK.%2BM.%26atitle%3DBicyclic%2520pyrimidine%2520modulators%2520of%2520Abeta%2520production%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2014%26spage%3DMEDI-265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Thompson, L. A.; Boy, K. M.; Zuev, D.; Guernon, J. M.; Zhang, Y.; Wu, Y.-J.; Marcin, L. R.; Higgins, M. A.; Shi, J.; Xu, L.; Toyn, J. H.; Meredith, J. E.; Burton, C. R.; Kimura, R.; Lentz, K. A.; Grace, J. E.; Denton, R.; Morrison, J.; Albright, C. F.; Ahlijanian, M. K.; Olson, R. E.; Macor, J. E.</span><span> </span><span class="NLM_article-title">Discovery and preclinical profile of BMS-932481, a gamma secretase modulator for the treatment of Alzheimer’s disease</span>. Presented at the 248th National Meeting of the American Chemical Society, San Francisco, CA, Aug 10–14,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Paper  <span class="NLM_fpage">MEDI-266</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thompson%2C+L.+A.%3B+Boy%2C+K.+M.%3B+Zuev%2C+D.%3B+Guernon%2C+J.+M.%3B+Zhang%2C+Y.%3B+Wu%2C+Y.-J.%3B+Marcin%2C+L.+R.%3B+Higgins%2C+M.+A.%3B+Shi%2C+J.%3B+Xu%2C+L.%3B+Toyn%2C+J.+H.%3B+Meredith%2C+J.+E.%3B+Burton%2C+C.+R.%3B+Kimura%2C+R.%3B+Lentz%2C+K.+A.%3B+Grace%2C+J.+E.%3B+Denton%2C+R.%3B+Morrison%2C+J.%3B+Albright%2C+C.+F.%3B+Ahlijanian%2C+M.+K.%3B+Olson%2C+R.+E.%3B+Macor%2C+J.+E.+Discovery+and+preclinical+profile+of+BMS-932481%2C+a+gamma+secretase+modulator+for+the+treatment+of+Alzheimer%E2%80%99s+disease.+Presented+at+the+248th+National+Meeting+of+the+American+Chemical+Society%2C+San+Francisco%2C+CA%2C+Aug+10%E2%80%9314%2C+2014%3B+Paper+MEDI-266."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DDiscovery%2520and%2520preclinical%2520profile%2520of%2520BMS-932481%252C%2520a%2520gamma%2520secretase%2520modulator%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2014%26spage%3DMEDI-266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Gasior, M.; Keswani, S. C.; AbuTarif, M.; Ahlijanian, M.; Berisha, F.; Zheng, N.</span><span> </span><span class="NLM_article-title">A Randomized, placebo-controlled, double-blind, single-dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of the gamma-secretase modulator BMS-932481 in healthy young and elderly individuals</span>. Presented at the Alzheimer’s Association International Conference 2013, Boston, MA, July 13–18,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>Abstract  <span class="NLM_fpage">P1-341</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+Gasior&author=S.+C.+Keswani&author=M.+AbuTarif&author=M.+Ahlijanian&author=F.+Berisha&author=N.+Zheng&title=A+Randomized%2C+placebo-controlled%2C+double-blind%2C+single-dose+study+to+evaluate+the+safety%2C+pharmacokinetics+and+pharmacodynamics+of+the+gamma-secretase+modulator+BMS-932481+in+healthy+young+and+elderly+individuals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGasior%26aufirst%3DM.%26atitle%3DA%2520Randomized%252C%2520placebo-controlled%252C%2520double-blind%252C%2520single-dose%2520study%2520to%2520evaluate%2520the%2520safety%252C%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520the%2520gamma-secretase%2520modulator%2520BMS-932481%2520in%2520healthy%2520young%2520and%2520elderly%2520individuals%26date%3D2013%26spage%3DP1-341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.</span><span> </span><span class="NLM_article-title">Design and optimization of tricyclic gamma-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1498</span><span class="NLM_x">–</span> <span class="NLM_lpage">1502</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2015.06.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1498-1502&author=J.+Shiauthor=D.+Zuevauthor=L.+Xuauthor=K.+A.+Lentzauthor=J.+E.+Graceauthor=J.+H.+Toynauthor=R.+E.+Olsonauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Design+and+optimization+of+tricyclic+gamma-secretase+modulators&doi=10.1016%2Fj.bmcl.2015.06.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DZuev%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DDesign%2520and%2520optimization%2520of%2520tricyclic%2520gamma-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1498%26epage%3D1502%26doi%3D10.1016%2Fj.bmcl.2015.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amegadzie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ncube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzasa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Morin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumfelt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tegley, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koegler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6447</span><span class="NLM_x">–</span> <span class="NLM_lpage">6454</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2013.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=24139583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Grsb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6447-6454&author=J.+J.+Chenauthor=W.+Qianauthor=K.+Biswasauthor=C.+Yuanauthor=A.+Amegadzieauthor=Q.+Liuauthor=T.+Nixeyauthor=J.+Zhuauthor=M.+Ncubeauthor=R.+M.+Rzasaauthor=F.+Chavezauthor=N.+Chenauthor=F.+De+Morinauthor=S.+Rumfeltauthor=C.+M.+Tegleyauthor=J.+R.+Allenauthor=S.+Hitchcockauthor=R.+Hungateauthor=M.+D.+Bartbergerauthor=L.+Zalamedaauthor=Y.+Liuauthor=J.+D.+McCarterauthor=J.+Zhangauthor=L.+Zhuauthor=S.+Babu-Khanauthor=Y.+Luoauthor=J.+Bradleyauthor=P.+H.+Wenauthor=D.+L.+Reidauthor=F.+Koeglerauthor=C.+Deanauthor=D.+Hickmanauthor=T.+L.+Correllauthor=T.+Williamsonauthor=S.+Wood&title=Discovery+of+2-methylpyridine-based+biaryl+amides+as+%CE%B3-secretase+modulators+for+the+treatment+of+alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2013.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Chen, Jian Jeffrey; Qian, Wenyuan; Biswas, Kaustav; Yuan, Chester; Amegadzie, Albert; Liu, Qingyian; Nixey, Thomas; Zhu, Joe; Ncube, Mqhele; Rzasa, Robert M.; Chavez, Frank, Jr.; Chen, Ning; De Morin, Frenel; Rumfelt, Shannon; Tegley, Christopher M.; Allen, Jennifer R.; Hitchcock, Stephen; Hungate, Randy; Bartberger, Michael D.; Zalameda, Leeanne; Liu, Yichin; McCarter, John D.; Zhang, Jianhua; Zhu, Li; Babu-Khan, Safura; Luo, Yi; Bradley, Jodi; Wen, Paul H.; Reid, Darren L.; Koegler, Frank; Dean, Charles, Jr.; Hickman, Dean; Correll, Tiffany L.; Williamson, Toni; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6447-6454</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">γ-Secretase modulators (GSMs) are potentially disease-modifying treatments for Alzheimer's disease.  They selectively lower pathogenic Aβ42 levels by shifting the enzyme cleavage sites without inhibiting γ-secretase activity, possibly avoiding known adverse effects obsd. with complete inhibition of the enzyme complex.  A cell-based HTS effort identified the sulfonamide 1 as a GSM lead.  Lead optimization studies identified compd. 25 with improved cell potency, PKDM properties, and it lowered Aβ42 levels in the cerebrospinal fluid (CSF) of Sprague-Dawley rats following oral administration.  Further optimization of 25 to improve cellular potency is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPfacRASb057Vg90H21EOLACvtfcHk0ljjYKj0TptmlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Grsb3F&md5=6282bfb2fc57efab5a32c15872e474b7</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DBiswas%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DAmegadzie%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DNcube%26aufirst%3DM.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DChavez%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DDe%2BMorin%26aufirst%3DF.%26aulast%3DRumfelt%26aufirst%3DS.%26aulast%3DTegley%26aufirst%3DC.%2BM.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DHitchcock%26aufirst%3DS.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DReid%26aufirst%3DD.%2BL.%26aulast%3DKoegler%26aufirst%3DF.%26aulast%3DDean%26aufirst%3DC.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DCorrell%26aufirst%3DT.%2BL.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25202-methylpyridine-based%2520biaryl%2520amides%2520as%2520%25CE%25B3-secretase%2520modulators%2520for%2520the%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6447%26epage%3D6454%26doi%3D10.1016%2Fj.bmcl.2013.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Cheng, S.; Comer, D. D.; Mao, L.; Balow, G. P.; Pleynet, D.</span><span> </span><span class="NLM_article-title">Aryl compounds and uses in modulating amyloid β</span>. WO2004110350A2,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+Cheng&author=D.+D.+Comer&author=L.+Mao&author=G.+P.+Balow&author=D.+Pleynet&title=Aryl+compounds+and+uses+in+modulating+amyloid+%CE%B2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DS.%26atitle%3DAryl%2520compounds%2520and%2520uses%2520in%2520modulating%2520amyloid%2520%25CE%25B2%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Kounnas, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyree, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleynet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digregorio, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velicelebi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauderman, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S. L.</span><span> </span><span class="NLM_article-title">Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span><span class="refDoi"> DOI: 10.1016/j.neuron.2010.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.neuron.2010.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=20826309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFamtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=769-780&author=M.+Z.+Kounnasauthor=A.+M.+Danksauthor=S.+Chengauthor=C.+Tyreeauthor=E.+Ackermanauthor=X.+Zhangauthor=K.+Ahnauthor=P.+Nguyenauthor=D.+Comerauthor=L.+Maoauthor=C.+Yuauthor=D.+Pleynetauthor=P.+J.+Digregorioauthor=G.+Velicelebiauthor=K.+A.+Staudermanauthor=W.+T.+Comerauthor=W.+C.+Mobleyauthor=Y.+M.+Liauthor=S.+S.+Sisodiaauthor=R.+E.+Tanziauthor=S.+L.+Wagner&title=Modulation+of+gamma-secretase+reduces+beta-amyloid+deposition+in+a+transgenic+mouse+model+of+alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuron.2010.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease</span></div><div class="casAuthors">Kounnas, Maria Z.; Danks, Anne M.; Cheng, Soan; Tyree, Curtis; Ackerman, Elizabeth; Zhang, Xulun; Ahn, Kwangwook; Nguyen, Phuong; Comer, Dan; Mao, Long; Yu, Chengzhi; Pleynet, David; Digregorio, Paul J.; Velicelebi, Gonul; Stauderman, Kenneth A.; Comer, William T.; Mobley, William C.; Li, Yue-Ming; Sisodia, Sangram S.; Tanzi, Rudolph E.; Wagner, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">769-780</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized pathol. by the abundance of senile plaques and neurofibrillary tangles in the brain.  We synthesized over 1200 novel γ-secretase modulator (GSM) compds. that reduced Aβ42 levels without inhibiting ε-site cleavage of APP and Notch, the generation of the APP and Notch intracellular domains, resp.  These compds. also reduced Aβ40 levels while concomitantly elevating levels of Aβ38 and Aβ37.  Immobilization of a potent GSM onto an agarose matrix quant. recovered Pen-2 and to a lesser degree PS-1 NTFs from cellular exts.  Moreover, oral administration (once daily) of another potent GSM to Tg 2576 transgenic AD mice displayed dose-responsive lowering of plasma and brain Aβ42; chronic daily administration led to significant redns. in both diffuse and neuritic plaques.  These effects were obsd. in the absence of Notch-related changes (e.g., intestinal proliferation of goblet cells), which are commonly assocd. with repeated exposure to functional γ-secretase inhibitors (GSIs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWuvRc6SXyvbVg90H21EOLACvtfcHk0ljjYKj0TptmlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFamtb%252FI&md5=0963d1dd659c7a9b0e7e876244eeab97</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2010.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2010.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DKounnas%26aufirst%3DM.%2BZ.%26aulast%3DDanks%26aufirst%3DA.%2BM.%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DTyree%26aufirst%3DC.%26aulast%3DAckerman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DComer%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DPleynet%26aufirst%3DD.%26aulast%3DDigregorio%26aufirst%3DP.%2BJ.%26aulast%3DVelicelebi%26aufirst%3DG.%26aulast%3DStauderman%26aufirst%3DK.%2BA.%26aulast%3DComer%26aufirst%3DW.%2BT.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DModulation%2520of%2520gamma-secretase%2520reduces%2520beta-amyloid%2520deposition%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D67%26spage%3D769%26epage%3D780%26doi%3D10.1016%2Fj.neuron.2010.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Wagner, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynearson, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span> </span><span class="NLM_article-title">Soluble γ-secretase modulators selectively inhibit the production of the 42-amino acid amyloid β peptide variant and augment the production of multiple carboxy-truncated amyloid β species</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span><span class="refDoi"> DOI: 10.1021/bi401537v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi401537v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=702-713&author=S.+L.+Wagnerauthor=C.+Zhangauthor=S.+Chengauthor=P.+Nguyenauthor=X.+Zhangauthor=K.+D.+Rynearsonauthor=R.+Wangauthor=Y.+Liauthor=S.+S.+Sisodiaauthor=W.+C.+Mobleyauthor=R.+E.+Tanzi&title=Soluble+%CE%B3-secretase+modulators+selectively+inhibit+the+production+of+the+42-amino+acid+amyloid+%CE%B2+peptide+variant+and+augment+the+production+of+multiple+carboxy-truncated+amyloid+%CE%B2+species&doi=10.1021%2Fbi401537v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fbi401537v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi401537v%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%2BL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRynearson%26aufirst%3DK.%2BD.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26atitle%3DSoluble%2520%25CE%25B3-secretase%2520modulators%2520selectively%2520inhibit%2520the%2520production%2520of%2520the%252042-amino%2520acid%2520amyloid%2520%25CE%25B2%2520peptide%2520variant%2520and%2520augment%2520the%2520production%2520of%2520multiple%2520carboxy-truncated%2520amyloid%2520%25CE%25B2%2520species%26jtitle%3DBiochemistry%26date%3D2014%26volume%3D53%26spage%3D702%26epage%3D713%26doi%3D10.1021%2Fbi401537v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Tanzi, R. E.; Wagner, S. L.; Cheng, S.; Mobley, W. C.</span><span> </span><span class="NLM_article-title">Gamma-secretase modulators and uses thereof for treating neurological diseases</span>. WO2014165263A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+E.+Tanzi&author=S.+L.+Wagner&author=S.+Cheng&author=W.+C.+Mobley&title=Gamma-secretase+modulators+and+uses+thereof+for+treating+neurological+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26atitle%3DGamma-secretase%2520modulators%2520and%2520uses%2520thereof%2520for%2520treating%2520neurological%2520diseases%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zultanski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuthall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smotrov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moxham, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bays, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Triazoloamides as potent γ-secretase modulators with reduced herg liability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3140</span><span class="NLM_x">–</span> <span class="NLM_lpage">3146</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.03.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2012.03.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22497762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVaisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3140-3146&author=C.+Fischerauthor=S.+L.+Zultanskiauthor=H.+Zhouauthor=J.+L.+Methotauthor=S.+Shahauthor=H.+Nuthallauthor=B.+L.+Hughesauthor=N.+Smotrovauthor=A.+Hillauthor=A.+A.+Szewczakauthor=C.+M.+Moxhamauthor=N.+Baysauthor=R.+E.+Middletonauthor=B.+Munozauthor=M.+S.+Shearman&title=Triazoloamides+as+potent+%CE%B3-secretase+modulators+with+reduced+herg+liability&doi=10.1016%2Fj.bmcl.2012.03.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Triazoloamides as potent γ-secretase modulators with reduced hERG liability</span></div><div class="casAuthors">Fischer, Christian; Zultanski, Susan L.; Zhou, Hua; Methot, Joey L.; Shah, Sanjiv; Nuthall, Hugh; Hughes, Bethany L.; Smotrov, Nadja; Hill, Armetta; Szewczak, Alexander A.; Moxham, Christopher M.; Bays, Nathan; Middleton, Richard E.; Munoz, Benito; Shearman, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3140-3146</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthesis and SAR studies of novel aryl triazoles as gamma secretase modulators (GSMs) are presented in this communication.  Starting from aryl triazole leads, optimization studies were continued and the series progressed towards novel amides and lactams.  Triazole I was identified as the most potent analog in this series, displaying single-digit nanomolar Aβ42 IC50 in cell-based assays and reduced affinity for the hERG channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiDFzfhAnInrVg90H21EOLACvtfcHk0lit_-E_akf8xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVaisrg%253D&md5=6585835e1ec8b679e19bf8d687f392bb</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.03.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.03.054%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DZultanski%26aufirst%3DS.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DNuthall%26aufirst%3DH.%26aulast%3DHughes%26aufirst%3DB.%2BL.%26aulast%3DSmotrov%26aufirst%3DN.%26aulast%3DHill%26aufirst%3DA.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DMoxham%26aufirst%3DC.%2BM.%26aulast%3DBays%26aufirst%3DN.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DTriazoloamides%2520as%2520potent%2520%25CE%25B3-secretase%2520modulators%2520with%2520reduced%2520herg%2520liability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3140%26epage%3D3146%26doi%3D10.1016%2Fj.bmcl.2012.03.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zultanski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mampreian, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuthall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smotrov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenific, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouthillette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeliazkova-Mecheva, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bays, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Triazoles as γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4083</span><span class="NLM_x">–</span> <span class="NLM_lpage">4087</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2011.04.089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4083-4087&author=C.+Fischerauthor=S.+L.+Zultanskiauthor=H.+Zhouauthor=J.+L.+Methotauthor=W.+C.+Brownauthor=D.+M.+Mampreianauthor=A.+J.+Schellauthor=S.+Shahauthor=H.+Nuthallauthor=B.+L.+Hughesauthor=N.+Smotrovauthor=C.+M.+Kenificauthor=J.+C.+Cruzauthor=D.+Walkerauthor=M.+Bouthilletteauthor=G.+N.+Nikovauthor=D.+F.+Savageauthor=V.+V.+Jeliazkova-Mechevaauthor=D.+Diazauthor=A.+A.+Szewczakauthor=N.+Baysauthor=R.+E.+Middletonauthor=B.+Munozauthor=M.+S.+Shearman&title=Triazoles+as+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2011.04.089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.089%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DZultanski%26aufirst%3DS.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DBrown%26aufirst%3DW.%2BC.%26aulast%3DMampreian%26aufirst%3DD.%2BM.%26aulast%3DSchell%26aufirst%3DA.%2BJ.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DNuthall%26aufirst%3DH.%26aulast%3DHughes%26aufirst%3DB.%2BL.%26aulast%3DSmotrov%26aufirst%3DN.%26aulast%3DKenific%26aufirst%3DC.%2BM.%26aulast%3DCruz%26aufirst%3DJ.%2BC.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DBouthillette%26aufirst%3DM.%26aulast%3DNikov%26aufirst%3DG.%2BN.%26aulast%3DSavage%26aufirst%3DD.%2BF.%26aulast%3DJeliazkova-Mecheva%26aufirst%3DV.%2BV.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DBays%26aufirst%3DN.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DTriazoles%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4083%26epage%3D4087%26doi%3D10.1016%2Fj.bmcl.2011.04.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zultanski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moxham, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bays, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smotrov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanga, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenific, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouthillette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeliazkova-Mecheva, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michener, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Preparation of triazolobenzazepinone derivatives as γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3488</span><span class="NLM_x">–</span> <span class="NLM_lpage">3494</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2015.07.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3488-3494&author=C.+Fischerauthor=S.+L.+Zultanskiauthor=H.+Zhouauthor=J.+L.+Methotauthor=S.+Shahauthor=I.+Hayashiauthor=B.+L.+Hughesauthor=C.+M.+Moxhamauthor=N.+W.+Baysauthor=N.+Smotrovauthor=A.+D.+Hillauthor=B.-S.+Panauthor=Z.+Wuauthor=L.+Y.+Moyauthor=F.+Tangaauthor=C.+Kenificauthor=J.+C.+Cruzauthor=D.+Walkerauthor=M.+Bouthilletteauthor=G.+N.+Nikovauthor=S.+V.+Deshmukhauthor=V.+V.+Jeliazkova-Mechevaauthor=D.+Diazauthor=M.+S.+Michenerauthor=J.+J.+Cookauthor=B.+Munozauthor=M.+S.+Shearman&title=Preparation+of+triazolobenzazepinone+derivatives+as+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2015.07.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DZultanski%26aufirst%3DS.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DHayashi%26aufirst%3DI.%26aulast%3DHughes%26aufirst%3DB.%2BL.%26aulast%3DMoxham%26aufirst%3DC.%2BM.%26aulast%3DBays%26aufirst%3DN.%2BW.%26aulast%3DSmotrov%26aufirst%3DN.%26aulast%3DHill%26aufirst%3DA.%2BD.%26aulast%3DPan%26aufirst%3DB.-S.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DMoy%26aufirst%3DL.%2BY.%26aulast%3DTanga%26aufirst%3DF.%26aulast%3DKenific%26aufirst%3DC.%26aulast%3DCruz%26aufirst%3DJ.%2BC.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DBouthillette%26aufirst%3DM.%26aulast%3DNikov%26aufirst%3DG.%2BN.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DJeliazkova-Mecheva%26aufirst%3DV.%2BV.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DMichener%26aufirst%3DM.%2BS.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DPreparation%2520of%2520triazolobenzazepinone%2520derivatives%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3488%26epage%3D3494%26doi%3D10.1016%2Fj.bmcl.2015.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivkin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahearn, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kattar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mampreian, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeliazkova-Mecheva, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenific, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moxham, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuthall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smotrov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">Potent benzoazepinone γ-secretase modulators with improved bioavailability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3495</span><span class="NLM_x">–</span> <span class="NLM_lpage">3500</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2015.06.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=26142947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVeitLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3495-3500&author=J.+L.+Methotauthor=C.+Fischerauthor=C.+Liauthor=A.+Rivkinauthor=S.+P.+Ahearnauthor=W.+C.+Brownauthor=S.+Kattarauthor=E.+Kelleyauthor=D.+M.+Mampreianauthor=A.+Schellauthor=A.+Rosenauauthor=H.+Zhouauthor=R.+Ballauthor=S.+V.+Deshmukhauthor=V.+V.+Jeliazkova-Mechevaauthor=D.+Diazauthor=L.+Y.+Moyauthor=C.+M.+Kenificauthor=C.+Moxhamauthor=S.+Shahauthor=H.+Nuthallauthor=A.+A.+Szewczakauthor=A.+Hillauthor=B.+Hughesauthor=N.+Smotrovauthor=B.+Munozauthor=T.+A.+Millerauthor=M.+S.+Shearman&title=Potent+benzoazepinone+%CE%B3-secretase+modulators+with+improved+bioavailability&doi=10.1016%2Fj.bmcl.2015.06.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Potent benzoazepinone γ-secretase modulators with improved bioavailability</span></div><div class="casAuthors">Methot, Joey L.; Fischer, Christian; Li, Chaomin; Rivkin, Alexey; Ahearn, Sean P.; Brown, William Colby; Kattar, Sam; Kelley, Elizabeth; Mampreian, Dawn M.; Schell, Adam; Rosenau, Andrew; Zhou, Hua; Ball, Richard; Deshmukh, Sujal V.; Jeliazkova-Mecheva, Valentina V.; Diaz, Damaris; Moy, Lily Y.; Kenific, Candia M.; Moxham, Chris; Shah, Sanjiv; Nuthall, Hugh; Szewczak, Alexander A.; Hill, Armetta; Hughes, Bethany; Smotrov, Nadya; Munoz, Benito; Miller, Thomas A.; Shearman, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3495-3500</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The triazolyl amide γ-secretase modulators are potent alternatives to the cinnamyl amides that have entered the clinic for the treatment of Alzheimer's disease.  Herein we build on the lead benzoazepinones described in our prior communication with imidazomethoxyarene moiety alternatives that offer opportunities to fine tune phys. properties as well as address hERG binding and PK.  Both half-life and bioavailability were significantly improved, esp. in dog, with robust brain Aβ42 lowering maintained in both transgenic mouse and rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSKJojr8UBzrVg90H21EOLACvtfcHk0lizUzIUZwKOGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVeitLzI&md5=8ca036e2583ca474516a7762e3da3c5d</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.032%26sid%3Dliteratum%253Aachs%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DRivkin%26aufirst%3DA.%26aulast%3DAhearn%26aufirst%3DS.%2BP.%26aulast%3DBrown%26aufirst%3DW.%2BC.%26aulast%3DKattar%26aufirst%3DS.%26aulast%3DKelley%26aufirst%3DE.%26aulast%3DMampreian%26aufirst%3DD.%2BM.%26aulast%3DSchell%26aufirst%3DA.%26aulast%3DRosenau%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DBall%26aufirst%3DR.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DJeliazkova-Mecheva%26aufirst%3DV.%2BV.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DMoy%26aufirst%3DL.%2BY.%26aulast%3DKenific%26aufirst%3DC.%2BM.%26aulast%3DMoxham%26aufirst%3DC.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DNuthall%26aufirst%3DH.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DHill%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DB.%26aulast%3DSmotrov%26aufirst%3DN.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DMiller%26aufirst%3DT.%2BA.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DPotent%2520benzoazepinone%2520%25CE%25B3-secretase%2520modulators%2520with%2520improved%2520bioavailability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3495%26epage%3D3500%26doi%3D10.1016%2Fj.bmcl.2015.06.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Takai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terauchi, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of piperazine derivatives as a novel class of γ-secretase modulators that selectively lower aβ42 production</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1923</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmc.2015.03.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1923-1934&author=T.+Takaiauthor=T.+Koikeauthor=E.+Hondaauthor=Y.+Kajitaauthor=M.+Nakamuraauthor=S.+Morimotoauthor=Y.+Hoashiauthor=M.+Kamataauthor=T.+Watanabeauthor=T.+Igariauthor=J.+Terauchi&title=Design+and+synthesis+of+piperazine+derivatives+as+a+novel+class+of+%CE%B3-secretase+modulators+that+selectively+lower+a%CE%B242+production&doi=10.1016%2Fj.bmc.2015.03.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.055%26sid%3Dliteratum%253Aachs%26aulast%3DTakai%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DHonda%26aufirst%3DE.%26aulast%3DKajita%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DMorimoto%26aufirst%3DS.%26aulast%3DHoashi%26aufirst%3DY.%26aulast%3DKamata%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DIgari%26aufirst%3DT.%26aulast%3DTerauchi%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520piperazine%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520%25CE%25B3-secretase%2520modulators%2520that%2520selectively%2520lower%2520a%25CE%25B242%2520production%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D1923%26epage%3D1934%26doi%3D10.1016%2Fj.bmc.2015.03.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teranishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobe, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of an aminopiperidine series of γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2013.10.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=378-381&author=T.+Kobayashiauthor=S.+Iwamaauthor=A.+Fusanoauthor=Y.+Katoauthor=A.+Ikedaauthor=Y.+Teranishiauthor=A.+Nishiharaauthor=M.+Tobe&title=Design+and+synthesis+of+an+aminopiperidine+series+of+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2013.10.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.063%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DIwama%26aufirst%3DS.%26aulast%3DFusano%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DA.%26aulast%3DTeranishi%26aufirst%3DY.%26aulast%3DNishihara%26aufirst%3DA.%26aulast%3DTobe%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520an%2520aminopiperidine%2520series%2520of%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D378%26epage%3D381%26doi%3D10.1016%2Fj.bmcl.2013.10.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F. J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaroskova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velter, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">Design and synthesis of bicyclic heterocycles as potent γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4794</span><span class="NLM_x">–</span> <span class="NLM_lpage">4800</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2013.06.100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4794-4800&author=D.+Oehlrichauthor=F.+J.+R.+Romboutsauthor=D.+Berthelotauthor=F.+P.+Bischoffauthor=M.+A.+J.+De+Cleynauthor=L.+Jaroskovaauthor=G.+Macdonaldauthor=M.+Merckenauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=S.+Van+Brandtauthor=A.+I.+Velterauthor=T.+Wuauthor=H.+J.+M.+Gijsen&title=Design+and+synthesis+of+bicyclic+heterocycles+as+potent+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2013.06.100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.100%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DJaroskova%26aufirst%3DL.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVelter%26aufirst%3DA.%2BI.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520bicyclic%2520heterocycles%2520as%2520potent%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4794%26epage%3D4800%26doi%3D10.1016%2Fj.bmcl.2013.06.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Velter, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaroskova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Roosbroeck, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masungi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span> </span><span class="NLM_article-title">Anilinotriazoles as potent gamma secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5805</span><span class="NLM_x">–</span> <span class="NLM_lpage">5813</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.10.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2014.10.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5805-5813&author=A.+I.+Velterauthor=F.+P.+Bischoffauthor=D.+Berthelotauthor=M.+De+Cleynauthor=D.+Oehlrichauthor=L.+Jaroskovaauthor=G.+Macdonaldauthor=G.+Minneauthor=S.+Pietersauthor=F.+Romboutsauthor=S.+Van+Brandtauthor=Y.+Van+Roosbroeckauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=T.+Wuauthor=H.+Borghysauthor=M.+Merckenauthor=C.+Masungiauthor=H.+Gijsen&title=Anilinotriazoles+as+potent+gamma+secretase+modulators&doi=10.1016%2Fj.bmcl.2014.10.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DVelter%26aufirst%3DA.%2BI.%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DJaroskova%26aufirst%3DL.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMinne%26aufirst%3DG.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVan%2BRoosbroeck%26aufirst%3DY.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DMasungi%26aufirst%3DC.%26aulast%3DGijsen%26aufirst%3DH.%26atitle%3DAnilinotriazoles%2520as%2520potent%2520gamma%2520secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5805%26epage%3D5813%26doi%3D10.1016%2Fj.bmcl.2014.10.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Minne, G. B.; Bischoff, F. P.; Gijsen, H. J. M.; Velter, A. I.; Pieters, S. M. A.; Berthelot, D. J.-C.</span><span> </span><span class="NLM_article-title">Preparation of substituted indole derivatives and related compounds as gamma secretase modulators</span>. WO2013010904A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=G.+B.+Minne&author=F.+P.+Bischoff&author=H.+J.+M.+Gijsen&author=A.+I.+Velter&author=S.+M.+A.+Pieters&author=D.+J.-C.+Berthelot&title=Preparation+of+substituted+indole+derivatives+and+related+compounds+as+gamma+secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMinne%26aufirst%3DG.%2BB.%26atitle%3DPreparation%2520of%2520substituted%2520indole%2520derivatives%2520and%2520related%2520compounds%2520as%2520gamma%2520secretase%2520modulators%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Velter, A. I.; Bischoff, F.; De Cleyn, M.; Gijsen, H.; MacDonald, G.; Oehlrich, D.; Rombouts, F.; Surkyn, M.; Van Brandt, S.; Zavattaro, C.; Austin, N.; Mercken, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a novel series of γ-secretase modulators: Cyanoindoles, moving toward a better drug-like space?</span> Presented at the 250th National Meeting of the American Chemical Society, Boston, MA, Aug 16–20,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>Paper  <span class="NLM_fpage">MEDI-354</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Velter%2C+A.+I.%3B+Bischoff%2C+F.%3B+De+Cleyn%2C+M.%3B+Gijsen%2C+H.%3B+MacDonald%2C+G.%3B+Oehlrich%2C+D.%3B+Rombouts%2C+F.%3B+Surkyn%2C+M.%3B+Van+Brandt%2C+S.%3B+Zavattaro%2C+C.%3B+Austin%2C+N.%3B+Mercken%2C+M.+Design+and+synthesis+of+a+novel+series+of+%CE%B3-secretase+modulators%3A+Cyanoindoles%2C+moving+toward+a+better+drug-like+space%3F+Presented+at+the+250th+National+Meeting+of+the+American+Chemical+Society%2C+Boston%2C+MA%2C+Aug+16%E2%80%9320%2C+2015%3B+Paper+MEDI-354."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVelter%26aufirst%3DA.%2BI.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520novel%2520series%2520of%2520%25CE%25B3-secretase%2520modulators%253A%2520Cyanoindoles%252C%2520moving%2520toward%2520a%2520better%2520drug-like%2520space%253F%26date%3D2015%26spage%3DMEDI-354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Takai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, T.</span><span> </span><span class="NLM_article-title">Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4245</span><span class="NLM_x">–</span> <span class="NLM_lpage">4249</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2015.07.101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=26298496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSlsb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4245-4249&author=T.+Takaiauthor=Y.+Hoashiauthor=Y.+Tomataauthor=S.+Morimotoauthor=M.+Nakamuraauthor=T.+Watanabeauthor=T.+Igariauthor=T.+Koike&title=Discovery+of+novel+5%2C6%2C7%2C8-tetrahydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyridine+derivatives+as+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2015.07.101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators</span></div><div class="casAuthors">Takai, Takafumi; Hoashi, Yasutaka; Tomata, Yoshihide; Morimoto, Sachie; Nakamura, Minoru; Watanabe, Tomomichi; Igari, Tomoko; Koike, Tatsuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4245-4249</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivs. were designed, synthesized, and evaluated as γ-secretase modulators (GSMs).  An optimization study of this series resulted in the identification of I, which showed a potent Aβ42-lowering effect, high bioavailability and good blood-brain barrier permeability in mice.  Oral administration of I significantly reduced brain Aβ42 in mice at a dose of 10 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonI7aEgBKCkrVg90H21EOLACvtfcHk0ljcafSEiI1NVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSlsb3M&md5=0515eae1461d3d3e33277d9ef6cfb09b</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.101%26sid%3Dliteratum%253Aachs%26aulast%3DTakai%26aufirst%3DT.%26aulast%3DHoashi%26aufirst%3DY.%26aulast%3DTomata%26aufirst%3DY.%26aulast%3DMorimoto%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DIgari%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%25205%252C6%252C7%252C8-tetrahydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyridine%2520derivatives%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4245%26epage%3D4249%26doi%3D10.1016%2Fj.bmcl.2015.07.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaratnam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2906</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2012.02.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=22429469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2906-2911&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=R.+Liraauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+P.+Tranauthor=B.+C.+Vetelinoauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=K.+M.+Woodauthor=C.+J.+O%E2%80%99Donnell&title=Design+and+synthesis+of+dihydrobenzofuran+amides+as+orally+bioavailable%2C+centrally+active+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2012.02.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Lira, Ricardo; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Vetelino, Beth C.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Wood, Kathleen M.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2906-2911</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of a novel series of dihydrobenzofuran amides as γ-secretase modulators (GSMs) is reported.  Strategies for aligning in vitro potency with drug-like physicochem. properties and good microsomal stability while avoiding P-gp mediated efflux are discussed.  Lead compds. such as I and II have moderate to good in vitro potency and excellent selectivity against Notch.  Good oral bioavailability was achieved as well as robust brain Aβ42 lowering activity at 100 mg/kg po dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIcSb2qlgrNLVg90H21EOLACvtfcHk0ljcafSEiI1NVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D&md5=63746bd0db38a20bb33b5e990e66610c</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.059%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dihydrobenzofuran%2520amides%2520as%2520orally%2520bioavailable%252C%2520centrally%2520active%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2906%26epage%3D2911%26doi%3D10.1016%2Fj.bmcl.2012.02.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaratnam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozdnyakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-secretase modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1062</span><span class="refDoi"> DOI: 10.1021/jm401782h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401782h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1046-1062&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+P.+Tranauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=B.+C.+Vetelinoauthor=K.+M.+Woodauthor=N.+Pozdnyakovauthor=P.+R.+Verhoestauthor=C.+J.+O%E2%80%99Donnell&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+a+novel+series+of+pyridopyrazine-1%2C6-dione+%CE%B3-secretase+modulators&doi=10.1021%2Fjm401782h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Pharmacological Evaluation of a Novel Series of Pyridopyrazine-1,6-dione γ-Secretase Modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Vetelino, Beth C.; Wood, Kathleen M.; Pozdnyakov, Nikolay; Verhoest, Patrick R.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1046-1062</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we describe the design and synthesis of a novel series of γ-secretase modulators (GSMs) that incorporates a pyridopiperazine-1,6-dione ring system.  To align improved potency with favorable ADME and in vitro safety, we applied prospective physicochem. property-driven design coupled with parallel medicinal chem. techniques to arrive at a novel series contg. a conformationally restricted core.  Lead compd. I exhibited good in vitro potency and ADME, which translated into a favorable in vivo pharmacokinetic profile.  Furthermore, robust redn. of brain Aβ42 was obsd. in guinea pig at 30 mg/kg dosed orally.  Through chem. biol. efforts involving the design and synthesis of a clickable photoreactive probe, we demonstrated specific labeling of the presenilin N-terminal fragment (PS1-NTF) within the γ-secretase complex, thus gaining insight into the binding site of this series of GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZjw9nXaFFiLVg90H21EOLACvtfcHk0lihibRVoxixqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVGkug%253D%253D&md5=a3d743eea05981a29143a0ec6b43549f</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm401782h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401782h%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520pyridopyrazine-1%252C6-dione%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1046%26epage%3D1062%26doi%3D10.1021%2Fjm401782h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos-Korcsok, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.12.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1016%2Fj.bmcl.2014.12.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=25582600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=908-913&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=J.+M.+Humphreyauthor=C.+W.+am+Endeauthor=E.+Evrardauthor=I.+Efremovauthor=G.+W.+Kauffmanauthor=A.+F.+Stepanauthor=C.+M.+Stiffauthor=L.+Xieauthor=K.+R.+Balesauthor=E.+Hajos-Korcsokauthor=H.+E.+Murreyauthor=L.+R.+Pustilnikauthor=S.+J.+Steynauthor=K.+M.+Woodauthor=P.+R.+Verhoest&title=Discovery+of+indole-derived+pyridopyrazine-1%2C6-dione+%CE%B3-secretase+modulators+that+target+presenilin&doi=10.1016%2Fj.bmcl.2014.12.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Humphrey, John M.; am Ende, Christopher W.; Evrard, Edelweiss; Efremov, Ivan; Kauffman, Gregory W.; Stepan, Antonia F.; Stiff, Cory M.; Xie, Longfei; Bales, Kelly R.; Hajos-Korcsok, Eva; Murrey, Heather E.; Pustilnik, Leslie R.; Steyn, Stefanus J.; Wood, Kathleen M.; Verhoest, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">908-913</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein we describe design strategies that led to the discovery of novel pyridopyrazine-1,6-dione γ-secretase modulators (GSMs) incorporating an indole motif as a heterocyclic replacement for a naphthyl moiety that was present in the original lead 9.  Tactics involving parallel medicinal chem. and in situ monomer synthesis to prep. focused libraries are discussed.  Optimized indole GSM 29 exhibited good alignment of in vitro potency and physicochem. properties, and moderate redn. of brain Aβ42 was achieved in a rat efficacy model when dosed orally at 30 mg/kg.  Labeling expts. using a clickable, indole-derived GSM photoaffinity probe demonstrated that this series binds to the presenilin N-terminal fragment (PS1-NTF) of the γ-secretase complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD9PU4TTU4b7Vg90H21EOLACvtfcHk0lihibRVoxixqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVOrsQ%253D%253D&md5=fc815b92689ab399b4186c71bd1c69b3</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.059%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DHajos-Korcsok%26aufirst%3DE.%26aulast%3DMurrey%26aufirst%3DH.%2BE.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DDiscovery%2520of%2520indole-derived%2520pyridopyrazine-1%252C6-dione%2520%25CE%25B3-secretase%2520modulators%2520that%2520target%2520presenilin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D908%26epage%3D913%26doi%3D10.1016%2Fj.bmcl.2014.12.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Design of pyridopyrazine-1,6-dione γ-secretase modulators that align potency, mdr efflux ratio, and metabolic stability</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVaksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=596-601&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=J.+M.+Humphreyauthor=T.+W.+Butlerauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=P.+B.+Mullinsauthor=C.+J.+O%E2%80%99Donnellauthor=A.+F.+Stepanauthor=C.+M.+Stiffauthor=C.+Subramanyamauthor=T.+P.+Tranauthor=B.+C.+Vetelinoauthor=E.+Yangauthor=L.+Xieauthor=K.+R.+Balesauthor=L.+R.+Pustilnikauthor=S.+J.+Steynauthor=K.+M.+Woodauthor=P.+R.+Verhoest&title=Design+of+pyridopyrazine-1%2C6-dione+%CE%B3-secretase+modulators+that+align+potency%2C+mdr+efflux+ratio%2C+and+metabolic+stability&doi=10.1021%2Facsmedchemlett.5b00070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Humphrey, John M.; Butler, Todd W.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Mullins, Patrick B.; O'Donnell, Christopher J.; Stepan, Antonia F.; Stiff, Cory M.; Subramanyam, Chakrapani; Tran, Tuan P.; Vetelino, Beth Cooper; Yang, Eddie; Xie, Longfei; Bales, Kelly R.; Pustilnik, Leslie R.; Steyn, Stefanus J.; Wood, Kathleen M.; Verhoest, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we describe the design and synthesis of a series of pyridopyrazine-1,6-dione γ-secretase modulators (GSMs) for Alzheimer's disease (AD) that achieve good alignment of potency, metabolic stability, and low MDR efflux ratios, while also maintaining favorable physicochem. properties.  Specifically, incorporation of fluorine enabled design of metabolically less liable lipophilic alkyl substituents to increase potency without compromising the sp3-character.  The lead compd. I (PF-06442609) displayed a favorable rodent pharmacokinetic profile, and robust redns. of brain Aβ42 and Aβ40 were obsd. in a guinea pig time-course expt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhW3RYEYEcOrVg90H21EOLACvtfcHk0lh7bBnMDtJycA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVaksrg%253D&md5=ba402f2e67fd9500123cbc7b215d3361</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00070%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DButler%26aufirst%3DT.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DDesign%2520of%2520pyridopyrazine-1%252C6-dione%2520%25CE%25B3-secretase%2520modulators%2520that%2520align%2520potency%252C%2520mdr%2520efflux%2520ratio%252C%2520and%2520metabolic%2520stability%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D596%26epage%3D601%26doi%3D10.1021%2Facsmedchemlett.5b00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Am Ende, C. W.; Green, M. E.; Johnson, D. S.; Kauffman, G. W.; O’Donnell, C. J.; Patel, N. C.; Pettersson, M. Y.; Stepan, A. F.; Stiff, C. M.; Subramanyam, C.; Tran, T. P.; Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Preparation of novel bicyclic pyridinones as γ-secretase modulators</span>. WO2014045156A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+W.+Am+Ende&author=M.+E.+Green&author=D.+S.+Johnson&author=G.+W.+Kauffman&author=C.+J.+O%E2%80%99Donnell&author=N.+C.+Patel&author=M.+Y.+Pettersson&author=A.+F.+Stepan&author=C.+M.+Stiff&author=C.+Subramanyam&author=T.+P.+Tran&author=P.+R.+Verhoest&title=Preparation+of+novel+bicyclic+pyridinones+as+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAm%2BEnde%26aufirst%3DC.%2BW.%26atitle%3DPreparation%2520of%2520novel%2520bicyclic%2520pyridinones%2520as%2520%25CE%25B3-secretase%2520modulators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Bischoff, F. P.; Velter, A. I.; Rombouts, F. J. R.; De Cleyn, M. A. J.; Van Brandt, S. F. A.; Gijsen, H. J. M.; Zavattaro, C.; Van den Keybus, F. A. M.</span><span> </span><span class="NLM_article-title">Preparation of novel substituted pyrido-piperazinone derivatives as gamma secretase modulators</span>. WO2014111457A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=F.+P.+Bischoff&author=A.+I.+Velter&author=F.+J.+R.+Rombouts&author=M.+A.+J.+De+Cleyn&author=S.+F.+A.+Van+Brandt&author=H.+J.+M.+Gijsen&author=C.+Zavattaro&author=F.+A.+M.+Van+den+Keybus&title=Preparation+of+novel+substituted+pyrido-piperazinone+derivatives+as+gamma+secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26atitle%3DPreparation%2520of%2520novel%2520substituted%2520pyrido-piperazinone%2520derivatives%2520as%2520gamma%2520secretase%2520modulators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Rombouts, F. J. R.; Trabanco-Suarez, A. A.; Gijsen, H. J. M.; Macdonald, G. J.; Bischoff, F. P.; Alonso-De Diego, S.-A.; Velter, A. I.; Van Roosbroeck, Y. E. M.</span><span> </span><span class="NLM_article-title">Preparation of substituted 3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6-dione derivatives useful for the treatment of Alzheimer’s disease</span>. WO2013171712A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=F.+J.+R.+Rombouts&author=A.+A.+Trabanco-Suarez&author=H.+J.+M.+Gijsen&author=G.+J.+Macdonald&author=F.+P.+Bischoff&author=S.-A.+Alonso-De+Diego&author=A.+I.+Velter&author=Y.+E.+M.+Van+Roosbroeck&title=Preparation+of+substituted+3%2C4-dihydro-2H-pyrido%5B1%2C2-a%5Dpyrazine-1%2C6-dione+derivatives+useful+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26atitle%3DPreparation%2520of%2520substituted%25203%252C4-dihydro-2H-pyrido%255B1%252C2-a%255Dpyrazine-1%252C6-dione%2520derivatives%2520useful%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Bischoff, F. P.; Gijsen, H. J. M.; Van den Keybus, F. A. M.; Rombouts, F. J. R.</span><span> </span><span class="NLM_article-title">Novel tricyclic 3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,6-dione derivatives as gamma secretase modulators and their preparation</span>. WO2014096212A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=F.+P.+Bischoff&author=H.+J.+M.+Gijsen&author=F.+A.+M.+Van+den+Keybus&author=F.+J.+R.+Rombouts&title=Novel+tricyclic+3%2C4-dihydro-2H-pyrido%5B1%2C2-a%5Dpyrazine-1%2C6-dione+derivatives+as+gamma+secretase+modulators+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26atitle%3DNovel%2520tricyclic%25203%252C4-dihydro-2H-pyrido%255B1%252C2-a%255Dpyrazine-1%252C6-dione%2520derivatives%2520as%2520gamma%2520secretase%2520modulators%2520and%2520their%2520preparation%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Findeis, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yager, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraering, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creaser, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C. B.</span><span> </span><span class="NLM_article-title">Discovery of a novel pharmacological and structural class of gamma secretase modulators derived from the extract of actaea racemosa</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">951</span><span class="refDoi"> DOI: 10.1021/cn3000857</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn3000857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Kms77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=941-951&author=M.+A.+Findeisauthor=F.+Schroederauthor=T.+D.+McKeeauthor=D.+Yagerauthor=P.+C.+Fraeringauthor=S.+P.+Creaserauthor=W.+F.+Austinauthor=J.+Clardyauthor=R.+Wangauthor=D.+Selkoeauthor=C.+B.+Eckman&title=Discovery+of+a+novel+pharmacological+and+structural+class+of+gamma+secretase+modulators+derived+from+the+extract+of+actaea+racemosa&doi=10.1021%2Fcn3000857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Pharmacological and Structural Class of Gamma Secretase Modulators Derived from the Extract of Actaea racemosa</span></div><div class="casAuthors">Findeis, Mark A.; Schroeder, Frank; McKee, Timothy D.; Yager, Debra; Fraering, Patrick C.; Creaser, Steffen P.; Austin, Wesley F.; Clardy, Jon; Wang, Rong; Selkoe, Dennis; Eckman, Christopher B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">941-951</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A screen of a library of synthetic drugs and natural product exts. identified a botanical ext. that modulates the processing of amyloid precursor protein (APP) in cultured cells to produce a lowered ratio of amyloid-beta peptide (1-42) (Aβ42) relative to Aβ40.  This profile is of interest as a potential treatment for Alzheimer's disease.  The ext., from the black cohosh plant (Actaea racemosa), was subjected to bioassay guided fractionation to isolate active components.  Using a combination of normal-phase and reverse-phase chromatog., a novel triterpene monoglycoside, 1, was isolated.  This compd. was found to have an IC50 of 100 nM for selectively reducing the prodn. of amyloidogenic Aβ42 while having a much smaller effect on the prodn. of Aβ40 (IC50 6.3 μM) in cultured cells overexpressing APP.  Using IP-MS methods, this compd. was found to modulate the pool of total Aβ produced by reducing the proportion of Aβ42 while increasing the relative amts. of shorter and less amyloidogenic Aβ37 and Aβ39.  Concns. of 1 sufficient to lower levels of Aβ42 substantially (up to 10 μM) did not significantly affect the processing of Notch or other aspects of APP processing.  When 1 (10 μg) was administered to CD-1 normal mice intracerebroventricularly, the level of Aβ42 in brain was reduced.  Assays for off-target pharmacol. and the absence of overt signs of toxicity in mice dosed with compd. 1 suggest a comparatively selective pharmacol. for this triterpenoid.  Compd. 1 represents a new lead for the development of potential treatments for Alzheimer's disease via modulation of gamma-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroImTrUZtKrrVg90H21EOLACvtfcHk0lh7bBnMDtJycA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Kms77I&md5=cb43bd10a89c2b456e0a98ad5421d1f7</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fcn3000857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn3000857%26sid%3Dliteratum%253Aachs%26aulast%3DFindeis%26aufirst%3DM.%2BA.%26aulast%3DSchroeder%26aufirst%3DF.%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DYager%26aufirst%3DD.%26aulast%3DFraering%26aufirst%3DP.%2BC.%26aulast%3DCreaser%26aufirst%3DS.%2BP.%26aulast%3DAustin%26aufirst%3DW.%2BF.%26aulast%3DClardy%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSelkoe%26aufirst%3DD.%26aulast%3DEckman%26aufirst%3DC.%2BB.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520pharmacological%2520and%2520structural%2520class%2520of%2520gamma%2520secretase%2520modulators%2520derived%2520from%2520the%2520extract%2520of%2520actaea%2520racemosa%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D941%26epage%3D951%26doi%3D10.1021%2Fcn3000857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Fuller, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creaser, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, R. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ives, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findeis, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronk, B. S.</span><span> </span><span class="NLM_article-title">Initial optimization of a new series of γ-secretase modulators derived from a triterpene glycoside</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span><span class="refDoi"> DOI: 10.1021/ml300256p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300256p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=908-913&author=N.+O.+Fullerauthor=J.+L.+Hubbsauthor=W.+F.+Austinauthor=S.+P.+Creaserauthor=T.+D.+McKeeauthor=R.+M.+B.+Loureiroauthor=B.+Tateauthor=W.+Xiaauthor=J.+L.+Ivesauthor=M.+A.+Findeisauthor=B.+S.+Bronk&title=Initial+optimization+of+a+new+series+of+%CE%B3-secretase+modulators+derived+from+a+triterpene+glycoside&doi=10.1021%2Fml300256p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Initial Optimization of a New Series of γ-Secretase Modulators Derived from a Triterpene Glycoside</span></div><div class="casAuthors">Fuller, Nathan O.; Hubbs, Jed L.; Austin, Wesley F.; Creaser, Steffen P.; McKee, Timothy D.; Loureiro, Robyn M. B.; Tate, Barbara; Xia, Weiming; Ives, Jeffrey L.; Findeis, Mark A.; Bronk, Brian S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">908-913</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of a new series of γ-secretase modulators is disclosed.  Starting from a triterpene glycoside γ-secretase modulator that gave a very low brain-to-plasma ratio, initial SAR and optimization involved replacement of a pendant sugar with a series of morpholines.  This modification led to two compds. with significantly improved central nervous system (CNS) exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSMG2H-MfULLVg90H21EOLACvtfcHk0ljwXhBWXSiupA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjO&md5=998a73e5df368087af6c75038cd74eaa</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fml300256p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300256p%26sid%3Dliteratum%253Aachs%26aulast%3DFuller%26aufirst%3DN.%2BO.%26aulast%3DHubbs%26aufirst%3DJ.%2BL.%26aulast%3DAustin%26aufirst%3DW.%2BF.%26aulast%3DCreaser%26aufirst%3DS.%2BP.%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DLoureiro%26aufirst%3DR.%2BM.%2BB.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DIves%26aufirst%3DJ.%2BL.%26aulast%3DFindeis%26aufirst%3DM.%2BA.%26aulast%3DBronk%26aufirst%3DB.%2BS.%26atitle%3DInitial%2520optimization%2520of%2520a%2520new%2520series%2520of%2520%25CE%25B3-secretase%2520modulators%2520derived%2520from%2520a%2520triterpene%2520glycoside%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D908%26epage%3D913%26doi%3D10.1021%2Fml300256p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Austin, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creaser, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, R. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findeis, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ives, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronk, B. S.</span><span> </span><span class="NLM_article-title">Sar investigations on a novel class of gamma-secretase modulators based on a unique scaffold</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span><span class="refDoi"> DOI: 10.1039/c3md20357c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1039%2Fc3md20357c" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=569-574&author=W.+F.+Austinauthor=J.+L.+Hubbsauthor=N.+O.+Fullerauthor=S.+P.+Creaserauthor=T.+D.+McKeeauthor=R.+M.+B.+Loureiroauthor=M.+A.+Findeisauthor=B.+Tateauthor=J.+L.+Ivesauthor=B.+S.+Bronk&title=Sar+investigations+on+a+novel+class+of+gamma-secretase+modulators+based+on+a+unique+scaffold&doi=10.1039%2Fc3md20357c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1039%2Fc3md20357c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md20357c%26sid%3Dliteratum%253Aachs%26aulast%3DAustin%26aufirst%3DW.%2BF.%26aulast%3DHubbs%26aufirst%3DJ.%2BL.%26aulast%3DFuller%26aufirst%3DN.%2BO.%26aulast%3DCreaser%26aufirst%3DS.%2BP.%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DLoureiro%26aufirst%3DR.%2BM.%2BB.%26aulast%3DFindeis%26aufirst%3DM.%2BA.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DIves%26aufirst%3DJ.%2BL.%26aulast%3DBronk%26aufirst%3DB.%2BS.%26atitle%3DSar%2520investigations%2520on%2520a%2520novel%2520class%2520of%2520gamma-secretase%2520modulators%2520based%2520on%2520a%2520unique%2520scaffold%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D569%26epage%3D574%26doi%3D10.1039%2Fc3md20357c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Loureiro, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ives, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronk, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span> </span><span class="NLM_article-title">Efficacy of spi-1865, a novel gamma-secretase modulator, in multiple rodent models</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="refDoi"> DOI: 10.1186/alzrt173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1186%2Falzrt173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3sXos1Oltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=19&author=R.+M.+Loureiroauthor=J.+A.+Duminauthor=T.+D.+McKeeauthor=W.+F.+Austinauthor=N.+O.+Fullerauthor=J.+L.+Hubbsauthor=R.+Shenauthor=J.+Jonkerauthor=J.+Ivesauthor=B.+S.+Bronkauthor=B.+Tate&title=Efficacy+of+spi-1865%2C+a+novel+gamma-secretase+modulator%2C+in+multiple+rodent+models&doi=10.1186%2Falzrt173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models</span></div><div class="casAuthors">Loureiro, Robyn M.; Dumin, Jo Ann; McKee, Timothy D.; Austin, Wesley F.; Fuller, Nathan O.; Hubbs, Jed L.; Shen, Ruichao; Jonker, Jeff; Ives, Jeff; Bronk, Brian S.; Tate, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">19</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Introduction: Modulation of the gamma-secretase enzyme, which reduces the prodn. of the amyloidogenic Aβ42 peptide while sparing the prodn. of other Aβ species, is a promising therapeutic approach for the treatment of Alzheimer's disease.  Satori has identified a unique class of small mol. gamma-secretase modulators (GSMs) capable of decreasing Aβ42 levels in cellular and rodent model systems.  The compd. class exhibits potency in the nM range in vitro and is selective for lowering Aβ42 and Aβ38 while sparing Aβ40 and total Aβ levels.  In vivo , a compd. from the series, SPI-1865, demonstrates similar pharmacol. in wild-type CD1 mice, Tg2576 mice and Sprague Dawley rats.  Methods: Animals were orally administered either a single dose of SPI-1865 or dosed for multiple days.  Aβ levels were measured using a sensitive plate-based ELISA system (MSD) and brain and plasma exposure of drug were assessed by LC/MS/MS.  Results: In wild-type mice using either dosing regimen, brain Aβ42 and Aβ38 levels were decreased upon treatment with SPI-1865 and little to no statistically meaningful effect on Aβ40 was obsd., reflecting the changes obsd. in vitro.  In rats, brain Aβ levels were examd. and similar to the mouse studies, brain Aβ42 and Aβ38 were lowered.  Comparable changes were also obsd. in the Tg2576 mice, where Aβ levels were measured in brain as well as plasma and CSF.  Conclusions: Taken together, these data indicate that SPI-1865 is orally bioavailable, brain penetrant, and effective at lowering Aβ42 in a dose responsive manner.  With this unique profile, the class of compds. represented by SPI-1865 may be a promising new therapy for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1X_YHlxYm6rVg90H21EOLACvtfcHk0ljwXhBWXSiupA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXos1Oltbc%253D&md5=f452b63f5a006a1bd8f379c64e14f6a4</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1186%2Falzrt173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt173%26sid%3Dliteratum%253Aachs%26aulast%3DLoureiro%26aufirst%3DR.%2BM.%26aulast%3DDumin%26aufirst%3DJ.%2BA.%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DAustin%26aufirst%3DW.%2BF.%26aulast%3DFuller%26aufirst%3DN.%2BO.%26aulast%3DHubbs%26aufirst%3DJ.%2BL.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DJonker%26aufirst%3DJ.%26aulast%3DIves%26aufirst%3DJ.%26aulast%3DBronk%26aufirst%3DB.%2BS.%26aulast%3DTate%26aufirst%3DB.%26atitle%3DEfficacy%2520of%2520spi-1865%252C%2520a%2520novel%2520gamma-secretase%2520modulator%252C%2520in%2520multiple%2520rodent%2520models%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2013%26volume%3D5%26spage%3D19%26doi%3D10.1186%2Falzrt173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><a href="http://www.alzforum.org/news/research-news/satori-pharmaceuticals-shuts-down-abandons-g-secretase-modulators" class="extLink">http://www.alzforum.org/news/research-news/satori-pharmaceuticals-shuts-down-abandons-g-secretase-modulators</a> (accessed Dec 1, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.alzforum.org%2Fnews%2Fresearch-news%2Fsatori-pharmaceuticals-shuts-down-abandons-g-secretase-modulators+%28accessed+Dec+1%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Jung, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsenstein, K. M.</span><span> </span><span class="NLM_article-title">Steroids as γ-secretase modulators</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3775</span><span class="NLM_x">–</span> <span class="NLM_lpage">3785</span><span class="refDoi"> DOI: 10.1096/fj.12-225649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=10.1096%2Ffj.12-225649" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=3775-3785&author=J.+I.+Jungauthor=T.+B.+Laddauthor=T.+Kukarauthor=A.+R.+Priceauthor=B.+D.+Mooreauthor=E.+H.+Kooauthor=T.+E.+Goldeauthor=K.+M.+Felsenstein&title=Steroids+as+%CE%B3-secretase+modulators&doi=10.1096%2Ffj.12-225649"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1096%2Ffj.12-225649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.12-225649%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DJ.%2BI.%26aulast%3DLadd%26aufirst%3DT.%2BB.%26aulast%3DKukar%26aufirst%3DT.%26aulast%3DPrice%26aufirst%3DA.%2BR.%26aulast%3DMoore%26aufirst%3DB.%2BD.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26atitle%3DSteroids%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DFASEB%2520J.%26date%3D2013%26volume%3D27%26spage%3D3775%26epage%3D3785%26doi%3D10.1096%2Ffj.12-225649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro adme, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.1021/cn100007x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+adme%2C+and+safety+attributes&doi=10.1021%2Fcn100007x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lghq8pidIE3aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520adme%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434%26doi%3D10.1021%2Fcn100007x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01960%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-16%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01960" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799f99cdf0a3ce2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
